UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-K
xANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 20182020
OR
¨TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission File Number 1-10258
TREDEGAR CORPORATION
(Exact name of registrant as specified in its charter)
Virginia54-1497771
(State or other jurisdiction
of incorporation or organization)
(I.R.S. Employer
Identification No.)
Virginia54-1497771
(State or other jurisdiction
of incorporation or organization)
(I.R.S. Employer
Identification No.)
1100 Boulders Parkway,
Richmond, Virginia
23225

Richmond,
Virginia23225
(Address of principal executive offices)(Zip Code)
Registrant’s telephone number, including area code: 804-330-1000
Securities registered pursuant to Section 12(b) of the Act:
Title of Each Classeach classTrading SymbolName of Each Exchangeeach exchange on Which Registeredwhich registered
Common StockTGNew York Stock Exchange
Securities registered pursuant to Section 12(g) of the Act:
None
(Title of class)
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.    Yes  ¨    No  x
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.    Yes  ¨    No  x
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for at least the past 90 days.    Yes  x No  ¨
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  x    No  ¨
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§ 229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K x.
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated fileroAccelerated filerxSmaller reporting companyo
Non-accelerated filer
o(Do not check if a smaller reporting company)
Emerging growth companyo
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. x
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).    Yes  ¨    No  x
Aggregate market value of voting and non-voting common equity held by non-affiliates of the registrant as of June 30, 20182020 (the last business day of the registrant’s most recently completed second fiscal quarter): $608,660,223*$406,328,122*
Number of shares of Common Stock outstanding as of January 31, 2019: 33,176,024 (33,189,073 as of June 30, 2018)
March 12, 2021: 33,537,892
*In determining this figure, an aggregate of 7,288,6387,133,634 shares of Common Stock beneficially owned by Floyd D. Gottwald, Jr., John D. Gottwald, William M. Gottwald and the members of their immediate families has been excluded because the shares are deemed to be held by affiliates. The aggregate market value has been computed based on the closing price in the New York Stock Exchange on June 30, 2018.2020.
Documents Incorporated By Reference
Portions of the Tredegar Corporation Proxy Statement for the 20192021 Annual Meeting of Shareholders (the “Proxy Statement”) are incorporated by reference into Part III of this Form 10-K.







Index to Annual Report on Form 10-K
Year Ended December 31, 20182020
 
Page
Page
Part I
Business
1-4
54-10
Properties
1211-13









PART I
Item 1.BUSINESS
Item 1.    BUSINESS
Description of Business
Tredegar Corporation (“Tredegar”), a Virginia corporation incorporated in 1988, is engaged, through its subsidiaries, in the manufacture of aluminum extrusions, polyethylene (“PE”) plastic films and polyester (“PET”) films and aluminum extrusions.films. Unless the context requires otherwise, all references herein to “Tredegar,” “the Company,” “we,” “us” or “our” are to Tredegar Corporation and its consolidated subsidiaries.
The Company's reportable business segments are Aluminum Extrusions, PE Films and Flexible Packaging Films.
On October 30, 2020, the Company completed the sale of its personal care films business (“Personal Care Films”). The transaction excluded the packaging film lines and related operations located at the Pottsville, Pennsylvania manufacturing site (“Pottsville Packaging”), which are now being reported within the Surface Protection component of PE Films. Commencing in the third quarter of 2020, all historical results for Personal Care Films have been presented as discontinued operations.
In December 2020, the Company entered into a definitive agreement and Aluminum Extrusions.
PE Films
completed the sale of Bright View Technologies (“Bright View”). The sale does not represent a strategic shift nor does it have a major effect on the Company’s historical and ongoing operations, thus all financial information for Bright View has been presented as continuing operations. Bright View historically has been reported in the PE Films manufactures plastic films, elasticssegment.
For more information on these transactions, see Note 2 “Discontinued Operations” to the Consolidated Financial Statements included in Item 15. “Exhibits and laminate materials primarily utilized in personal care materials, surface protection films,Financial Statement Schedules” of this Form 10-K (“Item 15”).
Aluminum Extrusions
Aluminum Extrusions, also referred to as Bonnell Aluminum, produces high-quality, soft-alloy and specialtymedium-strength custom fabricated and optical lighting applications. These products are manufactured atfinished aluminum extrusions for the building and construction, automotive and transportation, consumer durables, machinery and equipment, electrical and renewable energy, and distribution markets. Bonnell Aluminum has manufacturing facilities located in the United States (“U.S.”).
Aluminum Extrusions manufactures mill (unfinished), The Netherlands, Hungary, China, Brazilmachined, anodized and India. PE Filmspainted (finished) and fabricated aluminum extrusions for sale directly to fabricators and distributors. It also sells branded aluminum flooring trims under its Futura TransitionsTM line and aluminum framing systems under its TSLOTSTM line. Aluminum Extrusions competes in all of its marketsprimarily on the basis of product innovation, quality, service and price. Sales are made predominantly in the U.S.
Personal Care. Tredegar’s Personal Care unit is a global supplierThe end-uses in each of apertured, elastic and embossed films, laminate materials, and polyethylene and polypropylene overwrap films for personal care markets, including:
Aluminum Extrusions’ primary market segments include:
Major Markets
Apertured film and laminate materials for use as topsheet in feminine hygiene products, baby diapers and adult incontinence products (including materials sold under the Sure&Soft, ComfortAire, ComfortFeel and FreshFeel brand names);
End-Uses
Building & construction nonresidential
Elastic materials for use as components for baby diapers, adult incontinence productsCommercial windows and feminine hygiene products (including components sold under the ExtraFlexdoors, curtain walls, storefronts and FlexAire brand names);entrances, automatic entry doors, walkway covers, ducts, louvers and vents, office wall panels, partitions and interior enclosures, acoustical walls and ceilings, point of purchase displays, pre-engineered structures, and flooring trims (Futura TransitionsTM)
Building & construction - residentialResidential windows and doors, shower and tub enclosures, railing and support systems, venetian blinds, and swimming pools
Automotive and transportationAutomotive and light truck structural components, spare parts, after-market automotive accessories, grills for heavy trucks, travel trailers and recreation vehicles
Consumer durablesFurniture, pleasure boats, refrigerators and freezers, appliances and sporting goods
Machinery & equipment
Three-dimensional apertured film transfer layers for baby diapersMaterial handling equipment, conveyors and adult incontinence products sold under the AquiSoft, AquiDry®conveying systems, medical equipment, and AquiDry Plus brand names;aluminum framing systems (TSLOTSTM)
Distribution (metal service centers specializing in stock and release programs and custom fabrications to small manufacturers)Various custom profiles including storm shutters, pleasure boat accessories, theater set structures and various standard profiles (including rod, bar, tube and pipe)
Electrical and renewable energyLighting fixtures, electronic apparatus, solar panel brackets, and rigid and flexible conduits
Thin-gauge films that are readily printable and convertible on conventional processing equipment
1


Aluminum Extrusions’ net sales (sales less freight) by market segment for overwrap for bathroom tissue and paper towels; and
Polypropylene films for various industrial applications, including tape and automotive protection.the three years ended December 31, 2020 is shown below:
% of Aluminum Extrusions Net Sales by Market Segment
 202020192018
Building and construction:
Nonresidential56%51%51%
Residential9%8%8%
Automotive8%9%8%
Specialty:
Consumer durables10%11%12%
Machinery & equipment7%7%7%
Electrical4%7%7%
Distribution6%7%7%
Total100%100%100%
In 2020, 2019 and 2018, 2017nonresidential building and 2016, personal care materialsconstruction accounted for approximately 22%35%, 27%34% and 30%35% of Tredegar’s consolidated net sales, (sales less freight)respectively.
Raw Materials. The primary raw materials used by Aluminum Extrusions consist of aluminum ingot, aluminum scrap and various alloys, which are purchased from continuing operations, respectively.domestic and foreign producers in open-market purchases and under annual contracts. Aluminum Extrusions believes that it has adequate supply agreements for aluminum and other required raw materials and supplies in the foreseeable future.
Surface Protection.PE Films
PE Films is composed of surface protection films, polyethylene overwrap films and films for other markets. Tredegar’s Surface Protection unit produces single- and multi-layer surface protection films sold under the UltraMask®UltraMask®, ForceFieldForceField™, ForceField PEARL®and Pearl AA™ brand names. These films, which are manufactured at facilities in the U.S. and China, support manufacturers of optical and other specialty substrates used in high-technology applications, most notably protecting high-value components of flat panel and flexible displays used in televisions, monitors, notebooks, smart phones,smartphones, tablets, e-readers, automobiles and digital signage, during the manufacturing and transportation process. In 2018, 20172020, 2019 and 2016,2018, surface protection films accounted for approximately 10%15%, 11%13% and 11%, respectively,12% of Tredegar’s consolidated net sales, from continuing operations.respectively.
Bright View Technologies. Tredegar’s Bright View TechnologiesIn October 2020, the Surface Protection unit designsassumed responsibility for Pottsville Packaging, which was previously reported within the Personal Care component of PE Films. Pottsville Packaging produces thin-gauge films as overwrap for bathroom tissue and manufactures a range of advanced film-based components that provide specialized functionality for the global engineered optics market.  By leveraging multiple platforms, including film capabilities and its patented microstructure technology, Bright View Technologies offers high performance solutions for a variety of LED-based applications such as lighting, consumer electronics, automotive, and other optical management markets. paper towels.



PE Films’ net sales by market segment over the last three years is shown below:
% of PE Films Net Sales by Market Segment *
 2018 2017 2016
Personal Care68% 70% 72%
Surface Protection30% 28% 25%
Bright View2% 2% 3%
Total100% 100% 100%
      
* See previous discussion by market segment for comparison of net sales to the Company’s consolidated net sales for each of the years presented.
Raw Materials. The primary raw materials used by PE Films in films are low density, linear low density and high density polyethylene and polypropylene resins. These raw materials are obtained from domestic and foreign suppliers at competitive prices. PE Films believes that there will be an adequate supply of polyethylene and polypropylene resins in the foreseeable future.
Customers. PE Films also buys polypropylene-based nonwoven fabrics based on the resins previously noted and styrenic block copolymers, and it believes there will be an adequate supply of these raw materialsFilms’ products are sold primarily in the foreseeable future.
Customers. PE Films sells to many branded product producers throughout the world,U.S. and Asia, with the top fivefour customers, collectively, comprising 66%84%, 68%86% and 69%86% of its net sales in 2020, 2019 and 2018, 2017 and 2016, respectively. Its largestNo single PE Films customer is The Procter & Gamble Company (“P&G”). Net sales to P&G totaled $107 million in 2018, $122 million in 2017 and $129 million in 2016 (these amounts include film sold to third parties that converted the film into materials used with products manufactured by P&G).exceeds 10% of Tredegar’s consolidated net sales. For additional information, see “ItemItem 1A. Risk“Risk Factors” of this Form 10-K (“Item 1A”).
Flexible Packaging Films
Flexible Packaging Films is comprised of Terphane Holdings LLC (“Terphane”). Flexible Packaging Films produces PET-based films for use in packaging applications that have specialized properties, such as heat resistance, strength, barrier protection and the ability to accept high-quality print graphics. These differentiated, high-value films are primarily manufactured in Brazil and sold in Latin America and the U.S. under the Terphane® and Sealphane® brand names. Major end uses include food packaging and industrial applications. In 2018, 2017 and 2016, Flexible Packaging Films accounted for approximately 12%, 12% and 14%, respectively, of Tredegar’s consolidated net sales from continuing operations. Flexible Packaging Films competes in all of its markets on the basis of product quality, service and price.
Raw Materials. The primary raw materials used by Flexible Packaging Films to produce polyester resins are purified terephthalic acid (“PTA”) and monoethylene glycol (“MEG”). Flexible Packaging Films also purchases additional polyester resins directly from suppliers. All of theseThese raw materials are obtained from domestic Brazilian suppliers and foreign suppliers at competitive prices, andprices. Flexible Packaging Films believes that there will be an adequate supply of polyester resins, as well as PTA and MEG in the foreseeable future.
Aluminum Extrusions
The William L. Bonnell Company, Inc., known in the industry as Bonnell Aluminum, and its operating divisions, AACOA, Inc. and Futura Industries Corporation (“Futura”) (together “Aluminum Extrusions”), produce high-quality, soft-alloy and medium-strength aluminum extrusions primarily for building and construction, automotive, consumer durables, machinery and equipment, electrical and distribution markets. Aluminum Extrusions manufactures mill (unfinished), anodized and painted (finished) and fabricated aluminum extrusions for sale directly to fabricators and distributors. It also sells branded flooring trims and aluminum framing systems through its Futura operating division. Aluminum Extrusions competes primarily on the basis of product quality, service and price. Sales are made predominantly in the U.S.


The end-uses in each of Aluminum Extrusions’ primary market segments include:
2
Major MarketsEnd-Uses
Building & construction - nonresidentialCommercial windows and doors, curtain walls, storefronts and entrances, walkway covers, ducts, louvers and vents, office wall panels, partitions and interior enclosures, acoustical walls and ceilings, point of purchase displays, pre-engineered structures, and flooring trims
Building & construction - residentialShower and tub enclosures, railing and support systems, venetian blinds, swimming pools and storm shutters
AutomotiveAutomotive and light truck structural components, spare parts, after-market automotive accessories, grills for heavy trucks, travel trailers and recreation vehicles
Consumer durablesFurniture, pleasure boats, refrigerators and freezers, appliances and sporting goods
Machinery & equipment
Material handling equipment, conveyors and conveying systems, medical equipment, and aluminum framing systems (TSLOTSTM)
Distribution (metal service centers specializing in stock and release programs and custom fabrications to small manufacturers)Various custom profiles including storm shutters, pleasure boat accessories, theater set structures and various standard profiles (including rod, bar, tube and pipe)
ElectricalLighting fixtures, solar panels, electronic apparatus and rigid and flexible conduits
Aluminum Extrusions’ net sales by market segment over the last three years is shown below:


% of Aluminum Extrusions Net Sales by Market Segment*
 2018 2017 2016
Building and construction:     
Nonresidential51% 51% 59%
Residential8% 9% 6%
Automotive8% 8% 9%
Specialty:     
Consumer durables12% 12% 11%
Machinery & equipment7% 7% 6%
Electrical7% 7% 3%
Distribution7% 6% 6%
      
Total100% 100% 100%
*Includes Futura as of its acquisition date of February 15, 2017.
In 2018, 2017 and 2016, nonresidential building and construction accounted for approximately 28%, 26% and 27% of Tredegar’s consolidated net sales from continuing operations, respectively.
Raw Materials. The primary raw materials used by Aluminum Extrusions consist of aluminum ingot, aluminum scrap and various alloys, which are purchased from domestic and foreign producers in open-market purchases and under short-term contracts. Aluminum Extrusions believes that it has adequate supply agreements for aluminum and other required raw materials and supplies in the foreseeable future.


General
Intellectual Property. Tredegar considers patents, licenses and trademarks to be significantmaterial to PE Films. On December 31, 2018,2020, PE Films held 27354 patents (including 634 U.S. patents), licenses under patents owned by third parties, and 10982 registered trademarks (including 84 U.S. registered trademarks). Flexible Packaging Films held 1 U.S. patent and 1415 registered trademarks (including 2 U.S. registered trademarks). Aluminum Extrusions held no U.S. patents and 24 U.S. registered trademarks. OnAs of December 31, 2018,2020, these patents had remaining terms in the range of 13.5 to 2015.5 years.
Research and Development. Tredegar’s spending for research and development (“R&D”) activities in 2018, 20172020, 2019 and 20162018 was primarily related to PE Films. PE Films has technical centers in Durham, North Carolina; Richmond, Virginia; and Terre Haute, Indiana. Flexible Packaging has a technical center in Bloomfield, New York. R&D spending by the Company was approximately $18.7$8.4 million, $18.3$7.9 million and $19.1$6.7 million in 2020, 2019 and 2018, 2017 and 2016, respectively.
Backlog. Overall backlog in Aluminum Extrusions was approximately $74.2 million at December 31, 2020 compared to approximately $52.8 million at December 31, 2019, an increase of $21.4 million, or approximately 41%. Backlogs are not material to the operations in PE Films or Flexible Packaging Films. Overall backlog for continuing operations in Aluminum Extrusions was approximately $67.6 million at December 31, 2018 compared to approximately $46.2 million at December 31, 2017, an increase of $21.4 million, or approximately 46%. Net sales for Aluminum Extrusions, which the Company believes isare cyclical in nature, were $455.7 million in 2020, $529.6 million in 2019 and $573.1 million in 2018, $466.8 million in 20172018.
Government Regulation. The Company’s operations are subject to various local, state, federal and $360.1 million in 2016.foreign government regulations, including environmental, privacy and anti-corruption and anti-bribery laws and regulations.
Government Regulation.U.S. laws concerning the environment to which the Company’s domestic operations are or may be subject to include among others, the Clean Water Act, the Clean Air Act, the Resource Conservation and Recovery Act, the Occupational Safety and Health Act, the National Environmental Policy Act, the Toxic Substances Control Act, the Comprehensive Environmental Response, Compensation and Liability Act (“CERCLA”), regulations promulgated under these acts, and other federal, state or local laws or regulations governing environmental matters. Compliance with these laws is an important consideration because Tredegar uses hazardous materials in some of its operations, is a generator of hazardous waste, and wastewater from the Company’s operations is discharged to various types of wastewater management systems. Under CERCLA and other laws, Tredegar may be subject to financial exposure for costs associated with waste management and disposal, even if the Company fully complies with applicable environmental laws.
The U.S. Environmental Protection Agency has adopted regulations under the Clean Air Act relating to emissions of carbon dioxide and other greenhouse gases (“GHG”), including mandatory reporting and permitting requirements. Several of the Company’s manufacturing operations result in emissions of carbon dioxide or GHG and are subject to the current GHG regulations. The Company’s compliance with these regulations has yet to require significant expenditures. The cost of compliance with any future GHG legislation or regulations is not presently determinable, but Tredegar does not anticipate compliance to have a material adverse effect on its consolidated financial condition, results of operations and cash flows based on information currently available.
Tredegar is also subject to the governmental regulations in the countries where it conducts business.
At December 31, 2018, the Company believes that it was in material compliance with all applicablecapital expenditures; however, environmental laws, regulations and permits in the U.S. and other countries where it conducts business. Environmental standards tend to become more stringent over time. In addition, consumer preferences, ongoing health, safety and environmental studies on plastics and resins and other related legislative initiatives may adversely affect Tredegar’s business. InTherefore, in order to maintain substantial compliancecomply with such standards,current or future environmental legislation or regulations, the Company may be requiredsubject to incur additional capital expenditures, operating expenses or other compliance costs, the amounts and timing of which are not presently determinable but which could be significant, inincluding constructing new facilities or in modifying existing facilities. Furthermore,
For further discussion regarding certain privacy and anti-corruption and anti-bribery laws and regulations to which the Company is subject, see Item 1A. Risk Factors below. Like environmental regulations, current or future privacy and anti-corruption and anti-bribery legislation or regulations may subject the Company to additional capital expenditures, operating expenses or other compliance costs, the amounts and timing of which are not presently determinable but could be significant. Finally, any failure to comply with current or future laws and regulations could subject Tredegar to substantial penalties, fines, costs and expenses.
Employees. Human Capital Management. Tredegar employed approximately 3,2002,400 people at December 31, 2018.2020 located in the U.S., Brazil, and Asia. Approximately 34% of the Company’s employees are represented by labor unions located in the U.S. and Brazil under various collective bargaining agreements with varying durations and expiration dates. Generally, the total number of employees of Tredegar does not significantly fluctuate throughout the year. However, acquisition or divestiture activity, or changes in the level of business activity may impact employee levels.
The Company believes its employees are its most valuable asset and are critical to the success of the Company. Tredegar strictly complies with all applicable state, local and international laws governing nondiscrimination in employment in every location where Tredegar and its businesses have facilities to ensure healthy and positive working conditions. This applies to all terms and conditions of employment, including recruiting, hiring, job assignments, promotion, termination, layoff, recall, transfer, leaves of absence, compensation and training. All applicants and employees are treated with the same high level of respect regardless of their race, creed, color, religion, sex, sexual orientation, gender identity, age, pregnancy, national origin, ethnicity, political affiliation, union membership, marital status, citizenship status, veteran status, disability or other protected category. Employees who experience or witness discriminatory behavior are encouraged to report such behavior to their supervisor, Human Resources or Tredegar’s toll-free anonymous reporting hotline. Additionally, the Company spends significant resources in developing its employees. Among the five core principles of the “The Tredegar Way” that the Company uses to guide its organization, the “Leadership” principle is focused on building a team of motivated and engaged leaders at every level of the Company. Each business unit has identified specific action plans to promote the Leadership
3


principle among its employees. Action plans include talent development, skills training, reinforcement of strong cultural values, and robust systems to ensure a safe working environment.
The Company seeks to retain employees by offering competitive wages, benefits and training opportunities. To assess and monitor employee retention and engagement, the Company surveys employees and takes actions to address areas of employee concern. The annual employee engagement survey results are presented to Tredegar’s Board of Directors (“Board”). Additionally, the objectives of our executive compensation programs are to attract, motivate and retain highly qualified executive officers. To accomplish these objectives, we rely on a pay strategy that emphasizes performance-based compensation through annual and long-term incentives. We believe that this pay strategy creates a strong link between pay and performance and aligns with our business strategy of generating strong operating results and shareholder value creation while controlling fixed costs.
We are committed to holistically supporting our employees both at work and in their communities by:
Strictly following all applicable health, safety and non-discrimination laws in each country;
Promoting the highest standards for employee health and safety through innovative programs; and
Providing opportunities for community outreach and supporting programs that enhance the lives of children and families.
The Company uses various forms of employee safety metrics to assess the health and safety performance of its Aluminum Extrusions, PE Films and Flexible Packaging operations, including employee safety data which is available on its website at https://tredegar.com/about-tredegar/committed-to-our-employees. Tredegar has also instituted additional safety precautions during the ongoing COVID-19 pandemic as described in "The Impact of COVID-19" included in Item 7. "Management’s Discussion and Analysis of Financial Condition and Results of Operations" of this Form 10-K (“Item 7”).
Information About Our Executive Officers. See Item 10. “Directors, Executive Officers and Corporate Governance” of this Form 10-K.
Available Information and Corporate Governance Documents. Tredegar’s Internetwebsite address is www.tredegar.com. The Company makes available, free of charge through its website, its annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as soon as reasonably practicable after such documents are electronically filed with, or furnished to, the Securities and Exchange Commission (“SEC”). Information filed electronically with the SEC can be accessed on its website at www.sec.gov. In addition, the Company’s Corporate Governance Guidelines, Code of Conduct, and the charters of the Audit, Executive Compensation, and Nominating and Governance Committees and many other corporate policies are available on Tredegar’s website and are available in print without charge, to any shareholder upon request by contacting Tredegar’s Corporate Secretary at 1100 Boulders Parkway, Richmond, Virginia 23225. The information on or that can be accessed through the Company’s website is not, and shall not be deemed to be, a part of this Annual Report on Form 10-K for the year ended December 31, 20182020 (“Form 10-K”) or incorporated into other filings it makes with the SEC.


Item 1A.RISK FACTORS
Item 1A.    RISK FACTORS
There are a number of risks and uncertainties that could have a material adverse effect on the Company’s consolidated financial condition, results of operations or cash flows. The following risk factors should be considered, in addition to the other information included in this Form 10-K, when evaluating Tredegar and its businesses.
Risks Related to Aluminum Extrusions
Sales volume and profitability of Aluminum Extrusions is cyclical and seasonal and highly dependent on economic conditions of end-use markets in the U.S., particularly in the construction sector. Aluminum Extrusions’ end-use markets can be cyclical and subject to seasonal swings in volume, and have been adversely impacted during the coronavirus pandemic (“COVID-19”). Because of the capital intensive nature and level of fixed costs inherent in the aluminum extrusions business, the percentage drop in earnings before interest, taxes, depreciation and amortization (“EBITDA”) from ongiong operations in a cyclical downturn will likely exceed the percentage drop in volume. In addition, during an economic slowdown, excess industry capacity often drives increased pricing pressure in many end-use markets as competitors seek to protect their position with key customers. Any benefits associated with cost reductions and productivity improvements may not be sufficient to offset the adverse effects on profitability from pricing and margin pressure and higher bad debts (including a greater chance of loss associated with customers defaulting on fixed-price forward sales contracts) that usually accompany a downturn. In addition, higher energy costs can reduce profits unless offset by price increases or cost reductions and productivity improvements.
Failure to prevent competitors from evading anti-dumping and countervailing duties, or a reduction in such duties, could adversely impact Aluminum Extrusions. Effective April 25, 2017, the anti-dumping duty and countervailing duty orders on aluminum extrusions were extended for a period of five years.  The orders will be reviewed again beginning in
4


March 2022. Chinese and other overseas manufacturers continue to try to evade the anti-dumping and countervailing orders to avoid duties. A failure by, or the inability of, U.S. trade officials to curtail the evasion of these duties, or the potential reduction of applicable duties pursuant to annual administrative reviews of the orders by the Department of Commerce, could have a material adverse effect on the financial condition, results of operations and cash flows of Aluminum Extrusions.
The duty-free importation of goods allowed under the United States-Mexico-Canada Agreement (“USMCA”) could result in lower demand for aluminum extrusions made in the U.S., which could materially and negatively affect Bonnell Aluminum’s business and results of operations. In March 2018, the U.S. imposed tariffs of 10% on aluminum ingot and semi-finished aluminum imported in the U.S. from certain countries, including countries from which Bonnell Aluminum has historically sourced aluminum products.  In September 2019, the U.S., Canada and Mexico entered into the USMCA.  As a result of the 10% tariffs on aluminum ingot imported to the U.S. and the duty-free importation of goods allowed under USMCA, aluminum extrusions made in Canada and Mexico are free of the 10% tariff and can now be imported into and sold in the U.S. at very competitive prices.  This could result in lower demand for aluminum extrusions made in the U.S., which could materially and negatively affect Bonnell Aluminum’s business and results of operations.
Competition from China could increase significantly if China is granted market economy status by the World Trade Organization. China launched a formal complaint to the World Trade Organization (“WTO”) challenging its non-market economy status, claiming that as of December 11, 2016, China’s transition period as a non-market economy under its Accession Protocol to the WTO ended. China believes with respect to all Chinese-made products that it should receive market economy status and the rights attendant to that status under WTO rules.  The U.S. and the European Union have each rejected that interpretation.  If China is granted market economy status by the WTO, the extent to which the U.S. anti-dumping laws will be able to limit unfair trade practices from China will likely be limited because the U.S. government will be forced to utilize Chinese prices and costs that do not reflect market principles in anti-dumping duty investigations involving China, which could ultimately limit the level of anti-dumping duties applied to unfairly traded Chinese imports. The volume of unfairly traded imports of Chinese aluminum extrusions could increase as a result and this, in turn, would likely create substantial pricing pressure on Aluminum Extrusions’ products and could have a material adverse effect on the financial condition, results of operations and cash flows of Aluminum Extrusions. In June 2019, at China’s request, after certain preliminary rulings in the case went against the Chinese position, the WTO indefinitely suspended the proceedings on the Chinese WTO complaint.
The markets for Aluminum Extrusions’ products are highly competitive with product quality, service, delivery performance and price being the principal competitive factors. Aluminum Extrusions has approximately 1,450 customers that are in a variety of end-use markets within the broad categories of building and construction, distribution, automotive and other transportation, machinery and equipment, electrical and consumer durables. No single Aluminum Extrusions’ customer exceeds 4% of consolidated net sales. Future success and prospects depend on Aluminum Extrusions’ ability to provide superior service, high quality products, timely delivery and competitive pricing to retain existing customers and participate in overall industry cross-cycle growth. Failure in any of these areas could lead to a loss of customers, which could have an adverse material effect on the financial condition, results of operations and cash flows of Aluminum Extrusions.
Risks Related to PE Films
PE Films is highly dependent on sales associated with its top five customers, the largest of which is P&G.relatively few large customers. PE Films’ top fivefour customers comprised approximately 21%16%, 26%14% and 29%13% of Tredegar’s consolidated net sales in 2018, 20172020, 2019 and 2016, respectively, with net sales to P&G alone comprising approximately 10%, 13% and 16% in 2018, 2017 and 2016, respectively. The loss or significant reduction of sales associated with one or more of these customers without replacement by new business could have a material adverse effect on the Company.
Additionally, PE Films anticipates that a portion of its film products used in surface protection applications could be made obsolete by possible future customer product transitions to less costly alternative processes or materials. These transitions principally relate to one customer. The Company believes that previously reported delays in this customer's transitions were recently resolved by the customer and much of the remaining transitions could occur by the end of 2021. Under this scenario, the Company estimates that the contribution to EBITDA from ongoing operations for PE Films could decline due to the remaining customer product transitions by $18 million in 2021 versus 2020 and $4 million in 2022 versus 2021. To offset the expected adverse impact, the Company is aggressively pursuing and making progress in generating contribution from sales from new surface protection products, applications and customers and implementing cost savings measures. Annual contribution to EBITDA from ongoing operations for PE Films on surface protection products unrelated to the customer product transitions has increased since 2018 by approximately $12 million.
While PE Films is undertaking efforts to expand its customer base, there can be no assurance that such efforts will be successful, or that they will offset any loss of sales and profits associated with customer transitions and other large customer declines.
5


Failure of PE Films’ customers, who are subject to cyclical downturns, to achieve success or maintain market share could adversely impact PE Films’ sales and operating margins. PE Films’ plastic films are used in the production of various consumer products sold worldwide. A customer’s ability to successfully develop, manufacture and market those products is integral to PE Films’ success. Cyclical downturns and changing consumer preferences may negatively affect businesses that use PE Films’ plastic film products, which could adversely affect sales and operating margins. Other factors that could adversely affect the business include by way of example, (i) failure by a key customer to achieve success or maintain share in markets in which they sell products containing PE Films’ materials, including as a result of customer preferences for products other than plastics, (ii) key customers using products developed by others that replace PE Films’ business with such customer,customers, (iii) delays in a key customer rolling out products utilizing new technologies developed by PE Films, and (iv) operational decisions by a key customer that result in component substitution, inventory reductions and similar changes. While PE Films is undertaking efforts to expand its customer base, there can be no assurance that such efforts will be successful, or that they will offset any delay or loss of sales and profits associated with these large customers.
In recent years, PE Films lost substantial sales volume due to product transitions and incurred other sales losses associated with various customers. During October 2018, the Personal Care component of PE Films completed negotiations with a customer regarding a previously disclosed significant product transition. The total annual sales that will be adversely impacted by this product transition is approximately $70 million. During 2019, the Company expects sales for the product of $30 to $35 million with the potential for no sales thereafter. Any actions that the Company takes to reduce fixed costs to partially mitigate the decline in variable contribution that will accompany the decline in sales will depend on the level of success that Personal Care has with replacing the lost business with new products and business.
Personal Care has increased its annual R&D spending by approximately $5 million since 2014, reaching $12 million in 2018. Personal Care is also investing capital and is accelerating sales and marketing efforts to capture growth and diversify its customer base and product offerings in personal care products, but there can be no assurance that such efforts will be successful or that they will offset any loss of business due to product transitions.
The Personal Care component of PE Films had operating profit from ongoing operations plus depreciation and amortization in the fourth quarter of 2018 of $3.1 million. As a result of the decline in sales from the significant product transition discussed above, the Company expects operating profit from ongoing operations plus depreciation and amortization for this component of approximately negative $1.5 million during the first half of 2019. Personal Care projects its operating profit from ongoing operations plus depreciation and amortization to turn positive in the second half of 2019 assuming production and sales growth targets are achieved.
PE Films also anticipates that a portion of its film used in surface protection applications will be made obsolete by future customer product transitions to less costly alternative processes or materials. These transitions could possibly be fully implemented by the fourth quarter of 2019. When fully implemented, the Company estimates that the annualized adverse impact on future operating profit from this customer shift will be approximately $11 million. In response, the Company is aggressively pursuing new surface protection products, applications and customers, but there can be no assurance that such efforts will be successful or that they will offset any loss of business due to product transitions.
PE Films and its customers operate in highly competitive markets. PE Films competes on product innovation, quality, price and service, and its businesses and their customers operate in highly competitive markets. Global market conditions continue to exacerbate the Company’s exposure to margin compression due to competitive forces, especially as certain products move into the later stages of their product life cycles. In addition, the changing dynamics of consumer products retailing, including the impact of on-line retailers such as Amazon, is creating price and margin pressure on the customers of PE Films’ personal care business. While PE Films continually works to identify new business opportunities with new and existing customers, primarily through the development of new products with improved performance and/or cost characteristics, there can be no assurances that such efforts will be successful or that they will offset business lost from competitive dynamics or customer product transitions.
Our cost saving initiatives may not achieve the results we anticipate. PE Films has undertaken and will continue to undertake cost reduction initiatives to consolidate certain production, improve operating efficiencies and generate cost savings. PE Films cannot be certain that it will be able to complete these initiatives as planned or that the estimated operating efficiencies or cost savings from such activities will be fully realized or maintained over time. In addition, PE


Films may not be successful in moving production to other facilities or timely qualifying new production equipment. Failure to complete these initiatives could adversely affect PE Films’ financial condition, results of operations and cash flows.
Failure of PE Films’ customers, who are subject to cyclical downturns, to achieve success or maintain market share could adversely impact PE Films’ sales and operating margins. PE Films’ plastic films serve as components for, or are used in the production of, various consumer products sold worldwide. A customer’s ability to successfully develop, manufacture and market those products is integral to PE Films’ success. Also, consumers of premium products made with or using PE Films’ components may shift to less premium or less expensive products, reducing the demand for PE Films’ plastic films. Cyclical downturns may negatively affect businesses that use PE Films’ plastic film products, which could adversely affect sales and operating margins.
The Company’s inability to protect its intellectual property rights or its infringement of the intellectual property rights of others could have a material adverse impact on PE Films. PE Films operates in an industry where its significant customers and competitors have substantial intellectual property portfolios. The continued success of the PE Films’ business depends on its ability not only to protect its own technologies and trade secrets, but also to develop and sell new products that do not infringe upon existing patents or threaten existing customer relationships.patents. Intellectual property litigation is very costly and could result in substantial expense and diversions of Company resources, both of which could adversely affect its consolidated financial condition, results of operations and cash flows. In addition, there may be no effective legal recourse against infringement of the Company’s intellectual property by third parties, whether due to limitations on enforcement of rights in foreign jurisdictions or as a result of other factors.
An unstable economic environmentDisruptions to PE Films’ supply chain could have a disruptivematerial adverse impact on PE Films’ supply chain.Films. Certain raw materials used in manufacturing PE Films’ products are sourced from single suppliers, and PE Films may not be able to quickly or inexpensively re-source from other suppliers.  The risk of damage or disruption to its supply chain may increase if and when different suppliers consolidate their product portfolios, experience financial distress or disruption of manufacturing operations (such as, for example, the impact of hurricanes on petrochemical production). Failure to take adequate steps to effectively manage such events, which are intensified when a product is procured from a single supplier or location, could adversely affect PE Films’ consolidated financial condition, results of operations and cash flows, as well asand also require additional resources to restore its supply chain.
Rising trade tensions could cause an increase in the cost of PE Films’ products or otherwise negatively impact the Company. A portion of PE Film’s business involves imports to and from the U.S. and other countries where the Company produces and sells its products. Trade tensions have been rising between the U.S. and other countries, particularly China. An increase in tariffs and other trade barriers between the U.S. and China, or between the U.S. and other countries, could cause an increase in the cost of PE Films’ products or otherwise negatively impact the production and sale of the Company’s products in world markets.
Risks Related to Flexible Packaging Films
Overcapacity in Latin American polyester film production and a history of uncertain economic conditions in Brazil could adversely impact the financial condition, results of operations and cash flows of Flexible Packaging Films. Competition in Brazil, Terphane’s primary market, has been exacerbated by global overcapacity in the polyester industry generally, and by particularly acute overcapacity in Latin America. Additional PET capacity from a competitor in Latin America came on line in 2017. These factors have resulted in significant competitive pricing pressures and U.S. Dollar equivalent margin compression.
For flexible packaging films produced in Brazil, selling prices and key raw material costs for operationsare principally determined in Brazil have been adverselyU.S. Dollars and are impacted by inflation in Brazil that is higher than in the U.S.local economic conditions and local and global competitive dynamics. Flexible Packaging Films is exposed to additional foreign exchange translation risk (its functional currency is the Brazilian Real) because almost 90% of the sales of Flexible Packaging Films’ Brazilian salesFilms business unit in Brazil (“Terphane Ltda.”) and substantially all of its related raw material costs are quoted or priced in U.S. Dollars while a large part of its Brazilianvariable conversion, fixed conversion and sales, general and administrative costs before depreciation & amortization (collectively “Terphane Ltda. Operating Costs”) are quoted or priced in Brazilian Real. This mismatch, together with a variety of economic variables impacting currency exchange rates, causes volatility that could negatively or positively impact operating profitEBITDA from ongoing operations for Flexible Packaging Films. While Flexible Packaging Films hedges this exposure on a short-term basis with foreign exchange forward rate contracts, the exposure continues to exist beyond the hedging periods.
Governmental failure to extend anti-dumping duties in Brazil on imported products or prevent competitors from circumventing such duties could adversely impact Flexible Packaging Films. In recent years, excess global capacity in the industry has led to increased competitive pressures from imports into Brazil.  The Company believes that these conditions have shifted the competitive environment from a regional to a global landscape and have driven price convergence and lower product margins for Flexible Packaging Films. Favorable anti-dumping rulings or countervailing duties are in effect for products imported from China, Egypt, India, Mexico, UAE and Turkey.  In January 2018, the Brazilian government opened new anti-dumping investigations for products imported fromUnited Arab Emirates, Turkey, Peru and Bahrain. Competitors not currently subject to anti-dumping duties may choose to utilize their excess capacity by selling product in Brazil, which may result in pricing pressures that Flexible Packaging Films may not be able to offset with cost savings measures and/or manufacturing efficiency initiatives.  Brazilian authorities initiated an investigation for sunset review on anti-dumping rulings against China, India and Egypt and extended duties that would have expired in 2020 for
6


one year. There can be no assurance that efforts to imposeextend anti-dumping constraints on products imported to Brazil from Peru and Bahrain, or to extend duties beyond 20202021 on products imported from certainChina, India, Egypt and other countries will be successful.


Aluminum Extrusions
Sales volume and profitability of Aluminum Extrusions is cyclical and seasonal and highly dependent on economic conditions of end-use markets in the U.S., particularly in the construction sector. Aluminum Extrusions’ end-use markets can be cyclical and subject to seasonal swings in volume. Because of the capital intensive nature and level of fixed costs inherent in the aluminum extrusions business, the percentage drop in operating profits in a cyclical downturn will likely exceed the percentage drop in volume. In addition, during an economic slowdown, excess industry capacity often drives increased pricing pressure in many end-use markets as competitors protect their position with key customers. Any benefits associated with cost reductions and productivity improvements may not be sufficient to offset the adverse effects on profitability from pricing and margin pressure and higher bad debts (including a greater chance of loss associated with customers defaulting on fixed-price forward sales contracts) that usually accompany a downturn. In addition, higher energy costs can further reduce profits unless offset by price increases or cost reductions and productivity improvements.
Failure to prevent competitors from circumventing anti-dumping and countervailing duties, or a reduction in such duties, could adversely impact Aluminum Extrusions. As of April 2017, the antidumping duty and countervailing duty orders on aluminum extrusions from China will remain in place until the next five-year review of the orders. Chinese and other overseas manufacturers continue to try to circumvent the antidumping and countervailing orders to avoid duties. A failure by, or the inability of, U.S. trade officials to curtail efforts to circumvent these duties, or the potential reduction of applicable duties pursuant to annual reviews of the orders, could have a material adverse effect on the financial condition, results of operations and cash flows of Aluminum Extrusions.
The imposition of tariffs or duties on imported aluminum products could significantly increase the price of Aluminum Extrusions’ main raw material, which could adversely impact demand for its products. In March 2018, the U.S. imposed tariffs of 10% on aluminum ingot and semi-finished aluminum imported into the U.S. from certain countries, including countries from which Bonnell Aluminum has historically sourced aluminum supplies. These tariffs have increased the cost of aluminum ingot used by Bonnell Aluminum to make its products.  For the vast majority of its business, Bonnell Aluminum expects to be able to pass through higher aluminum costs to customers.  However, sustained higher costs for aluminum extrusions could result in reduced demand and product substitutions in place of aluminum extrusions, which could materially and negatively affect Bonnell Aluminum’s business and results of operations.
Competition from China could increase significantly if China is granted market economy status by the World Trade Organization. China has launched a formal complaint at the World Trade Organization challenging its non-market economy status, claiming that as of December 11, 2016, China’s transition period as a non-market economy under its Accession Protocol to the World Trade Organization ended. China believes with respectRisks Related to all Chinese-made products that it should receive market economy status and the rights attendant to that status under World Trade Organization rules.  The U.S. and the European Union have each rejected that interpretation.  If China is granted market economy status, the extent to which the U.S. antidumping laws will be able to limit unfair trade practices from China will likely be limited because the U.S. government will be forced to utilize Chinese prices and costs that do not reflect market principles in antidumping duty investigations involving China, which could ultimately limit the level of antidumping duties applied to unfairly traded Chinese imports. The volume of unfairly traded imports of Chinese aluminum extrusions could increase as a result and this, in turn, would likely create substantial pricing pressure on Aluminum Extrusions’ products and could have a material adverse effect on the financial condition, results of operations and cash flows of Aluminum Extrusions.
Tredegar Businesses
The markets for Aluminum Extrusions’ products are highly competitive with product quality, service, delivery performance and price being the principal competitive factors. Aluminum Extrusions has approximately 1,400 customers that are in a variety of end-use markets within the broad categories of building and construction, distribution, automotive and other transportation, machinery and equipment, electrical and consumer durables. No single customer exceeds 4% of Aluminum Extrusions’ net sales. Future success and prospects depend on Aluminum Extrusions’ ability to provide superior service, high quality products, timely delivery and competitive pricing to retain existing customers and participate in overall industry cross-cycle growth. Failure in any of these areas could lead to a loss of customers, which could have an adverse material effect on the financial condition, results of operations and cash flows of Aluminum Extrusions.
Aluminum Extrusions may not have sufficient capacity to meet its growth targets and service all of its customers. Aluminum Extrusions’ ability to grow and service existing customers is closely tied to having sufficient capacity. In recent years, increased demand, primarily from the nonresidential building and construction sector, has substantially increased Aluminum Extrusions’ average capacity utilization.


General
The Company has identified material weaknesses in its internal control over financial reporting at December 31, 2017 and 2018.reporting. The Company’s failure to establish and maintain effective internal control over financial reporting and to maintain effective disclosure controls and procedures increases the risk of a material misstatement in its consolidated financial statements, and its failure to meet its reporting and financial obligations, whichcould, in turn, could have a negative impact on its financial condition.
Maintaining effective internal control over financial reporting is necessary for the Company to producean integral part of producing reliable financial statements. As discussed in Item 9A. “Controls and Procedures,”Procedures” of this Form 10-K (“Item 9A”), the Company’s management concluded that the Company’s internal control over financial reporting was not effective as of December 31, 2017 or December 31, 2018,for the periods referred to therein as a result of certain deficiencies that were determined to constitute material weaknesses in the Company’s internal control over financial reporting.
Under standards established by the Public Company Accounting Oversight Board, (“PCAOB”), a material weakness is defined as a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis. Under the criteria set forth in Internal Control - Integrated Framework 2013 issued by the Committee of Sponsoring Organizations of the Treadway Commission, a material weakness in the design of monitoring controls indicates that the Company has not sufficiently developed and/or documented internal controls by which management can review and oversee the Company’s financial information to detect and correct material errors or that the personnel responsible for performing the review did not have the sufficient skill set or knowledge of the subject matter to perform a proper assessment.
As discussed in Item 9A. “Controls and Procedures,”9A to remediate the material weaknesses, the Company, with the assistance of its outside consultant, is in the process of implementing certain changes to its internal controls and reviewing the entire control environment to help ensure that there are no other material weaknesses. The Company believes that its remediation plan will be sufficient to remediate the identified material weaknesses and strengthen its internal control over financial reporting. However,The Company’s remediation efforts are ongoing, and it will continue its initiatives to implement and document policies and procedures. Remediation of the identified material weaknesses and strengthening the Company’s internal control environment will require a substantial effort throughout 2019,have extended into 2021. In addition, the Company is monitoring the impact of COVID-19 on its remediation plan. Depending on the severity and those efforts may extend beyond 2019. length of the pandemic, the remediation timeline could be negatively impacted because of inefficiencies caused by COVID-related limitations on travel, meetings, on-site work and close collaboration and the related increase in time necessary to complete remediation projects.
As the Company continues to evaluate and work to improve its internal control over financial reporting and disclosure controls and procedures, management may determine to take additional measures to address control deficiencies or determine to modify the remediation plan. The Company cannot assure you,provide assurance, however, as to when it will remediate all such weaknesses, nor can it be certain of whether additional actions will be required or the costs of any such actions. Moreover, the Company cannot assure youprovide assurance that additional material weaknesses will not arise in the future.
While the material weaknesses discussed in Item 9A. “Controls and Procedures”9A did not result in material misstatements of the Company’s financial statements as of and for the yearyears ended December 31, 2020, 2019, 2018 and 2017 or December 31, 2018, or anyin the intervening interim periodperiods during 2017 or 2018,those respective years, any failure to remediate the material weaknesses, or the development of new material weaknesses in its internal control over financial reporting, could result in material misstatements in the Company’s consolidated financial statements and cause it to fail to meet its reporting and financial obligations, which in turn could have a negative impact on its financial condition.
Tredegar has an underfunded defined benefit (pension) plan. Tredegar sponsors a pension plan that covers certain hourly and salaried employees in the U.S. The plan was substantially frozenclosed to new participants in 2007, and substantially frozen to benefit accruals for active participants in 2014. As of January 31, 2018, the plan no longer accrued benefits associated with crediting employees for service, thereby freezing all future benefits under the plan. As of December 31, 2018,2020, the plan was underfunded under U.S. generally accepted accounting principles (“GAAP”) measures by $81.9$103.1 million. Tredegar expects that it will be required to make a cash contribution of approximately $8.1$11.7 million to its underfunded pension plan in 2019,2021, and may be required to make higher cash contributions in future periods depending on the level of interest rates and investment returns on plan assets.
Noncompliance with any of the covenants in the Company’s $400$375 million revolving credit facility, as amended on December 1, 2020, which matures in March of 2021,June 2024, could result in all debt under the agreement outstanding at such time becoming due and limiting itsthe Company’s borrowing capacity, which could have a material adverse effect on its consolidated financial condition and liquidity. The credit agreement governing Tredegar’s revolving credit facility contains restrictions and financial covenants that, if violated, could restrict the Company’s operational and financial
7


flexibility. Failure to comply with these covenants could result in an event of default, which if not cured or waived, would result in all outstanding debt under the credit facility at such time becoming due, which could have a material adverse effect on the Company’s consolidated financial condition and liquidity.


Tredegar’s performance is influenced by costs incurred by its operating companies, including, for example, the cost of raw materials and energy. These costs include without limitation, the cost of aluminum (the raw material on which Aluminum Extrusions primarily depends), resin (the raw material on which PE Films primarily depends), PTA and MEG (the raw materials on which Flexible Packaging Films primarily depends), aluminum (the raw material on which Aluminum Extrusions primarily depends), natural gas (the principal fuel necessary for Aluminum Extrusions’ plants to operate), electricity and diesel fuel. Resin, aluminumAluminum, resin and natural gas prices are volatile as shown in the charts in the Quantitative and Qualitative Disclosuressection. in Item 7. The Company attempts to mitigate the effects of increased costs through price increases and contractual pass-through provisions, but there are no assurances that higher prices can effectively be passed through to customers or that Tredegar will be able to offset fully or on a timely basis the effects of higher raw material and energy costs through price increases or pass-through arrangements. Further, the Company’s cost control efforts may not be sufficient to offset any increases in raw material, energy or other costs.
Tredegar may not be able to successfully integrate strategic acquisitions. Acquisitions involve special risks, including, without limitation, meeting revenue, margin, working capital and capital expenditure expectations that substantially drive valuation, diversion of management’s time and attention from existing businesses, the potential assumption of unanticipated liabilities and contingencies and potential difficulties in integrating acquired businesses and achieving anticipated operational improvements.  Acquired businesses may not achieve expected results.
Tredegar is subject to variouscurrent and future governmental regulation, including environmental laws and regulations, and could become exposed to material liabilities and costs associated with such laws.regulation. The Company is subject to various environmental obligationsregulation by local, state, federal and could become subject to additional obligations in the future. Changes in environmentalforeign governmental authorities.  New laws and regulations, or their application,changes to existing laws, including those relating to environmental matters (including global climate change and plastic products,products), and  privacy matters, could subject Tredegar to significant additional capital expenditures, and operating expenses.expenses or other compliance costs. Moreover, future developments in federal, state, local and international environmental laws and regulations, including environmental laws, are difficult to predict. Environmental laws and privacy restrictions have become and are expected to continue to become increasingly strict. As a result, Tredegar expects to be subject to new environmental and privacy laws and regulations. However, any such changes are uncertain and, therefore, it is not possible for the Company to predict with certainty the amount of additional capital expenditures or operating expenses that could be necessary for compliance with respect to any such changes. See Government Regulationin “ItemItem 1. Business”“Business” of this Form 10-K for a further discussion of this risk factor.
We are subject to the U.S. Foreign Corrupt Practices Act, Brazilian anti-corruption laws and similar anti-bribery laws in other jurisdictions, which generally prohibit companies and their intermediaries from making improper payments to foreign officials for the purpose of obtaining or retaining business. Although we have policies and procedures designed to facilitate compliance with these laws and regulations, our employees, contractors and agents may take actions in violation of our policies. Any such violation, even if prohibited by our policies, could adversely affect our business and/or our reputation.
Material disruptions at one of the Company’s major manufacturing facilities could negatively impact financial results. Tredegar believes its facilities are operated in compliance with applicable local laws and regulations and that the Companyit has implemented measures to minimize the risks of disruption at its facilities. SuchHowever, a disruption could beoccur as a result of any number of events: an equipment failure with repairs requiring long lead times, labor stoppages or shortages, cybersecurity attacks, utility disruptions, constraints on the supply or delivery of critical raw materials, and severe weather conditions. A material disruption in one of the Company’s operating locations could negatively impact production and itsthe Company’s consolidated financial condition, results of operations and cash flows.
An inability to renegotiate the Company’s collective bargaining agreements could adversely impact its consolidated financial condition, results of operations and cash flows.Some Approximately 34% of the Company’s employees are represented by labor unions located in the U.S. and Brazil under various collective bargaining agreements with varying durations and expiration dates. Tredegar may not be able to satisfactorily renegotiate collective bargaining agreements when they expire, which could result in strikes or work stoppages or higher labor costs. In addition, existing collective bargaining agreements may not prevent a strike or work stoppage at the Company’s facilities in the future. Any such work stoppages (or potential work stoppages) could negatively impact Tredegar’s ability to manufacture its products and adversely affect its consolidated financial condition, results of operations and cash flows. None of Tredegar’s collective bargaining agreements expire before the fourth quarter of 2021.
Our business and operations, and the operations of our customers, suppliers and others we do business with, may be adversely affected by epidemics such as the recent COVID-19 pandemic, which could adversely affect our financial condition, results of operations and cash flows. We may face risks related to health epidemics or outbreaks of communicable diseases. The outbreak of such a communicable disease could result in a widespread health crisis that could adversely affect general commercial activity and the economies and financial markets of many countries. For example, COVID-19 has spread across the globe to every country in which the Company does business and is impacting worldwide economic activity. A public health epidemic, including COVID-19, poses the risk that we or our contractors, suppliers, customers and other business partners may be prevented or otherwise adversely affected in the conduct of business activities for an indefinite period of time, including due to shutdowns that may be requested or mandated by governmental authorities and by other government mandates or policy changes. We may also face staffing issues if our employees
8


become ill from an epidemic, are subject to epidemic-related “stay-at-home” orders, or absenteeism increases because of fear of epidemic-related health risks. An epidemic may also cause a significant reduction in demand for one or more of our products as a result of a drop in product-specific demand, because of an epidemic’s impact on the world economy generally, or for other reasons. Bonnell Aluminum is experiencing higher than normal absenteeism and hiring difficulties due to COVID-19 factors. As a result, it is having difficulty maintaining sufficient labor to meet desired shipping levels. As a result of an epidemic, we may be unable to meet our supply commitments or otherwise fulfill our customers’ needs due to disruptions in our manufacturing and supply arrangements, including as a result of constrained workforce capacity, interruption of raw material supplies, transportation disruptions or a loss or disruption of other key elements of our manufacturing and distribution capability. An epidemic may cause the failure of, or default in performance by, third parties we rely on to supply our manufacturing operations, to process, transport or purchase our products, to finance our operations, and to otherwise provide products and services to the Company in support of our business and operations. While it is not possible at this time to estimate the impact that any particular epidemic, including COVID-19, could have on the Company’s business, the extent of that impact would likely be affected by factors outside of our control such as the severity, duration and spread of such an epidemic, the measures taken by the governments of countries affected and the ability of our customers and consumers to access government programs providing liquidity and support during the crisis. The impact of an epidemic on our employees, our customers, our supply chains, demand for our products, our ability to supply customers, our operating costs and our other business activities, could adversely affect our financial condition, results of operations and cash flows. For more information on the effect of COVID-19 on our business and financial condition, refer to “The Impact of COVID-19 in Item 7.
Tredegar’s valuation of its $7.5 million cost-basis investment in kaléo is volatile and uncertain. Tredegar uses the fair value method to account for its fully-diluted ownership interest of approximately 20% in kaleo, Inc. (“kaléo”), a privately held specialty pharmaceutical company. There is no active secondary market for buying or selling stock in kaléo. The Company’s fair value estimates can fluctuate materially between reporting periods primarily due to varianceschanges in its performance versus expectationskaléo’s projections, which rely on numerous assumptions, and changes in the valuation of guideline public companies as measured by their enterprise value-to-EBITDA (earnings before interest, taxes, depreciation and amortization) multiples. Additionally, theThe estimated fair value of the Company’s investment in kaléo could decline. Kaléo’s first product, anmay significantly decline due to pricing pressures and expected changes in market access as well as continued lower market demand for epinephrine auto-injector, was licensed to Sanofi-Aventis U.S. LLC (“Sanofi”)delivery devices resulting from COVID-19-driven delays in 2009. Sanofi commenced commercial sales inin-person back-to-school schedules and social distancing guidelines. Additionally, the first quarter of 2013. Kaléo subsequently developed and commenced commercial sales of its second product, a naloxone auto-injector (“Evzio”), in the third quarter of 2014. Public pressure to lower the price of pharmaceutical products continues to mount, which could affect the price at which kaléo sells its products. The U.S. Department of Justice began an investigation of kaléo’s Evzio business in 2018, the impact of which on kaléo and on the value of the Company’s interest in kaléo cannot yet be estimated with any certainty. See Note 4 toDuring 2020, kaléo discontinued the Notes to Financial Statements (“Note 4”) for more information.
marketing of its Evzio product.


Rising trade tensions. A significant portion of the Company’s business involves imports to and from the U.S. and other countries where the Company produces and sells its products. Trade tensions have been rising between the U.S. and other countries, particularly China. An increase in tariffs and other trade barriers between the U.S. and China, or between the U.S. and other countries, could cause an increase in the cost of the Company’s products or otherwise negatively impact the production and sale of the Company’s products in world markets.
A failure in the Company’s information technology systems as a result of cybersecurity attacks or other causes could negatively affect Tredegar’s business. The Company depends on information technology (“IT”) to record and process customers'customers’ orders, manufacture and ship products in a timely manner, secure its production processes and know-how, and maintain the financial accuracy of its business records.records and maintain personally identified information of its employees. An IT system failure due to computer viruses, internal or external security breaches, cybersecurity attacks or other malicious causes could disrupt our operations and prevent us from being able to process transactions with our customers, operate our manufacturing facilities and properly report transactions in a timely manner. Increased global IT security threats and cyber-crime pose a potential risk to the security and availability of the Company’s IT systems, networks and services, including those that are managed, hosted, provided or used by third parties, as well as to the confidentiality, availability and integrity of the Company’s data. To date, interruptions of the Company’s IT systems have been infrequent and have not had a material impact on the Company’s operations. A significant protracted failure of or security breach of the IT systems, networks or service providers the Company relies upon, or a loss or disclosure of business or other sensitive information, or personally identified information, as a result of a cybersecurity incident or other cause, could result in substantial costs to the Company, damage to the Company’s reputation, regulatory enforcement actions and legal challenges,lawsuits and could adversely affect ourthe Company’s results of operations, financial condition or cash flows.


Item 1B.    UNRESOLVED STAFF COMMENTS


Item 1B.UNRESOLVED STAFF COMMENTS
None.
Item 2.PROPERTIES
Item 2.    PROPERTIES
General
Most of the improved real property and the other assets used in the Company’s operations are owned. Certain of the owned property is subject to an encumbrance under the Company’s revolving credit facilityagreement (see Note 11 “Debt and Credit Agreements” to the Consolidated Financial Statements in Item 15 for more information).
Tredegar considers the manufacturing facilities, warehouses and other properties and assets that it owns or leases to be in generally good condition. Capacity utilization at its various manufacturing facilities can vary with product mix and normal
9


fluctuations in sales levels. The Company believes that its Bonnell Aluminum, PE Films and Flexible Packaging Films manufacturing facilities have sufficient capacity to meet current production requirements. Bonnell Aluminum’s average capacity utilization during the fourth quarter of 2018 was in excess of 90%. Tredegar’s corporate headquarters, which is leased, is located at 1100 Boulders Parkway, Richmond, Virginia 23225.
The Company’s principal manufacturing plants and facilities as of December 31, 20182020 are listed below:
PE Films
Aluminum Extrusions
Locations in the U.S.Locations Outside the U.S.Principal Operations
Lake Zurich, IllinoisCarthage, Tennessee
Clearfield, Utah (leased)
Elkhart, Indiana
Newnan, Georgia
Niles, Michigan
NoneProduction of aluminum extrusions, fabrication and finishing
PE Films
Durham, North Carolina (technical center and production facility) (leased)
Locations in the U.S.Locations Outside the U.S.Principal Operations
Pottsville, Pennsylvania
Richmond, Virginia (technical center) (leased)
Terre Haute, Indiana (technical center and production facility)
Guangzhou, China
Kerkrade, The Netherlands
Pune, India
Rétság, Hungary
São Paulo, Brazil
Production of plastic films elastics and laminate materials
Flexible Packaging Films
Locations in the U.S.Locations Outside the U.S.Principal Operations
Bloomfield, New York (technical center and production facility)

Cabo de Santo Agostinho, BrazilProduction of PET-based films
Aluminum Extrusions
Item 3.    LEGAL PROCEEDINGS
The information required by this Item 3 is set forth in Note 18 "Contingencies" to the Consolidated Financial Statements in Item 15 and is hereby incorporated herein by reference.
Item 4.    MINE SAFETY DISCLOSURES
Locations in the U.S.Principal Operations
Carthage, Tennessee
Elkhart, Indiana
Newnan, Georgia
Niles, Michigan
Clearfield, Utah (leased)
Production of aluminum extrusions, fabrication and finishing
Item 3.LEGAL PROCEEDINGS
None.
10
Item 4.MINE SAFETY DISCLOSURES
None.






PART II
Item 5.MARKET FOR TREDEGAR’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
Market Prices of Common Stock and Shareholder DataItem 5.    MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
Tredegar’s common stock is traded on the New York Stock Exchange (“NYSE”) under the ticker symbol “TG”. There were 33,176,02433,537,892 shares of common stock held by 1,9481,747 shareholders of record on December 31, 2018.
The following table shows the reported high and low closing prices of Tredegar’s common stock by quarter for the past two years.
 2018 2017
 High Low High Low
First quarter$20.25
 $15.60
 $25.00
 $16.50
Second quarter24.60
 16.99
 17.65
 14.90
Third quarter26.25
 20.60
 18.35
 14.85
Fourth quarter21.56
 15.00
 20.20
 18.20
The closing price of Tredegar’s common stock on March 11, 2019 was $17.21.12, 2021.
Dividend Information
Tredegar has paid a regular cash dividend every quarter since becoming a public company in July 1989. During1989 and expects that comparable regular cash dividends will continue to be paid in the past three years,future. In addition, Tredegar has paid special cash dividends from time to time. On December 1, 2020, the Company paid quarterly dividendsBoard declared a special dividend of 11 cents$200 million, or $5.97 per share, on the Company’s common stock (the “Special Dividend”). The Special Dividend was paid in each quarter of 2016, 2017 and 2018.December 2020.
All decisions with respect to the declaration and payment of future dividends will be made by the Board of Directors (“Board”) in its sole discretion based upon earnings, financial condition, anticipated cash needs, restrictions in the Company’s revolving credit facility and other such considerations as the Board deems relevant. See Note 11 "Debt and Credit Agreements" to the Consolidated Financial Statements in Item 15 for the restrictions on the payment of dividends contained in the Company’s revolving credit agreement related to aggregate dividends permitted.
Issuer Purchases of Equity Securities
On January 7, 2008, Tredegar announced that itsthe Board approved a share repurchase program whereby management is authorized at its discretion to purchase, in the open market or in privately negotiated transactions, up to 5 million shares of the Company’s outstanding common stock. The authorization has no time limit. Tredegar did not repurchase any shares in the open market or otherwise in 2018, 20172020, 2019 or 20162018 under this standing authorization. The maximum number of shares remaining under this standing authorization was 1,732,003 at December 31, 2018.2020.


Comparative Tredegar Common Stock Performance Graph
The following graph compares cumulative total shareholder returns for Tredegar, the S&P SmallCap 600 Stock Index (an index comprised of companies with market capitalizations similar to Tredegar) and the Russell 2000 Index for the five years ended December 31, 2018.2020. Tredegar is part of both the S&P SmallCap 600 Index and Russell 2000 Index.


COMPARISON OF 5 YEAR CUMULATIVE TOTAL RETURN*
Among Tredegar Corporation, the S&P SmallCap 600 Index, and the Russell 2000 Index


chart-a6f3d8d3ad7755fdacc.jpg
tg-20201231_g1.jpg
*$100 invested on 12/31/1315 in stock or index, including reinvestment of dividends.
Fiscal year ending December 31.

Copyright© 2019

Copyright© 2021 Standard & Poor's, a division of S&P Global. All rights reserved.
Copyright© 2019
Copyright© 2021 Russell Investment Group. All rights reserved.



11



Quarterly InformationItem 6.    SELECTED FINANCIAL DATA
Tredegar does not generate or distribute quarterly reports to its shareholders. Information on quarterly results can be obtained from the Company’s website, www.tredegar.com. In addition, Tredegar files quarterly, annual and other information electronically with the SEC, which can be accessed on its website at www.sec.gov.


Item 6.SELECTED FINANCIAL DATA
The tables that follow present certain selected financial and segment information for the five years ended December 31, 2018.2020. All historical results for Personal Care Films have been presented as discontinued operations. The surface protection component of the PE Films segment now includes Pottsville Packaging.

FIVE-YEAR SUMMARY
Tredegar Corporation and Subsidiaries
Years Ended December 312020 2019 2018 2017 2016 
(In thousands, except per-share data)          
Results of Operations:
Sales$755,290 $826,324   $851,834   $725,867   $595,665   
Other income (expense), net (g)(67,294)(a) 28,371 (a) 30,455 (a) 51,718 (b) 2,225 (b)
Total687,996   854,695   882,289   777,585   597,890   
Cost of goods sold (i)558,967 (a) 641,140 (a) 679,665 (a) 579,545 (b) 472,767 (b) 
Freight25,686   28,980   27,170   22,273   17,864   
Selling, general & administrative (i)84,246 (a) 76,598 (a) 67,929 (a) 65,189 (b) 58,334 (b) 
Research and development8,398   7,893   6,672   6,189   6,877   
Amortization of identifiable intangibles3,017   13,601   3,976   6,198   3,978   
Pension and postretirement benefits (i)14,720 9,642 10,406 10,193 11,047 
Interest expense2,587   4,051   5,702   6,170   3,806   
Asset impairments and costs associated with exit and disposal activities, net of adjustments1,725 (a) 784 (a) 398 (a) 102,114 (b) 302 (b) 
Goodwill impairment13,696 (c)— — — — 
Total713,042   782,689   801,918   797,871   574,975   
Income (loss) from continuing operations before income taxes(25,046)  72,006   80,371   (20,286)  22,915   
Income tax expense (benefit)(8,213)13,545 18,807 (57,753)4,786 
Income (loss) from continuing operations(16,833)  58,461   61,564   37,467   18,129 
Income (loss) from discontinued operations, net of tax(58,611) (10,202) (36,722)784 6,337 
Net income (loss)$(75,444)  $48,259   $24,842   $38,251   $24,466 
Diluted earnings (loss) per share:
Continuing operations$(0.51)  $1.76   $1.86   $1.14 $0.55 
Discontinued operations(1.75)(0.31)(1.11)0.02 0.20 
Diluted earnings (loss) per share$(2.26)  $1.45   $0.75   $1.16 $0.75   
Refer to Notes to Financial Tables that follow these tables.
12


FIVE-YEAR SUMMARY
Tredegar Corporation and Subsidiaries
 
Years Ended December 3120202019201820172016
(In thousands, except per-share data)     
Share Data:
Equity per share (h)$3.26 $11.29 $10.70 $10.41 $9.44 
Cash dividends declared per share (n)$6.45 $0.46 $0.44 $0.44 $0.44 
Weighted average common shares outstanding during the period33,402 33,236 33,068 32,946 32,762 
Shares used to compute diluted earnings (loss) per share during the period33,402 33,258 33,092 32,951 32,775 
Shares outstanding at end of period33,457 33,365 33,176 33,017 32,934 
Closing market price per share:
High$22.32 $23.31 $26.25 $25.00 $25.55 
Low$11.32 $15.59 $15.00 $14.85 $11.68 
End of year$16.70 $22.35 $15.86 $19.20 $24.00 
Total return to shareholders (d)(n)3.6 %43.8 %(15.1)%(18.2)%79.4 %
Financial Position:
Total assets$514,870 $712,668 $707,373 $755,743 $651,162 
Cash and cash equivalents$11,846 $31,422 $34,397 $36,491 $29,511 
Debt$134,000 $42,000 $101,500 $152,000 $95,000 
Shareholders’ equity$109,055 $376,749 $354,857 $343,780 $310,783 
Equity market capitalization (e)$558,735 $745,709 $526,172 $633,935 $790,411 
Years Ended December 312018  2017  2016  2015  2014 
(In thousands, except per-share data)              
               
Results of Operations:              
Sales$1,065,471
  $961,330
   $828,341
   $896,177
   $951,826
  
Other income (expense), net (k)30,459
(a)  51,713
(b)  2,381
(c)  (20,113)  (6,697)(f) 
 1,095,930
   1,013,043
   830,722
   876,064
   945,129
  
Cost of goods sold (m)849,756
(a)  767,550
(b)  659,867
(c)  715,744
(e)  772,897
(f) 
Freight36,027
   33,683
   29,069
   29,838
   28,793
  
Selling, general & administrative expenses (m)85,283
(a)  83,386
(b)  73,466
(c)  69,384
(e)  68,110
 
Research and development expenses18,707
   18,287
   19,122
   16,173
   12,147
  
Amortization of identifiable intangibles3,976
   6,198
   3,978
   4,073
   5,395
  
Pension and postretirement benefits (m)10,406
  10,193
  11,047
  12,242
  6,632
 
Interest expense5,702
   6,170
   3,806
   3,502
   2,713
  
Asset impairments and costs associated with exit and disposal activities2,913
(a)  102,488
(b)  2,684
(c)  3,850
(e)  3,026
(f) 
Goodwill impairment charge46,792
(d) 
  
  44,465
(d) 
  
 1,059,562
   1,027,955
   803,039
   899,271
   899,713
  
Income (loss) from continuing operations before income taxes36,368
   (14,912)   27,683
   (23,207)   45,416
  
Income tax expense (benefit)11,526
  (53,163)  3,217
  8,928
  9,387
 
Income (loss) from continuing operations24,842
   38,251
   24,466
   (32,135)   36,029
 
Income (loss) from discontinued operations, net of tax
  
  
  
  850
(g) 
Net income (loss)$24,842
   $38,251
   $24,466
   $(32,135)   $36,879
 
Diluted earnings (loss) per share:              
Continuing operations$0.75
   $1.16
   $0.75
   $(0.99)  $1.11
  
Discontinued operations
  
  
  
  0.02
(g) 
Net income (loss)$0.75
   $1.16
   $0.75
   $(0.99)  $1.13
  
Refer to Notes to Financial Tables that follow these tables.


FIVE-YEAR SUMMARY
Tredegar Corporation and Subsidiaries

13

Years Ended December 312018 2017 2016 2015 2014 
(In thousands, except per-share data)          
           
Share Data:          
Equity per share (l)$10.70
 $10.41
 $9.44
 $8.35
 $11.47
 
Cash dividends declared per share$0.44
 $0.44
 $0.44
 $0.42
 $0.34
 
Weighted average common shares outstanding during the period33,068
 32,946
 32,762
 32,578
 32,302
 
Shares used to compute diluted earnings (loss) per share during the period33,092
 32,951
 32,775
 32,578
 32,554
 
Shares outstanding at end of period33,176
 33,017
 32,934
 32,682
 32,422
 
Closing market price per share:          
High$26.25
 $25.00
 $25.55
 $23.76
 $28.45
 
Low$15.00
 $14.85
 $11.68
 $12.63
 $16.76
 
End of year$15.86
 $19.20
 $24.00
 $13.62
 $22.49
 
Total return to shareholders (h)(15.1)% (18.2)% 79.4% (37.6)% (20.8)% 
Financial Position:          
Total assets$707,373
 $755,743
 $651,162
 $623,260
 $788,626
 
Cash and cash equivalents$34,397
 $36,491
 $29,511
 $44,156
 $50,056
 
Debt$101,500
 $152,000
 $95,000
 $104,000
 $137,250
 
Shareholders’ equity (net book value)$354,857
 $343,780
 $310,783
 $272,748
 $372,029
 
Equity market capitalization (i)$526,172
 $633,935
 $790,411
 $445,131
 $729,173
 

Refer to Notes to Financial Tables that follow these tables.



SEGMENT TABLES
Tredegar Corporation and Subsidiaries
Net Sales (f)
Years Ended December 3120202019201820172016
(In thousands)     
Aluminum Extrusions$455,711 $529,602 $573,126 $466,833 $360,098 
PE Films139,288 133,807 127,708 128,406 109,674 
Flexible Packaging Films134,605 133,935 123,830 108,355 108,028 
Total net sales729,604 797,344 824,664 703,594 577,800 
Add back freight25,686 28,980 27,170 22,273 17,864 
Sales as shown in Consolidated Statements of Income$755,290 $826,324 $851,834 $725,867 $595,664 
Identifiable Assets     
As of December 3120202019201820172016
(In thousands)     
Aluminum Extrusions$244,560 $265,027 $281,372 $268,127 $147,639 
PE Films119,013 124,269 118,496 123,507 117,307 
Flexible Packaging Films66,453 74,016 58,964 49,915 156,836 
Subtotal430,026 463,312 458,832 441,549 421,782 
General corporate71,508 109,655 99,570 109,882 37,345 
Cash and cash equivalents11,846 31,422 34,397 36,491 29,511 
Discontinued operations1,490 108,279 114,574 167,821 162,524 
Total$514,870 $712,668 $707,373 $755,743 $651,162 
Net Sales (j)         
Years Ended December 312018 2017 2016 2015 2014
(In thousands)         
PE Films$332,488
 $352,459
 $331,146
 $385,550
 $464,339
Flexible Packaging Films123,830
 108,355
 108,028
 105,332
 114,348
Aluminum Extrusions573,126
 466,833
 360,098
 375,457
 344,346
Total net sales1,029,444
 927,647
 799,272
 866,339
 923,033
Add back freight36,027
 33,683
 29,069
 29,838
 28,793
Sales as shown in Consolidated Statements of Income$1,065,471
 $961,330
 $828,341
 $896,177
 $951,826
          
Identifiable Assets         
As of December 312018 2017 2016 2015 2014
(In thousands)         
PE Films$231,720
 $289,514
 $278,558
 $270,236
 $283,606
Flexible Packaging Films58,964
 49,915
 156,836
 146,253
 262,604
Aluminum Extrusions281,372
 268,127
 147,639
 136,935
 143,328
Subtotal572,056
 607,556
 583,033
 553,424
 689,538
General corporate100,920
 111,696
 38,618
 25,680
 49,032
Cash and cash equivalents34,397
 36,491
 29,511
 44,156
 50,056
Total$707,373
 $755,743
 $651,162
 $623,260
 $788,626
Refer to Notes to Financial Tables that follow these tables.




14


SEGMENT TABLES
Tredegar Corporation and Subsidiaries
EBITDA from Ongoing Operations (l)
Years Ended December 312020 2019 2018 2017 2016 
(In thousands)          
Aluminum Extrusions:
Ongoing operations:
EBITDA$55,137 $65,683 $65,479 $58,524 $46,967 
Depreciation & amortization (j)(17,403)(16,719)(16,866)(15,070)(9,173)
EBIT (m)37,734 48,964 48,613 43,454 37,794 
Plant shutdowns, asset impairments, restructurings and other(3,506)(a) (561)(a) (505)(a)321 (b)(741)(b)
Goodwill impairment charge(13,696)(c)—   —   —   —   
Trade name accelerated amortization (10,040)(j)— — — 
PE Films:
Ongoing operations:
EBITDA45,107 41,133 32,404 37,029 21,535 
Depreciation & amortization(6,762)(5,860)(6,201)(6,117)(5,718)
EBIT (m)38,345 35,273 26,203 30,912 15,817 
Plant shutdowns, asset impairments, restructurings and other(1,974)(a) (733)(a) (186)(a)(157)(b)(1)(b)
Flexible Packaging Films:
Ongoing operations:
EBITDA30,645 14,737 11,154 7,817 11,279 
Depreciation & amortization(1,761)(1,517)(1,262)(10,443)(9,505)
EBIT (m)28,884 13,220 9,892 (2,626)1,774 
Plant shutdowns, asset impairments, restructurings and other(18) — (a) (45)(a)(89,398)(b)(214)(b)
Total85,769   86,123   83,972   (17,494)  54,429   
Interest income44   66   146   54   106   
Interest expense2,587   4,051   5,702   6,170   3,806   
Gain (loss) on investment in kaléo accounted for under the fair value method (g)(60,900)28,482 30,600 33,800 1,600 
Loss on sale of Bright View (o)(2,299)— — — — 
Loss on sale of investment property — (38)— — 
Unrealized loss on investment property — (186)— (1,032)
Stock option-based compensation expense2,161 4,132   1,156 245   81   
Corporate expenses, net (k)42,912 (a) 34,482 (a)27,265 (a) 30,231 (b) 28,301 (b) 
Income (loss) from continuing operations before income taxes(25,046)72,006 80,371   (20,286)  22,915   
Income tax expense (benefit)(8,213)13,545 18,807 (57,753)4,786 
Income (loss) from continuing operations(16,833)  58,461   61,564   37,467   18,129 
Income (loss) from discontinued operations, net of tax(58,611)(10,202)(36,722)784 6,337 (g)
Net income (loss)$(75,444)  $48,259   $24,842   $38,251   $24,466   
Operating Profit              
Years Ended December 312018  2017  2016  2015  2014 
(In thousands)              
               
PE Films:              
Ongoing operations$36,181
  $41,546
   $26,312
   $48,275
   $60,971
  
Plant shutdowns, asset impairments, restructurings and other(5,905)(a)  (4,905)(b) (4,602)(c)  (4,180)(e)  (12,236)(f) 
       Goodwill impairment charge(46,792)(d) 
  
  
  
 
Flexible Packaging Films:              
Ongoing operations9,892
  (2,626)  1,774
  5,453
  (2,917) 
Plant shutdowns, asset impairments, restructurings and other(45)(a)  (89,398)(b) (214)(c) (185)(e)  (591)(f) 
Goodwill impairment charge
  
  
  (44,465)(d) 
 
Aluminum Extrusions:              
Ongoing operations48,613
   43,454
   37,794
   30,432
   25,664
 
Plant shutdowns, asset impairments, restructurings and other(505)(a)  321
(b) (741)(c)  (708)(e)  (976)(f) 
Total41,439
   (11,608)   60,323
   34,622
   69,915
  
Interest income369
   209
   261
   294
   588
  
Interest expense5,702
   6,170
   3,806
   3,502
   2,713
  
Gain (loss) on investment in kaléo accounted for under the fair value method (k)30,600
  33,800
  1,600
  (20,500)  2,000
 
Gain (loss) on sale of investment property(38)  
  
  
  1,208
(f) 
Unrealized loss on investment property186
  
  1,032
  
  
 
Stock option-based compensation expense1,221
  264
   56
  483
   1,272
  
Corporate expenses, net28,893
(a)  30,879
(b) 29,607
(c)  33,638
(e)  24,310
(f) 
Income (loss) from continuing operations before income taxes36,368
  (14,912)  27,683
   (23,207)   45,416
  
Income tax expense (benefit)11,526
  (53,163)  3,217
  8,928
  9,387
 
Income (loss) from continuing operations24,842
   38,251
   24,466
   (32,135)   36,029
 
Income (loss) from discontinued operations, net of tax
  
  
  
  850
(g)
Net income (loss)$24,842
   $38,251
   $24,466
   $(32,135)   $36,879
  
Refer to Notes to Financial Tables that follow these tables.

15



SEGMENT TABLES
Tredegar Corporation and Subsidiaries

Depreciation and Amortization
Years Ended December 3120202019201820172016
(In thousands)     
Aluminum Extrusions$17,403 $26,759 $16,866 $15,070 $9,173 
PE Films6,762 5,860 6,201 6,117 5,716 
Flexible Packaging Films1,761 1,517 1,262 10,443 9,505 
Subtotal25,926 34,136 24,329 31,630 24,394 
General corporate (k)520 186 163 155 141 
Discontinued operations5,511 9,962 9,312 8,492 7,937 
Total depreciation and amortization expense$31,957 $44,284 $33,804 $40,277 $32,472 
Capital Expenditures     
Years Ended December 3120202019201820172016
(In thousands)     
Aluminum Extrusions$10,260 $17,855 $12,966 $25,653 $15,918 
PE Films6,024 8,567 2,523 4,648 9,411 
Flexible Packaging Films4,959 8,866 5,423 3,619 3,391 
Subtotal21,243 35,288 20,912 33,920 28,720 
General corporate200 223 427 61 389 
Discontinued operations1,912 15,353 19,475 10,381 16,348 
Total capital expenditures$23,355 $50,864 $40,814 $44,362 $45,457 
Depreciation and Amortization
         
Years Ended December 312018 2017 2016 2015 2014
(In thousands)         
PE Films$15,513
 $14,609
 $13,653
 $15,480
 $21,399
Flexible Packaging Films1,262
 10,443
 9,505
 9,697
 9,331
Aluminum Extrusions16,866
 15,070
 9,173
 9,698
 9,974
Subtotal33,641
 40,122
 32,331
 34,875
 40,704
General corporate163
 155
 141
 107
 114
Total depreciation and amortization expense$33,804
 $40,277
 $32,472
 $34,982
 $40,818
          
Capital Expenditures         
Years Ended December 312018 2017 2016 2015 2014
(In thousands)         
PE Films$21,998
 $15,029
 $25,759
 $21,218
 $17,000
Flexible Packaging Films5,423
 3,619
 3,391
 3,489
 21,806
Aluminum Extrusions12,966
 25,653
 15,918
 8,124
 6,092
Subtotal40,387
 44,301
 45,068
 32,831
 44,898
General corporate427
 61
 389
 
 
Total capital expenditures$40,814
 $44,362
 $45,457
 $32,831
 $44,898
Refer to Notes to Financial Tables that follow these tables.


16


NOTES TO FINANCIAL TABLES
(a)Plant shutdowns, asset impairments, restructurings and other charges for 2018 include charges of $3.3 million associated with the shutdown of PE Films’ manufacturing facility in Shanghai, China, which consists of severance and other employee-related costs of $2.2 million ($0.4 million included in “Cost of goods sold” in the consolidated statements of income), accelerated depreciation of $0.6 million (included in “Cost of goods sold” in the consolidated statements of income) and other facility consolidation-related expenses of $0.5 million ($0.1 million included in “Cost of goods sold” in the consolidated statements of income); charges of $2.0 million for estimated excess costs associated with the ramp-up of new product offerings and additional expenses for strategic capacity expansion projects (included in “Cost of goods sold” in the consolidated statements of income); charges of $0.8 million for professional fees associated with the Terphane Limitada worthless stock deduction, the impairment of assets of Flexible Packaging Films, determining the effect of the new U.S. federal income tax law, and a market study for PE Films (included in “Selling, general and administrative expense” in the consolidated statements of income); charges of $0.8 million for severance and other employee-related costs associated with restructurings in PE Films ($0.7 million) and Aluminum Extrusions ($0.1 million); charges of $0.5 million associated with a business development projects (included in “Selling, general and administrative” in the consolidated statements of income); charges of $0.3 million related to expected environmental costs at certain Aluminum Extrusions manufacturing facilities (included in “Cost of goods sold” in the consolidated statements of income); charges of $0.5 million for professional fees associated with the implementation of new accounting guidance and analysis and revision to the Company’s internal control over financial reporting (included in “Selling, general and administrative” in the consolidated statements of income); income of $0.3 million from the reversal of a PE Films’ contingent liability related to the acquisition of Bright View Technologies (included in “Other income (expense), net” in the consolidated statements of income); charges of $0.1 million related to wind damage that occurred in the third quarter of 2018 at the aluminum extrusions manufacturing facility in Elkhart, Indiana (included in “Selling, general and administrative expense” in the consolidated statements of income); and charges of $0.1 million related to a fire that occurred in the fourth quarter of 2018 at the PE Films facility in Retsag, Hungary (included in “Selling, general and administrative expense” in the consolidated statements of income).
(b)Plant shutdowns, asset impairments, restructurings and other charges for 2017 include charges of $101.3 million related to the impairment of assets of Flexible Packaging Films; income of $11.9 million related to the settlement of an escrow arrangement established upon the acquisition of Terphane in 2011 (included in “Other income (expense), net” in the consolidated statements of income); charges of $3.3 million related to the acquisition of Futura ($1.7 million included in “Cost of goods sold” and $1.6 million included in “Selling, general and administrative expense” in the consolidated statements of income), offset by pretax income of $0.7 million related to the fair valuation of an earnout provision (included in “Other income (expense), net” in the condensed consolidated statements of income); charges of $4.1 million for estimated excess costs associated with the ramp-up of new product offerings and additional expenses for strategic capacity expansion projects (included in “Cost of goods sold” in the consolidated statements of income); income of $5.6 million related to the explosion that occurred in the second quarter of 2016 at the aluminum extrusions manufacturing facility in Newnan, Georgia, including the recognition of a gain of $5.3 million for a portion of the insurance recoveries received from the insurer for the replacement of capital equipment, plus the recovery of excess production costs incurred in 2016 for which recovery from insurance carriers was not previously considered to be reasonably assured, net of other nonrecoverable costs, of $0.3 million ($0.4 million benefit included in “Cost of goods sold” in the consolidated statements of income and $0.1 million charge included in “Selling, general and administrative expenses” in the consolidated statements of income); charges of $0.8 million associated with the consolidation of domestic PE Films manufacturing facilities, which includes asset impairments of $0.1 million, accelerated depreciation of $0.3 million and other facility consolidation-related expenses of $0.5 million (included in “Cost of goods sold” in the consolidated statements of income) offset by income of $0.1 million related to a reduction of severance and other employee-related accrued costs; charges of $2.4 million associated with business development projects (included in “Selling, general and administrative” in the consolidated statements of income); charges of $1.9 million related to expected future environmental costs at certain Aluminum Extrusions manufacturing facilities (included in “Cost of goods sold” in the consolidated statements of income); charges of $0.8 million at Corporate related to expected future environmental costs at various shutdown facilities (included in “Cost of goods sold” in the consolidated statements of income); charge of $0.7 million for severance and other employee-related costs associated with restructurings in PE Films ($0.2 million), Aluminum Extrusions ($0.1 million) and Corporate ($0.4 million, included in “Corporate expenses, net” in the statements of net sales and operating profit by segment); charges of $0.4 million for professional fees associated with the Terphane Limitada worthless stock deduction and impairment of assets of Flexible Packaging Films; charges of $0.3 million associated with asset impairments in PE Films; and charges of $0.2 million associated with the settlement of customer claims and the shutdown of the aluminum extrusions manufacturing facility in Kentland, Indiana.
(c)Plant shutdowns, asset impairments, restructurings and other charges for 2016 include income of $0.4 million related to the explosion that occurred in the second quarter of 2016 at the aluminum extrusions manufacturing facility in Newnan, Georgia, which includes the recognition of a gain of $1.9 million for a portion of the insurance recoveries approved by the insurer to begin the replacement of capital equipment, offset by the impairment of equipment damaged by the explosion of $0.3 million (net amount included in “Other income (expense), net” in the consolidated statements of income) and other costs related to the explosion that are not recoverable from insurance of $0.6 million (included in “Selling, general and administrative”) and excess production costs for which recovery from insurance is not assured of $0.6 million (included in “Cost of goods sold” in the consolidated statements of income); charges of $4.3 million associated with the consolidation of domestic PE Films manufacturing facilities, which includes severance and other employee-related costs of $1.2 million, asset impairments of $0.4 million, accelerated depreciation of $0.6 million (included in “Cost of goods sold” in the consolidated statements of income) and other facility consolidation-related expenses of $2.0 million ($1.6 million is included in “Cost of goods sold” in the consolidated statements of income); charges of $0.4 million associated with a business development project included in “Selling, general and administrative” in the consolidated statements of income); charges of $0.3 million for severance and other employee-related costs associated with restructurings in PE Films ($0.1 million) and Corporate ($0.2 million); charges of $0.6 million associated with the acquisition of Futura (included in “Selling, general and administrative” in the consolidated statements of income); charges of $0.5 million related to expected future environmental costs at the Company’s aluminum extrusions manufacturing facility in Newnan, Georgia (included in “Cost of goods sold” in the consolidated statements of income); charges of $0.3 million related to the settlement of a tax dispute in the Flexible Packaging Films segment (included in “Cost of goods sold” in the consolidated statements of income); charges of $0.2 million associated with asset impairments in PE Films; gain of $0.1 million from the settlement of a Terphane pre-acquisition contingency (included in “Other income (expense), net” in the consolidated statements of income); charge of $0.1 million from the sale of the aluminum extrusions manufacturing facility in Kentland, Indiana, which includes a pretax gain of $0.2 million, related to the sale of property, offset by pretax charges of $0.3 million associated with the shutdown of this facility.
(d)Results for 2018 included a goodwill impairment charge of $46.8 million ($38.2 million after taxes) recognized in PE Films in the third quarter of 2018 upon completion of an impairment analysis performed as of September 30, 2018. Results for 2015 included a goodwill impairment charge of $44.5 million ($44.5 million after taxes) recognized in Flexible Packaging Films in the third quarter of 2015 upon completion of an impairment analysis performed as of September 30, 2015.
(e)Plant shutdowns, asset impairments, restructurings and other charges for 2015 include charges of $3.9 million (included in “Selling, general and administrative” in the consolidated statements of income) for severance and other employee-related costs associated with the resignation of the Company’s former chief executive and chief financial officers; charges of $2.2 million associated with the consolidation of domestic PE Films manufacturing facilities, which includes severance and other employee-related costs of $0.8 million, asset impairments of $0.4 million, accelerated depreciation of $0.4 million (included in “Cost of goods sold” in the consolidated statements of income) and other facility consolidation-related expenses of $0.6 million ($0.1 million is included in “Cost of goods sold” in the consolidated statements of income); charge of $2.2 million for severance and other employee-related costs associated with restructurings in PE Films ($2.0 million) ($0.4 million included in “Selling, general and administrative expense” in the consolidated statement of income), Flexible Packaging Films ($0.2 million), Aluminum Extrusions ($35,000) and Corporate ($26,000); charges of $1.0 million associated with a business development project (included in “Cost of goods sold” in the consolidated statements of income); charges of $0.4 million associated with the shutdown of the aluminum extrusions manufacturing facility in Kentland, Indiana; and charges of $0.3 million related to expected future environmental costs at the aluminum extrusions manufacturing facility in Newnan, Georgia (included in “Cost of goods sold” in the consolidated statements of income).
(f)Plant shutdowns, asset impairments, restructurings and other for 2014 include a charge of $10.0 million (included in “Other income (expense), net” in the consolidated statements of income) associated with the one-time, lump sum license payment to 3M Company (“3M”) after the Company settled all litigation issues associated with a patent infringement complaint; charges of $2.3 million for severance and other employee-related costs in connection with restructurings in PE Films ($1.7 million), Flexible Packaging Films ($0.6 million) and Aluminum Extrusions ($31,000); charges of $0.9 million related to expected future environmental costs at the aluminum extrusions manufacturing facility in Newnan, Georgia (included in “Cost of goods sold” in the consolidated statement of income); charges of $0.7 million associated with the shutdown of the film products manufacturing facility in Red Springs, North Carolina, which includes severance and other employee-related costs of $0.4 million and asset impairment and other shutdown-related charges of $0.3 million; gain of $0.1 million related to the sale of previously shutdown film products manufacturing facility in LaGrange, Georgia (included in “Other income (expense), net” in the consolidated statements of income); and charges of $54,000 associated with the shutdown of the aluminum extrusions manufacturing facility in Kentland, Indiana. The unrealized loss of $0.8 million on the Company’s investment in Harbinger Capital Partners Special Situations Fund L.P. (“Harbinger”) and the gain of $1.2 million on sale on a portion the Company’s investment property in Alleghany and Bath County, Virginia in 2014 are included in “Other income (expense), net” in the consolidated statements of income.
(g)On February 12, 2008, Tredegar sold its aluminum extrusions business in Canada. All historical results for this business have been reflected as discontinued operations. In 2014, accruals for indemnifications under the purchase agreement were adjusted, resulting in income from discontinued operations of $0.9 million.
(h)Total return to shareholders is defined as the change in stock price during the year plus dividends per share, divided by the stock price at the beginning of the year.
(i)Equity market capitalization is the closing market price per share for the period multiplied by the shares outstanding at the end of the period.
(j)Net sales represent gross sales less freight. Net sales is the measure used by the chief operating decision maker for purposes of assessing performance.
(k)The gains and losses on the Company’s investment in kaléo are included in “Other income (expense), net” in the consolidated statements of income.
(l)Equity per share is computed by dividing shareholders’ equity at year end by the shares outstanding at end of period.
(m)For the years ended December 31, 2014 to 2017, the pension and postretirement benefit expenses recorded in Cost of goods sold and Selling, general and administrative have been reclassified to a new line item, Pension and postretirement benefits, on the consolidated statements of income, due to the retrospective adoption of ASU 2017-07.

(a)For a description of plant shutdowns, asset impairments, restructurings and other charges for 2020, 2019, and 2018, see the plant shutdowns, asset impairments, restructurings and other tables for the respective periods in Results of Operations in Item 7.

(b)For a description of plant shutdowns, asset impairments, restructurings and other charges for 2017 and 2016, see Item 6. “Selected Financial Data” of the Company’s Annual Report on Form 10-K for the year ended December 31, 2018.
Item 7.MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
(c)Results for 2020 included a goodwill impairment charge of $13.7 million ($10.5 million after taxes) recognized in Bonnell Aluminum in the first quarter of 2020 upon completion of an impairment analysis performed as of March 31, 2020.
(d)Total return to shareholders is defined as the change in stock price during the year plus dividends per share, divided by the stock price at the beginning of the year.
(e)Equity market capitalization is the closing market price per share for the period multiplied by the shares outstanding at the end of the period.
(f)Net sales represents gross sales less freight. The Company uses net sales as its measure of revenues from external customers at the segment level.
(g)The gains and losses on the Company’s investment in kaléo are included in “Other income (expense), net” in the consolidated statements of income. See Note 4 to the Consolidated Financial Statements in Item 15 for more details for the years 2020, 2019 and 2018.
(h)Equity per share is computed by dividing shareholders’ equity at year end by the shares outstanding at year end.
(i)For the year ended December 31, 2017, the pension and postretirement benefit expenses recorded in Cost of goods sold and Selling, general and administrative expenses were reclassified to a new line item, Pension and postretirement benefits, on the consolidated statements of income, due to the retrospective adoption of Accounting Standards Update (“ASU”) 2017-07.
(j)Depreciation and amortization (“D&A”) in 2019 for Aluminum Extrusions excludes $10.0 million for accelerated amortization of trade names as a result of a rebranding initiative.
(k)Corporate depreciation and amortization is included in Corporate expenses, net, on the EBITDA from ongoing operations table above.
(l)In the fourth quarter of 2019, the Company changed its segment measure of profit and loss from operating profit from ongoing operations to EBITDA (earnings before interest, taxes, depreciation and amortization) from ongoing operations.  EBITDA from ongoing operations is the key profitability metric used by the Company’s chief operating decision maker to assess segment financial performance. See Note 5 to the Consolidated Financial Statements in Item 15 for additional business segment information.
(m)EBIT (earnings before interest and taxes) from ongoing operations is a non-GAAP financial measure included in the reconciliation of segment financial information to consolidated results for the Company.  It is not intended to represent the stand-alone results for Tredegar’s ongoing operations under GAAP and should not be considered as an alternative to net income as defined by GAAP.  EBIT is a widely understood and utilized metric that is meaningful to certain investors.  We believe that including this financial metric in the reconciliation of management’s performance metric, EBITDA from ongoing operations, provides useful information to those investors that primarily utilize EBIT to analyze the Company’s core operations.
(n)On December 1, 2020, the Board declared a special cash dividend of $200 million or $5.97 per share on the Company’s common stock. The special cash dividend was payable on December 18, 2020 to shareholders of record at the close of business on December 11, 2020.
(o)In December 2020, the Company entered into a definitive agreement and completed the sale of Bright View. See Note 2 to the Consolidated Financial Statements in Item 15 for more details.
17



Item 7.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Forward-looking and Cautionary Statements
Some of the information contained in this Form 10-K may constitute “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. When using the words “believe,” “estimate,” “anticipate,” “expect,” “project,” “plan,” “likely,” “may” and similar expressions, Tredegar does so to identify forward-looking statements. Such statements are based on Tredegar’s then current expectations and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those addressed in the forward-looking statements. It is possible that Tredegar’s actual results and financial condition may differ, possibly materially, from the anticipated results and financial condition indicated in or implied by these forward-looking statements. In addition, the Company's current projections for its businesses could be materially affected by the highly uncertain impact of COVID-19. As a consequence, the Company's results could differ significantly from its projections, depending on, among other things, the duration of "shelter in place" orders and the ultimate impact of the pandemic on employees, supply chains, customers and the U.S. and world economies. Accordingly, you should not place undue reliance on these forward-looking statements. For risks and important factors that could cause actual results to differ from expectations, refer to the reports that Tredegar files with or furnishes the SEC from time-to-time, including the risks and important factors set forth in “Risk Factors” in Part I, Item 1A of this Form 10-K.1A. Readers are urged to review and consider carefully the disclosures Tredegar makes in the reports Tredegar files with or furnishes to the SEC. Tredegar does not undertake, and expressly disclaims any duty, to update any forward-looking statement to reflect any change in management’s expectations or any change in conditions, assumptions or circumstances on which such statements are based, except as required by applicable law.
Executive Summary
General
Tredegar Corporation is aan industrial manufacturer of polyethylene (“PE”) plasticwith three primary businesses: custom aluminum extrusions for the North American building & construction, automotive and specialty end-use markets through its Aluminum Extrusions segment; surface protection films for high-technology applications in the global electronics industry through its PE Films segment; and specialized polyester films primarily for the Latin American flexible packaging market through its Flexible Packaging Films segment. With approximately 2,400 employees, the Company operates manufacturing facilities in North America, South America, and aluminum extrusions. DescriptionsAsia.
On October 30, 2020, the Company completed the sale of allits personal care films business (“Personal Care Films”). The transaction excluded the Company’s businessespackaging film lines and related operations located at the Pottsville, Pennsylvania manufacturing site (“Pottsville Packaging”), which are providednow being reported within the Surface Protection component of PE Films. Commencing in the Business section.third quarter of 2020, all historical results for Personal Care Films have been presented as discontinued operations. For more information on these transactions, see Note 2 to the Consolidated Financial Statements in Item 15.
Sales were $1.1 billion$755.3 million in 20182020 compared to $961.3$826.3 million in 2017.2019. Net incomeloss from continuing operations was $24.8$16.8 million ($0.750.51 per diluted share) in 2018,2020, compared with $38.3net income from continuing operations of $58.5 million ($1.161.76 per diluted share) in 2017.2019.
The 20182020 results include:
An after-tax loss on the Company’s investment in kaléo of $47.6 million ($1.42 per diluted share), which is accounted for under the fair value method (see Note 4 to the Consolidated Financial Statements in Item 15 for more details); and
An impairment of the total goodwill balance of PE Films’ Personal Care divisionAluminum Extrusions' reporting unit acquired in the AACOA acquisition in 2012 was recorded in the after-tax amount of $38.2$10.5 million ($1.150.32 per share after-tax)diluted share). See
The 2019 results include:
An after-tax dividend received from kaléo of $14.8 million ($0.45 per diluted share); and
An unrealized after-tax gain on the Customer Product TransitionsCompany’s investment in Personal Care and Surface Protection section below and Note 8 for more details; and
kaléo of $8.5 million ($0.26 per diluted share).
The 2018 results include:
An unrealized after-tax gain on the Company’s investment in kaléo of $23.9 million ($0.72 per diluted share), which is accounted for under the fair value method (see Note 4 for more details);.
The 2017 results include:
An unrealized after-tax gain on the Company’s investment in kaléo of $24.0 million ($0.73 per share);
An after-tax gain of $11.9 million ($0.36 per share) from the settlement of an escrow agreementOther losses related to the Terphane acquisition in 2011 (see Note 17 for more details);
An income tax benefit of $61.4 million ($1.86 per share)asset impairments and costs associated with the write-off of the stock basis of Terphane Limitada, Terphane’s Brazilian subsidiary,exit and Terphane’s U.S. subsidiary, Terphane Inc., computed at the 35% U.S. corporate federal income tax rate in effect in 2017 ($56.6 million ($1.72 per share) when reduceddisposal activities for continuing operations were not material for the deductions applicable to the 21% U.S. corporate federal income tax rate effective inyears ended December 31, 2020, 2019 and 2018, under the Tax Cuts and Jobs Act (the “TCJA”)) (see Note 16 for more details);
An income tax benefit from the adjustment of deferred income tax liabilities as a result of the reduction of U.S. federal corporate income tax rates effective in 2018 and other law changes of $4.4 million ($0.13 per share) (see Note 16 for more details); and
An after-tax write-down of the assets of Flexible Packaging Films of $87.2 million ($2.65 per share) (see Note 17 for more details).
Other lossesrespectively. Losses associated with plant shutdowns, asset impairments, and restructurings and gains and losses on the sale of assets, and other items are described in Note 17. Net sales (sales less freight)Results of Operations. Earnings before interest, taxes, depreciation and operating profitamortization (“EBITDA”) from ongoing operations areis the measuresmeasure of salesprofit and operating profitloss used by theTredegar’s chief operating decision maker of each segment(“CODM”) for purposes of assessing financial performance. The Company uses sales less
18


freight (“net sales”) from continuing operations as its measure of revenues from external customers at the segment level. This measure is separately included in the financial information regularly provided to the CODM.
EBIT (earnings before interest and taxes) from ongoing operations is a non-GAAP financial measure included in the reconciliation of segment financial information to consolidated results for the Company. It is not intended to represent the stand-alone results for Tredegar’s ongoing operations under GAAP and should not be considered as an alternative to net income as defined by GAAP. EBIT is a widely understood and utilized metric that is meaningful to certain investors. We believe that including this financial metric in the reconciliation of management’s performance metric, EBITDA from ongoing operations, provides useful information to those investors that primarily utilize EBIT to analyze the Company’s core operations.
THE IMPACT OF COVID-19
Essential Business and Employee Considerations
The Company’s priorities during the COVID-19 pandemic continue to be to protect the health and safety of employees while keeping its manufacturing sites open due to the essential nature of many of its products. Within the limitations imposed by the health and safety procedures described below, the Company has continued to manufacture the full range of products at its facilities.
The Company’s protocols to protect the health and well-being of its employees from COVID-19 continue to develop as COVID-19 informed work practices evolve and the Company responds to recommended and mandated actions of government and health authorities. In addition, to facilitate a return to fully functional operations, the Company has undertaken an education campaign to provide employees with the most accurate and up-to-date information available, particularly from the Centers for Disease Control (“CDC”), the Office of the Surgeon General and state and local health departments. The Company believes that these efforts will encourage employees to receive a vaccine when they are eligible.
The Company has educated employees about COVID-19, including how the virus is spread, COVID-19 symptoms and mitigation efforts to keep employees safe. Even in those facilities not bound by the Families First Coronavirus Response Act, the Company has adopted COVID-19 related pay and sick leave policies and remote work policies that require employees to stay home if they feel ill or have been exposed to others with the illness, until they are cleared to return to work by our Human Resources team, who applies CDC and other state health department guidance to each case. The Company’s policies include: mandating employees self-monitor for symptoms; taking an employee’s temperature before entering production facilities; answering self-screening questions related to potential exposure and COVID-19 symptoms; mandating frequent handwashing; requiring social distancing; requiring face coverings on production floors at all times and in common areas and office settings where social distancing is difficult; streamlining onsite personnel to only those required for production and distribution; strongly encouraging and, where mandated, requiring remote work for all those who can work from home; limiting travel to essential business purposes; and regularly cleaning and disinfecting facilities. In the U.S., the Company has educated employees on COVID-19-related government benefits and has provided such benefits even in those facilities where the government benefits are not mandated.
Bonnell Aluminum is experiencing higher than normal absenteeism and hiring difficulties, which it attributes to COVID-19-related factors. Bonnell Aluminum attempts to match its direct labor with demand and is facing difficulty maintaining sufficient labor to meet desired shipment levels.
Financial Considerations
The 2020 annual plan for Bonnell Aluminum (pre-COVID-19) included sales volume of 201 million pounds and EBITDA from ongoing operations of $65 million, versus 2019 sales volume of 208 million pounds and EBITDA from ongoing operations of $65.7 million. Actual 2020 sales volume was 186 million pounds and EBITDA from ongoing operations was $55.1 million. Approximately 62% of Bonnell Aluminum’s sales volume in 2020 was related to building and construction (“B&C”) markets (non-residential B&C of 55% and residential B&C of 7%). Much of the 2020 sales volume associated with the B&C market was related to contracts that existed at the start of the COVID-19 pandemic. With the completion of many of these contracts, Bonnell began experiencing weakness in the B&C market during the fourth quarter of 2020. Overall, the Company believes that volume results for Bonnell Aluminum in 2020 have outperformed the industry, and performance to date during the COVID-19 environment has exceeded the Company's expectations, with current bookings and backlog at high levels. No significant issues have arisen to date on the collection of accounts receivable at Bonnell Aluminum.
Demand has remained strong under COVID-19 conditions for the Company’s flexible food packaging films produced by Terphane. The Surface Protection component of PE Films had record performance for EBITDA from ongoing operations in the second quarter and first half of 2020, but it experienced a slowdown in the third quarter, with a portion of the decline in volume related to a previously disclosed customer product transition and customer inventory corrections. The Company believes that while Surface Protection’s customer inventory corrections were largely resolved during the third quarter of 2020, it will experience a significant decline in volume and profitability in the first quarter of 2021 as a result of the customer product
19


transition. See the tablePE Films section below for further discussion. No significant issues have arisen to date on the collection of accounts receivable at Terphane or Surface Protection.
Tredegar owns approximately 20% of kaleo, Inc. (“kaléo”), which makes and sells an epinephrine delivery device under the name AUVI-Q®. The Company accounts for its investment in Note 5kaléo on a fair value basis. The Company’s estimate of the fair value of its interest in kaléo at December 31, 2020 was $34.6 million ($29.7 million after taxes), which represents an increase of $0.1 million ($0.1 million after taxes) and a decrease of $60.9 million ($47.6 million after taxes) since September 30, 2020 and December 31, 2019, respectively. The decline in estimated fair value in 2020 was primarily due to: (i) current projections that assume ongoing pricing pressures, (ii) expected changes in market access as well as continued lower market demand for epinephrine delivery devices resulting from COVID-19-driven delays in in-person back-to-school schedules and social distancing guidelines, and (iii) a higher private company liquidity discount.kaléo’s stock is not publicly traded. The ultimate value of Tredegar’s ownership interest in kaléo could be materially different from the $34.6 million estimated fair value reflected in the Company’s financial statements at December 31, 2020.
Total debt was $134 million at December 31, 2020, compared to $42 million at December 31, 2019. Net debt (debt in excess of cash and cash equivalents), a non-GAAP financial measure, was $122.2 million at December 31, 2020, compared to $10.6 million at December 31, 2019. In December 2020, the Company paid a special dividend of $5.97 per share or $200 million, as a result of strong cash generation and overall net cash proceeds of approximately $46 million relating to the sale of Personal Care Films. The overall net cash proceeds resulted from net proceeds of $53 million received in the fourth quarter of 2020 less $7 million of expected expenditures during 2021, primarily related to information technology transition services and severance. The Company’s revolving credit agreement allows borrowings of up to $375 million and matures in June 2024. The Company believes that its most restrictive covenant (computed quarterly) is the leverage ratio, which permits maximum borrowings of up to 4x EBITDA, as defined under the revolving credit agreement for the trailing four quarters (“Credit EBITDA”). The Company had Credit EBITDA and a leverage ratio (calculated in the “Liquidity and Capital Resources” below) of $93.4 million and 1.43x, respectively, at December 31, 2020. The Company’s current stress testing under a COVID-19-driven recession indicates a low probability that a future leverage ratio will exceed 4.0x. See the “Liquidity and Capital Resources” below for a presentationreconciliation of Tredegar’s net debt, a non-GAAP financial measure, to the most directly comparable GAAP financial measure.
OPERATIONS REVIEW
Segment Analysis. A summary of results for 2020 versus 2019 for each of the Company’s reporting segments is shown below.
Aluminum Extrusions
A summary of results for Aluminum Extrusions is provided below: 
Year EndedFavorable/
(In thousands, except percentages)December 31,(Unfavorable)
20202019% Change
Sales volume (lbs)186,391 208,249 (10.5)%
Net sales$455,711 $529,602 (14.0)%
Ongoing operations:
EBITDA$55,137 $65,683 (16.1)%
Depreciation & amortization*(17,403)(16,719)(4.1)%
EBIT**$37,734 $48,964 (22.9)%
Capital expenditures$10,260 $17,855 
* Excludes pre-tax accelerated amortization of trade names of $10.0 million in the year ended December 31, 2019.
** See the table in Item 6. “Selected Financial Data” of this Form 10-K (“Item 6”) for a reconciliation of this non-GAAP measure to GAAP.
Net sales in 2020 decreased by 14.0% versus 2019 primarily due to lower sales volume and the pass-through of lower metal costs, partially offset by an increase in average selling prices to cover higher operating profitcosts. Sales volume in 2020 decreased by segment10.5% versus 2019 with declines in all key markets, which the Company believes was mainly a result of COVID-19-related lower demand.
EBITDA from ongoing operations in 2020 decreased by $10.5 million in comparison to 2019 due to lower volume ($16.1 million) and higher labor and employee-related costs ($4.3 million), partially offset by higher pricing ($8.1 million), lower freight ($0.8 million) and lower travel and entertainment expenses as a result of COVID-19 ($0.9 million).
20


Projected Capital Expenditures and Depreciation & Amortization
Capital expenditures are projected to be $21 million in 2021, including $3 million for infrastructure upgrades at the years ended December 31, 2018Carthage, Tennessee and 2017.


Newnan, Georgia facilities, $3 million for a roof replacement at the Elkhart, Indiana site and $4 million for strategic projects. In addition, approximately $11 million will be required to support continuity of current operations. Depreciation expense is projected to be $14 million in 2021. Amortization expense is projected to be $3 million in 2021.
PE Films
A summary of operating results for PE Films is provided below: 
Year EndedFavorable/
(In thousands, except percentages)
Year Ended
December 31
 
Favorable/
(Unfavorable)
(In thousands, except percentages)December 31,(Unfavorable)
2018 2017 % Change20202019% Change
Sales volume (lbs)123,583
 138,999
 (11.1)%Sales volume (lbs)45,175 43,983 2.7 %
Net sales$332,488
 $352,459
 (5.7)%Net sales$139,288 $133,807 4.1 %
Operating profit from ongoing operations$36,181
 $41,546
 (12.9)%
Ongoing operations:Ongoing operations:
EBITDAEBITDA$45,107 $41,133 9.7 %
Depreciation & amortizationDepreciation & amortization(6,762)(5,860)(15.4)%
EBIT*EBIT*$38,345 $35,273 8.7 %
Capital expendituresCapital expenditures$6,024 $8,567 
* See the table in Item 6 for a reconciliation of this non-GAAP measure to GAAP.* See the table in Item 6 for a reconciliation of this non-GAAP measure to GAAP.
Net sales increased by 4.1% in 2018 decreased by $20.0 million2020 versus 20172019 primarily due to:
The volume decline in Personal Care was primarily related to topsheet business lost from competitive pressures in North America, Europe and Asia, including at the Shanghai, China, facility that was shut down in the fourth quarterhigher sales of 2018. A small portion of the volume decline was associated with the start of the previously disclosed customer product transition discussed below. Volume for elastics products in Personal Care increased year-over-year.
Slightly lower sales in Surface Protection caused by lower volume and the adverse impact of quality claims, partially offset by higher volume-based selling prices.
Operating profit from ongoing operations in 2018 decreased by $5.4 million versus 2017 primarily due to:
Lower contributionunrelated to profits from Personal Care, primarily due to lower volume and unfavorablecustomer product mixtransitions ($9.312.0 million), partially offset by volume-based higher selling pricinglower sales associated with the customer product transitions this year ($2.26.8 million), lower fixed and selling, general and administrative costs ($1.1 million), the timing of resin cost passthroughs ($0.7 million), productivity improvements ($0.3 million) and net favorable impact.
EBITDA from the changeongoing operations in U.S. Dollar value of currencies for operations outside of the U.S. ($0.8 million);
2020 increased by $4.0 million versus 2019 primarily due to:
Lower contribution to profitsA $3.2 million increase from Surface Protection, primarily due to lower volumes and unfavorablesales of products unrelated to the customer product mixtransitions ($4.1 million), the adverse impact of quality claims ($1.3 million), higher fixed and other manufacturing costs ($1.6 million), higher research and development spending and selling, general and administrative costs ($0.4 million) and higher freight costs ($0.58.3 million), partially offset by volume-based higher selling prices ($4.4 million); and
Realized cost savingslower sales associated with the North American consolidation of our PE Films manufacturing facilities completed in 2017customer product transitions ($2.44.5 million).
; and
In June 2018, the Company announced plansA $0.8 million increase from Pottsville Packaging primarily related to close its facility in Shanghai, China, which primarily produced topsheet films used as components for personal care products.  Production ceased at this plant during the fourth quarter of 2018. Net annual cash savings from consolidating operations is projected at $1.7 million. Additional information on costs associated with exithigher sales volume and disposal activities (currently estimated at $5.0 million) and other details are available in Note 17.favorable raw materials pricing.
Customer Product Transitions in Personal Care and Surface Protection
During October 2018, the Personal Care component of PE Films completed negotiations with a customer regarding a previously disclosed significant product transition. The total annual sales that will be adversely impacted by this product transition is approximately $70 million. During 2019, the Company expects sales for the product of $30 to $35 million with the potential for no sales thereafter. Any actions that the Company takes to reduce fixed costs to partially mitigate the decline in variable contribution that will accompany the decline in sales will depend on the level of success that Personal Care has with replacing the lost business with new products and business.
Personal Care has increased its annual R&D spending by approximately $5 million since 2014, reaching $12 million in 2018. Personal Care is also investing capital and is accelerating sales and marketing efforts to capture growth and diversify its customer base and product offerings.
The Personal Care component of PE Films had operating profit from ongoing operations plus depreciation and amortization in the fourth quarter of 2018 of $3.1 million. As a result of the decline in sales from the significant product transition discussed above, the Company expects operating profit from ongoing operations plus depreciation and amortization for this component of approximately negative $1.5 million during the first half of 2019. Personal Care projects its operating


profit from ongoing operations plus depreciation and amortization to turn positive in the second half of 2019 assuming production and sales growth targets are achieved.
Because of the significance of the customer transition discussed above, the Company performed an asset recoverability test and goodwill impairment analysis for the Personal Care component of PE Films. The Company’s analysis concluded that the fair value of the Personal Care reporting unit was less than its carrying value. Accordingly, the goodwill associated with Personal Care of $46.8 million ($38.2 million after deferred income tax benefits) was written off during the third quarter of 2018.
The Surface Protection component of PE Films supports manufacturers of optical and other specialty substrates used in flat panel display products. These films are primarily used by customers to protect components of displays in the manufacturing and transportation processes and then discarded.
The Company previously reported the risk that a portion of its film products used in surface protection applications will be made obsolete by possible future customer product transitions to less costly alternative processes or materials. These transitions could possibly be fully implementedprincipally relate to one customer. The Company believes that previously reported delays in this customer's transitions were recently resolved by the fourth quartercustomer and much of 2019. When fully implemented,the remaining transitions could occur by the end of 2021. Under this scenario, the Company estimates that the annualizedcontribution to EBITDA from ongoing operations for PE Films could decline due to the remaining customer product transitions by $18 million in 2021 versus 2020 and $4 million in 2022 versus 2021. To offset the expected adverse impact, on future operating profit from this customer shift will be approximately $11 million. Thethe Company is aggressively pursuing and making progress in generating contribution from sales from new surface protection products, applications and customers.
Capital Expenditurescustomers and Depreciation
Capital expenditures in PE Films were $22.0 million in 2018 comparedimplementing cost savings measures. Annual contribution to $15.0 million in 2017. The Company’s business plans for 2019 include projected capital expenditures of approximately $45 million including: $12 million of a total $25 million needed to complete the North American capacity expansion for elastics products and $9 million for other projects to support next generation elastics in Personal Care; $5 million in Personal Care in support of topsheet products; $4 million for a new scale-up line in Surface Protection to improve development and speed to market for new products; $5 million for other development projects; and $10 million for capital expenditures required to support continuity of current operations.
From 2016 to 2018, the Company spent annually on average approximately $15 million less than originally planned for capital expenditures.  Actual capital expenditures in 2019 will depend on approval of specific capital project requests and will consider progress towards replacing lost business with new products and business in Personal Care.
Depreciation expense was $15.4 million in 2018 and $14.5 million in 2017. Depreciation expense is projected to be $16 million in 2019.
Flexible Packaging Films
A summary of operating results for Flexible Packaging Films is provided below:
(In thousands, except percentages)
Year Ended
December 31
 
Favorable/
(Unfavorable)
2018 2017 % Change
Sales volume (lbs)98,994
 89,325
 10.8%
Net sales$123,830
 $108,355
 14.3%
Operating profit (loss) from ongoing operations$9,892
 $(2,626) n/a

Net sales in 2018 increased versus 2017 primarily due to higher sales volume and increased selling prices associated with the pass-through of higher resin costs. The higher sales volume was supported by increased production capacity for Brazilian operations resulting from the re-start in June 2018 of a previously idled production line.
Terphane had operating profitEBITDA from ongoing operations infor PE Films on surface protection products unrelated to the customer product transitions has increased since 2018 of $9.9 million versus an operating loss from ongoing operations in 2017 of $2.6by approximately $12 million. The resulting favorable change of $12.5 million for the period was primarily due to:
Significantly lower depreciation and amortization of $8.9 million resulting from the $101 million non-cash asset impairment loss recognized in the fourth quarter of 2017;
A benefit from higher volume ($5.5 million) and favorable tax incentives ($1.3 million), partially offset by the unfavorable impact of mix and higher resin costs, net of higher selling prices ($2.2 million);


Higher fixed and other manufacturing costs and selling, general and administrative costs, primarily related to higher volume ($2.0 million);
Favorable foreign currency translation of Real-denominated operating costs ($3.2 million), which was offset by a $1.7 million loss on foreign currency forward contracts that partially hedged Real-denominated operating costs; and
Unfavorable net foreign currency transaction impact ($0.6 million) resulting from foreign currency transaction losses of $0.8 million in 2018 and losses of $0.2 million in 2017.
Projected Capital Expenditures and Depreciation & Amortization
Capital expenditures in Flexible Packaging were $5.4 million in 2018 compared to $3.6 million in 2017. Capital expenditures are projected to be $13$5 million in 2019, including $72021, including: $2 million for new capacity for value-added products and productivity projects and $6$3 million for capital expenditures required to support continuity of current operations. Depreciation expense was $0.8 million in 2018 and $7.5 million in 2017. Depreciation expense is projected to be $1$6 million in 2019. Amortization expense was $0.4 million in 2018 and $3.0 million in 2017, and2021. There is projected to be $0.5 million in 2019. Depreciation andno amortization expense projections in 2018 were significantly lower than 2017 due to the non-cash write-down of Terphane’s long-lived assets during the fourth quarter of 2017.for PE Films.
Aluminum Extrusions
21


Flexible Packaging Films
A summary of operating results for Aluminum ExtrusionsFlexible Packaging Films is provided below:
(In thousands, except percentages)
Year Ended
December 31
 
Favorable/
(Unfavorable)
2018 2017 % Change
Sales volume (lbs)*190,696
 176,269
 8.2%
Net sales$573,126
 $466,833
 22.8%
Operating profit from ongoing operations$48,613
 $43,454
 11.9%
*Sales volume for the years ended December 31, 2018 and 2017 excludes sales volume of 33,170 lbs. and 23,166 lbs., respectively, associated with Futura, which was acquired on February 15, 2017.
Year EndedFavorable/
(Unfavorable)
% Change
(In thousands, except percentages)December 31,
20202019
Sales volume (lbs)113,115 105,276 7.4 %
Net sales$134,605 $133,935 0.5 %
Ongoing operations:
EBITDA$30,645 $14,737 107.9 %
Depreciation & amortization(1,761)(1,517)(16.1)%
EBIT*$28,884 $13,220 118.5 %
Capital expenditures$4,959 $8,866 
* See the table in Item 6 for a reconciliation of this non-GAAP measure to GAAP.
Net sales in 20182020 increased 0.5% versus 20172019 while volume increased 7.4% versus 2019 primarily due to higher volume and an increase in averagelower selling prices from the pass-through of higher market-drivenlower raw material costs.  Futura contributed $102.5 million of net salescosts and changes in 2018 versus $71.0 million for the 10½ months owned during 2017.  Excluding the impact of Futura, the increase in net sales was the result of higher sales volume ($32.4 million), an increase in average selling prices as noted above ($31.7 million) and improved mix ($10.8 million).product mix.
Volume on an organic basis, (which excludes the impact of the Futura acquisition) increased by 8.2% in 2018 versus 2017 due to higher volume in all of Aluminum Extrusion’s primary markets. Overall average capacity utilization during the fourth quarter of 2018 was in excess of 90%.  Bookings and backlog at the end of 2018 remained strong.
Operating profitTerphane’s EBITDA from ongoing operations in 20182020 increased by $5.2$15.9 million in comparison to 2017.  Excluding theversus 2019 due to:
Lower raw material costs, net of lower selling prices ($8.9 million), higher sales volume ($3.3 million), favorable profit impact of owning Futura for a full twelve-month periodproduct mix ($2.82.2 million) and the benefit for inventories accounted for under the LIFO method in the fourth quarter of 2018, as noted abovelower fixed costs ($2.31.0 million), operating profit from ongoing operations increased $0.1 million, primarily due to:
Higher volume ($5.1 million) and favorable mix ($5.8 million), which werepartially offset by higher employee-relatedvariable costs ($5.21.1 million), higher supplies and maintenance ($2.3 million), higher freight ($1.7 million), higher utilities, primarily in the first quarter of 2018 at the Newnan, Georgia facility ($0.9 million), and higher depreciationselling and general administration expenses ($0.90.4 million).;
The Company continuesNet favorable foreign currency translation of Real-denominated costs ($1.5 million);
Foreign currency transaction losses of $0.5 million in 2020 versus gains of $0.2 million in 2019; and
A benefit of $1.2 million in 2020 resulting from the favorable settlement of a dispute related to focus on fixing inefficiencies associated with the new extrusion line at its Niles, Michigan plant and estimates that operating profit from ongoing operations in 2018 would have been higher by $3 million if not for these inefficiencies. These inefficiencies are reflected in the higher costs noted above. value-added taxes.
Projected Capital Expenditures and Depreciation & Amortization
Capital expenditures for Aluminum Extrusions were $13.0 million in 2018 compared to $25.7 million in 2017. Capital expenditures are projected to be $18$9 million in 2019,2021, including approximately $9$5 million for infrastructure upgrades at the


Carthage, Tennessee facilitynew capacity for value-added products and other productivity improvement projects and approximately $8$4 million for capital expenditures required to support continuity of current operations. Depreciation expense was $13.4 million in 2018 compared to $11.9 million in 2017 and is projected to be $13$2 million in 2019.2021. Amortization expense was $3.4 million in 2018 and $3.1 million in 2017 and is projected to be $4$0.4 million in 2019.2021.
Corporate Expenses, Investments, Interest and Income Taxes
Pension expense was $10.3$14.6 million in 2018,2020, an unfavorable change of $0.2$5.1 million from 2017. Most of the2019. The impact on earnings from lower pension expense is reflected in “Corporate expenses, net” in the Operating Profitnet sales and operating profit by segment table in Note 5.5 to the Consolidated Financial Statements in Item 15. Pension expense is projected to be $9.6$14.0 million in 2019. Corporate2021, which is determined at the beginning of the year based on the funded status of the Company’s defined benefit pension plan and actuarial assumptions at that time. In addition to the higher pension expense in 2020 compared to 2019, corporate expenses, net, decreased in 2018 versus 2017increased primarily due to lowerhigher professional fees ($3.4 million) related to business development activities and environmental costs,higher stock compensation expense ($1.0 million), partially offset by higher stock-based employee benefit costs.lower environmental expenses ($0.6 million) and lower other employee-related compensation ($1.3 million).
Interest expense decreased to $5.7$2.6 million in 20182020 from $6.2$4.1 million in 2017,2019, primarily due to lower average debt levels, partially offset by higher interest rateslevels.
The effective tax rate used to compute income taxes for continuing operations in 2018.
During 2018,2020 was 32.8% compared to 18.8% in 2019. The differences between the Company recognized consolidated income tax expense of $11.5 million based on pretax income of $36.4 million. During 2017, the Company recognized a consolidated income tax benefit of $53.2 million based on pretax loss of $14.9 million. Information on the significant differences betweenU.S. federal statutory rate and the effective tax rate for income2020 and the U.S. federal statutory rate for 2018 and 20172019 are further detailedshown in Note 16 in the effective income tax rate reconciliation provided in Note 16.Notes to the Financial Statements.
Total debt was $101.5 million at December 31, 2018, compared to $152.0 million at December 31, 2017. Net debt (debt in excess of cash and cash equivalents) was $67.1 million at December 31, 2018, compared to $115.5 million at December 31, 2017. The decline in net debt includes the impact of U.S. federal income tax refunds of $26 million received in 2018. Net debt is calculated as follows:
(In millions) December 31, 2018 December 31, 2017
Debt $101.5
 $152.0
Less: Cash and cash equivalents 34.4
 36.5
Net debt $67.1
 $115.5
Net debt, a financial measure that is not calculated or presented in accordance with GAAP, is not intended to represent debt as defined by GAAP, but is utilized by management in evaluating financial leverage and equity valuation. The Company believes that investors also may find net debt helpful for the same purposes. Consolidated net capitalization and other credit measures are provided in the Financial Condition section.Liquidity and Capital Resources, below.
Critical Accounting Policies
In the ordinary course of business, the Company makes a number of estimates and assumptions relating to the reporting of results of operations and financial position in the preparation of financial statements in conformity with GAAP. Actual results could differ significantly from those estimates under different assumptions and conditions. The Company believes the following discussion addresses its critical accounting policies. These policies require management to exercise judgments that are often difficult, subjective and complex due to the necessity of estimating the effect of matters that are inherently uncertain.
22


Impairment and Useful Lives of Long-lived Identifiable Assets and Goodwill
The Company assesses its long-lived identifiable assets for impairment when events or circumstances indicate that their carrying value may not be recoverable from future cash flows. Any necessary impairment charges are recorded when the Company does not believe the carrying value of the long-lived asset(s) will be recoverable. Tredegar also reassesses the useful lives of its long-lived assets based on changes in the business and technologies.
The Company assesses goodwill for impairment when events or circumstances indicate that the carrying value may not be recoverable, or, at a minimum, on an annual basis (December 1st of each year). When assessing goodwill for impairment, accounting guidance allows the Company to first perform a qualitative assessment about the likelihood of the carrying value of a reporting unit exceeding its fair value, referred to as the "Step 0"Step 0 assessment. The Step 0 assessment requires the evaluation of certain qualitative factors, including macroeconomic conditions, industry and market considerations, cost factors and overall financial performance, as well as company and reporting unit factors. If the Company's Step 0 analysis indicates that it is more likely than not that the fair value of a reporting unit is less than the carrying amount, then the Company would perform a quantitative impairment test.


As of December 31, 2018,1, 2020, the Company applied the Step 0 assessment to its PE Films’ Surface Protection operatingreporting unit and its Aluminum Extrusions’ AACOA operatingFutura reporting unit, which bothwas created as a result of an acquisition in 2017. Each reporting unit had a fair valuesvalue significantly in excess of theirits carrying amountsamount when last tested in 2017.using the quantitative impairment test. The Company's Step 0 analysis in 20182020 of thethese reporting units concluded that it is not more likely than not that the fair value of theeach reporting unit iswas less than its carrying amount. Therefore, the quantitative goodwill impairment test for these reporting units was not necessary in 2018.
Goodwill for Surface Protection and AACOAFutura totaled $57.3 million and $13.7$10.4 million, respectively, at December 31, 2018. The goodwill of AACOA is associated with its October 2012 acquisition.
Goodwill in the amount of $10.4 million from Aluminum Extrusions acquisition of Futura in February 2017, was tested for impairment at the annual testing date, with the estimated fair value of this reporting unit exceeding the carrying value of its net assets at December 1, 2018.2020.
In assessing the recoverability of goodwill and long-lived identifiable assets, the Company primarily estimates fair value using discounted cash flow analysisanalyses and comparative enterprise value-to-EBITDA (earnings before interest, taxes, depreciation and amortization) multiples. These calculations require management to make assumptions regarding estimated future cash flows, discount rates and other factors to determine if an impairment exists. If these estimates or their related assumptions change in the future, the Company may be required to record additional impairment charges.
All goodwill associated with PE Films’ Personal Care operating unit, inDuring the amountfirst three months of $46.8 million ($38.2 million after deferred income tax benefits), was impaired in2020, the third quarter of 2018. TheCompany performed goodwill impairment chargetests for the Aluminum Extrusions’ AACOA reporting unit, which was recognized upon the completioncreated as a result of an asset recoverability testacquisition in 2011, and impairment analysis performed asthe Futura reporting unit using a combination of September 30, 2018. This non-operating, non-cash charge, as computed under GAAP, resulted from the expectation of a significant customer transition. The Company performed an asset recoverability testincome and impairment analysis using projections under various business planning scenariosmarket approaches and concludeddetermined that the fair value of the Personal CareFutura reporting unit was less thanexceeded its carrying value.
In 2017, Flexible Packaging Films recorded However, the fair value of the AAOCA reporting unit did not exceed its carrying value. As a result, the Company recognized a goodwill impairment charge forof $13.7 million ($10.5 million after taxes), which represented the impairment of assets in theentire amount of $101 million. As part of this write-down, trade names, customer relationships and proprietary technology were impaired by $4.0 million, $9.4 million and $4.1 million, respectively;goodwill associated with the remaining partAACOA reporting unit. The operations of the write-downAACOA reporting unit, which includes the Niles, Michigan and Elkhart, Indiana facilities, was relatedexpected to property, plantbe severely impacted by COVID-19 at that time, with over 80% of the aluminum extrusions manufactured at these facilities sold to customers that make consumer durable products, such as recreational boating and equipment.
In additionpower sports vehicles, and to customers serving the impairment of Terphane’s assets in 2017, based upon assessments performed as to the recoverability of other long-lived identifiable assets, the Company recorded an asset impairment loss for continuing operations of $2.9 million, $1.2 millionbuilding and $0.6 million in 2018, 2017construction and 2016, respectively.automotive markets.
Investment Accounted for Under the Fair Value Method
In August 2007 and December 2008, Tredegar made an aggregate investment of $7.5 million in kaléo (formerly Intelliject, Inc.), a privately held specialty pharmaceutical company. This investment is accounted for under the fair value method. At the time of the initial investment, the Company elected the fair value option of accounting since its investment objectives were similar to those of venture capitalists, which typically do not have controlling financial interests (venture capital funds generally use the fair value methodoption to account for their investment portfolios). At December 31, 2018,2020, Tredegar’s ownership interest was approximately 20% on a fully diluted basis.
The Company considers its investment in kaléo to be a Level 3 investment under the fair value hierarchy described in GAAP. The Company discloses the level of its investments within the fair value hierarchy in which fair value measurements for its investments,in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). The Company believes that its fair value estimates will continue to be based upon Level 3 inputs since there is no secondary market for Tredegar’s ownership and a new round of equity financing that would establish a Level 1 fair value is not likely needed.ownership. See Note 4 to the Consolidated Financial Statements in Item 15 for more information on valuation methods used. Adjustments to the estimated fair value of this investment will be made in the period uponin which such changes can be quantified.
23


At December 31, 20182020 and 2017,2019, the fair value of the Company’s investment in kaléo (also the carrying value, which is separately stated in the consolidated balance sheets) was estimated at $84.6$34.6 million and $54.0$95.5 million, respectively. The weighted average cost of capital used in the fair market valuation of the Company’s interest in kaléo was 35% and 29% as of December 31, 2020 and 2019. The ultimate value of the Company’s ownership interest in kaléo will be determined and realized only if and when a liquidity event occurs, and the ultimate value could be materially different from the $84.6$34.6 million estimated fair value reflected in the Company’s financial statements at December 31, 2018.


2020. The fair market valuation of Tredegar’s interest in kaléo is sensitive to changes in the weighted average cost of capital used to discount cash flow projections for the high degree of risk and wide range of possible outcomes. At December 31, 2020, the effect of a 500 basis point decrease in the weighted average cost of capital assumption would have further increased the fair value of the Company’s interest in kaléo by approximately $5 million, and a 500 basis point increase in the weighted average cost of capital assumption would have decreased the fair value of the Company’s interest by approximately $6 million.
Pension Benefits
Tredegar sponsors noncontributory defined benefit (pension) plans in its continuing operations that have resulted in varying amounts of net pension income or expense, as developed from actuarial valuations. Inherent in these valuations are key assumptions including discount rates, expected return on plan assets and rate of future compensation increases. The Company is required to consider current market conditions, including changes in interest rates and plan asset investment returns, in determining these assumptions. Actuarial assumptions may differ materially from actual results due to changing market and economic conditions, higher or lower withdrawal rates or longer or shorter life spans of participants. These differences may result in a significant impact to the amount of net pension income or expense recorded in future periods.
The discount rate is used to determine the present value of future payments. The discount rate is the single rate that, when applied to expected benefit payments, provides a present value equal to the present value of expected benefit payments determined by using the AA-rated bond yield curve. In general, the pension liability increases as the discount rate decreases and vice versa. The weighted average discount rate utilized was 4.40%2.57%, 3.72%3.27% and 4.29%4.40% at the end of 2018, 20172020, 2019 and 2016,2018, respectively, with changes between periods due to changes in market interest rates. Pay for active participants of the plan was frozen as of December 31, 2007. As of January 31, 2018, the plan no longer accrued benefits associated with crediting employees for service, thereby freezing all future benefits under the plan.
A lower expected return on plan assets increases the amount of expense and vice versa. Decreases in the level of actual plan assets will also serve to increase the amount of pension expense. The total return on plan assets (net of fees and plan expenses), which is primarily affected by the change in fair value of plan assets, current year contributions and current year payments to participants, was approximately 10.9% in 2020, 11.8% in 2019 and negative 3.9%5.4% in 2018 and positive 11.6% and 7.9% in 2017 and 2016, respectively.2018. The expected long-term return on plan assets, relating to continuing operations, which is estimated by asset class and generally based on inflation-adjusted historical returns, volatilities, risk premiums and managed asset premiums, was 6.50%5.00%, 6.00% and 6.50% in 2020, 2019 and 7.00% in 2018, 2017 and 2016, respectively. The Company anticipates that its expected long-term return on plan assets will be 6.00%5.00% for 2019.2021. See Note 13 to the Consolidated Financial Statements in Item 15 for more information on expected long-term return on plan assets and asset mix.
See the Executive Summary section above for further discussion regarding the financial impact of the Company’s pension plans.
Income Taxes
On a quarterly basis, Tredegar reviews its judgments regarding uncertain tax positions and the likelihood that the benefits of a deferred income tax asset will be realized. As circumstances change, the Company reflects in earnings any adjustments to unrecognized benefits for uncertain tax positions and valuation allowances for deferred income tax assets.
For financial reporting purposes, unrecognized tax benefits on uncertain tax positions were $3.4 million, $2.0$0.6 million and $3.3$0.9 million as of December 31, 2018, 20172020 and 2016,2019, respectively. Tax payments resulting from the successful challenge by the taxing authority on uncertain tax positions taken by Tredegar would possibly result in the payment of interest and penalties. Accordingly, the Company also accrues for possible interest and penalties on uncertain tax positions. The balance of accrued interest and penalties on deductions taken relating to uncertain tax positions was $0.2$0.1 million, $0.1 million and $0.1$0.2 million at December 31, 2018, 20172020, 2019 and 2016,2018, respectively ($0.20.1 million, $0.1 million and $0.1$0.2 million, respectively, net of corresponding U.S. federal and state income tax benefits). Accruals for possible interest and penalties on uncertain tax positions are reflected in income tax expense for financial reporting purposes.
Tredegar, or one of its subsidiaries, files income tax returns in the U.S. federal jurisdiction, various states and jurisdictions outside the U.S. With few exceptions, Tredegar is no longer subject to U.S. federal, state or non-U.S. income tax examinations by tax authorities for years before 2014.2017.
As of December 31, 20182020 and 2017,2019, valuation allowances relating to deferred income tax assets were $24.7$17.5 million and $28.5$3.8 million, respectively. For more information on deferred income tax assets and liabilities, see Note 16.
Recently Issued Accounting Standards
Refer16 to the section Recently Issued Accounting StandardsConsolidated Financial Statements in Note 1 for information concerning the effect of recently issued accounting pronouncements.Item 15.
24


Results of Continuing Operations
20182020 versus 20172019
Revenues. Sales in 2018 increased2020 decreased by 10.8%8.6% compared with 20172019 primarily due to lower sales in Aluminum Extrusions partially offset by higher sales in all segments, except PE Films. Net sales decreased 5.7%14.0% in Aluminum Extrusions primarily due to lower sales volume and the pass-through of lower metal costs, partially offset by an increase in average selling prices to cover higher operating costs. Net sales increased 4.1% in PE Films primarily due to topsheet business lost from competitive pressureshigher sales of products in Europe and Asia,


including atSurface Protection unrelated to customer product transitions, partially offset by lower sales associated with the Shanghai, China, facility that was recently shut down.customer product transitions. Net sales increased in Flexible Packaging Films by 14.3%0.5% primarily due to higher sales volume, increased selling prices associated with the pass-through of higher resin costs and increased production capacity from an idle line that was restarted in June 2018. Net sales increased 22.8% in Aluminum Extrusions primarily due to a full year of sales by Futura (acquired February 15, 2017), higher volume and an increasechanges in average selling prices from the pass-through of higher market-driven raw material costs.product mix. For more information on changes in net sales and volume, see the Executive Summary.section above.
Operating Costs and Expenses. Consolidated gross profit margin (sales minus cost of goods sold and freight as a percentage of sales) was 16.9%22.6% in 20182020 versus 16.7%18.9% in 2017. The gross profit margin in PE Films decreased due to lower volume, as discussed above, unfavorable product mix and increased operating costs, partially offset by the realized cost savings of a restructuring completed in 2017.2019. The gross profit margin in Flexible Packaging Films increased due to significantlyhigher sales volume, lower depreciationraw material costs and amortization costs in 2018 compared to 2017, resulting from the $101 million non-cash asset impairment charge recognized in the fourth quarter of 2017, higher production primarily from the restart of an idle line in June 2018, and higher overall demand.favorable product mix. The gross profit margin in PE Films and Aluminum Extrusions decreased primarily as a result of operating inefficiencies relatingwas flat compared to the operation of its Niles, Michigan facility.2019.
For more information on changes in operating costs and expenses, see the Executive Summary.section above.
Selling, General and Administrative. As a percentage of sales, selling, general and administrative (“SG&A”) and R&D expenses were 9.8%12.3% in 2018,2020, which decreasedincreased from 10.6%10.2% in 2017. The decrease in selling, general and administrative2019. SG&A and R&D expenses as a percentage ofwere up year-over-year, while net sales can be primarily attributed to higher sales as a result of the acquisition of Futura and the restart of a production line by Flexible Packaging Films, overall higher demand at Aluminum Extrusions and higher selling pricesdecreased. Increased SG&A expense was primarily due to higher professional fees related to business development activities, higher stock-based compensation expense, and corporate costs incurred during 2020 associated with the pass-through to customerssale of higher market-driven raw material costs.Personal Care Films.
Please note that the 2017 and 2016 percentages in the Operating Costs and Expenses and Selling, General and Administrative sections (above and in 2017 versus 2016 below) have changed from the amounts disclosed in the prior year due to the retrospective adoption of FASB’s Accounting Standards Update (“ASU”) 2017-07, which resulted in the separate presentation of “Pension and postretirement benefits” expense in the consolidated statements of income. Historically the Company had reported a portion of its pension and postretirement benefit expenses in cost of goods sold and selling, general and administrative expenses.
Plant shutdowns, asset impairments, restructurings and other. PlantPre-tax losses associated with plant shutdowns, asset impairments, restructurings and other items for continuing operations in 20182020 detailed below are shown in the statements of net sales and EBITDA from ongoing operations by segment operating profit table in Note 5 to the Consolidated Financial Statements in Item 15 and are describedincluded in detail“Asset impairments and costs associated with exit and disposal activities, net of adjustments” in Note 17.the consolidated statements of income, unless otherwise noted. A discussion of unrealized gains and losses on investments can also be found in Note 4.4 to the Financial Statements in Item 15 and additional information on restructuring costs can be found in Note 17 to the Consolidated Financial Statements in Item 15.

25


($ in millions)Q1Q2Q3Q42020
Aluminum Extrusions:
Losses from sale of assets, investment writedowns and other items:
Consulting expenses for ERP feasibility study2
$0.7 $0.2 $0.3 $0.1 $1.3 
Environmental charges at Newnan, Georgia plant1
— — — 0.3 0.3 
COVID-19-related expenses2
— 0.9 0.5 0.5 1.9 
Total for Aluminum Extrusions$0.7 $1.1 $0.8 $0.9 $3.5 
PE Films:
Losses associated with plant shutdowns, asset impairments and restructurings:
Surface Protection restructuring costs - severance$— $— $— $1.6 $1.6 
(Gains) losses from sale of assets, investment writedowns and other items:
COVID-19-related expenses3
— 0.1 — 0.2 0.3 
Total for PE Films$— $0.1 $— $1.8 $1.9 
Corporate:
Professional fees associated with: internal control over financial reporting; business development activities; and implementation of new accounting guidance2
$1.8 $1.8 $0.6 $1.3 $5.5 
Accelerated recognition of stock option-based compensation2
— 0.1 — — 0.1 
Corporate costs associated with the divestiture of Personal Care Films2
— — 1.1 (0.3)0.8 
Loss on sale of Bright View3
— — — 2.3 2.3 
Write-down of investment in Harbinger Capital Partners Special Situations Fund3
0.2 — 0.1 0.1 0.4 
Stock compensation expense associated with the fair value remeasurement of awards granted at the time of the Special Dividend2
— — — 0.4 0.4 
Total for Corporate$2.0 $1.9 $1.8 $3.8 $9.5 
1. Included in “Cost of goods sold” in the consolidated statements of income.
2. Included in “Selling, general and administrative” in the consolidated statements of income.
3. Included in “Other income (expense), net” in the consolidated statements of income.
Interest Income and Expense.Interest income,expense, which is net of amounts capitalized and included in “Other income (expense)property, plant and equipment ($0.1 million and $0.3 million capitalized in 2020 and 2019, respectively), net”was $2.6 million in 2020, compared to $4.1 million for 2019. Average debt outstanding and interest rates were as follows:
(In millions, except percentages)20202019
Floating-rate debt with interest charged on a rollover basis at one-month LIBOR plus a credit spread:
Average outstanding debt balance$33.5 $85.0 
Average interest rate2.3 %4.0 %
2019 versus 2018
Revenues. Sales in 2019 decreased by 3.0% compared with 2018 due to lower sales in Aluminum Extrusions partially offset by higher sales in PE Films and Flexible Packaging Films. Net sales decreased 7.6% in Aluminum Extrusions primarily due to lower sales volume and the pass-through of lower metal costs, partially offset by an increase in average selling prices to cover higher operating costs. Net sales increased 4.8% in PE Films primarily due to higher sales volume and increased selling prices. Net sales increased in Flexible Packaging Films by 8.2% primarily due to higher sales volume and increased selling prices. For more information on changes in net sales and volume, see the Segment Analysis below.
Operating Costs and Expenses. Consolidated gross profit (sales minus cost of goods sold and freight) as a percentage of sales (gross profit margin) was 18.9% in 2019 versus 17.0% in 2018. The gross profit margin in Aluminum Extrusions increased primarily as a result of higher selling prices. The gross profit margin in PE Films increased primarily due to higher profits in Surface Protection as a result of higher sales volume and increased selling prices. The gross profit margin in Flexible Packaging Films was essentially unchanged from 2018 to 2019. For more information on changes in operating costs and expenses, see the Segment Analysis below.
26


Selling, General and Administrative. As a percentage of sales, SG&A and R&D expenses were 10.2% in 2019, which increased from 8.8% in 2018. The increase in SG&A and R&D expenses as a percentage of sales can be primarily attributed to lower sales for Aluminum Extrusions. Increased spending was due to higher stock-based compensation and consulting fees for remediation activities and other costs relating to the Company’s material weaknesses in internal control over financial reporting, business development activities and implementation of new accounting guidance.
Plant shutdowns, asset impairments, restructurings and other. Pre-tax losses associated with plant shutdowns, asset impairments, restructurings and other items for continuing operations in 2019 and 2018 detailed below are shown in the statements of net sales and EBITDA from ongoing operations by segment table in Note 5 to the Consolidated Financial Statements in Item 15 and are included in “Asset impairments and costs associated with exit and disposal activities, net of adjustments” in the consolidated statements of income, was $0.4 millionunless otherwise noted. A discussion of unrealized gains and losses on investments can also be found in 2018Note 4 to the Consolidated Financial Statements in Item 15 and $0.2 millionadditional information on restructuring costs can be found in 2017.Note 17 to the Consolidated Financial Statements in Item 15.
($ in millions)Q1Q2Q3Q42019
Aluminum Extrusions:
(Gains) losses from sale of assets, investment writedowns and other items:
Wind damage to roof of Elkhart, Indiana plant2
$— $— $0.3 $(0.4)$(0.1)
Environmental charges at Carthage Tennessee plant1
— — 0.4 0.2 0.6 
Total for Aluminum Extrusions$— $— $0.7 $(0.2)$0.5 
PE Films:
Losses associated with plant shutdowns, asset impairments and restructurings:
Write-off of films production line - Guangzhou, China facility$0.4 $— $— $— $0.4 
Surface Protection restructuring costs - severance— — 0.1 0.2 0.3 
Total for PE Films$0.4 $— $0.1 $0.2 $0.7 
Corporate:
Professional fees associated with: internal control over financial reporting; business development activities; and implementation of new accounting guidance2
$0.9 $0.9 $1.5 $0.2 $3.5 
Accelerated recognition of stock option-based compensation2
— — — 1.3 1.3 
Environmental costs not associated with a business unit2
— — — 0.6 0.6
Total for Corporate$0.9 $0.9 $1.5 $2.1 $5.4 
1. Included in “Cost of goods sold” in the consolidated statements of income.
2. Included in “Selling, general and administrative” in the consolidated statements of income.
27


($ in millions)Q1Q2Q3Q42018
Aluminum Extrusions:
Losses associated with plant shutdowns, asset impairments and restructurings:
Other restructuring costs - severance$0.1 $— $— $— $0.1 
(Gains) losses from sale of assets, investment writedowns and other items:
Wind damage to roof of Elkhart, Indiana plant2
— — 0.1 — 0.1 
Environmental charges at Carthage Tennessee plant1
— — 0.2 0.1 0.3 
Total for Aluminum Extrusions$0.1 $— $0.3 $0.1 $0.5 
PE Films:
Losses associated with plant shutdowns, asset impairments and restructurings:
Surface Protection restructuring costs - severance$— $— $— $0.2 $0.2 
(Gains) losses from sale of assets, investment writedowns and other items:
Costs to prepare a market study2
— — 0.2 — 0.2 
Gain on reversal of contingent liability3
— — — (0.3)(0.3)
Total for PE Films$— $— $0.2 $(0.1)$0.1 
Corporate:
Professional fees associated with: internal control over financial reporting; and implementation of new accounting guidance2
$0.3 $— $0.2 $0.6 $1.1 
Write-down of investment in Harbinger Capital Partners Special Situations Fund3
— 0.2 0.2 0.1 0.5 
Business development projects2
— — — 0.5 0.5 
Total for Corporate$0.3 $0.2 $0.4 $1.2 $2.1 
1. Included in “Cost of goods sold” in the consolidated statements of income.
2. Included in “Selling, general and administrative” in the consolidated statements of income.
3. Included in “Other income (expense), net” in the consolidated statements of income.
Interest Expense. Interest expense, which is net of amounts capitalized and included in property, plant and equipment ($0.3 million and $0.4$0.1 million capitalized in 20182019 and 2017,2018, respectively), was $4.1 million in 2019, compared to $5.7 million in 2018, compared to $6.2 million for 2017.2018. Average debt outstanding and interest rates were as follows:
(In millions, except percentages)20192018
Floating-rate debt with interest charged on a rollover basis at one-month LIBOR plus a credit spread:
Average outstanding debt balance$85.0 $121.3 
Average interest rate4.0 %3.8 %

28


(In millions, except percentages)2018 2017
Floating-rate debt with interest charged on a rollover   
basis at one-month LIBOR plus a credit spread:   
Average outstanding debt balance$121.3
 $175.0
Average interest rate3.8% 3.0%
Fixed-rate and other debt:   
Average outstanding debt balance$
 $
Average interest raten/a
 n/a
Total debt:   
Average outstanding debt balance$121.3
 $175.0
Average interest rate3.8% 3.0%


Identifiable Assets. A summary of identifiable assets for the year ended December 31, 2018 versus 2017 is provided below: 
(In thousands)Year Ended
December 31
  
 2018 2017 Variance
PE Films$231,720
 $289,514
 $(57,794)
Flexible Packaging Films58,964
 49,915
 9,049
Aluminum Extrusions281,372
 268,127
 13,245
      Subtotal572,056
 607,556
 (35,500)
General corporate100,920
 111,696
 (10,776)
Cash and cash equivalents34,397
 36,491
 (2,094)
      Total$707,373
 $755,743
 $(48,370)
Identifiable assets in PE Films decreased at December 31, 2018 from December 31, 2017 primarily due to the $46.8 million write-off of goodwill in the Personal Care component of PE Films. For more information, see the PE Films section of the Executive Summary. Identifiable assets in Flexible Packaging Films increased at December 31, 2018 from December 31, 2017 primarily due to current year capital expenditures and higher inventory balances to support increased demand. Identifiable assets in Aluminum Extrusions increased at December 31, 2018 from December 31, 2017 primarily due to current year capital expenditures, higher accounts receivable balances due to the timing of collections and higher inventory balances. Identifiable assets in General corporate decreased at December 31, 2018 from December 31, 2017 due to a decrease in income taxes recoverable.
2017 versus 2016
Revenues. Sales in 2017 increased by 16.1% compared with 2016 due to higher sales in all segments and, in particular, from the acquisition of Futura by Aluminum Extrusions in February 2017. Net sales increased 6.4% in PE Films primarily due to increased volume and favorable sales mix for surface protection films, acquisition distribution layer materials and overwrap products. Net sales were relatively flat in Flexible Packaging Films (0.3% increase). Net sales increased 29.6% in Aluminum Extrusions primarily due to the acquisition of Futura, higher sales volume, improved product mix, and an increase in average selling prices primarily due to the pass-through to customers of higher market-driven raw material costs.
Operating Costs and Expenses. Consolidated gross profit margin (sales minus cost of goods sold and freight as a percentage of sales) was 16.7% in 2017 and 16.8% in 2016. The gross profit margin in PE Films increased due to higher revenue, as discussed above, the realized cost savings of a restructuring completed in 2017, productivity efficiencies in surface protection films and personal care, and a favorable LIFO inventory adjustment. The gross profit margin in Flexible Packaging Films decreased primarily as a result of lower production primarily due to numerous intermittent power outages at Terphane’s Cabo, Brazil plant, during the third quarter, higher raw material and other costs related to adverse impact of high inflation in Brazil, partially offset by lower foreign currency transaction losses in 2017 versus 2016. The gross profit margin in Aluminum Extrusions increased slightly due to higher sales volume and improved product mix noted above, partially offset by increased operating costs, disruptions to normal plant production associated with the startup of a new press at the Niles, Michigan plant and an unfavorable LIFO adjustment.
Selling, General and Administrative. As a percentage of sales, selling, general and administrative and R&D expenses were 10.6% in 2017, which decreased from 11.2% in 2016. The decrease in selling, general and administrative and R&D expenses as a percentage of sales can be primarily attributed to higher sales as a result of the acquisition of Futura.
Plant shutdowns, asset impairments, restructurings and other. Plant shutdowns, asset impairments, restructurings and other items in 2017 are shown in the segment operating profit table in Note 5 and are described in detail in Note 17. A discussion of unrealized gains and losses on investments can also be found in Note 4.
Interest Income and Expense. Interest income, which is included in “Other income (expense), net” in the consolidated statements of income, was $0.2 million in 2017 and $0.3 million in 2016.


Interest expense, which is net of amounts capitalized and included in property, plant and equipment ($0.4 million and $0.3 million capitalized in 2017 and 2016, respectively), was $6.2 million in 2017, compared to $3.8 million for 2016. In February 2017, the Company borrowed $87 million under its revolving credit agreement to fund the acquisition of Futura. Interest expense in 2016 included the write-off of $0.2 million in unamortized loan fees from Tredegar’s revolving credit facility that was refinanced in the first quarter of 2016. Average debt outstanding and interest rates were as follows:
(In millions, except percentages)2017 2016
Floating-rate debt with interest charged on a rollover   
basis at one-month LIBOR plus a credit spread:   
Average outstanding debt balance$175.0
 $103.5
Average interest rate3.0% 2.3%
Fixed-rate and other debt:   
Average outstanding debt balance$
 $
Average interest raten/a
 n/a
Total debt:   
Average outstanding debt balance$175.0
 $103.5
Average interest rate3.0% 2.3%
Identifiable Assets. A summary of identifiable assets for the year ended December 31, 2017 versus 2016 is provided below: 
(In thousands)Year Ended
December 31
  
 2017 2016 Variance
PE Films$289,514
 $278,558
 $10,956
Flexible Packaging Films49,915
 156,836
 (106,921)
Aluminum Extrusions268,127
 147,639
 120,488
      Subtotal607,556
 583,033
 24,523
General corporate111,696
 38,618
 73,078
Cash and cash equivalents36,491
 29,511
 6,980
      Total$755,743
 $651,162
 $104,581
Identifiable assets in PE Films increased at December 31, 2017 from December 31, 2016 primarily due to higher property, plant and equipment balances as a result of higher current year capital expenditures. Identifiable assets in Flexible Packaging Films decreased at December 31, 2017 from December 31, 2016 due to the impairment of assets recognized during the fourth quarter of 2017. Identifiable assets in Aluminum Extrusions increased at December 31, 2017 from December 31, 2016 primarily due to the acquisition of Futura and higher property, plant and equipment balances as a result of current year capital expenditures, higher accounts receivable balances due to the timing of collections and higher inventory balances. Identifiable assets in General corporate increased at December 31, 2017 from December 31, 2016 due to an increase in income taxes recoverable and an increase in the value of the Company’s investment in kaléo.
Segment Analysis. A summary of operating results for 20172019 versus 20162018 for each of the Company’s reporting segments is shown below.
Aluminum Extrusions
A summary of results for Aluminum Extrusions is provided below:
Year EndedFavorable/
(In thousands, except percentages)December 31,(Unfavorable)
20192018% Change
Sales volume (lbs)208,249 223,866 (7.0)%
Net sales$529,602 $573,126 (7.6)%
Ongoing operations:
EBITDA$65,683 $65,479 0.3 %
Depreciation & amortization*(16,719)(16,866)0.9 %
EBIT**$48,964 $48,613 0.7 %
Capital expenditures$17,855 $12,966 
* Excludes pre-tax accelerated amortization of trade names of $10.0 million in the year ended December 31, 2019.
** See the table in Item 6 for a reconciliation of this non-GAAP measure to GAAP.
Net sales in 2019 decreased versus 2018 primarily due to lower sales volume and the pass-through of lower metal costs, partially offset by an increase in average selling prices to cover higher operating costs.
EBITDA from ongoing operations in 2019 increased slightly in comparison to 2018. Excluding the adverse impact of the accounting for inventories under the last in, first out method in the fourth quarter of 2019 versus 2018 ($1.5 million), EBITDA from ongoing operations increased $1.7 million despite a 7% decline in sales volume. The increase was primarily due to higher pricing ($22.8 million) and fabrication profits ($1.0 million), partially offset by lower sales volume ($8.7 million), increased labor and employee-related expenses ($7.4 million), higher supplies, maintenance, utilities and other operating costs ($2.0 million), increased freight costs ($2.0 million) and increased general and administrative expenses ($1.9 million).
PE Films
A summary of operating results for PE Films is provided below: 
Year EndedFavorable/
(In thousands, except percentages)
Year Ended
December 31
 
Favorable/
(Unfavorable)
(In thousands, except percentages)December 31,(Unfavorable)
2017 2016 % Change20192018% Change
Sales volume (lbs)138,999
 139,020
  %Sales volume (lbs)43,983 40,173 9.5 %
Net sales$352,459
 $331,146
 6.4 %Net sales$133,807 $127,708 4.8 %
Operating profit from ongoing operations$41,546
 $26,312
 57.9 %
Ongoing operations:Ongoing operations:
EBITDAEBITDA$41,133 $32,404 26.9 %
Depreciation & amortizationDepreciation & amortization(5,860)(6,201)5.5 %
EBIT*EBIT*$35,273 $26,203 34.6 %
Capital expendituresCapital expenditures$8,567 $2,523 
* See the table in Item 6 for a reconciliation of this non-GAAP measure to GAAP.* See the table in Item 6 for a reconciliation of this non-GAAP measure to GAAP.
Net sales in 20172019 increased by $21.3$6.1 million versus 20162018 primarily due to higher sales in Surface Protection. Surface Protection’s sales increased $5.8 million due to higher sales volume and increased selling prices, partially offset by unfavorable product mix.
EBITDA from ongoing operations in 2019 increased by $8.7 million versus 2018 primarily due to:
Higher salesA $6.8 million increase from surface protection films ($15.1 million),Surface Protection, primarily due to higher volumeselling prices ($6.0 million), quality claims in 2018 that did not recur in 2019 ($1.2 million), production efficiencies ($1.4 million) and a favorable sales mix; and
Higher volume for acquisition distribution layer materials and overwrap products, and a favorable sales mix in personal care materialsraw material costs ($12.01.9 million), partially offset by unfavorable mix (net impact of $2.0 million) and higher fixed manufacturing and general and administrative costs ($1.5 million); and
A $1.6 million increase from Pottsville Packaging primarily related to higher sales volume reductions from the winding down of known lost business in personal care that was substantially completed by the end of 2016 ($6.2 million).
Operating profit from ongoing operations in 2017 increased by $15.2 million versus 2016 primarily due to:
Higher contribution to profits from surface protection films ($12.31.5 million), primarily due to higher volume, a favorable sales mix,increased productivity ($0.5 million) and production efficiencies;
Higher contribution to profits from personal care materials, primarily due to improved volume, production efficiencies and favorable pricingincreased selling prices ($7.30.2 million), partially offset by known lost businessunfavorable product mix ($2.11.0 million);.
A benefit for inventories accounted for under the LIFO method of $1.1 million in 2017 versus a charge of $0.9 million in 2016; and
29

Higher net general, selling and plant expenses ($7.3 million), primarily associated with strategic hires and an increase in employee incentive costs, partially offset by realized cost savings of $3.1 million associated with the North American facility consolidation.

Restructuring
In July 2015, the Company began a consolidation of its domestic production for PE Films by restructuring the operations in its manufacturing facility in Lake Zurich, Illinois. This restructuring was completed in the third quarter of 2017, with expected annualized savings excluding depreciation expenses of $6.0 million. Total expenses associated with the restructuring were $0.8 million in 2017 (included in “Cost of goods sold” in the consolidated statements of income) and the total expenses for the project since inception were $7.3 million. Cash expenditures for the North American facility consolidation project were $1.9 million in 2017, which includes capital expenditures of $0.1 million. Total cash expenditures for the project since inception were $16.0 million, which includes $11.2 million for capital expenditures.
Capital Expenditures and Depreciation
Capital expenditures in PE Films were $15.0 million in 2017 compared to $25.8 million in 2016. Depreciation expense was $14.5 million in 2017 and $13.5 million in 2016.
Flexible Packaging Films
A summary of operating results for Flexible Packaging Films is provided below:
Year EndedFavorable/
(Unfavorable)
% Change
(In thousands, except percentages)
Year Ended
December 31
 
Favorable/
(Unfavorable)
(In thousands, except percentages)December 31,
2017 2016 % Change20192018
Sales volume (lbs)89,325
 89,706
 (0.4)%Sales volume (lbs)105,276 98,994 6.3 %
Net sales$108,355
 $108,028
 0.3 %Net sales$133,935 $123,830 8.2 %
Operating profit (loss) from ongoing operations$(2,626) $1,774
 n/a
Ongoing operations:Ongoing operations:
EBITDAEBITDA$14,737 $11,154 32.1 %
Depreciation & amortizationDepreciation & amortization(1,517)(1,262)(20.2)%
EBIT*EBIT*$13,220 $9,892 33.6 %
Capital expendituresCapital expenditures$8,866 $5,423 
* See the table in Item 6 for a reconciliation of this non-GAAP measure to GAAP.* See the table in Item 6 for a reconciliation of this non-GAAP measure to GAAP.
Net sales andin 2019 increased versus 2018 primarily due to higher sales volume in 2017 were relatively flat compared to 2016, and adversely impacted by production issues due to intermittent power outages at increased selling prices.
Terphane’s Cabo de Santo Agostinho, Brazil plant during the third quarter.
Terphane had an operating lossEBITDA from ongoing operations in 2017 of $2.62019 increased by $3.6 million versus an operating profit from ongoing operations in 2016 of $1.8 million. The resulting unfavorable change of $4.4 million for the period was primarily2018 due to:
Lower production, primarily due to numerous intermittent power outages during the third quarterHigher volume ($0.52.6 million), and lower average sales pricehigher selling prices ($1.6 million), partially offset by higher fixed and variable costs, including costs related to a restarted line ($2.0 million);
Net favorable sales mix ($1.5 million);
Higher raw materialforeign currency translation of Real-denominated operating costs of $1.8 million in 2017 that could not be passed through to customers due to competitive pressures versus a benefit from lower raw material costs of $1.2 million in 2016;$0.4 million; and
Foreign currency transaction losses primarily associated with U.S. Dollar denominated export sales in Brazilgains of $0.2$1.0 million in 20172019 versus foreign currency transaction losses of $3.5$0.8 million in 2016;2018.


Higher costsLiquidity and expenses of $3.2 million primarily related to the adverse impact of high inflation in Brazil and the appreciation by approximately 9% of the average exchange rate for the Brazilian Real relative to the U.S. Dollar; and
Higher depreciation and amortization costs ($0.9 million).
Terphane Asset Impairment Loss and Worthless Stock DeductionCapital Resources
The Company acquired Terphane in October 2011, and since that time Terphane’s selling prices, margins and overall performance have been adversely impacted by excess industry capacity, particularly in Latin America, and by a period of poor economic conditions in Brazil. Moreover, significant additional capacity came on-line late in the third quarter of 2017 from a competitor in Latin America. As a result, Terphane has struggled with profitability and incurred operating losses from ongoing operations in two of the last five years, including an operating loss of $2.6 million in 2017. Terphane’s quarterly financial results have been volatile, and the Company expects continued uncertainty and volatility until industry capacity utilization and the competitive dynamics in Latin America improve.
During the fourth quarter of 2017, in conjunction with annual business planning as well as valuation activities and other efforts, the Company determined that the carrying value of Terphane’s remaining long-lived assets were impaired (Terphane’s goodwill was written off in 2015).  Accordingly, the Company wrote down these assets basedcontinuously focuses on an enterprise valuation for all of Terphane of approximately $30 million. This write-down resulted in a non-cash asset impairment loss recognized during the fourth quarter of 2017 of $101 million ($87 million after non-cash tax benefits).
Also during the fourth quarter of 2017, as a result of the valuation activities referred to above, the Company claimed an ordinary loss for U.S. federal and state income tax purposes of $153 million for the write-off of the stock basis of Terphane Limitada (Terphane’s Brazilian subsidiary). The Terphane Limitada worthless stock deduction resulted in an overall reduction of Tredegar’s U.S. income tax liability of approximately $49 million. The full net tax benefit expected from the Terphane Limitada worthless stock deduction was accrued during the fourth quarter of 2017 and reflected as a reduction to Tredegar’s consolidated income tax expense. During the second quarter of 2017, the Company recognized a worthless stock deduction for Terphane, Inc. (Terphane’s U.S. subsidiary), which resulted in an income tax benefit recognized of $8.1 million.
Capital Expenditures, Depreciation & Amortization
Capital expenditures in Flexible Packaging were $3.6 million in 2017 compared to $3.4 million in 2016. Depreciation expense was $7.5 million in 2017 and $6.7 million in 2016. Amortization expense was $3.0 million in 2017 and $2.8 million in 2016.
Aluminum Extrusions
A summary of operating results for Aluminum Extrusions, including the results of Futura (except sales volume) since its date of acquisition, is provided below:
(In thousands, except percentages)
Year Ended
December 31
 
Favorable/
(Unfavorable)
2017 2016 % Change
Sales volume (lbs)*176,269
 172,986
 1.9%
Net sales$466,833
 $360,098
 29.6%
Operating profit from ongoing operations$43,454
 $37,794
 15.0%
*Excludes sales volume for Futura, which was acquired on February 15, 2017.
Net sales in 2017 increased versus 2016 primarily due to the addition of Futura. Futura contributed net sales of $71.0 million in 2017. Excluding the impact of Futura, net sales improved due to higher sales volume, improved product mix, and an increase in average selling prices primarily due to the pass-through to customers of higher market-driven raw material costs.
Volume on an organic basis (which excludes the impact of the Futura acquisition) in 2017 increased by 1.9% versus 2016. Higher volume in specialty and automotive & light truck markets were the primary drivers.
Operating profit in 2017 increased by $5.7 million versus 2016. Excluding the favorable profit impact of Futura ($8.2 million), operating profit decreased $2.5 million, primarily due to:
Higher volume and inflation-related sales prices ($7.3 million benefit);


Increased operating costs, including utilities and employee-related expenses and higher depreciation ($3.9 million);
Higher costs associated with the startup of the new press at the Niles, Michigan plant, resulting from disruptions to normal plant production ($4.3 million); and
A charge for inventories accounted for under the LIFO method of $1.3 million in 2017 versus a benefit of $0.5 million in 2016.
Cast House Explosion
On June 29, 2016, the Bonnell Aluminum plant in Newnan, Georgia suffered an explosion in the casting department, causing significant damage to the cast house and related equipment. The Company completed the process of replacing the damaged casting equipment, and the cast house resumed production in the third quarter of 2017.
During 2017, Bonnell incurred $5.6 million of additional operational expenses as a result of the explosion; $5.5 million of this amount was fully offset by insurance recoveries. Also, $0.6 million of additional operational expenses incurred in 2016 that were previously considered not reasonably assured of being covered by insurance recoveries were recovered. Each of these amounts is recorded in “Plant shutdowns, asset impairments, restructurings and other” in the Operating Profit table in Note 5 and in “Cost of goods sold” in the Consolidated Statements of Income. In the fourth quarter of 2017, all remaining insurance claims associated with this matter were settled, and a gain on involuntary conversion of the old cast house of $5.3 million was recorded in “Other income (expense), net” in the Consolidated Statements of Income and in “Plant shutdowns, asset impairments, restructurings and other” in the Operating Profit table in Note 5.
Capital Expenditures and Depreciation & Amortization
Capital expenditures for Aluminum Extrusions were $25.7 million in 2017 compared to $15.9 million in 2016. Depreciation expense was $11.9 million in 2017, which included $2.9 million from the addition of Futura, compared to $8.1 million in 2016. Amortization expense was $3.1 million in 2017, which included $2.1 million from the addition of Futura, and $1.0 million in 2016.

Financial Condition
Assets and Liabilities
Tredegar’s management continues to focus on improving working capital management. Measures such as days sales outstanding (“DSO”), days inventory outstanding (“DIO”) and days payables outstanding (“DPO”) are used by the Company to evaluate changes in working capital. Significant changesChanges in operating assets and liabilities from continuing operations from December 31, 20172019 to December 31, 20182020 are summarized below:below. Cash flows for discontinued operations have not been separately disclosed in the consolidated statements of cash flows.
Accounts and other receivables increased $4.6decreased $2.8 million (3.8%(3.1%).
Accounts and other receivables in PE FilmsAluminum Extrusions decreased by $5.0$3.3 million primarily due mainly to lower net sales for certain Personal Care products, a focus on collection efforts,volume and lower sales prices from the usepass-through of supply chain financing arrangements and the timing of cash receipts.lower metal costs, partially offset by an increase in average selling prices. DSO (computed using trailing 12 months net sales and a rolling 12-month average of accounts and other receivables balances) was approximately 43.247.5 days in 20182020 and 48.448.5 days in 2017.2019.
Accounts and other receivables in PE Films decreased by $0.3 million as the removal of assets related to Bright View was partially offset by increased accounts receivables in Surface Protection due to higher sales. DSO was approximately 30.2 days in 2020 and 34.7 days in 2019.
Accounts and other receivables in Flexible Packaging Films decreased by $2.9 million primarily dueremained consistent compared to the negotiation of shorter payments terms with certain customers, the use of supply chain financing arrangements and the timing of cash receipts.prior year. DSO was approximately 43.741.0 days in 20182020 and 53.237.7 days in 2017.2019.
Accounts and other receivablesInventories increased $2.2 million (3.5%).
Inventories in Aluminum Extrusions increased by $12.5$3.2 million primarily due to higher average aluminum prices resulting from the pass-through of higher metal costs. DSO was approximately 44.6 days in 2018 and 43.3 days in 2017.
Inventories increased $6.9 million (7.9%).
Inventories in PE Films decreased by $5.7 million primarily due to lower salesCOVID-19-related operational and the timing of raw material purchases.production inefficiencies. DIO (computed using trailing 12 months costs of goods sold calculated on a first-in, first-outfirst in, first out basis and a rolling 12-month average of inventory balances calculated on the first-in, first-out basis) was approximately 54.939.3 days in 20182020 and 55.038.6 days in 2017.2019.
Inventories in PE Films increased by $0.7 million primarily due to higher raw material levels in Surface Protection partially offset by the removal of assets related to Bright View. DIO was approximately 59.2 days in 2020 and 51.3 days in 2019.
Inventories in Flexible Packaging Films increaseddecreased by $9.5$1.6 million primarily due to aincreased sales volume and lower resin costs partially offset by higher production level leading to more finished goods on hand and higher levels of raw materials to support increased production, and the impact of


the change in the value of the U.S. Dollar relative to the Brazilian real.material levels. DIO was approximately 77.989.4 days in 20182020 and 70.194.3 days in 2017.2019.
Inventories in Aluminum Extrusions increased by $3.2 million primarily due to an increase in raw material prices and the timing of purchases. DIO was approximately 33.5 days in 2018 and 32.6 days in 2017.
Net property, plant and equipment increaseddecreased by $5.3$7.0 million (2.4%(4.0%primarily due primarily to depreciation expenses of $23.4 million, a reduction from the effect of changes in foreign exchange rates of $3.3 million and the removal of assets related to Bright View of $2.3 million, partially offset by capital expenditures of $40.8 million, offset by depreciation of $29.8 million and a change in the value of the U.S. dollar relative to foreign currencies ($5.2 million decrease).$21.4 million.
30


Identifiable intangible assets, net decreased by $4.3$3.8 million (10.5%(16.9%) primarily due to amortization expense of $4.0 million.
Goodwill decreased by $46.8$3.0 million (36.5%) due toand the write-offremoval of all of the goodwillassets related to the Personal Care componentBright View of PE Films.$0.6 million.
Accounts payable increased by $4.4$2.4 million (4.0%(2.8%).
Accounts payable in PE Films decreasedAluminum Extrusions increased by $5.6$3.3 million, primarily due to increased inventory levels as a result of COVID-19-related lower planned production and the normal volatility associated with the timing of payments.demand. DPO (computed using trailing 12 months costs of goods sold calculated on a first-in, first-outfirst in, first out basis and a rolling 12-month average of accounts payable balances) was approximately 43.753.1 days in 20182020 and 40.649.9 days in 2017.2019.
Accounts payable in Flexible PackagingPE Films increaseddecreased by $3.4$3.2 million primarily due to higher production levels and inventory levels to meet market demandeffective working capital management and the normal volatility associated with the timing of payments. DPO was approximately 51.936.8 days in 20182020 and 42.837.1 days in 2017.2019.
Accounts payable in Aluminum ExtrusionsFlexible Packaging Films increased by $5.5$0.5 million, primarily due to higher volume, an increase in metal prices,the negotiation of longer payment terms and the normal volatility associated with the timing of payments.partially offset by reduced resin costs. DPO was approximately 49.761.7 days in 20182020 and 48.055.2 days in 2017.2019.
Accrued expenses increasedNet cash provided by $0.1operating activities was $74.4 million (0.1%) from December 31, 2017in 2020 compared to $115.9 million in 2019. The decrease is primarily due to normal fluctuationssignificant net working capital efficiencies in 2019 versus 2020 ($28.5 million), a dividend received from kaléo in 2019 ($17.6 million), and higher pension and postretirement benefit plan contributions ($4.1 million), partially offset by higher EBITDA from ongoing operations for business segments of $9.3 million in 2020 versus the accrual accounts.prior period.
Cash provided by investing activities was $32.9 million in 2020 compared to cash used in investing activities of $39.9 million in 2019. Cash provided by investing activities in 2020 includes the net cash proceeds received for the sale of Personal Care Films ($55.1 million) and Bright View ($1.1 million), partially offset by capital expenditures of $23.4 million. Cash used in investing activities in 2019 includes capital expenditures of $50.9 million, which was partially offset by $10.9 million of cash proceeds received for the sale of the PE Films’ Shanghai manufacturing facility.
Net noncurrent deferred income tax assetscash used in excessfinancing activities of noncurrent deferred income tax liabilities decreased by $11.1$125.6 million in 2020 compared to $77.3 million in 2019. The increase is primarily due to higher net borrowings of $151.5 million under the Credit Agreement (as defined below) and higher dividend payments to shareholders of $200.7 million primarily due to numerous changes between years in the balance$200 million Special Dividend (partially funded from borrowings under the Credit Agreement, as defined below), partially offset by lower debt financing costs of the components shown in the December 31, 2018 and 2017 schedule of deferred income tax assets and liabilities provided in Note 16. The Company had a current income tax receivable of $6.8 million at December 31, 2018 compared to a current income tax receivable of $32.1 million at December 31, 2017. The change is primarily due to timing of tax payments and refunds from net operating losses and tax credits carried back to prior years.


$1.1 million.
On MarchDecember 1, 2016, the Company2020, Tredegar entered into aan amendment (“Amendment No. 1”) to its five-year $400 million secured revolving credit agreement that expires(the “Credit Agreement”), which matures in June 2024. The material changes from Amendment No. 1 are as follows:
Aggregate borrowings available under the facility were reduced from $500 million to $375 million.
The definition of Credit EBITDA was amended to permit certain adjustments for prepayment of pension obligations on Marcha pro forma basis.
Amendments were made to certain of the negative covenants, including, among other amendments, the following: (i) the restricted payments covenant was amended to permit a one-time special dividend payment of up to $200 million and allow for an aggregate amount of dividend payments up to $75 million subsequent to Amendment No. 1 2021 (“revolving credit agreement”). through the maturity date of the Credit Agreement; (ii) the asset disposition covenant was amended to reduce the general basket to 20% of consolidated total assets over the life of the facility and was reset as of December 1, 2020; and (iii) the indebtedness covenant was amended to reduce several baskets to $25 million each.
31


Net capitalization and indebtedness as defined under the revolving credit agreementCredit Agreement as of December 31, 20182020 were as follows:
Net Capitalization and Indebtedness as of December 31, 2018
(In thousands)
 
Net capitalization: 
Cash and cash equivalents$34,397
Debt: 
$400 million revolving credit agreement maturing March 1, 2021101,500
Other debt
Total debt101,500
Debt net of cash and cash equivalents67,103
Shareholders’ equity354,857
Net capitalization$421,960
Indebtedness as defined in revolving credit agreement: 
Total debt$101,500
Face value of letters of credit2,686
Capital lease29
Other
Indebtedness$104,215
Net Capitalization and Indebtedness as of December 31, 2020
(In thousands)
Net capitalization:
Cash and cash equivalents$11,846 
Debt:
Credit Agreement134,000 
Debt, net of cash and cash equivalents122,154 
Shareholders’ equity109,055 
Net capitalization$231,209 
Indebtedness as defined in Credit Agreement:
Total debt$134,000 
Indebtedness$134,000 
The credit spread and commitment fees charged on the unused amount under our revolving credit agreementthe Credit Agreement at various indebtedness-to-adjustedindebtedness-to-Credit EBITDA levels are as follows:
Pricing Under Revolving Credit Agreement (Basis Points)
Indebtedness-to-Adjusted EBITDA Ratio
Credit Spread
Over LIBOR
 
Commitment
Fee
Pricing Under Credit Agreement (Basis Points)Pricing Under Credit Agreement (Basis Points)
Indebtedness-to-Credit EBITDA RatioIndebtedness-to-Credit EBITDA RatioCredit Spread
Over LIBOR
Commitment
Fee
> 3.5x but <= 4.0x250
 45
> 3.5x but <= 4.0x200.0 40 
> 3.0x but <= 3.5x225
 40
> 3.0x but <= 3.5x187.5 35 
> 2.0x but <= 3.0x200
 35
> 2.0x but <= 3.0x175.0 30 
> 1.0x but <= 2.0x175
 30
> 1.0x but <= 2.0x162.5 25 
<= 1.0x150
 25
<= 1.0x150.0 20 
At December 31, 2018,2020, the interest rate on debt under the revolving credit agreementCredit Agreement existing at that date was priced at one-month LIBOR plus the applicable credit spread of 150162.5 basis points. Under the revolving credit agreement,Credit Agreement, borrowings are permitted up to $400$375 million, and approximately $298$241 million was available to borrow at December 31, 2018,2020, based upon the most restrictive covenant within the revolving credit agreement.
As of December 31, 2018, Tredegar was in compliance with all financial covenants outlined in its revolving credit agreement. Noncompliance with any of the debt covenants may have a material adverse effect on financial condition or liquidity in the event such noncompliance cannot be cured or should the Company be unable to obtain a waiver from the lenders. Renegotiation of the covenant(s) through an amendment to the revolving credit agreement may effectively cure the noncompliance, but may have an effect on financial condition or liquidity depending upon how the amended covenant is renegotiated.Credit Agreement.
The computations of adjustedCredit EBITDA, adjusted EBIT, the leverage ratio and interest coverage ratio as defined in the revolving credit agreementCredit Agreement are presented below along with the related most restrictive covenants. AdjustedCredit EBITDA and adjusted EBIT as defined in the revolving credit agreement areCredit Agreement is not intended to represent net income or cash flow from operations as defined by GAAP and should not be considered as either an alternative to net income or to cash flow.



32


Computations of Adjusted EBITDA, Adjusted EBIT, Leverage Ratio and Interest Coverage Ratio as Defined in the Revolving Credit Agreement Along with Related Most Restrictive Covenants
As of and for the Twelve Months Ended December 31, 2018 (In thousands)
Computations of adjusted EBITDA and adjusted EBIT as defined in revolving credit agreement for the twelve months ended December 31, 2018
Net income$24,842
Plus: 
After-tax losses related to discontinued operations
Total income tax expense for continuing operations11,526
Interest expense5,702
Depreciation and amortization expense for continuing operations33,804
All non-cash losses and expenses, plus cash losses and expenses not to exceed $10,000, for continuing operations that are classified as unusual, extraordinary or which are related to plant shutdowns, asset impairments and/or restructurings (cash-related of $7,774)55,160
Charges related to stock option grants and awards accounted for under the fair value-based method1,221
Losses related to the application of the equity method of accounting
Losses related to adjustments in the estimated fair value of assets accounted for under the fair value method of accounting
Minus: 
After-tax income related to discontinued operations
Total income tax benefits for continuing operations
Interest income(369)
All non-cash gains and income, plus cash gains and income in excess of $10,000, for continuing operations that are classified as unusual, extraordinary or which are related to plant shutdowns, asset impairments and/or restructurings(250)
Income related to changes in estimates for stock option grants and awards accounted for under the fair value-based method
Income related to the application of the equity method of accounting
Income related to adjustments in the estimated fair value of assets accounted for under the fair value method of accounting(30,600)
Plus cash dividends declared on investments accounted for under the equity method of accounting
Plus or minus, as applicable, pro forma EBITDA adjustments associated with acquisitions and asset dispositions
Adjusted EBITDA as defined in revolving credit agreement101,036
Less: Depreciation and amortization expense for continuing operations (including pro forma for acquisitions and asset dispositions)(33,804)
Adjusted EBIT as defined in revolving credit agreement$67,232
Computations of leverage and interest coverage ratios as defined in revolving credit agreement at December 31, 2018:
Leverage ratio (indebtedness-to-adjusted EBITDA)1.03x
Interest coverage ratio (adjusted EBIT-to-interest expense)11.79x
Most restrictive covenants as defined in revolving credit agreement: 
Maximum permitted aggregate amount of dividends that can be paid by Tredegar during the term of the revolving credit agreement ($100,000 plus 50% of net income generated for each quarter beginning January 1, 2016)$169,844
Maximum leverage ratio permitted4.00x
Minimum interest coverage ratio permitted2.50x



Tredegar is obligated to make future payments under various contracts as set forth below:
 Payments Due by Period
(In millions)2019 2020 2021 2022 2023 Remainder Total
Debt:             
Principal payments$
 $
 $101.5
 $
 $
 $
 $101.5
Estimated interest expense4.2
 4.2
 0.7
 
 
 
 9.1
Estimated contributions required: (1)
             
Defined benefit plans8.3
 12.0
 12.2
 14.8
 12.9
 18.8
 79.0
Other postretirement benefits0.5
 0.5
 0.5
 0.5
 0.5
 2.2
 4.7
Capital expenditure commitments14.1
 
 
 
 
 
 14.1
Leases4.5
 4.0
 3.6
 2.4
 1.2
 2.6
 18.3
Estimated obligations relating to uncertain tax positions (2)

 
 
 
 
 2.9
 2.9
Other (3)
1.1
 
 
 
 
 
 1.1
Total$32.7
 $20.7
 $118.5
 $17.7
 $14.6
 $26.5
 $230.7
(1)Estimated minimum required contributions for defined benefit plansComputations of Credit EBITDA, Leverage Ratio and benefit payments for other postretirement plans are based on actuarial estimates using current assumptions for discount rates, long-term rateInterest Coverage Ratio as Defined in the Credit Agreement Along with Related Most Restrictive Covenants
As of return on plan assets, rate of compensation increases and health care cost trends. The expected defined benefit plan contribution estimates for 2019 through 2028 were determined under provisions of the Pension Protection Act of 2006 using the preliminary assumptions chosen by Tredegar for the 2019 plan year. Tredegar has determined that it is not practicable to presentTwelve Months Ended December 31, 2020 (In thousands)
Computations of Credit EBITDA as defined benefit contributions and other postretirement benefit payments beyond 2028.in Credit Agreement for the twelve months ended December 31, 2020
Net income (loss)$(75,444)
(2)Amounts for which reasonable estimates about the timing of payments cannot be made are included in the remainder column.
Plus:
(3)After-tax losses related to discontinued operationsIncludes contractual severance58,611 
Total income tax expense for continuing operations— 
Interest expense2,587 
Depreciation and other miscellaneous contractual arrangements.amortization expense for continuing operations26,446 
All non-cash losses and expenses, plus cash losses and expenses not to exceed $10,000, for continuing operations that are classified as unusual, extraordinary or which are related to plant shutdowns, asset impairments and/or restructurings (cash-related of $10,000)26,384 
Charges related to stock option grants and awards accounted for under the fair value-based method2,161 
Losses related to the application of the equity method of accounting— 
Losses related to adjustments in the estimated fair value of assets accounted for under the fair value method of accounting60,900 
Minus:
After-tax income related to discontinued operations— 
Total income tax benefits for continuing operations(8,213)
Interest income(44)
All non-cash gains and income, plus cash gains and income in excess of $10,000, for continuing operations that are classified as unusual, extraordinary or which are related to plant shutdowns, asset impairments and/or restructurings— 
Income related to changes in estimates for stock option grants and awards accounted for under the fair value-based method— 
Income related to the application of the equity method of accounting— 
Income related to adjustments in the estimated fair value of assets accounted for under the fair value method of accounting— 
Plus cash dividends declared on investments in an amount not to exceed $10,000 for such period— 
Plus or minus, as applicable, pro forma EBITDA adjustments associated with acquisitions and asset dispositions— 
Plus or minus, as applicable, pro forma EBITDA adjustments to pension expense associated with the early payment of pension obligations— 
Credit EBITDA as defined in Credit Agreement$93,388 
Computations of leverage and interest coverage ratios as defined in Credit Agreement at December 31, 2020:
Leverage ratio (indebtedness-to-Credit EBITDA)1.43x
Interest coverage ratio (Credit EBITDA-to-interest expense)36.1x
Most restrictive covenants as defined in Credit Agreement:
Maximum permitted aggregate amount of dividends that can be paid by Tredegar subsequent to Amendment No. 1 of the Credit Agreement ($75,000)75,000 
Maximum leverage ratio permitted4.00x
Minimum interest coverage ratio permitted3.00x
Tredegar was in compliance with all of its debt covenants as of December 31, 2020. Noncompliance with any of the debt covenants may have a material adverse effect on its financial condition or liquidity, in the event such noncompliance cannot be cured or should the Company be unable to obtain a waiver from the lenders. Renegotiation of the covenant through an amendment to the Credit Agreement may effectively cure the noncompliance, but may have an effect on its financial condition or liquidity depending upon how the covenant is renegotiated.
The Company believes that existing borrowing availability, current cash balances and cash flow from operations will be sufficient to satisfy working capital, capital expenditure and dividend requirements for at least the next twelve months.
At December 31, 2020, Tredegar had cash and cash equivalents of $11.8 million, including funds held in locations outside the U.S. of $9.4 million.
33


Contractual Obligations, Contingent Liabilities and Commitments
Following is a table which summarizes the continuing operations contractual obligations of Tredegar as of December 31, 2020:
 Payments Due by Period
(In millions)20212022202320242025RemainderTotal
Debt:
Principal payments$— $— $— $134.0 $— $— $134.0 
Estimated interest expense2.3 2.3 2.3 1.1 — — 8.0 
Estimated contributions required: (1)
Defined benefit plans11.7 12.0 11.9 11.3 9.7 9.5 66.1 
Other postretirement benefits0.5 0.5 0.5 0.5 0.5 2.1 4.6 
Capital expenditure commitments1.3 3.1 — — — — 4.4 
Leases(2)
3.2 2.9 2.6 2.5 2.4 7.4 21.0 
Estimated obligations relating to uncertain tax positions (3)
0.1 — — — — 0.6 0.7 
Other (4)
4.2 0.6 — — — — 4.8 
Total$23.3 $21.4 $17.3 $149.4 $12.6 $19.6 $243.6 
(1)    Estimated minimum required contributions for defined benefit plans and benefit payments for other postretirement plans are based on actuarial estimates using current assumptions for discount rates, long-term rate of return on plan assets, rate of compensation increases and health care cost trends. The expected defined benefit plan contribution estimates for 2021 through 2030 were determined under provisions of the Pension Protection Act of 2006 using the preliminary assumptions chosen by Tredegar for the 2021 plan year. Tredegar has determined that it is not practicable to present defined benefit contributions and other postretirement benefit payments beyond 2030.
(2)    Contractual lease payments for 2021 include $0.5 million of short term lease payments and $0.3 million of variable lease costs.
(3)    Amounts for which reasonable estimates about the timing of payments cannot be made are included in the remainder column.
(4)    Includes contractual severance and other miscellaneous contractual arrangements.
From time to time, the Company enters into transactions with third parties in connection with the sale of assets or businesses in which it agrees to indemnify the buyers or third parties involved in the transaction, or the sellers or third parties involved in the transaction agree to indemnify Tredegar, for certain liabilities or risks related to the assets or business. Also, in the ordinary course of business, the Company may enter into agreements with third parties for the sale of goods or services that may contain indemnification provisions. In the event that an indemnification claim is asserted, liability for indemnification would be subject to an assessment of the underlying facts and circumstances under the terms of the applicable agreement. Further, any indemnification payments may be limited or barred by a monetary cap, a time limitation, or a deductible or basket. For these reasons, the Company is unable to estimate the maximum potential amount of the potential future liability under the indemnity provisions of these agreements. Tredegar does, however, accrue for losses for any known contingent liability, including those that may arise from indemnification provisions, when future payment is probable and the amount is reasonably estimable. The Company discloses contingent liabilities if the probability of loss is reasonably possible and material.
At December 31, 2018, Tredegar had cash and cash equivalents of $34.4 million, including funds held in locations outside the U.S. of $31.1 million. Tredegar’s policy is to accrue U.S. federal income taxes on unremitted earnings of all foreign subsidiaries where required. However, due to changes in the taxation of dividends under TCJA, Tredegar will only record U.S. federal income taxes on unremitted earnings of its foreign subsidiaries where Tredegar cannot take steps to eliminate any potential tax on future distributions from its foreign subsidiaries. Prior to the second quarter of 2016, deferred U.S. federal income taxes had not been recorded for the undistributed earnings for Terphane Limitada because the Company had intended to permanently reinvest these earnings. During 2016, Terphane Limitada paid dividends totaling $13.3 million to the Company. Because of the accumulation of significant losses related to foreign currency translations at Terphane Limitada, there were no unrecorded deferred income tax liabilities associated with the U.S. federal income taxes and foreign withholding taxes on Terphane Limitada’s undistributed earnings as of December 31, 2018 and December 31, 2017.
The Company believes that existing borrowing availability, current cash balances and cash flow from operations will be sufficient to satisfy working capital, capital expenditure and dividend requirements for at least the next twelve months.
Shareholders’ Equity
At December 31, 2018, Tredegar had 33,176,024 shares of common stock outstanding and a total market capitalization of $526.2 million, compared with 33,017,422 shares of common stock outstanding and a total market capitalization of $633.9 million at December 31, 2017.
Tredegar did not repurchase any shares on the open market in 2018, 2017 or 2016 under its approved share repurchase program.


Cash Flows
The discussion in this section supplements the information presented in the Consolidated Statements of Cash Flows.
Cash provided by operating activities was $97.8 million in 2018 compared with $88.2 million in 2017. The increase is primarily due to higher operating profit before depreciation and amortization from ongoing operations ($5.6 million) and the net of income tax refunds received in 2018 over income tax payments made in the same period in 2017 ($33.2 million), primarily offset by higher working capital and larger pension contributions in 2018 versus 2017 ($29.3 million).
Cash used in investing activities was $34.1 million in 2018 compared with $125.6 million in 2017. Cash used in investing activities primarily represents the acquisition of Futura in 2017 for $87.1 million and capital expenditures, which were $40.8 million and $44.4 million in 2018 and 2017, respectively. Additionally, in the first quarter of 2018, the Company received $5 million from escrowed funds related to an earnout from the acquisition of Futura, of which $4.3 million was classified in cash flows for investing activities.
Net cash flow used in financing activities was $64.1 million in 2018, primarily due to net repayments under the revolving credit agreement of $50.5 million and the payment of regular quarterly dividends aggregating for the year to $14.6 million ($0.44 per share annually), partially offset by the proceeds from the exercise of stock options and other financing activities of $1.0 million. Cash provided by financing activities was $43.2 million in 2017, including net borrowings under the revolving credit agreement of $57.0 million. These net borrowings plus cash provided by operating activities of $88.2 million in 2017 were used to fund the acquisition of Futura for $87.1 million and regular quarterly dividends aggregating for the year to $14.5 million ($0.44 per share annually).

Quantitative and Qualitative Disclosures about Market Risk
Tredegar has exposure to the volatility of interest rates, polyethylene polypropylene and polyesterpolypropylene resin prices, PTATerephthalic Acid (“PTA”) and MEGMonoethylene Glycol (“MEG”) prices, aluminum ingot and scrap prices, energy prices, foreign currencies and emerging markets. See the AssetsLiquidity and Liabilities sectionCapital Resources regarding interest rate exposures related to borrowings under the revolving credit agreement.Credit Agreement.
Profit margins in Aluminum Extrusions are sensitive to fluctuations in aluminum ingot and scrap prices as well as natural gas prices (natural gas is the principal energy source used to operate its casting furnaces). Changes in polyethylene resin prices and the timing of those changes could have a significant impact on profit margins in PE Films. Changes in polyester resin, PTA and MEG prices, and the timing of those changes, could have a significant impact on profit margins in Flexible Packaging Films. Profit margins in Aluminum Extrusions are sensitive to fluctuations in aluminum ingot and scrap prices as well as natural gas prices (natural gas is the principal energy source used to operate its casting furnaces). There is no assurance of the Company’s ability to pass through higher raw material and energy costs to its customers.
See the Executive Summary and the Results of Continuing Operations sections for discussion regarding the impact of the lag in the pass-through of resin price changes.


The volatility of average quarterly prices of low density polyethylene resin in the U.S. (a primary raw material for PE Films products) is shown in the chart below:
chart-923b8aa1fead5d8cb53.jpg
Source: Quarterly averages computed by Tredegar using monthly data provided by IHS, Inc. In January 2015, IHS reflected a 21 cents per pound non-market adjustment based on their estimate of the growth of discounts in prior periods. The 4th quarter 2014 average rate of $1.09 per pound is shown on a pro forma basis as if the non-market adjustment was made in the fourth quarter of 2014.
Polyethylene resin prices in Europe, Asia and South America have exhibited similar long-term trends. The price of resin is driven by several factors, including supply and demand and the price of oil, ethylene and natural gas. To address fluctuating resin prices, PE Films has index-based pass-through raw material cost agreements for the majority of its business. However, under certain agreements, changes in resin prices are not passed through for an average period of 90 days (see the Executive Summary and the Results of Continuing Operations sections for more information). Pricing on the remainder of the business is based upon raw material costs and supply/demand dynamics within the markets in which the Company operates.
Polyester resins, MEG and PTA used by Flexible Packaging Films in Brazil are primarily purchased domestically, with other sources available, mostly from Asia and the U.S. Given the nature of these products as commodities, pricing is derived from Asian pricing indexes. The volatility of the average quarterly prices for polyester fibers in Asia, which is representative of polyester resin (a primary raw material for polyester film products) prices, is shown in the chart below:
chart-2c430f121c845c85ba8.jpg
Source: Quarterly averages computed by Tredegar using monthly data from CMAI Global Index data.



The volatility of average quarterly prices of PTA and MEG in Asia (raw materials used in the production of polyester resins produced by Flexible Packaging Films) is shown in the chart below:


chart-16eed9612a8959de898.jpg
Source: Quarterly averages computed by Tredegar using monthly data from CMAI Global Index data.
In the normal course of business, Aluminum Extrusions enters into fixed-price forward sales contracts with certain customers for the sale of fixed quantities of aluminum extrusions at scheduled intervals. In order to hedge its exposure to aluminum price volatility (see the chart below) under these fixed-price arrangements, which generally have a duration of not more than 12 months, the Company enters into a combination of forward purchase commitments and futures contracts to acquire or hedge aluminum, based on the scheduled deliveries. See Note 9 to the Consolidated Financial Statements in Item 15 for moreadditional information.
The volatility of quarterly average aluminum prices is shown in the chart below:
chart-27a63bf1d75e5ad495f.jpgbelow.
34


tg-20201231_g2.jpg
Source: Quarterly averages computed by Tredegarthe Company using daily Midwest average prices provided by Platts.
From time-to-time, Aluminum Extrusions hedges a portion of its exposure to natural gas price volatility by entering into fixed-price forward purchase contracts with its natural gas suppliers. The Company estimates that, in an unhedged situation, every $1 per mmBtu per month change in the market price of natural gas has a $102,000 impact on the continuing monthly operating profit for U.S. operations in Aluminum Extrusions. There is an energy surcharge for Aluminum Extrusions in the U.S. that is applied when the previous quarter’s NYMEX natural gas average settlement price is in excess of $8.85 per mmBtu.


The volatility of quarterly average natural gas prices is shown in the chart below:below.
chart-1b868b2524695f3d9d4.jpgtg-20201231_g3.jpg
Source: Quarterly averages computed by Tredegar using monthly NYMEX settlement prices.
35



The volatility of average quarterly prices of polyethylene resin in the U.S. (a primary raw material for PE Films products) is shown in the chart below:
tg-20201231_g4.jpg
Source: Quarterly averages computed by Tredegar using monthly data provided by IHS, Inc. In February 2020, IHS reflected a 32 cents per pound non-market adjustment based on their estimate of the growth of discounts in prior periods. The 4th quarter 2019 average rate of $0.51 per pound is shown on a pro forma basis as if the non-market adjustment was made in the fourth quarter of 2019.
The price of resin is driven by several factors, including supply and demand and the price of oil, ethylene and natural gas. Selling prices to customers are set considering numerous factors, including the expected volatility of resin prices. In certain situations, PE Films has index-based pass-through raw material cost arrangements with customers. However, under certain agreements, changes in resin prices are not passed through for a period of 90 days or more. Pricing on the remainder of the business is based upon raw material costs and supply/demand dynamics within the markets that the Company competes.
Polyester resins, MEG and PTA used in flexible packaging films produced in Brazil are primarily purchased domestically, with other sources available mostly from Asia and the U.S. Given the nature of these products as commodities, pricing is derived from Asian pricing indexes. The volatility of the average quarterly prices for polyester fibers in Asia, which is representative of polyester resin (a primary raw material for Flexible Packaging Films) pricing trends, is shown in the chart below:
tg-20201231_g5.jpg
Source: Quarterly averages computed by Tredegar using monthly data from CMAI Global Index data.
36


The volatility of average quarterly prices of PTA and MEG in Asia (raw materials used in the production of polyester resins produced by Flexible Packaging Films) is shown in the chart below:
tg-20201231_g6.jpg
Source: Quarterly averages computed by Tredegar using monthly data from CMAI Global Index data.
The Company sells to customers in foreign markets through its foreign operations and through exports from U.S. plants. The percentage of sales and total assets for manufacturing operations related to foreign markets for 2018, 20172020, 2019 and 20162018 are as follows:
Tredegar Corporation—Continuing Operations
Percentage of Net Sales and Total Assets Related to Foreign Markets
 2018 2017 2016
 % of Total 
% Total
Assets -
Foreign
Oper-
ations *
 % of Total 
% Total
Assets -
Foreign
Oper-
ations *
 % of Total 
% Total
Assets -
Foreign
Oper-
ations *
 Net Sales *  Net Sales *  Net Sales * 
 
Exports
From
U.S.
 
Foreign
Oper-
ations
  
Exports
From
U.S.
 
Foreign
Oper-
ations
  
Exports
From
U.S.
 
Foreign
Oper-
ations
 
Canada5
 
 
 5
 
 
 6
 
 
Europe1
 8
 6
 1
 9
 6
 1
 10
 6
Latin America**1
 10
 8
 2
 9
 7
 
 11
 21
Asia7
 1
 4
 9
 2
 5
 9
 3
 6
Total % exposure to foreign markets14
 19
 18
 17
 20
 18
 16
 24
 33
Tredegar Corporation
Percentage of Net Sales and Total Assets Related to Foreign Markets*
 202020192018
 % of Total% Total
Assets - Foreign Operations
% of Total% Total
Assets - Foreign
Operations
% of Total% Total
Assets -Foreign
Operations
 Net SalesNet SalesNet Sales
 Exports
From
U.S.
Foreign OperationsExports
From
U.S.
Foreign OperationsExports
From
U.S.
Foreign Operations
Canada2   — — — — 
Europe1   — — — — — 
Latin America 13 10 12 — 10 
Asia11  4 10 — 
Total14 13 14 14 12 10 11 11 10 
*The percentages for foreign markets are relative to Tredegar’s consolidated net sales and total assets from continuing operations.
**
In 2017, Flexible Packaging Films’ recorded a charge for the impairment of assets in the amount of $101 million. See Terphane Asset Impairment Loss and Worthless Stock Deduction in Flexible Packaging Films in the Executive Summary section for more details.
.
Tredegar attempts to match the pricing and cost of its products in the same currency and generally views the volatility of foreign currencies and emerging markets, and the corresponding impact on earnings and cash flow as part of the overall risk of operating in a global environment (for additional information, see trends for the Euro, Brazilian Real and Chinese Yuan in the charts on the following page). Exports from the U.S. are generally denominated in U.S. Dollars. The Company’s foreign currency exposure on income from continuing foreign operations relates to the Euro, the Chinese Yuan the Hungarian Forint,and the Brazilian Real and the Indian Rupee.Real.
PE Films is generally able to match the currency of its sales and costs for its product lines. For flexible packaging films produced in Brazil, selling prices and key raw material costs are principally determined in U.S. Dollars and are impacted by local economic conditions. Competition in Brazil, Terphane’s primary market, has been exacerbated byconditions and local and global overcapacity in the polyester industry generally, and by particularly acute overcapacity in Latin America. Additional PET capacity from a competitor in Latin America came on line in September 2017. These factors have resulted in significant competitive pricing


pressures and U.S. Dollar equivalent margin compression. Moreover, variable conversion, fixed conversion and sales, general and administrative costs for operations in Brazil have been adversely impacted by inflation in Brazil that is higher than in the U.S.dynamics. Flexible Packaging Films is exposed to additional foreign exchange translation risk (its functional currency is the Brazilian Real) because almost 90% of the sales of Flexible Packaging Films business unit in Brazil Terphane Limitada's (“Terphane Ltda.”) salesand substantially all of its related raw material costs are quoted or priced in U.S. Dollars while a large majority of its Brazilianvariable conversion, fixed conversion and sales, general and administrative costs before depreciation & amortization (collectively “Terphane Ltda. Operating Costs”) are quoted or priced in Brazilian Real. This mismatch, together
37


with a variety of economic variables impacting currency exchange rates, causes volatility that could negatively or positively impact operating profitEBITDA from ongoing operations for Flexible Packaging Films.
The Company's earnings are exposed to foreign currency exchange risk primarily through the translation of the financial statements of subsidiaries that have a functional currency other than the U.S. Dollar. The Company estimates thatannual net costs of R$119 million for the net mismatch translation exposure between Terphane Ltda.’s U.S. Dollar quoted or priced sales and raw material costs and underlying Brazilian Real quoted or priced operating costs (excluding depreciation and amortization) is annual net costs of R$125 million.Terphane Ltda. Operating Costs. Terphane Ltda. has outstanding foreign exchange average forward rate contracts to purchase Brazilian Real and sell U.S. Dollars to hedge its exposure. See Note 89 to the Consolidated Financial Statements in Item 15 for more information on outstanding hedging contracts and this hedging program.
Tredegar estimates that the change in the value of foreign currencies relative to the U.S. Dollar on PE Films had a favorablean unfavorable impact on operating profitEBITDA from ongoing operations in PE Films of $0.8$0.7 million in 20182020 compared to 20172019 and an unfavorable impact on operating profitEBITDA from ongoing operations of $0.3$0.5 million in 20172019 compared with 2016.
Trends for the Euro are shown in the chart below:
chart-892e687b2b915020bab.jpg
Source: Quarterly averages computed by Tredegar using daily closing data provided by Bloomberg.


2018.
Trends for the Brazilian Real and Chinese Yuan are shown in the chart below:
chart-68358e1fc24357668c1.jpgtg-20201231_g7.jpg
Source: Quarterly averages computed by Tredegar using daily closing data provided by Bloomberg.


38
Item 7A.QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK



Item 7A.    QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
See discussion of Quantitative and Qualitative Disclosures about Market Risk in Management’s DiscussionItem 7.
Item 8.    FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
The information required by this Item 8 is set forth in Item 15 and Analysis of Financial Condition and Results of Operations.is hereby incorporated herein by reference.
Item 8.FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
See the Index to Financial Statements and Supplementary Data for references to the report of the independent registered public accounting firm, the consolidated financial statements and selected quarterly financial data.
Item 9.    CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE
Item 9.
CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE
None.
Item 9A.CONTROLS AND PROCEDURES
Update on Prior Period Disclosure Controls and Procedures and Internal Control Over Financial ReportingItem 9A.CONTROLS AND PROCEDURES
On November 1, 2018, the Company filed a Current Report on Form 8-K (the “November 2018 Form 8-K”) to disclose that, on October 26, 2018, its former independent registered public accounting firm, PricewaterhouseCoopers LLP (“PwC”), and the Company concluded that the control deficiencies listed in the November Form 8-K constituted material weaknesses in the Company’s internal control over financial reporting. As a result of the material weaknesses disclosed therein, the November Form 8-K also indicated that Management’s Report on Internal Control Over Financial Reporting and the Evaluation of Disclosure Controls and Procedures included in Item 9A. “Controls and Procedures” of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2017 and PwC’s opinion relating to the effectiveness of the Company’s internal control over financial reporting as of December 31, 2017 should no longer be relied upon, and that the items pertaining to controls and procedures in certain previous filings should no longer be relied upon. Management determined that deficiencies in internal control over financial reporting, including those described in the November Form 8-K, were pervasive throughout


the Company’s internal control over financial reporting. For further information, on matters referred to in this paragraph, see the November 2018 Form 8-K and Item 4. “Controls and Procedures” of the Company’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2018.2018 (the “2018 Third Quarter 10-Q”).
The material weaknesses identified did not result in a material misstatement of the Company’s financial statements for the year ended December 31, 2017 or any interim period during 2017.
Evaluation of Disclosure Controls and Procedures as of December 31, 2018
In connection with the preparation of this Form 10-K, pursuant to Rule 13a-15(b) under the Exchange Act, the Company carried out an evaluation, with the participation of its management, including its Chief Executive Officer (principal executive officer) and Chief Financial Officer (principal financial officer), of the effectiveness of disclosure controls and procedures (as defined under Rule 13a-15(e) orand 15d-15(e) under the Exchange Act) as of December 31, 2018.2020.
Based on this evaluation, the Company’s Chief Executive Officer and Chief Financial Officer concluded that, because of the material weaknesses in internal control over financial reporting discussed below, the Company’s disclosure controls and procedures were not effective as of December 31, 2018,2020, to ensure: (i) that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act, is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms, and (ii) that such information is accumulated and communicated to management, including the Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.
Management’s Report on Internal Control Over Financial Reporting as of December 31, 2018
The Company’s management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act. The Company’s internal control over financial reporting is a process designed by or under the supervision of the Company’s Chief Executive Officer and Chief Financial Officer, and overseen by the Board of Directors, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of published financial statements for external purposes in accordance with U.S. GAAP and includes policies and procedures that:
Pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the Company’s assets;
Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, and that the Company’s receipts and expenditures are being made only in accordance with the authorization of its management and directors; and
Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company’s assets that could have a material effect on the consolidated financial statements.

Because of its inherent limitations, internal control over financial reporting is not intended to provide absolute assurance that a misstatement of the Company’s consolidated financial statements would be prevented or detected. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis.
Management conducted an evaluation of the effectiveness of the Company’s internal control over financial reporting using the criteria in Internal Control - Integrated Framework 2013 issued by the Committee of Sponsoring Organizations of the Treadway Commission (the “2013 COSO Framework”). As a result of this evaluation, management concluded that the
39


Company’s internal control over financial reporting was not effective as of December 31, 2018,2020, because of the material weaknesses in internal control over financial reporting discussed below.
Control Environment: The Company did not have a sufficient number of trained resources with assigned responsibility and accountability for the design, operation and documentation of internal control over financial reporting in accordance with the 2013 COSO Framework.


Risk Assessment: The Company did not have an effective risk assessment process that defined clear financial reporting objectives and evaluated risks, including fraud risks, and risks resulting from changes in the external environment and business operations, at a sufficient level of detail to identify all relevant risks of material misstatement across the entity.
Information and Communication: The Company did not have an effective information and communication process that identified and assessed the source of and controls necessary to ensure the reliability of information used in financial reporting and that communicates relevant information about roles and responsibilities for internal control over financial reporting.
Monitoring Activities: The Company did not have effective monitoring activities to assess the operation of internal control over financial reporting, including the continued appropriateness of control design and level of documentation maintained to support control effectiveness.
Control Activities: As a consequence of the material weaknesses described above, internal control deficiencies related to the design and operation of process-level controls and general information technology controls were determined to be pervasive throughout the Company’s financial reporting processes.

While these material weaknesses did not result in material misstatements of the Company’s financial statements as of and for the year ended December 31, 2018,2020, these material weaknesses create a reasonable possibility that a material misstatement of account balances or disclosures in annual or interim consolidated financial statements may not be prevented or detected in a timely manner. Accordingly, the Company concluded that the deficiencies represent material weaknesses in its internal control over financial reporting and its internal control over financial reporting was not effective as of December 31, 2018.2020.
The Company’s independent registered public accounting firm, KPMG LLP, which audited the 20182020 consolidated financial statements included in this Form 10-K, has expressed an adverse opinion on the operating effectiveness of the Company's internal control over financial reporting. KPMG LLP's report appears on pages 50-51page 47 of this Form 10-K.

Remediation Plan
The Company’s remediation efforts are ongoing, and it will continue its initiatives to implement and document policies and procedures, and strengthen the Company’s internal control environment. Remediation of the identified material weaknesses and strengthening the Company’s internal control environment will require a substantial effort throughout 2019,has extended into 2021. In addition, the Company is monitoring the impact of COVID-19 on its remediation plan. Depending on the severity and those efforts may extend beyond 2019. The Company will testlength of the design, implementationpandemic, the remediation timeline could be negatively impacted because of inefficiencies caused by COVID-related limitations on travel, meetings, on-site work and operating effectiveness of its internal control over financial reporting, including any new controls implementedclose collaboration and the related increase in time necessary to complete remediation of existing controls, in future periods. projects.
The material weaknesses cannot be considered completely remediated until the applicable controls have operated for a sufficient period of time and management has concluded, through testing, that these controls are operating effectively.
To remediate the material weaknesses described above, the Company plans to pursueis pursuing the six remediation steps identified in the 2018 Third Quarter 10-Q. To date, the Company has accomplished the following as part of those remediation steps:
1.Perform a comprehensive financial risk assessment and internal control gap analysis to ensure that all relevant risks of material misstatement to the Company’s financial statements are identified and that the Company’s internal controls are sufficient to address those risks.
2.Review and update, as necessary, documentation of relevant processes, policies and procedures, and design of relevant controls, with respect to the Company’s internal control over financial reporting. The Company intends to implement any necessary changes as a result of deficiencies identified in its relevant processes, policies and procedures as promptly as practical and to satisfy documentation requirements under Section 404 of the Sarbanes-Oxley Act.
3.Seek to ensure that the Company’s internal control over financial reporting is properly designed, implemented, operating effectively, and appropriately documented by (i) enhancing the design of existing control activities and/or implementing additional control activities, as needed, (ii) monitoring the operating effectiveness of those controls, and (iii) ensuring that sufficient documentation exists to evidence the design, implementation, and operation of those controls.
4.Evaluate and enhance the Company’s monitoring activities to ensure the components of internal control under the 2013 COSO Framework are present, functioning, and able to be appropriately evidenced.
5.Design, execute and monitor a plan, with appropriate executive sponsorship, and with the assistance of outside consultants, to enhance the Company’s internal control over financial reporting and accomplish the goals of the remediation plan as set forth above.

a.Identified material processes and significant locations for the purpose of identifying risks of material misstatement to the Company’s financial statements,

b.Conducted interviews with relevant parties to ensure our understanding of the activities involved in the recording of transactions within material processes,
6.Continue to seek, train and retain individuals that have the appropriate skills and experience related to designing, operating and documenting internal controls.

c.Substantially completed a comprehensive review and update, as necessary, of the documentation of relevant processes with respect to the Company’s internal control over financial reporting,
d.Documented significant elements of a comprehensive risk assessment and internal control gap analysis and commenced the validation thereof with key stakeholders,
e.Commenced the design of certain new or redesigned internal controls, and
f.Commenced the design and implementation of internal controls for certain processes within its Aluminum Extrusions business, PE Films business, its Flexible Packaging business, and its corporate functions.
The Company has hiredcontinues to work with its outside consultant, an internationally recognized accounting firm, as its outside consultant, to assist in achievingcompleting the objectives described above.remediation plan. The Company believes that its remediation plan will be sufficient to remediate the identified
40


material weaknesses and strengthen its internal control over financial reporting. As the Company continues to evaluate, and works to improve, its internal control over financial reporting, management may determine that additional measures to address control deficiencies or modifications to the remediation plan are necessary. The Company cannot assure you, however, when it will remediate such weaknesses, nor can it be certain whether additional actions will be required or the costs of any such actions. Moreover, the Company cannot assure you that additional material weaknesses will not arise in the future.
Changes in Internal Control Over Financial Reporting
The Company is in the process of implementing certain changes in its internal controls to remediate the material weaknesses described above. The implementation of the material aspects of this plan will beginbegan in the second quarter of 2019. During the quarter ended December 31, 2020, the Company, with the assistance of its outside consultant, continued the design and implementation of internal controls for certain processes within its Aluminum business, PE Films business, Flexible Packaging business and its corporate function. Except foras noted above with respect to the identificationimplementation of the material weaknesses described above, which originated in prior periods,remediation plan, there has been no change in the Company’s internal control over financial reporting during the quarter ended December 31, 2018,2020, that has materially affected, or is reasonably likely to materially affect, its internal control over financial reporting.

Item 9B.    OTHER INFORMATION
Item 9B.OTHER INFORMATION
None.

41





PART III
Item 10.DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
Item 10.    DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
The information concerning directors and persons nominated to become directors of Tredegar to be included in the Proxy Statement under the headings “Proposal 1: Election of Directors” and “Tredegar’s Board of Directors” is incorporated herein by reference.
The information concerning corporate governance to be included in the Proxy Statement under the headings “Board Meetings, Meetings of Non-Management Directors and the Board Committees” and “Corporate Governance” is incorporated herein by reference.
The information to be included in the Proxy Statement under the heading “Section 16(a) Beneficial Ownership Reporting Compliance” is incorporated herein by reference.
Set forth below are the names, ages and titles of the Company’s executive officers:
NameAgeTitle
John D. GottwaldM. Steitz6462 
President and Chief Executive Officer
D. Andrew Edwards6062 
Executive Vice President and Chief Financial Officer
Michael J. SchewelKevin C. Donnelly6546 
Vice President, General Counsel and Corporate Secretary
John D. Gottwald. M. Steitz. Mr. GottwaldSteitz was elected President and Chief Executive Officer on August 18, 2015. From June 26, 2015 until August 17, 2015, he served as interim President and Chief Executive Officer.effective March 19, 2019.  He previously served as the Company’s President and Chief Executive Officer of Addivant Corporation, a leading global supplier of antioxidants, intermediates, inhibitors, modifiers, UV stabilizers and other additives to the plastic and rubber industries, from March 1, 20062015 until January 31, 2010,2019, as President and as the Company’s ChairmanChief Operating Officer of the BoardPQ Corporation, a leading worldwide producer of specialty inorganic performance chemicals and catalysts, from September 2001October 2013 until February 2008. Mr. Gottwald also servedMarch 2015, as the Company’s President and Chief Executive Officer of Avantor Performance Materials, a global supplier of ultra-high-purity life sciences materials with strict regulatory and performance specifications, from July 1989September 2012 until September 2001.2013, as President and Chief Operating Officer of Albemarle Corporation from March 2012 until August 2012, and as Chief Operating Officer and Executive Vice President of Albemarle from April 2007 until March 2012.
D. Andrew Edwards.Mr. Edwards was electednamed Executive Vice President and Chief Financial Officer effective August 6, 2020. Mr. Edwards had been Vice President and Chief Financial Officer since July 20, 2015. He previously served as the Chief Financial Officer of United Sporting Companies, Inc., a wholesale distributor of outdoor sporting goods, from February 2013 until July 2015 and as Vice President, Controller and Chief Accounting Officer of Owens & Minor, Inc., a distributor of acute medical products, from April 2010 to February 2013 and as Acting Chief Financial Officer of Owens & Minor, Inc. from March 2012 to February 2013. Mr. Edwards also served as Vice President, Finance, of Owens & Minor, Inc. from December 2009 until April 2010.  Mr. Edwards previously served as the Company’s Vice President, Chief Financial Officer and Treasurer from August 2003 to December 2009 and as the Company’s Vice President, Finance from November 1998 to August 2003. Mr. Edwards also served as the Company’s Treasurer from May 1997 to December 2009 and as the Company’s Controller from October 1992 until July 2000.
Michael J. SchewelKevin C. Donnelly.  Mr. SchewelDonnelly was elected Vice President, General Counsel and Corporate Secretary effective May 9, 2016.January 1, 2021. He was previously a partner with the law firm of McGuire Woods, LLP from 1986 until May 2016, except for four years from 2002 until 2006 when hejoined Tredegar in 2010 and served as Secretaryits Associate General Counsel from 2013 to 2020. Prior to joining Tredegar, Mr. Donnelly was an associate at Hunton & Williams LLP (now Hunton Andrews Kurth LLP). He received a B.A. degree from the University of CommerceRichmond and Trade fora J.D. from the CommonwealthUniversity of Virginia.
On February 28, 2019, the Company announced that John D. Gottwald was retiring as its president and chief executive officer effective immediately after the filing of this Annual Report on Form 10-K. He will continue to be a member of Tredegar’s board of directors.  Tredegar’s board of directors elected John M. Steitz to succeed Mr. Gottwald as president and chief executive officer effective upon Mr. Gottwald’s retirement.  Mr. Steitz has been a director of Tredegar since 2017.
Tredegar has adopted a Code of Conduct that applies to all of its directors, officers and employees (including its chief executive officer, chief financial officer and principal accounting officer) and has posted the Code of Conduct on its website. All amendments to or waivers from any provision of the Company’s Code of Conduct applicable to the chief executive officer, chief financial officer and principal accounting officer will be disclosed on the Company’s website. The Company’s internet address is www.tredegar.com.


Item 11.EXECUTIVE COMPENSATION
Item 11.    EXECUTIVE COMPENSATION
The information to be included in the Proxy Statement under the headings “Compensation of Directors,” “Board Meetings, Meetings of Non-Management Directors and Board Committees—Committees - Executive Compensation Committee Interlocks and Insider Participation,” “Compensation Discussion and Analysis,” “Executive Compensation Committee Report” and “Compensation of Executive Officers” is incorporated herein by reference.
42
Item 12.
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT ANDRELATED STOCKHOLDER MATTERS


Item 12.    SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT ANDRELATED STOCKHOLDER MATTERS
The information to be included in the Proxy Statement under the heading “Stock Ownership”“Equity Compensation Plan Information” is incorporated herein by reference. The following table summarizes information with respect to equity compensation plans under which securities are authorized for issuance as of December 31, 2018.
  Column (a) Column (b) Column (c)
Plan Category
Number of Securities
to be Issued Upon
Exercise of
Outstanding Options,
Warrants and Rights*
 Weighted-Average Exercise Price of Outstanding Options, Warrants and Rights 
Number of Securities
Remaining Available for
Future Issuance Under
Equity Compensation Plans,
Excluding Securities
Reflected in Column (a)
Equity compensation plans approved by security holders1,319,561
 $19.69
 1,548,917
Equity compensation plans not approved by security holders
 
 
Total1,319,561
 $19.69
 1,548,917
Item 13.    CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE
*Includes performance stock units that give the holder the right to receive shares of Tredegar common stock upon the satisfaction of certain performance criteria.

Item 13.CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE
The information to be included in the Proxy Statement under the headings “Certain Relationships and Related Transactions”,Transactions,” “Tredegar’s Board of Directors” and “Board Meetings, Meetings of Non-Management Directors and Board Committees” is incorporated herein by reference.
Item 14.PRINCIPAL ACCOUNTING FEES AND SERVICES
Item 14.    PRINCIPAL ACCOUNTING FEES AND SERVICES
The following is incorporated herein by reference:
Information on accounting fees and services to be included in the Proxy Statement under the heading “Audit and Non-Audit Fees;” and
Information on the Audit Committee’s procedures for pre-approving certain audit and non-audit services to be included in the Proxy Statement under the heading “Board Meetings, Meetings of Non-Management Directors and Board Committees—Audit Committee Matters.”


43



PART IV

Item 15.EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
(a)List of documents filed as a part of the report:
(1)Financial statements:
Tredegar Corporation
Index to Financial Statements and Supplementary DataItem 15.    EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

44
Page
Auditors’ Opinions:
Reports of Independent Registered Public Accounting Firm - KPMG LLP
Report of Independent Registered Public Accounting Firm - PricewaterhouseCoopers LLP
Financial Statements:
Consolidated Balance Sheets as of December 31, 2018 and 2017
Consolidated Statements of Income for the Years Ended December 31, 2018, 2017 and 2016
Consolidated Statements of Comprehensive Income (Loss) for the Years Ended December 31, 2018, 2017 and 2016
Consolidated Statements of Cash Flows for the Years Ended December 31, 2018, 2017 and 2016
Consolidated Statements of Shareholders' Equity for the Years Ended December 31, 2018, 2017 and 2016
Notes to Financial Statements
(2)Financial statement schedules:
None
(3)Exhibits:


See Exhibit Index on pages:





Report of Independent Registered Public Accounting Firm


To the Shareholders and Board of Directors
Tredegar Corporation:

Opinion on the ConsolidatedFinancial Statements
We have audited the accompanying consolidated balance sheetsheets of Tredegar Corporation and subsidiaries (the Company) as of December 31, 2018,2020 and 2019, the related consolidated statements of income, comprehensive income (loss), cash flows, and shareholders’ equity for each of the yearyears in the three-year period ended December 31, 2018,2020, and the related notes (collectively, the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2018,2020 and 2019, and the results of its operations and its cash flows for each of the yearyears in the three-year period ended December 31, 2018,2020, in conformity with U.S. generally accepted accounting principles.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company’s internal control over financial reporting as of December 31, 2018,2020, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission, and our report dated March 18, 201916, 2021 expressed an adverse opinion on the effectiveness of the Company’s internal control over financial reporting.
Change in Accounting Principle
As discussed in Note 1 to the consolidated financial statements, the Company has changed its method of accounting for revenue in 2018 due to the adoption of Financial Accounting Standards Board Accounting Standards Codification Topic 606, Revenue from Contracts with Customers.
Basis for Opinion
These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. Our audit included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audit provides a reasonable basis for our opinion.

/s/ KPMG LLP
We have served as the Company’s auditor since 2018.

Richmond, Virginia
March 18, 2019


Report of Independent Registered Public Accounting Firm
To the Shareholders and Board of Directors
Tredegar Corporation:
Opinion on Internal Control Over Financial Reporting
We have audited Tredegar Corporation and subsidiaries’ (the Company) internal control over financial reporting as of December 31, 2018, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. In our opinion, because of the effect of the material weaknesses, described below, on the achievement of the objectives of the control criteria, the Company has not maintained effective internal control over financial reporting as of December 31, 2018, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheet of the Company as of December 31, 2018, the related consolidated statements of income, comprehensive income (loss), cash flows, and shareholders’ equity for the year ended December 31, 2018, and the related notes (collectively, the consolidated financial statements), and our report dated March 18, 2019 expressed an unqualified opinion on those consolidated financial statements.
A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company’s annual or interim financial statements will not be prevented or detected on a timely basis. Material weaknesses related to an ineffective control environment resulting from an insufficient number of trained resources, ineffective risk assessment, ineffective information and communication, and ineffective monitoring activities resulting in ineffective control activities related to the design and operation of process-level controls and general information technology controls across all financial reporting processes have been identified and included in management’s assessment. The material weaknesses were considered in determining the nature, timing, and extent of audit tests applied in our audit of the 2018 consolidated financial statements, and this report does not affect our report on those consolidated financial statements.
Basis for Opinion
The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Report on Internal Control Over Financial Reporting as of December 31, 2018. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.
Definition and Limitations of Internal Control Over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.


Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

/s/ KPMG LLP
Richmond, Virginia
March 18, 2019



Report of Independent Registered Public Accounting Firm

To the Board of Directors and Shareholders of Tredegar Corporation

Opinion on the Financial Statements

We have audited the accompanying consolidatedbalance sheet of Tredegar Corporation and its subsidiaries(the “Company”) as of December 31, 2017,and the related consolidated statements of income, of comprehensive income (loss), of shareholders’ equity, and of cash flowsfor each of the two years in the period ended December 31, 2017,including the related notes(collectively referred to as the “consolidated financial statements”).In our opinion, the consolidatedfinancial statements present fairly, in all material respects, the financial position ofthe Company as of December 31, 2017, and the results of its operations and itscash flows for each of the two years in the period ended December 31, 2017 in conformity with accounting principles generally accepted in the United States of America.

Change in Accounting Principle

As discussed in Note 1 to the consolidated financial statements, the Company has changed its method of accounting for leases as of January 1, 2019 due to the manner in which it accounts for pension and postretirement benefits in 2018.

adoption of Accounting Standards Codification Topic 842, Leases.
Basis for Opinion

These consolidated financial statements are the responsibility of the Company'sCompany’s management. Our responsibility is to express an opinion on the Company’sthese consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB)PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits of these consolidatedfinancial statements in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud.

Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.

Critical Audit Matter
/s/ PricewaterhouseCoopers LLP

Richmond, Virginia
February 21, 2018, except forThe critical audit matter communicated below is a matter arising from the change incurrent period audit of the manner in whichconsolidated financial statements that was communicated or required to be communicated to the Companyaudit committee and that: (1) relates to accounts for pension and postretirement benefits discussed in Note 1or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of a critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.
Valuation of investment in kaleo, Inc.
As discussed in Notes 1 and 4 to the dateconsolidated financial statements, the Company accounts for its ownership interest in kaleo, Inc. (“kaléo”) under the fair value option of accounting. The Company estimates the fair value of its investment in kaléo by computing the weighted average estimated enterprise value utilizing both the discounted cash flow method (the “DCF method”) and the application of a market multiple to earnings before interest, taxes, depreciation and amortization (the “EBITDA multiple method”), and applying certain other adjustments. The Company applied an 80% weighting to the DCF method and a 20% weighting to the EBITDA multiple method. As of December 31, 2020, the estimated fair value of the Company’s ownership interest in kaléo was $34.6M.
We identified the assessment of the fair value of the Company’s ownership interest in kaléo as a critical audit matter. Subjective auditor judgment was required to evaluate certain assumptions used in the DCF method. Specifically, the weighted average cost of capital (“WACC”), which was used as the basis for the discount rate, is March 18, 2019sensitive to variation such that minor changes to this assumption could have a significant impact on the estimated fair value of the Company’s ownership interest in kaléo.

The following are the primary procedures we performed to address the critical audit matter. We involved valuation professionals with specialized skills and knowledge who assisted in:
45


— evaluating the Company’s discount rate by comparing it to a discount rate that was independently developed using publicly available third-party market data for comparable entities
— developing an estimate of fair value using kaléo’s forecasted cash flows and the independently developed discount rate, and comparing the results of our estimate of fair value to the Company’s fair value estimate.

/s/ KPMG LLP

We have served as the Company'sCompany’s auditor since 2018.

Richmond, Virginia
March 16, 2021
46


Report of Independent Registered Public Accounting Firm


To the Shareholders and Board of Directors
Tredegar Corporation:

Opinion on Internal Control Over Financial Reporting
We have audited Tredegar Corporation and subsidiaries’(the Company) internal control over financial reporting as of December 31, 2020, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. In our opinion, because of the effect of the material weaknesses, described below, on the achievement of the objectives of the control criteria, the Company has not maintained effective internal control over financial reporting as of December 31, 2020, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of the Company as of December 31, 2020 and 2019, the related consolidated statements of income, comprehensive income (loss), cash flows, and shareholders’ equity for each of the years in the three-year period ended December 31, 2020, and the related notes (collectively, the consolidated financial statements), and our report dated March 16, 2021 expressed an unqualified opinion on those consolidated financial statements.
A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company’s annual or interim financial statements will not be prevented or detected on a timely basis. Material weaknesses related to an ineffective control environment resulting from 1989an insufficient number of trained resources, ineffective risk assessment, ineffective information and communication, and ineffective monitoring activities resulting in ineffective control activities related to 2018.

the design and operation of process-level controls and general information technology controls across all financial reporting processes have been identified and included in management’s assessment. The material weaknesses were considered in determining the nature, timing, and extent of audit tests applied in our audit of the 2020 consolidated financial statements, and this report does not affect our report on those consolidated financial statements.

Basis for Opinion
The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.
Definition and Limitations of Internal Control Over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

/s/ KPMG LLP

Richmond, Virginia
March 16, 2021
47


CONSOLIDATED BALANCE SHEETS
Tredegar Corporation and Subsidiaries
December 31
December 31 2018 2017
20202019
(In thousands, except share data)(In thousands, except share data)   (In thousands, except share data)
AssetsAssets   Assets
Current assets:Current assets:   Current assets:
Cash and cash equivalentsCash and cash equivalents$34,397
 $36,491
Cash and cash equivalents$11,846 $31,422 
Accounts and other receivables, net of allowance for doubtful accounts and sales returns of $2,937 in 2018 and $3,304 in 2017124,727
 120,135
Accounts and other receivables, net of allowance for doubtful accounts and sales returns of $2,797 in 2020 and $1,904 in 2019Accounts and other receivables, net of allowance for doubtful accounts and sales returns of $2,797 in 2020 and $1,904 in 201986,327 89,117 
Income taxes recoverableIncome taxes recoverable6,783
 32,080
Income taxes recoverable2,807 2,661 
InventoriesInventories93,810
 86,907
Inventories66,437 64,205 
Prepaid expenses and otherPrepaid expenses and other9,564
 8,224
Prepaid expenses and other19,679 8,333 
Current assets of discontinued operationsCurrent assets of discontinued operations1,339 37,418 
Total current assetsTotal current assets269,281
 283,837
Total current assets188,435 233,156 
Property, plant and equipment, at cost:Property, plant and equipment, at cost:   Property, plant and equipment, at cost:
Land and land improvementsLand and land improvements8,772
 8,723
Land and land improvements4,544 4,554 
BuildingsBuildings101,332
 101,271
Buildings66,406 64,311 
Machinery and equipmentMachinery and equipment682,968
 660,898
Machinery and equipment404,669 413,856 
Total property, plant and equipmentTotal property, plant and equipment793,072
 770,892
Total property, plant and equipment475,619 482,721 
Less accumulated depreciationLess accumulated depreciation(564,703) (547,801)Less accumulated depreciation(309,074)(309,165)
Net property, plant and equipmentNet property, plant and equipment228,369
 223,091
Net property, plant and equipment166,545 173,556 
Right-of-use leased assetsRight-of-use leased assets16,037 18,492 
Investment in kaléo (cost basis of $7,500)Investment in kaléo (cost basis of $7,500)84,600
 54,000
Investment in kaléo (cost basis of $7,500)34,600 95,500 
Identifiable intangible assets, netIdentifiable intangible assets, net36,295
 40,552
Identifiable intangible assets, net18,820 22,636 
GoodwillGoodwill81,404
 128,208
Goodwill67,708 81,404 
Deferred income tax assetsDeferred income tax assets3,412
 16,636
Deferred income tax assets19,068 12,435 
Other assetsOther assets4,012
 9,419
Other assets3,506 4,628 
Non-current assets of discontinued operationsNon-current assets of discontinued operations151 70,861 
Total assetsTotal assets$707,373
 $755,743
Total assets$514,870 $712,668 
Liabilities and Shareholders’ EquityLiabilities and Shareholders’ Equity   Liabilities and Shareholders’ Equity
Current liabilities:Current liabilities:   Current liabilities:
Accounts payableAccounts payable$112,758
 $108,391
Accounts payable$89,702 $87,296 
Accrued expensesAccrued expenses42,495
 42,433
Accrued expenses40,741 39,465 
Lease liability, short-termLease liability, short-term2,082 2,427 
Income taxes payableIncome taxes payable706 
Current liabilities of discontinued operationsCurrent liabilities of discontinued operations7,521 23,280 
Total current liabilitiesTotal current liabilities155,253
 150,824
Total current liabilities140,752 152,468 
Lease liability, long-termLease liability, long-term14,949 17,338 
Long-term debtLong-term debt101,500
 152,000
Long-term debt134,000 42,000 
Pension and other postretirement benefit obligations, netPension and other postretirement benefit obligations, net88,124
 98,837
Pension and other postretirement benefit obligations, net110,585 107,446 
Deferred income tax liabilitiesDeferred income tax liabilities
 2,123
Deferred income tax liabilities0 11,019 
Other noncurrent liabilities7,639
 8,179
Other non-current liabilitiesOther non-current liabilities5,529 5,297 
Non-current liabilities of discontinued operationsNon-current liabilities of discontinued operations0 351 
Total liabilitiesTotal liabilities352,516
 411,963
Total liabilities405,815 335,919 
Commitments and contingencies (Notes 15 and 18)
 
Shareholders’ equity:Shareholders’ equity:   Shareholders’ equity:
Common stock (no par value):Common stock (no par value):   Common stock (no par value):
Authorized 150,000,000 shares;Authorized 150,000,000 shares;   Authorized 150,000,000 shares;
Issued and outstanding—33,176,024 shares in 2018 and 33,017,422 in 2017 (including restricted stock)38,892
 34,747
Common stock held in trust for savings restoration plan (72,883 shares in 2018 and 71,309 in 2017)(1,559) (1,528)
Issued and outstanding— 33,457,176 shares in 2020 and 33,365,039 in 2019 (including restricted stock)Issued and outstanding— 33,457,176 shares in 2020 and 33,365,039 in 2019 (including restricted stock)50,066 45,514 
Common stock held in trust for savings restoration plan (105,067 shares in 2020 and 74,798 in 2019)Common stock held in trust for savings restoration plan (105,067 shares in 2020 and 74,798 in 2019)(2,087)(1,592)
Accumulated other comprehensive income (loss):Accumulated other comprehensive income (loss):   Accumulated other comprehensive income (loss):
Foreign currency translation adjustmentForeign currency translation adjustment(96,940) (86,178)Foreign currency translation adjustment(84,149)(100,663)
Gain (loss) on derivative financial instrumentsGain (loss) on derivative financial instruments(1,601) 459
Gain (loss) on derivative financial instruments2,264 (1,307)
Pension and other postretirement benefit adjustmentsPension and other postretirement benefit adjustments(81,446) (90,950)Pension and other postretirement benefit adjustments(96,519)(95,681)
Retained earningsRetained earnings497,511
 487,230
Retained earnings239,480 530,478 
Total shareholders’ equityTotal shareholders’ equity354,857
 343,780
Total shareholders’ equity109,055 376,749 
Total liabilities and shareholders’ equityTotal liabilities and shareholders’ equity$707,373
 $755,743
Total liabilities and shareholders’ equity$514,870 $712,668 
    
See accompanying notes to financial statements.

48



CONSOLIDATED STATEMENTS OF INCOME
Tredegar Corporation and Subsidiaries
Years Ended December 31
Years Ended December 31 2018 2017 2016
202020192018
(In thousands, except per-share data)(In thousands, except per-share data)     (In thousands, except per-share data)
Revenues and other:Revenues and other:     Revenues and other:
SalesSales$1,065,471
 $961,330
 $828,341
Sales$755,290 $826,324 $851,834 
Other income (expense), netOther income (expense), net30,459
 51,713
 2,381
Other income (expense), net(67,294)28,371 30,455 
1,095,930
 1,013,043
 830,722
687,996 854,695 882,289 
Costs and expenses:Costs and expenses:     Costs and expenses:
Cost of goods soldCost of goods sold849,756
 767,550
 659,867
Cost of goods sold558,967 641,140 679,665 
FreightFreight36,027
 33,683
 29,069
Freight25,686 28,980 27,170 
Selling, general and administrativeSelling, general and administrative85,283
 83,386
 73,466
Selling, general and administrative84,246 76,598 67,929 
Research and developmentResearch and development18,707
 18,287
 19,122
Research and development8,398 7,893 6,672 
Amortization of identifiable intangiblesAmortization of identifiable intangibles3,976
 6,198
 3,978
Amortization of identifiable intangibles3,017 13,601 3,976 
Pension and postretirement benefitsPension and postretirement benefits10,406
 10,193
 11,047
Pension and postretirement benefits14,720 9,642 10,406 
Interest expenseInterest expense5,702
 6,170
 3,806
Interest expense2,587 4,051 5,702 
Asset impairments and costs associated with exit and disposal activities2,913
 102,488
 2,684
Goodwill impairment charge46,792
 
 
Asset impairments and costs associated with exit and disposal activities, net of adjustmentsAsset impairments and costs associated with exit and disposal activities, net of adjustments1,725 784 398 
Goodwill impairmentGoodwill impairment13,696 
TotalTotal1,059,562
 1,027,955
 803,039
Total713,042 782,689 801,918 
Income (loss) before income taxes36,368
 (14,912) 27,683
Income (loss) from continuing operations before income taxesIncome (loss) from continuing operations before income taxes(25,046)72,006 80,371 
Income tax expense (benefit)Income tax expense (benefit)11,526
 (53,163) 3,217
Income tax expense (benefit)(8,213)13,545 18,807 
Net income$24,842
 $38,251
 $24,466
Net income (loss) from continuing operationsNet income (loss) from continuing operations(16,833)58,461 61,564 
Income (loss) from discontinued operations, net of taxIncome (loss) from discontinued operations, net of tax(58,611)(10,202)(36,722)
Net income (loss)Net income (loss)$(75,444)$48,259 $24,842 
     
Earnings per share:     
Earnings (loss) per share:Earnings (loss) per share:
Basic:Basic:
Continuing operationsContinuing operations$(0.51)$1.76 $1.86 
Discontinued operationsDiscontinued operations(1.75)(0.31)(1.11)
Basic earnings (loss) per shareBasic earnings (loss) per share$(2.26)$1.45 $0.75 
Diluted:Diluted:
Continuing operationsContinuing operations$(0.51)$1.76 $1.86 
Discontinued operationsDiscontinued operations(1.75)(0.31)(1.11)
Diluted earnings (loss) per shareDiluted earnings (loss) per share$(2.26)$1.45 $0.75 
Shares used to compute earnings (loss) per share:Shares used to compute earnings (loss) per share:
BasicBasic$0.75
 $1.16
 $0.75
Basic33,40233,23633,068
DilutedDiluted$0.75
 $1.16
 $0.75
Diluted33,40233,25833,092
See accompanying notes to financial statements.

49



CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
Tredegar Corporation and Subsidiaries
Years Ended December 31 2018 2017 2016
(In thousands, except per-share data)     
Net income$24,842
 $38,251
 $24,466
Other comprehensive income (loss):     
Unrealized foreign currency translation adjustment (net of tax of $281 in 2018, tax benefit of $371 in 2017 and tax benefit of $729 in 2016)(10,762) 7,792
 18,837
Derivative financial instruments adjustment (net of tax benefit of $503 in 2018, net of tax of $111 in 2017 and tax of $727 in 2016)(2,060) (404) 1,236
Pension & other postretirement benefit adjustments:     
Net gains (losses) and prior service costs (net of tax benefit of $319 in 2018, tax benefit of $2,518 in 2017 and tax benefit of $1,874 in 2016)(1,118) (8,634) (3,288)
Amortization of prior service costs and net gains or losses (net of tax of $3,028 in 2018, tax of $4,234 in 2017 and tax of $4,398 in 2016)10,622
 7,811
 8,700
Other comprehensive income (loss)(3,318) 6,565
 25,485
Comprehensive income (loss)$21,524
 $44,816
 $49,951
Years Ended December 31
202020192018
(In thousands)
Net income (loss)$(75,444)$48,259 $24,842 
Other comprehensive income (loss):
Unrealized foreign currency translation adjustment (net of tax benefit of $897 in 2020, net of tax benefit of $623 in 2019 and net of tax of $281 in 2018)(8,781)(3,723)(10,762)
Reclassification of foreign currency translation loss realized on the sale of Personal Care Films25,295 
Derivative financial instruments adjustment (net of tax of $790 in 2020, net of tax of $71 in 2019 and net of tax benefit of $503 in 2018)3,571 294 (2,060)
Pension & other postretirement benefit adjustments:
Net gains (losses) and prior service costs (net of tax benefit of $4,228 in 2020, net of tax benefit of $6,417 in 2019 and net of tax benefit of $319 in 2018)(12,197)(22,508)(1,118)
Amortization of prior service costs and net gains or losses (net of tax of $3,937 in 2020, net of tax of $2,359 in 2019 and net of tax of $3,028 in 2018)11,359 8,273 10,622 
Other comprehensive income (loss)19,247 (17,664)(3,318)
Comprehensive income (loss)$(56,197)$30,595 $21,524 
See accompanying notes to financial statements.

50



CONSOLIDATED STATEMENTS OF CASH FLOWS
Tredegar Corporation and Subsidiaries
Years Ended December 31 2018 2017 2016
(In thousands)     
Cash flows from operating activities:     
Net income$24,842
 $38,251
 $24,466
Adjustments for noncash items:     
Depreciation29,828
 34,079
 28,494
Amortization of identifiable intangibles3,976
 6,198
 3,978
Goodwill impairment charge46,792
 
 
Deferred income taxes8,626
 (36,414) (3,689)
Accrued pension and postretirement benefits10,406
 10,193
 11,047
(Gain) loss on investment in kaléo accounted for under the fair value method(30,600) (33,800) (1,600)
Loss on asset impairments223
 101,282
 1,436
(Gain) loss on sale of assets(46) 553
 (220)
Gain from insurance recoveries
 (5,261) (1,634)
Changes in assets and liabilities:     
Accounts and other receivables(11,883) (10,566) 92
Inventories(9,577) (9,128) 1,127
Income taxes recoverable/payable25,018
 (24,449) (7,061)
Prepaid expenses and other(1,924) (784) (1,914)
Accounts payable and accrued expenses5,571
 21,123
 161
Pension and postretirement benefit plan contributions(8,907) (5,829) (8,061)
Other, net5,449
 2,767
 2,250
Net cash provided by operating activities97,794
 88,215
 48,872
Cash flows from investing activities:     
Capital expenditures(40,814) (44,362) (45,457)
Acquisitions, net of cash acquired
 (87,110) 
Return of escrowed funds relating to acquisition earn-out4,250
 
 
Net proceeds from the sale of investment property1,384
 
 
Insurance proceeds from cast house explosion
 5,739
 1,156
Proceeds from the sale of assets and other1,098
 129
 2,308
Net cash used in investing activities(34,082) (125,604) (41,993)
Cash flows from financing activities:     
Borrowings76,750
 190,750
 96,750
Debt principal payments(127,250) (133,750) (105,750)
Dividends paid(14,592) (14,532) (14,456)
Debt financing costs
 
 (2,606)
Proceeds from exercise of stock options and other1,004
 695
 2,313
Net cash provided by (used in) financing activities:(64,088) 43,163
 (23,749)
Effect of exchange rate changes on cash(1,718) 1,206
 2,225
Increase (decrease) in cash and cash equivalents(2,094) 6,980
 (14,645)
Cash and cash equivalents at beginning of period36,491
 29,511
 44,156
Cash and cash equivalents at end of period$34,397
 $36,491
 $29,511
Supplemental cash flow information:     
Interest payments$5,421
 $5,808
 $3,074
Income tax payments (refunds), net$(24,020) $9,193
 $15,406
Years Ended December 31
202020192018
(In thousands)
Cash flows from operating activities:
Net income (loss)$(75,444)$48,259 $24,842 
Adjustments for noncash items:
Depreciation28,940 30,683 29,828 
Amortization of identifiable intangibles3,017 13,601 3,976 
Goodwill impairment13,696 46,792 
Reduction of right-of-use lease asset2,753 2,588 
Deferred income taxes(16,892)5,856 8,626 
Accrued pension and postretirement benefits14,720 9,642 10,406 
(Gain) loss on investment in kaléo accounted for under the fair value method60,900 (10,900)(30,600)
Loss on sale of divested businesses52,326 
Net gain on disposal of assets0 (6,334)(46)
Changes in assets and liabilities:
Accounts and other receivables(335)16,471 (11,883)
Inventories(4,366)11,315 (9,577)
Income taxes recoverable/payable1,617 2,644 25,018 
Prepaid expenses and other(2,203)795 (1,924)
Accounts payable and accrued expenses4,045 (2,937)5,571 
Lease liability(3,049)(2,723)
Pension and postretirement benefit plan contributions(12,681)(8,614)(8,907)
Other, net7,329 5,517 5,672 
Net cash provided by operating activities74,373 115,863 97,794 
Cash flows from investing activities:
Capital expenditures(23,355)(50,864)(40,814)
Return of escrowed funds relating to acquisition earn-out0 4,250 
Net proceeds on sale of divested businesses56,236 
Net proceeds from the sale of investment property1,384 
Proceeds from the sale of assets and other0 10,936 1,098 
Net cash provided by (used in) investing activities32,881 (39,928)(34,082)
Cash flows from financing activities:
Borrowings162,250 65,500 76,750 
Debt principal payments(70,250)(125,000)(127,250)
Dividends paid(216,049)(15,325)(14,592)
Debt financing costs(693)(1,817)
Repurchase of employee common stock for tax withholdings(850)(854)(328)
Proceeds from exercise of stock options and other0 184 1,332 
Net cash provided by (used in) financing activities:(125,592)(77,312)(64,088)
Effect of exchange rate changes on cash(1,238)(1,598)(1,718)
Increase (decrease) in cash and cash equivalents(19,576)(2,975)(2,094)
Cash and cash equivalents at beginning of period31,422 34,397 36,491 
Cash and cash equivalents at end of period$11,846 $31,422 $34,397 
Supplemental cash flow information:
Interest payments$1,679 $4,358 $5,421 
Income tax payments (refunds), net$1,670 $2,595 $(24,020)
See accompanying notes to financial statements.


51


CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY
Tredegar Corporation and Subsidiaries
         Accumulated Other Comprehensive Income (Loss)  
 Common Stock 
Retained
Earnings
 Trust for Savings Restora-tion Plan 
Foreign
Currency
Trans-lation
 
Gain
(Loss) on
Derivative
Financial Instruments
 
Pension & Other Post-
retirement Benefit Adjust.
 
Total
Share-
holders’ Equity
(In thousands, except share and per-share data)Shares Amount      
Balance at January 1, 201632,682,162
 $29,467
 $453,467
 $(1,467) $(112,807) $(373) $(95,539) $272,748
Net loss
 
 24,466
 
 
 
 
 24,466
Foreign currency translation adjustment (net of tax benefit of $729)
 
 
 
 18,837
 
 
 18,837
Derivative financial instruments adjustment (net of tax of $727)
 
 
 
 
 1,236
 
 1,236
Net gains or losses and prior service costs (net of tax benefit of $1,874)
 
 
 
 
 
 (3,288) (3,288)
Amortization of prior service costs and net gains or losses (net of tax of $4,398)
 
 
 
 
 
 8,700
 8,700
Cash dividends declared ($0.44 per share)
 
 (14,456) 
 
 
 
 (14,456)
Stock-based compensation expense127,169
 1,461
 
 
 
 
 
 1,461
Issued upon exercise of stock options (including related income tax of $1,109) & other124,476
 1,079
 
 
 
 
 
 1,079
Tredegar common stock purchased by trust for savings restoration plan
 
 30
 (30) 
 
 
 
Balance at December 31, 201632,933,807
 32,007
 463,507
 (1,497) (93,970) 863
 (90,127) 310,783
Net income
 
 38,251
 
 
 
 
 38,251
Foreign currency translation adjustment (net of tax benefit of $371)
 
 
 
 7,792
 
 
 7,792
Derivative financial instruments adjustment (net of tax of $111)
 
 
 
 
 (404) 
 (404)
Net gains or losses and prior service costs (net of tax benefit of $2,518)
 
 
 
 
 
 (8,634) (8,634)
Amortization of prior service costs and net gains or losses (net of tax of $4,234)
 
 
 
 
 
 7,811
 7,811
Cash dividends declared ($0.44 per share)
 
 (14,532)         (14,532)
Stock-based compensation expense49,475
 2,018
 
 
 
 
 
 2,018
Issued upon exercise of stock options & other34,140
 695
 
 
 
 
 
 695
Cumulative effect adjustment for adoption of stock-based compensation accounting guidance
 27
 (27) 
 
 
 
 
Tredegar common stock purchased by trust for savings restoration plan
 
 31
 (31) 
 
 
 
Balance at December 31, 201733,017,422
 34,747
 487,230
 (1,528) (86,178) 459
 (90,950) 343,780
Net income
 
 24,842
 
 
 
 
 24,842
Foreign currency translation adjustment (net of tax of $281)
 
 
 
 (10,762) 
 
 (10,762)
Derivative financial instruments adjustment (net of tax benefit of $503)
 
 
 
 
 (2,060) 
 (2,060)
Net gains or losses and prior service costs (net of tax benefit of $319)
 
 
 
 
 
 (1,118) (1,118)
Amortization of prior service costs and net gains or losses (net of tax of $3,028)
 
 
 
 
 
 10,622
 10,622
Cash dividends declared ($0.44 per share)
 
 (14,592) 
 
 
 
 (14,592)
Stock-based compensation expense102,762
 3,141
 
 
 
 
 
 3,141
Issued upon exercise of stock options & other55,840
 1,004
 
 
 
 
 
 1,004
Tredegar common stock purchased by trust for savings restoration plan
 
 31
 (31) 
 
 
 
Balance at December 31, 201833,176,024
 $38,892
 $497,511
 $(1,559) $(96,940) $(1,601) $(81,446) $354,857
    Accumulated Other Comprehensive Income (Loss)
 Common StockRetained
Earnings
Trust for Savings Restoration PlanForeign Currency TranslationGain (Loss) on Derivative Financial InstrumentsPension & Other 
Postretirement Benefit Adjust
Total Shareholders’ Equity
(In thousands, except share and per-share data)SharesAmount
Balance at January 1, 201833,017,422 $34,747 $487,230 $(1,528)$(86,178)$459 $(90,950)$343,780 
Net income— — 24,842 — — — — 24,842 
Foreign currency translation adjustment— — — — (10,762)— — (10,762)
Derivative financial instruments adjustment— — — — — (2,060)— (2,060)
Net gains or losses and prior service costs— — — — — — (1,118)(1,118)
Amortization of prior service costs and net gains or losses— — — — — — 10,622 10,622 
Cash dividends declared ($0.44 per share)— — (14,592)— — — — (14,592)
Stock-based compensation expense102,762 3,141 — — — — — 3,141 
Repurchase of employee common stock for tax withholdings(17,558)(328)— — — — — (328)
Issued upon exercise of stock options73,398 1,332 — — — — — 1,332 
Tredegar common stock purchased by trust for savings restoration plan— — 31 (31)— — — 
Balance at December 31, 201833,176,024 38,892 497,511 (1,559)(96,940)(1,601)(81,446)354,857 
Net income— — 48,259 — — — — 48,259 
Foreign currency translation adjustment— — — — (3,723)— — (3,723)
Derivative financial instruments adjustment— — — — — 294 — 294 
Net gains or losses and prior service costs— — — — — — (22,508)(22,508)
Amortization of prior service costs and net gains or losses— — — — — — 8,273 8,273 
Cash dividends declared ($0.46 per share)— — (15,325)— — — — (15,325)
Stock-based compensation expense228,959 7,292 — — — — — 7,292 
Repurchase of employee common stock for tax withholdings(49,444)(854)— — — — — (854)
Issued upon exercise of stock options9,500 184 — — — — — 184 
Tredegar common stock purchased by trust for savings restoration plan— — 33 (33)— — — 
Balance at December 31, 201933,365,039 45,514 530,478 (1,592)(100,663)(1,307)(95,681)376,749 
Net loss  (75,444)    (75,444)
Foreign currency translation adjustment    (8,781)  (8,781)
Foreign currency translation loss realized on the sale of Personal Care Films25,295 25,295 
Derivative financial instruments adjustment     3,571  3,571 
Net gains or losses and prior service costs      (12,197)(12,197)
Amortization of prior service costs and net gains or losses      11,359 11,359 
Cash dividends declared ($6.45 per share)  (216,049)    (216,049)
Stock-based compensation expense131,354 5,402      5,402 
Repurchase of employee common stock for tax withholdings(39,217)(850)     (850)
Tredegar common stock purchased by trust for savings restoration plan  495 (495)   0 
Balance at December 31, 202033,457,176 $50,066 $239,480 $(2,087)$(84,149)$2,264 $(96,519)$109,055 
See accompanying notes to financial statements.

52



NOTES TO FINANCIAL STATEMENTS
Tredegar Corporation and Subsidiaries
1SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Organization and 1    NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Nature of Operations. Tredegar Corporation and subsidiaries (collectively “Tredegar,” “the Company,” “we,” “us” or “our”) are primarily engagedis an industrial manufacturer with three primary businesses: custom aluminum extrusions for the North American building & construction, automotive and specialty end-use markets; surface protection films for high-technology applications in the manufacture ofglobal electronics industry; polyethylene overwrap films polyesterused in bathroom tissue and paper towels; and polyester-based films for use in packaging applications that have specialized properties primarily for the Latin American and aluminum extrusions, whichthe United States (“U.S.”) flexible packaging markets. The Company’s business segments are reported for business segment purposes under PE Films, Flexible Packaging Films (also referred to as Terphane) and Aluminum Extrusions (also referred to as Bonnell Aluminum), respectively.PE Films, and Flexible Packaging Films (also referred to as Terphane). More information on the Company’s business segments is provided in Note 5. See
On October 30, 2020, the Company completed the sale of its personal care films business (“Personal Care Films”), which was part of its PE Films segment. The transaction excluded the packaging film lines and related operations located at the Pottsville, Pennsylvania manufacturing site (“Pottsville Packaging”), which are now being reported within the Surface Protection component of PE Films. Commencing in the third quarter of 2020, all historical results for Personal Care Films have been presented as discontinued operations.
In December 2020, the Company entered into a definitive agreement to sell Bright View Technologies (“Bright View”), with the transaction completed on December 31, 2020. The sale does not represent a strategic shift nor does it have a major effect on the Company’s historical and ongoing operations, thus all financial information for Bright View has been presented as continuing operations. Bright View historically has been reported in the PE Films segment.
For more information on these transactions, see Note 2 in the Notes 10 and 17 regarding restructurings.to Financial Statements
Basis of Presentation.Presentation and Principles of Consolidation. The consolidated financial statements include the accounts and operations of Tredegarthe Company and all of its majority-owned subsidiaries.have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”). Intercompany accountsbalances and transactions have been eliminated in consolidation.
The preparation of financial statements in conformity with United States (“U.S.”) generally accepted accounting principles (“GAAP”) requires Tredegar to make estimates and assumptions that affect the reported amounts of revenues, expenses, assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. Actual results could differ from those estimates.
Certain amounts for the prior years have been reclassified to conform to current year presentation. For the years ended December 31, 2017 and 2016, the pension and postretirement benefit expenses recorded in Cost of goods sold and Selling, general and administrative have been reclassified to a new line item, Pension and postretirement benefits, on the consolidated statements of income, due to the retrospective adoption of ASU 2017-07.
Fiscal Year End. The Company operates on a calendar fiscal year except for the Aluminum Extrusions segment, which operates on a 52/53-week fiscal year basis. References to Aluminum Extrusions for 2018, 20172020, 2019 and 20162018 relate to the 52-week fiscal year ended December 27, 2020, the 52-week fiscal year ended December 29, 2019 and the 53-week fiscal year ended December 30, 2018, and the 52-week fiscal years ended December 24, 2017 and December 26, 2016, respectively. The Company does not believe the impact of reporting the results of this segment as stated abovein this manner is material to the consolidated financial results. The Company may fund or receive cash from the Aluminum Extrusions segment based on Aluminum Extrusion’s cash flows from operations during the intervening period from Aluminum Extrusion’s fiscal year end to the Company’s calendar year end. As a result, the Company’s cash and cash equivalents declined by $3.8 million as of December 31, 2020 since the Company made payments to the Aluminum Extrusions segment to fund its working capital during the intervening period.
Use of Estimates. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses and disclosure of contingent assets and liabilities (if any). Actual results could differ from those estimates.
Risk and Uncertainties. While it is not possible to estimate the impact that the coronavirus pandemic (“COVID-19”) may have on the Company’s business, estimates related to the accounting for impairment of long-lived assets and goodwill, an investment accounted for under the fair value method, pension benefits and income taxes could be materially adversely affected in future periods. Due to the uncertainty with respect to the magnitude of the impact and duration of COVID-19, future developments associated with COVID-19 may adversely affect the Company's financial condition, results of operations and cash flows. The Company continues to monitor the impact of COVID-19 on the business and its effect on the consolidated financial statements.
Foreign Currency Translation. The financial statements of subsidiaries located outside the U.S., where the local currency is the functional currency, are translated into U.S. Dollars using exchange rates in effect at the period end for assets and liabilities and average exchange rates during each reporting period for results of operations. Adjustments resulting from the translation of these financial statements are reflected as a separate component of shareholders’ equity. There are no operating subsidiaries located outside the U.S. where the U.S. Dollar is the functional currency.
Transaction and remeasurement gains or losses included in income were gains of $0.6 million, losses of $0.5 million, $0.8$0.6 million and $3.6gains of $0.1 million in 2018, 20172020, 2019 and 2016,2018, respectively. These amounts do not include the effects between reporting periods that exchange rate changes have on income of the locations outside the U.S. that result from translation into U.S. Dollars.
Cash and Cash Equivalents. Cash and cash equivalents consist of cash on hand in excess of daily operating requirements and highly liquid investments with original maturities of three months or less. At December 31, 20182020 and 2017,2019, Tredegar had cash
53


and cash equivalents of $34.4$11.8 million and $36.5$31.4 million, respectively, including funds held in locations outside the U.S. of $31.1$9.4 million and $32.7$8.9 million, respectively.
The Company’s policy permits investment of excess cash in marketable securities that have the highest credit ratings and maturities of less than one year. The primary objectives of the policy are safety of principal and liquidity.
Accounts and Other Receivables. Accounts receivable are stated at the amount invoiced to customers less allowances for doubtful accounts and sales returns. Accounts receivable are non-interest bearing and arise from the sale of product to customers under typical industry trade terms. Notes receivable are not significant. Past due amounts are determined based on established terms and charged-off when deemed uncollectible. The allowance for doubtful accounts is determined based on an assessment of probable losses taking into account past due amounts, customer credit profile, historical experience and current economic conditions. For receivables that do not have a specific allowance, the loss rate is computed by segment to apply to the remaining receivables balance, using each segment’s historic loss rate. Other receivables include value-added taxes related to certain foreign subsidiaries and other miscellaneous receivables due within one year. For certain customers, the Company has arrangements in place with financial institutions whereby certain customer receivables are sold to the financial institution at a discount and without recourse. Upon sale, the associated receivable is derecognizedunrecognized and the discount is recognized.recognized as a reduction of sales. For more information on accounts receivable and other receivables, net, see Note 6.
Inventories. Inventories are stated at the lower of cost or market, with cost determined using the last-in, first-outlast in, first out (“LIFO”), the weighted average cost or the first-in, first-outfirst in, first out method. Cost elements included in work-in-process and finished goods inventories are raw materials, direct labor and manufacturing overhead. Finished goods, work-in-process, raw materials and


supplies, stores and other inventory are reviewed to determine if inventory quantities are in excess of forecasted usage or if they have become obsolete.
Property, Plant and Equipment. Accounts include costs of assets constructed or purchased, related delivery and installation costs and interest incurred on significant capital projects during their construction periods. Expenditures for renewals and betterments also are capitalized, but expenditures for repairs and maintenance are expensed as incurred. The cost and accumulated depreciation applicable to assets retired or sold are removed from the respective accounts, and gains or losses thereon are included in income.
Capital expenditures for property, plant and equipment include capitalized interest. Capitalized interest included in capital expenditures for property, plant and equipment was $0.1 million, $0.3 million $0.4 million and $0.3$0.1 million in 2020, 2019 and 2018, 2017 and 2016, respectively.
Depreciation is computed primarily by the straight-line method based on the estimated useful lives of the assets that except for isolated exceptions,generally range from 5 to 40 years for buildings and land improvements and 2 to 20 years for machinery and equipment.
Investments in Private Entities with Less Than or Equal to 50% Voting Ownership Interest. The Company accounts for its investments in private entities where its voting ownership is less than or equal to 50% based on the facts and circumstances surrounding the investment.
For those investments measured at fair value, GAAP requires disclosure of the level within the fair value hierarchy in which fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). For more information on investments, see Note 4.
Goodwill and Identifiable Intangibles. The excess of the purchase price over the fair value of identifiable net assets of acquired companies is allocated to goodwill. The Company assesses goodwill for impairment when events or circumstances indicate that the carrying value may not be recoverable or, at a minimum, on an annual basis (December 1st of each year). When assessing goodwill for impairment, accounting guidance allows the Company to first perform a qualitative assessment about the likelihood of the carrying value of a reporting unit exceeding its fair value, referred to as the "Step 0" assessment. The Step 0 assessment requires the evaluation of certain qualitative factors, including macroeconomic conditions, industry and market considerations, cost factors and overall financial performance, as well as company and reporting unit factors. If the Company's Step 0 analysis indicates that it is more likely than not that the fair value of a reporting unit is less than the carrying amount, then the Company would perform a quantitative impairment test.
During the first three months of 2020, the Company performed goodwill impairment tests and recognized a goodwill impairment charge of $13.7 million ($10.5 million after taxes), which represented the entire amount of goodwill associated with Aluminum Extrusions’ AACOA reporting unit. The operations of the AACOA reporting unit, which includes the Niles, Michigan and Elkhart, Indiana facilities, were expected to be severely impacted by COVID-19, with over 80% of the aluminum extrusions manufactured at these facilities sold to customers that make consumer durable products, such as recreational boating and power sports vehicles, and to customers serving the building and construction and automotive markets.
As of December 1, 2020, the Company’s significant operatingreporting units with goodwill were Surface Protection in PE Films include Personal Care and Surface Protection. There are three operating unitsFutura in Aluminum Extrusions: Bonnell Aluminum, AACOA and Futura. EachExtrusions. Both of these reporting units hashave separately identifiable operating net assets (operating assets including goodwill and identifiable intangible assets net of operating liabilities).
The Company recorded a goodwill impairment charge of $46.8 million ($38.2 million after taxes) to write off the goodwill associated with the Personal Care reporting unit of PE Films in the third quarter of 2018. See Note 8for additional details.
The Company estimates the fair value of its reporting units using discounted cash flow analysisanalyses and comparative enterprise value-to-EBITDA (earnings before interest, taxes, depreciation and amortization) multiples. Goodwill of Aluminum Extrusions operating unit, Futura, in the amount of $10.4 million was tested for impairment at the annual testing date, with the estimated fair value of this reporting unit exceeding the carrying value of its net assets at December 1, 2018. The Surface Protection reporting unit of PE Films and the AACOA, Inc. (“AACOA”) reporting unit of Aluminum Extrusions had goodwill in the amounts of $57.3 million and $13.7 million, respectively, at December 1, 2018. The goodwill in Aluminum Extrusions is associated with the October 2012 acquisition of AACOA and the February 2017 acquisition of Futura Industries Corporation (“Futura”).
54


As of December 31, 2018,1, 2020, the Company applied the Step 0 goodwill assessment to Surface Protection and AACOA,Futura, which both had fair values significantly in excess of their carrying amounts when last tested in 2017.using the quantitative impairment test. The Company's Step 0 analysisanalyses in 20182020 of thethese reporting units concluded that it is not more likely than not that the fair values of theeach reporting units areunit was less than theirits carrying amounts.amount. Therefore, the quantitative goodwill impairment testtests for these reporting units waswere not necessary in 2018.


2020. The Surface Protection and Futura reporting units had goodwill in the amounts of $57.3 million and $10.4 million, respectively, at December 31, 2020.
Indefinite-lived identifiable intangible assets are assessed for impairment when events or circumstances indicate that the carrying value may not be recoverable. The Company estimates the fair value of its trade names using a relief-from-royalty method that relies upon a corresponding discounted cash flow analysis.
For AACOA and Futura, the indefinite-lived identifiable intangible assets for each were assessed for indicators of impairment at the annual testing date. No indicators of impairment were identified.
Based on a valuation analysis conducted in the fourth quarter of 2017, Terphane recorded an impairment of its assets. Indefinite-lived trade names for Terphane were written down by $4.0 million to $2.4 million and were assigned estimated useful lives of 5 to 13 years. Also, Terphane recorded a reduction of the carrying value of definite-lived identifiable intangible assets in the amount of $14.0 million.
Additional disclosure of TredegarTredegar’s goodwill and identifiable intangible assets and the impairments recorded in 20172018 are included in Note 8.
Impairment of Long-Lived Assets. The Company reviews long-lived assets for possible impairment when events indicate that an impairment may exist. For assets that are held and used in operations, if events indicate that an asset may be impaired, the Company estimates the future unlevered pre-tax cash flows expected to result from the use of the asset and its eventual disposition. Assets are grouped for this purpose at the lowest level for which there are identifiable and independent cash flows. If the sum of these undiscounted pre-tax cash flows is less than the carrying amount of the asset group, an impairment loss is calculated. Measurement of the impairment loss is the amount by which the carrying amount exceeds the estimated fair value of the asset group.
During the fourth quarter of 2017, in conjunction with annual business planning as well as valuation activities (including the use of discounted cash flow and comparative enterprise value-to-EBITDA multiple methods) and other efforts, the Company determined that the carrying value of Terphane’s remaining long-lived assets were impaired.  Accordingly, the Company wrote down these assets based on an enterprise valuation for all of Terphane of approximately $30 million. This write-down resulted in a non-cash asset impairment loss recognized during the fourth quarter of 2017 of $101 million ($87 million after non-cash tax benefits). See Note 17 for more information on this impairment.
Assets that are held for sale are reported at the lower of their carrying amount or estimated fair value less cost to sell, with an impairment loss recognized for any write-down required.
Pension Costs and Postretirement Benefit Costs Other than Pensions. Pension costs and postretirement benefit costs other than pensions have been accrued over the period employees provided service to Tredegar. Liabilities and expenses for pension plans and other postretirement benefits are determined using actuarial methodologies and incorporate significant assumptions, including the rate used to discount the future estimated liability, the long-term rate of return on plan assets, and several assumptions relating to the employee workforce. The Company recognizes the funded status of its pension and other postretirement plans in the accompanying consolidated balance sheets. Tredegar’s policy is to fund its pension plans at amounts not less than the minimum requirements of the Employee Retirement Income Security Act (“ERISA”) of 1974 and to fund postretirement benefits other than pensions when claims are incurred.
Additional disclosure regarding Tredegar’s pension costs and postretirement benefit costs other than pensions is included in Note 13.
Revenue Recognition. Revenue The Company’s revenue is primarily generated from the sale of finished products which is shown net of estimatedto customers. Those sales returnspredominantly contain a single performance obligation and allowances,revenue is recognized at athe point in time when control has passedof the product is transferred to customers, along with the customer. Control passes totitle, risk of loss and rewards of ownership. Depending on the arrangement with the customer, generallythese criteria are met either at the time the product is shipped or when the customer takes physical possessionproduct is made available or when title passes if defined separatelydelivered at the destination specified in the agreement with the customer.
Sales revenue is recognized in an amount that reflects the consideration the Company expects to be entitled to in exchange for that finished product. The Company offers various discounts, rebates and allowances to customers, (collectively, “allowances”), all of which are considered when determining the transaction price. Certain allowances are fixed and determinable at the time of sale and are recorded at the time of sale as a reduction to revenues. Other allowances can vary depending on future outcomes such as customer sales agreement. volume and represent variable consideration.
Amounts billed to customers related to freight are classified as sales inrevenue and the accompanying consolidated statements of income. The cost of freight is classified as a separate line in the accompanying consolidated statements of income. Taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction between Tredegar and its customers (such as value-added taxes) are accounted for on a net basis and therefore excluded from revenues. See Note 5 for disaggregation of revenue by segment and type. See Note 6 for a table showing accounts and other receivables, net of allowance for bad debts and sales returns.
For the year ended December 31, 2018, the Company had no material bad-debt expense and there were no material contract assets, contract liabilities or deferred contract costs recorded on the Consolidated Balance Sheet as of December 31, 2018. Payment terms start from the date of satisfaction of the performance obligation and vary from COD (cash on delivery) to 120 days. The Company’s contracts generally include one performance obligation, which is satisfied at a point in time.
For the year ended December 31, 2018, revenue recognized from performance obligations related to prior periods (for example, changes in transaction price), was not material.


Revenue expected to be recognized in any future period related to remaining performance obligations, excluding i) revenue pertaining to contracts that have an original expected duration of one year or less, ii) contracts where revenue is recognized as invoiced and iii) variable consideration related to unsatisfied performance obligations, is not expected to materially impact the Company’s financial results. 
Research & Development (“R&D”) Costs. R&D costs are expensed as incurred and include primarily salaries, wages, employee benefits, equipment depreciation, facility costs and the cost of materials consumed relating to R&D efforts. R&D costs include a reasonable allocation of indirect costs.
55


Leases. In February 2016, the Financial Accounting Standards Board (“FASB”) issued a revised standard on lease accounting, ASU 2016-2, Leases (Topic 842). The Company adopted the standard effective January 1, 2019. At inception, the Company determines if an arrangement contains a lease and whether that lease meets the classification criteria of a finance or operating lease. The Company has elected to not record short-term leases with an original lease term of one year or less in the consolidated balance sheet. To the extent such leases contain renewal options that the Company intends to exercise, the related Right-of-Use (“ROU”) asset and lease liability are included in the consolidated balance sheet. Some of the Company’s lease arrangements contain lease components (e.g., minimum rent payments) and non-lease components (e.g., maintenance, labor charges, etc.). The Company generally accounts for the lease and non-lease components as a single lease component.
Certain of the Company’s lease agreements include rental payments that are adjusted periodically for an index or rate. The leases are initially measured using the projected payments adjusted for the index or rate in effect at the commencement date. The Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants.
Operating leases are included in “Right-of-use lease assets”, “Lease liabilities - short-term” and “Lease liabilities - long-term” on the consolidated balance sheets. These assets and liabilities are recognized at the commencement date based on the present value of remaining lease payments over the lease term using the Company’s secured incremental borrowing rates, adjusted for term and geographic location using country-based swap rates. As a result of the Company’s review of new and existing lease contracts, there were no instances where the Company could readily determine a rate implicit in the lease.
Lease expense for operating leases is recognized on a straight-line basis over the lease term. Variable lease expense is recognized in the period in which the obligation for those payments is incurred. Depending upon the specific use of the ROU asset, lease expense is included in the “Cost of goods sold”, “Freight”, “Selling, general and administrative”, and “Research and development” line items on the consolidated statements of income. Lease income is not material to the results of operations for the years ended December 31, 2020 and 2019, respectively. Additional disclosure regarding Tredegar’s leases is included in Note 15.
Income Taxes. Income taxes are recognized during the period in which transactions enter into the determination of income for financial reporting purposes, with deferred income taxes being provided at enacted statutory tax rates on the differences between the financial reporting and tax bases of assets and liabilities (see Note 16). Tredegar’s policy is to accrue U.S. federal income taxes to the extent required under GAAP on unremitted earnings of all foreign subsidiaries where required. However, due to changes in the taxation of dividends under the Tax Cuts and Jobs Act (the “TCJA”) enacted by the U.S. government in December 2017, Tredegar only records U.S. federal income taxes on unremitted earnings of its foreign subsidiaries where Tredegar cannot take steps to eliminate any potential tax on future distributions from its foreign subsidiaries. Prior to the second quarter of 2016, deferred U.S. federal income taxes had not been recorded for the undistributed earnings for Terphane Limitada because the Company had intended to permanently reinvest these earnings. Due to concerns about the political and economic conditions in Brazil, Terphane Limitada began making cash distributions to the Company. During 2016, Terphane Limitada paid dividends totaling $13.3 million to the Company. Because of the accumulation of significant losses related to foreign currency translations at Terphane Limitada, there were no unrecorded deferred income tax liabilities associated with the U.S. federal income taxes and foreign withholding taxes on Terphane Limitada’s undistributed earnings as of December 31, 20182020 and December 31, 2017.2019.
A valuation allowance is recorded in the period when the Company determines that it is more likely than not that all or a portion of deferred income tax assets may not be realized. The establishment and removal of a valuation allowance requires the Company to consider all positive and negative evidence and make a judgmental decision regarding the amount of valuation allowance required as of a reporting date. The benefit of an uncertain tax position is included in the accompanying financial statements when the Company determines that it is more likely than not that the position will be sustained, based on the technical merits of the position, if the taxing authority examines the position and the dispute is litigated. This determination is made on the basis of all the facts, circumstances and information available as of the reporting date.
Earnings Per Share. Basic earnings per share is computed using the weighted average number of shares of common stock outstanding. Diluted earnings per share is computed using the weighted average common and potentially dilutive common equivalent shares outstanding, determined as follows:
2018 2017 2016202020192018
Weighted average shares outstanding used to compute basic earnings per share33,067,800
 32,945,961
 32,761,793
Weighted average shares outstanding used to compute basic earnings per share33,402,147 33,236,115 33,067,800 
Incremental shares attributable to stock options and restricted stock24,674
 5,327
 13,279
Incremental shares attributable to stock options and restricted stock0 22,022 24,674 
Shares used to compute diluted earnings per share33,092,474
 32,951,288
 32,775,072
Shares used to compute diluted earnings per share33,402,147 33,258,137 33,092,474 
Incremental shares attributable to stock options and restricted stock are computed using the average market price during the related period. The Company had a net loss from continuing operations for the year ended December 31, 2020, so there is no dilutive impact for such shares. If the Company had reported net income from continuing operations for the year ended December 31, 2020, average out-of-the-money options to purchase shares that were excluded from the calculation of incremental shares attributable to stock options and restricted stock were 1,212,375. For the years ended December 31, 2019 and 2018, average out-of-the-money options to purchase shares that were excluded from the calculation of incremental shares attributable to stock options and restricted stock were 209,592 and 726,475, in 2018 and 397,669 in 2017 and 128,200 in 2016.respectively.
56


Stock-Based Employee Compensation Plans. Compensation expense is recorded onThe cost of all share-based awardspayments is recognized using itsthe calculated fair value at the grant date, or the date of any later modification, over the requisite service period under the graded-vesting method. The fair value of stock option awards was estimated as of the grant date using the Black-Scholes options-pricing model. The fair value of restricted stock awards was estimated as of the grant date using the closing stock price on that date.See Note 12 for additional information.


The assumptions used in this model for valuing Tredegar stock options granted in 2018 and 2017 (no grants in 2016) were as follows:
 2018 2017
Dividend yield2.3% 1.9%
Weighted average volatility percentage38.3% 38.3%
Weighted average risk-free interest rate2.8% 1.8%
Holding period (years):   
Officers5
 5
Management5
 5
Weighted average exercise price at date of grant (also weighted average market price at date of grant):   
Officers$19.35
 $15.65
Management$19.35
 $15.65
The dividend yield is the actual dividend yield on Tredegar’s common stock at the date of grant, which the Company believes is a reasonable estimate of the expected yield during the holding period. The expected volatility is based on the historical volatility of Tredegar’s common stock using a sequential period of historical data equal to the expected holding period of the option. The Company has no reason to believe that future volatility for this period is likely to differ from the past. The assumed risk-free interest rate is based on observed interest rates (zero coupon U.S. Treasury debt securities) appropriate for the expected holding period.
In March 2016, the Financial Accounting Standards Board (“FASB”) issued Account Standards Update (“ASU”) 2016-09, which amended guidance to simplify several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, and classification on the statement of cash flows. The Company adopted the new guidance in the first quarter of 2017. Under the new guidance, excess tax benefits related to equity compensation were recognized in income tax expense (benefit) in the consolidated statements of income rather than in accumulated other comprehensive income in the consolidated balance sheets and were applied on a prospective basis. If these amounts had been included in the consolidated statements of income in previous years, net income would have been reduced by $1.1 million in 2016. Changes to the statements of cash flows related to the classification of excess tax benefits and employee taxes paid for share-based payment arrangements were implemented on a retrospective basis. In addition, the updated guidance allows the Company to make an accounting policy election to account for forfeitures as they occur. Previously, the Company was required to estimate forfeitures at the grant date, accounting for estimated forfeitures over the requisite service period.
Tredegar stock options granted during 2018 and 2017 (no grants in 2016), and related estimated fair value at the date of grant, are as follows:
 2018 2017
Stock options granted (number of shares):   
Officers425,228
 151,992
Management25,855
 57,559
Total451,083
 209,551
Estimated weighted average fair value of options per share at date of grant:   
Officers$5.87
 $4.69
Management$5.87
 $4.69
Total estimated fair value of stock options granted (in thousands)$2,648
 $983
Additional disclosure of Tredegar stock options is included in Note 12.
Financial Instruments. Tredegar uses derivative financial instruments for the purpose of hedging aluminum price volatility and currency exchange rate exposures that exist as part of transactions associated with ongoing business operations. The Company’s derivative financial instruments are designated as and qualify as cash flow hedges and are recognized in the accompanying balance sheet at fair value. A change in the fair value of the derivative that is highly effective and that is designated and qualifies as a cash flow hedge is recorded in other comprehensive income. Gains and losses reported in other


comprehensive income (loss) are reclassified to earnings in the periods in which earnings are affected by the variability of cash flows of the hedged transaction. Such gains and losses are reported on the same line as the underlying hedged item, and the cash flows related to financial instruments are classified in the consolidated statements of cash flows in a manner consistent with those of the transactions being hedged. Any hedge ineffectiveness (which represents the amount by which the changes in the fair value of the derivative exceed the variability in the cash flows of the forecasted transaction) is recorded in current period earnings. The amount of gains and losses recognized for hedge ineffectiveness were not material in 2018, 20172020, 2019 and 2016.2018.
The Company’s policy requires that it formally document all relationships between hedging instruments and hedged items, as well as its risk management objective and strategy for undertaking various hedge transactions. The Company also formally assesses (both at the hedge’s inception and on an ongoing basis) whether the derivatives that are used in hedging transactions have been highly effective in offsetting changes in the fair value or cash flows of hedged items and whether those derivatives may be expected to remain highly effective in future periods. When it is determined that a derivative is not (or has ceased to be) highly effective as a hedge, the Company discontinues hedge accounting prospectively.
As a policy, Tredegar does not engage in speculative or leveraged transactions, nor does it hold or issue financial instruments for trading purposes. Additional disclosure of the utilization of derivative hedging instruments is included in Note 9.
Comprehensive Income (Loss). Comprehensive income (loss) is defined as net income or loss as adjusted by other comprehensive income or loss items. Other comprehensive income (loss) includes changes in foreign currency translation adjustments, unrealized gains and losses on derivative financial instruments, prior service costs and net gains or losses from pension and other postretirement benefit plans arising during the period and amortization of these prior service costs and net gain or loss adjustments, all recorded net of deferred income taxes.

The following table summarizes the after-tax changes in accumulated other comprehensive income (loss) for the year ended December 31, 2018:2020:

(In thousands)Foreign currency translation adjustmentGain (loss) on derivative financial instrumentsPension and other post-retirement benefit adjustmentsTotal
Beginning balance, January 1, 2020$(100,663)$(1,307)$(95,681)$(197,651)
Other comprehensive income (loss) before reclassifications(8,781)(3,285)(12,197)(24,263)
Amounts reclassified from accumulated other comprehensive income (loss)25,295 6,856 11,359 43,510 
Net other comprehensive income (loss) - current period16,514 3,571 (838)19,247 
Ending balance, December 31, 2020$(84,149)$2,264 $(96,519)$(178,404)








57

(In thousands)Foreign currency translation adjustment Gain (loss) on derivative financial instruments Pension and other post-retirement benefit adjustments Total
Beginning balance, January 1, 2018$(86,178) $459
 $(90,950) $(176,669)
Other comprehensive income (loss) before reclassifications(10,762) (2,978) (1,118) (14,858)
Amounts reclassified from accumulated other comprehensive income (loss)
 918
 10,622
 11,540
Net other comprehensive income (loss) - current period(10,762) (2,060) 9,504
 (3,318)
Ending balance, December 31, 2018$(96,940) $(1,601) $(81,446) $(179,987)


The following table summarizes the after-tax changes in accumulated other comprehensive income (loss) for the year ended December 31, 2017:2019:
(In thousands)Foreign currency translation adjustmentGain (loss) on derivative financial instrumentsPension and other post-retirement benefit adjustmentsTotal
Beginning balance, January 1, 2019$(96,940)$(1,601)$(81,446)$(179,987)
Other comprehensive income (loss) before reclassifications(3,723)(2,686)(22,508)(28,917)
Amounts reclassified from accumulated other comprehensive income (loss)2,980 8,273 11,253 
Net other comprehensive income (loss) - current period(3,723)294 (14,235)(17,664)
Ending balance, December 31, 2019$(100,663)$(1,307)$(95,681)$(197,651)
Reclassifications of balances out of accumulated other comprehensive income (loss) into net income during 2020 are summarized as follows:
(In thousands)Amount reclassified from other comprehensive income (loss)Location of gain (loss) reclassified from accumulated other comprehensive income (loss) to net income (loss)
Gain (loss) on derivative financial instruments:
Aluminum future contracts, before taxes$(2,717)Cost of goods sold
Foreign currency forward contracts, before taxes(6,069)Selling, general and administrative
Foreign currency forward contracts, before taxes62Cost of goods sold
Total, before taxes(8,724)
Income tax expense (benefit)(1,868)Income tax expense (benefit)
Total, net of tax$(6,856)
Amortization of pension and other post-retirement benefits:
Actuarial gain (loss) and prior service costs, before taxes$(15,296)(a)
Income tax expense (benefit)(3,937)Income tax expense (benefit)
Total, net of tax$(11,359)
Reclassification adjustment of foreign currency translation loss included in income:
Realized loss on foreign currency translation adjustments related to the sale of Personal Care Films$(25,295)Income (loss) from discontinued operations, net of tax
(a) This component of accumulated other comprehensive income is included in the computation of net periodic pension cost (see Note 13 for additional detail).











58


(In thousands)Foreign currency translation adjustment Gain (loss) on derivative financial instruments Pension and other post-retirement benefit adjustments Total
Beginning balance, January 1, 2017$(93,970) $863
 $(90,127) $(183,234)
Other comprehensive income (loss) before reclassifications7,792
 538
 (8,634) (304)
Amounts reclassified from accumulated other comprehensive income (loss)
 (942) 7,811
 6,869
Net other comprehensive income (loss) - current period7,792
 (404) (823) 6,565
Ending balance, December 31, 2017$(86,178) $459
 $(90,950) $(176,669)
Reclassifications of balances out of accumulated other comprehensive income (loss) into net income during 2019 are summarized as follows:

(In thousands)Amount reclassified from other comprehensive income (loss)Location of gain (loss) reclassified from accumulated other comprehensive income (loss) to net income
Gain (loss) on derivative financial instruments:
Aluminum future contracts, before taxes$(2,736)Cost of goods sold
Foreign currency forward contracts, before taxes(904)Selling, general and administrative
Foreign currency forward contracts, before taxes62 Cost of goods sold
Total, before taxes(3,578)
Income tax expense (benefit)(598)Income tax expense (benefit)
Total, net of tax$(2,980)
Amortization of pension and other post-retirement benefits:
Actuarial gain (loss) and prior service costs, before taxes$(10,632)(a)
Income tax expense (benefit)(2,359)Income tax expense (benefit)
Total, net of tax$(8,273)
(a) This component of accumulated other comprehensive income is included in the computation of net periodic pension cost (see Note 13 for additional detail).


Reclassifications of balances out of accumulated other comprehensive income (loss) into net income during 2018 are summarized as follows:
(In thousands)Amount reclassified from other comprehensive income (loss)Location of gain (loss) reclassified from accumulated other comprehensive income (loss) to net income
Gain (loss) on derivative financial instruments:
Aluminum future contracts, before taxes$1,069 Cost of goods sold
Foreign currency forward contracts, before taxes(1,796)Selling, general and administrative
Foreign currency forward contracts, before taxes62 Cost of goods sold
Total, before taxes(665)
Income tax expense (benefit)253 Income tax expense (benefit)
Total, net of tax$(918)
Amortization of pension and other post-retirement benefits:
Actuarial gain (loss) and prior service costs, before taxes$(13,650)(a)
Income tax expense (benefit)(3,028)Income tax expense (benefit)
Total, net of tax$(10,622)
(a) This component of accumulated other comprehensive income is included in the computation of net periodic pension cost (see Note 13 for additional detail).
(In thousands)Amount reclassified from other comprehensive income (loss) Location of gain (loss) reclassified from accumulated other comprehensive income (loss) to net income (loss)
Gain (loss) on derivative financial instruments:   
Aluminum future contracts, before taxes$1,069
 Cost of goods sold
Foreign currency forward contracts, before taxes62
 Cost of goods sold
Foreign currency forward contracts, before taxes(1,796) Selling, general and administrative
Total, before taxes(665)  
Income tax expense (benefit)253
 Income taxes
Total, net of tax$(918)  
Amortization of pension and other post-retirement benefits:   
Actuarial gain (loss) and prior service costs, before taxes$(13,650) (a)
Income tax expense (benefit)(3,028) Income taxes
Total, net of tax$(10,622)  
    
(a) This component of accumulated other comprehensive income is included in the computation of net periodic pension cost (see Note 13 for additional detail).

Reclassifications of balances out of accumulated other comprehensive income (loss) into net income during 2017 are summarized as follows:
(In thousands)Amount reclassified from other comprehensive income (loss) Location of gain (loss) reclassified from accumulated other comprehensive income (loss) to net income
Gain (loss) on derivative financial instruments:   
Aluminum future contracts, before taxes$1,210
 Cost of goods sold
Foreign currency forward contracts, before taxes62
 Cost of goods sold
Foreign currency forward contracts, before taxes(43) Selling, general and administrative
Total, before taxes1,229
  
Income tax expense (benefit)287
 Income taxes
Total, net of tax$942
  
Amortization of pension and other post-retirement benefits:   
Actuarial gain (loss) and prior service costs, before taxes$(12,045) (a)
Income tax expense (benefit)(4,234) Income taxes
Total, net of tax$(7,811)  
    
(a) This component of accumulated other comprehensive income is included in the computation of net periodic pension cost (see Note 13 for additional detail).

Reclassifications of balances out of accumulated other comprehensive income (loss) into net income during 2016 are summarized as follows:


(In thousands)Amount reclassified from other comprehensive income (loss) Location of gain (loss) reclassified from accumulated other comprehensive income (loss) to net income
Gain (loss) on derivative financial instruments:   
Aluminum future contracts, before taxes$(1,630) Cost of goods sold
Foreign currency forward contracts, before taxes62
 Cost of goods sold
Total, before taxes(1,568)  
Income tax expense (benefit)(579) Income taxes
Total, net of tax$(989)  
Amortization of pension and other post-retirement benefits:   
Actuarial gain (loss) and prior service costs, before taxes$(13,098) (a)
Income tax expense (benefit)(4,398) Income taxes
Total, net of tax$(8,700)  
    
(a) This component of accumulated other comprehensive income is included in the computation of net periodic pension cost (see Note 13 for additional detail).

Recently Issued Accounting Standards Adopted.
ASU 2014-09, REVENUE FROM CONTRACTS WITH CUSTOMERS (TOPIC 606)
In May 2014, the FASB and International Accounting Standards Board issued their converged standard on revenue recognition. The revised revenue standard contains principles that an entity will apply to direct the measurement of revenue and timing of when it is recognized. The core principle of the guidance is that the recognition of revenue should depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which an entity expects to be entitled in exchange for those goods and services. To achieve that core principle, an entity will utilize a principle-based five-step approach model. The converged standard also includes more robust disclosure requirements which requires entities to provide sufficient information to enable users of financial statements to understand the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. In March 2016, amended guidance was issued regarding clarifying the implementation guidance on principal versus agent considerations and in April 2016, clarifying guidance was issued relating to identifying performance obligations and licensing implementation. The Company adopted the new standard effective January 1, 2018, using the modified retrospective approach applied to all contracts as of the date of adoption. Comparative periods have not been adjusted and continue to be reported under the accounting standards in effect for those periods. The adoption of ASU 2014-09, as amended, had no material impact on the Company’s consolidated financial position, results of operations, equity or cash flows upon adoption. The Company has included the disclosures required by ASU 2014-09.
ASU 2016-01, FINANCIAL INSTRUMENTS (SUBTOPIC 825-10)
In JanuaryJune 2016, the FASB issued amended guidance associatedASU 2016-13, “Financial Instruments - Credit Losses (Topic 326).” The pronouncement replaces the incurred loss methodology to record credit losses with accountinga methodology that reflects the expected credit losses for equity investments measured at fair value. The amended guidance requires all equity investments to be measuredfinancial assets not accounted for at fair value with changes in the fair valuegains and losses recognized through net income (other than those accounted for under equity method of accounting or those that result in consolidation of the investee or those without a readily determinable fair value). The amended guidance also requires an entity to present separately in other comprehensive income the portion of the total change in the fair value of a liability resulting from a change in the instrument-specific credit risk when the entity has elected to measure the liability at fair value in accordance with the fair value option for financial instruments.income. In addition, the amendments in this update eliminate the requirement to disclose the fair value of financial instruments measured at amortized cost for entities that are not public business entities and the requirement to disclose the method(s) and significant assumptions used to estimate the fair value that is required to be disclosed for financial instruments measured at amortized cost on the balance sheet for public business entities. The Company adopted this amended guidance in the first quarter of 20182020, the Company adopted ASU 2016-13 which resulted in an adjustment of less than $0.2 million and, the adoptiontherefore, did not have a material impact on the Company’s consolidated financial statements.


ASU 2016-02, LEASES (TOPIC 842)
In February 2016,August 2018, the FASB issued a revised standard on lease accounting. Lessees will needASU 2018-13, Fair Value Measurement: Changes to recognize virtually all of their leases with a term longer than 12 months on the balance sheet,Disclosure Requirements for Fair Value Measurement (“ASU 2018-13”), which changes the disclosure requirements for fair value measurements by recording a right-of-use (“ROU”) assetremoving, adding and lease liability. The revised standard requires additional analysis of the components of a transaction to determine if a right-of-use asset is embedded in the transaction that needs to be treated as a lease. Substantial additional disclosures are also required by the revised standard. The revised standardmodifying certain disclosures. ASU 2018-13 is effective for the Company for fiscal years beginning after December 31, 2018, including the interimannual periods within those fiscal years. A modified retrospective transition approach which requires a cumulative-effect adjustment to the opening balance of retained earnings on the effective date is required for leases existing at, or entered into after, the effective date, with certain practical expedients available. The Company expects to use certain transition practical expedients that will allow it to elect to not reassess: i) whether expired or existing contracts contain leases under the new definition of a lease; ii) lease classification for expired or existing leases; and iii) whether previously capitalized initial direct costs would qualify for capitalization under Topic 842. The Company has substantially completed its evaluations of the impacts of the accounting and disclosure requirements on its business processes, controls and systems and does not expect that this standard will have a material effect on its consolidated financial statements. The Company has a process in place to analyze the impact of the standard, and the related guidance issued, on all leases throughout the Company. This process includes reviewing all active leases, which have been identified. The most significant impact of the new standard will be the recognition of new ROU assets and lease liabilities for real estate, office equipment and vehicle operating leases. Upon adoption, the Company will recognize operating lease liabilities with corresponding ROU assets calculated based on the present value of the remaining minimum rental payments for existing operating leases.
ASU 2016-16, INCOME TAXES (TOPIC 740)
In October 2016, the FASB issued guidance that requires an entity to recognize the income tax consequences of an intra-entity transfer of an asset other than inventory when the transfer occurs. The amendments are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2017, and should be applied2019, with early adoption permitted. This ASU became effective on a modified retrospective basis through a cumulative-effect adjustment directly to retained earnings at the beginning of the period of adoption. The Company adopted this guidance in the first quarter of 2018January 1, 2020 and the adoptionrequirements of this ASU did not have a material impact on the Company’s consolidated financial statements.Company's fair value disclosures.
ASU 2017-04, INTANGIBLES - GOODWILL AND OTHER (TOPIC 350)
59


Accounting Standards Not Yet Adopted.
In January 2017,December 2019, the FASB issued amended guidance that eliminatesASU 2019-12, which simplifies the requirement to determine the fair value of individual assets and liabilities of a reporting unit to measure goodwill impairment. Under the amendments in theaccounting for income taxes. The new guidance goodwill impairment testing will be performedsimplifies the accounting for income taxes by comparingeliminating certain exceptions related to the fair valueapproach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, hybrid taxes and the recognition of deferred tax liabilities for outside basis differences. It also clarifies and simplifies other aspects of the reporting unit with its carrying amount and recognizing an impairment chargeaccounting for the amount by which the carrying amount exceeds the reporting unit’s fair value.income taxes. The new standard isamendments are effective for annual and interim goodwill impairment tests in fiscal years beginning after December 15, 2019, and should be applied on a prospective basis. Early adoption is permitted for annual or interim goodwill impairment testing performed after January 1, 2017. The Company elected to early adopt for goodwill impairment testing starting in the third quarter of 2018.
ASU 2017-07, COMPENSATION - RETIREMENT BENEFITS (TOPIC 715)
In March 2017, the FASB issued final guidance on the presentation of net periodic pension and postretirement benefit cost (net benefit cost). Previously, net benefit cost was reported as an employee cost within operating income. This new guidance requires the bifurcation of net periodic pension and postretirement benefit costs. Service cost will be part of operating income (and is the only piece eligible to be capitalized). All other components will be shown outside of operations. The new standard is effective for annual2020 and interim periods in fiscal years beginning after December 15, 2017, and should be applied on a retrospective basis, except for the amendments related to capitalization of benefit cost, which should be applied on a prospective basis. The Company adopted this amended guidance in the first quarter of 2018 by separately presenting “Pension and postretirement benefits” expense in its consolidated statements of income.
ASU 2017-12, DERIVATIVES AND HEDGING (TOPIC 815)
In August 2017, the FASB issued amended guidance on the accounting for hedging activities. The amended guidance makes more hedging strategies qualify for hedge accounting. After initial qualification, the amended guidance permits a qualitative effectiveness assessment for certain hedges instead of a quantitative test, if the company can reasonably support an expectation of effectiveness throughout the term of the hedge. The amended guidance is effective for annual and interim periods beginning after January 1, 2019, but may be adopted immediately. Thetherein, with early adoption should be on a cumulative effect basis


and applied prospectively.permitted. The Company is currently evaluating the amended guidance but does not expect there to be an impact of adopting this guidance on the Company’s consolidated financial statements.new guidance.

2    DIVESTITURES AND ASSETS HELD FOR SALE
2ACQUISITIONS
Divestitures
Personal Care Films
On February 15, 2017, Bonnell Aluminum acquired 100%August 24, 2020, the Company entered into a definitive agreement to sell Personal Care Films for an aggregate purchase price of approximately $60.5 million, subject to customary adjustments. Upon completion of the stocksale on October 30, 2020, the Company recognized a pre-tax loss of Futura Industries Corporation (“Futura”)$50.0 million ($46.7 million after-tax) for the year ended December 31, 2020, which includes the realization of other comprehensive losses on a net debt-free basis for approximately $92foreign currency translation adjustments of $25.3 million (the “Initial Purchase Price”). The amount actually fundedpreviously reflected in cash at the transaction date was approximately $87.0 million (the “Initial Cash Funding”), which was the Initial Purchase Price net of preliminary closing adjustments for working capital and seller transaction-related obligations assumed and subsequently paid by Bonnell Aluminum.shareholder’s equity. In addition, the Company was refunded $5 millionagreed to provide certain transition services related to finance, human resources and information technology which are expected to end in the first quarterhalf of 2018 since Futura did not meet certain performance requirements for the 2017 fiscal year (“Earnout Provision”). The acquisition, which2021. Personal Care Films was funded using Tredegar’s revolving credit facility, was treated as an asset purchase for U.S. federal income tax purposes.

Futura, headquartered in Clearfield, Utah, with a national sales presence and particular strengthpreviously reported in the western U.S., designs and manufactures a wide range of extruded aluminum products, including branded flooring trims and TSLOTSTM, as well as OEM (original equipment manufacturer) components for truck grills, solar panels, fitness equipment and other applications. As a result of this transaction, Futura is now a wholly-owned subsidiary ofPE Films segment.
The following table summarizes the William L. Bonnell Company, Inc. (which is a wholly-owned subsidiary of Tredegar) and operates as a division of Bonnell Aluminum, and itsfinancial results of discontinued operations are included in Tredegar’s consolidated financial statements from the date of acquisition.

Under the terms of the transaction, $5 million of the Initial Cash Funding was placed in escrow (the “Earnout Escrow”) and was returned to Bonnell Aluminum because Futura did not achieve a targeted EBITDA level (as defined in the Stock Purchase Agreement) for the last eleven months of the fiscal year ended December 2017. At the acquisition date, the Company performed a probability weighted assessment in order to determine the fair value of this contingent asset. The assessment estimated a fair value of $4.3 million and a receivable (“Initial Earnout Receivable”) was recorded by Bonnell Aluminum. In the second quarter of 2017, the Company updated its valuation of this contingent asset, which resulted in a fair value of $5.0 million. The receivable was increased to $5.0 million, and $0.7 million was recognized as income in the second quarter of 2017 in Other income (expense), netreflected in the Consolidated Statements of Income.

The net purchase priceIncome for financial reporting purposes was set at approximately $82.9 million (the “Adjusted Net Purchase Price”), which was the Initial Cash Funding less the Initial Earnout Receivable and the net settlement of certain post-closing adjustments of $0.1 million paid to the seller during the second quarter of 2017. Adjustments to the purchase price were made retrospectively as if the accounting had been completed on the acquisition date. Based upon management’s valuation of the fair value of tangible and identifiable intangible assets acquired (net of cash acquired) and liabilities assumed, the allocation of the Adjusted Net Purchase Price is as follows:
(In thousands) 
Accounts receivable$6,680
Inventories10,342
Prepaid expenses and other current assets240
Property, plant & equipment32,662
Identifiable intangible assets: 
      Customer relationships24,000
      Trade names6,700
Trade payables & accrued expenses(8,135)
      Total identifiable net assets72,489
      Adjusted Net Purchase Price82,860
Goodwill$10,371

The goodwill and identifiable intangible asset balances associated with this acquisition will be deductible for tax purposes on a straight-line basis over a period of approximately 15 years. For financial reporting purposes, customer relationships are being amortized over 12 years and trade names are being amortized over 13 years. Goodwill is not subject to amortization for financial reporting purposes.



For the year ended December 31, 2017, Tredegar’s consolidated results2020, 2019 and 2018:
Years Ended December 31
(In thousands)202020192018
Revenues and other items:
Sales$110,246 $146,034 $213,637 
Other income (expense), net(333)6,424 
109,913 152,458 213,641 
Costs and expenses:
Cost of goods sold92,079 126,371 170,091 
Freight5,229 7,083 8,857 
Selling, general and administrative16,824 17,754 17,354 
Research and development8,863 11,743 12,035 
Asset impairments and costs associated with exit and disposal activities, net of adjustments1,529 3,341 2,515 
Goodwill impairment0 46,792 
Loss on sale of business50,027 
Total174,551 166,292 257,644 
Income (loss) from discontinued operations before income taxes(64,638)(13,834)(44,003)
Income tax expense (benefit)(6,027)(3,632)(7,281)
Income (loss) from discontinued operations, net of tax$(58,611)$(10,202)$(36,722)
60


The assets and liabilities of the discontinued operations reflected in the Consolidated Balance Sheets as of December 31, 2020 and its Aluminum Extrusions business segment included the following Futura results for the 10.5 months owned: sales of $71.0 million, operating profit from ongoing operations of $8.2 million, depreciation and amortization of $5.0 million, and capital expenditures of $2.5 million.2019, respectively were as follows:

December 31
(In thousands)20202019
Assets
Accounts and other receivables, net$0 $18,441 
Income tax recoverable0 1,439 
Inventories0 17,175 
Prepaid expenses and other (b)1,339 363 
Total current assets1,339 37,418 
Property, plant and equipment, net0 69,334 
Right-of-use leased assets0 728 
Deferred income taxes0 694 
Other assets151 105 
Total non-current assets151 70,861 
Total assets of discontinued operations$1,490 $108,279 
Liabilities
Accounts payable$0 $16,361 
Accrued expenses (b)7,521 6,344 
Lease liability, short-term0 575 
Total current liabilities7,521 23,280 
Lease liability, long-term0 351 
Total non-current liabilities0 351 
Total liabilities of discontinued operations (a)$7,521 $23,631 
(a) Pension and other postretirement benefit liabilities related to Personal Care Films have been retained by the Company.
(b) The consolidated balance sheet of discontinued operations as of December 31, 2020 includes $0.4 million of other receivables related to the settlement of customary post-closing adjustments, deferred assets of $0.9 million and deferred obligations of $5.3 million related to transition services, accrued severance of $2.1 million, and other miscellaneous accrued expenses of $0.2 million.
The following unaudited supplemental pro forma data presents Tredegar’stable provides significant operating and investing cash flow information for discontinued operations:
Year Ended December 31,
(In thousands)202020192018
Operating activities:
Depreciation and amortization$5,511 $9,962 $9,312 
Gain from the sale of the Shanghai manufacturing facility assets0 (6,316)
Loss on sale of Personal Care Films50,027 
Total55,538 3,646 9,312 
Investing activities:
Net proceeds on sale of Personal Care Films$55,115 $$
Proceeds from the sale of the Shanghai manufacturing facility assets0 10,936 
Capital expenditures(1,912)(15,353)(19,475)
Total$53,203 $(4,417)$(19,475)
Bright View
In December 2020, the Company entered into a definitive agreement and completed the sale of Bright View for an aggregate purchase price of $1.5 million, subject to customary adjustments, which resulted in the recognition of a pre-tax loss of $2.3 million ($1.8 million after-tax) included in “Other income (expense), net” in the consolidated sales, netstatements of income and related earnings per share as if the acquisition of Futura had been consummated at the beginning of 2016, and is not necessarily indicative of the Company’s financial performance if the acquisition had actually been consummated as of that date, or of future performance. The supplemental unaudited pro forma measures for the yearsyear ended December 31, 20172020. In addition, the Company agreed to provide certain transition services related to information technology. The sale does not represent a strategic shift nor does it have a major effect on the Company’s
61


historical and 2016 are presented below:

Tredegar Pro Forma Results with Futura Acquisition 
(In thousands, except per-share data)2017 2016
Sales$968,340
 $904,877
Net income$37,974
 $27,805
Earnings per share:   
    Basic$1.15
 $0.85
    Diluted$1.15
 $0.85

Futura’s pre-acquisition results for the period from January 1 to February 14, 2017, and therefore the pro formaongoing operations, thus all financial information for 2017Bright View has been presented above, were adversely impacted by significant disruptionsas continuing operations. Bright View historically has been reported in the PE Films segment.
Assets Held For Sale
In July 2019, the Company committed to a plan to close its manufacturing operations and sales causedfacility in Lake Zurich, Illinois, which historically was reported by the renovationCompany within the personal care component of its anodizing line. The actual accretionPE Films segment. In March 2020, this facility was shut down and the production of elastic materials it previously produced was transferred to Tredegar’s diluted earnings per share from FuturaTerre Haute, Indiana.
In the third quarter of 2020, the held for sale criteria was met since the acquisition date was 12 cents per share for 2017.Company expected the sale of the facility to be completed within one year. As of December 31, 2020, the disposal group carrying value of $4.6 million consists of land, building, and building improvements and is reported in "Prepaid expenses and other" in the Consolidated Balance Sheet. These assets were not included as part of the sale of Personal Care Films.

The Company’s pro forma net income was computed for the periods shown as: (i) the Company’s reported net income, plus (ii) Futura’s historical pre-acquisition period earnings before interest, taxes, depreciation and amortization and excluding one-time purchase accounting and transaction-related expenses, minus (iii) the pro forma pre-acquisition period depreciation and amortization for Futura under purchase accounting for the Company, minus (iv) the pro forma pre-acquisition period interest expense for the Company applied at an annual rate of 3.0% to the $87.0 million Initial Cash Funding, minus (v) the pro forma pre-acquisition period income taxes applied at a rate of 39.1% to the pro forma pre-acquisition earnings before income taxes computed from items (ii) through (iv).3    OTHER INCOME (EXPENSE), NET
3OTHER INCOME (EXPENSE), NET
Other income (expense), net consists of the following:
(In thousands)202020192018
(Loss) gain on investment in kaléo accounted for under fair value method$(60,900)$28,482 $30,600 
Loss on sale of Bright View Technologies(2,299)
Corporate costs associated with the divestiture of Personal Care Films(851)
COVID-19-related expenses (a)(2,231)
Other(1,013)(111)(145)
Total$(67,294)$28,371 $30,455 
(a) Costs associated with operating under COVID-19 conditions include employee overtime expenses associated with absenteeism, personal protective equipment supplies and facility maintenance.
(In thousands)2018 2017 2016
Gain (loss) on investment in kaléo accounted for under fair value method$30,600
 $33,800
 $1,600
Gain associated with the settlement of an escrow agreement related to Terphane, acquired in October 2011
 11,856
 
Gain from insurance recoveries
 5,261
 1,902
Unrealized loss on investment property(186) 
 (1,032)
Other45
 796
 (89)
Total$30,459
 $51,713
 $2,381
The gain on investment in kaléo accounted for under the fair value method of $28.5 million includes a cash dividend of $17.6 million received in 2019 from kaléo. See Note 174 for more details on the items broken out separatelyinvestment in the table above.kaléo.



4    INVESTMENTS
4INVESTMENTS
In August 2007 and December 2008, the Company made an aggregate investment of $7.5 million in kaleo, Inc. (“kaléo”), a privately held specialty pharmaceutical company dedicated to building innovative solutions for serious and life-threatening medical conditions. Tredegar owns Series A-3 Preferred Stock and Series B Preferred Stock in kaléo that, taken together, represents on a fully-diluted basis an approximate 20% interest in kaléo. Tredegar accounts for its investment in kaléo under the fair value method.option. At the time of the initial investment, the Company elected the fair value option of accounting since its investment objectives were similar to those of venture capitalists, which typically do not have controlling financial interests. Kalékaléo’s stock is not publicly traded.

The estimated fair value of the Company’s investment was $84.6$34.6 million as of December 31, 20182020 and $54.0$95.5 million as of December 31, 2017.2019. The Company recognized unrealized gainsa pre-tax loss on its investment in kaléo of $30.6$60.9 million ($23.9 million after taxes) and $33.8 million ($24.047.6 million after taxes) in 20182020, which was primarily due to: (i) current projections that assume ongoing pricing pressures, (ii) expected changes in market access as well as continued lower market demand for epinephrine delivery devices resulting from COVID-19-driven delays in in-person back-to-school schedules and 2017, respectively. Unrealized gains or lossessocial distancing guidelines, and (iii) a higher private company liquidity discount. The net appreciation on its investment of $28.5 million ($23.4 million after taxes) in 2019 included a pre-tax cash dividend of $17.6 million received on April 30, 2019. Future dividends are subject to the discretion of kaléo’s board of directors. Amounts recognized associated with the Company’s investment in kaléo are included in “Other income (expense), net” in the consolidated statements of income and separately stated in the segment operating profitEBITDA from ongoing operations table in Note 5.

Kaléo has transitioned from a company with net losses in 2017 to a company with net income in 2018. Tredegar’s assessment of kaléo’s risk profile has improved during this transition resulting in a lower discount rate versus a year ago that is applied to kaléo’s projected unlevered after-tax cash flows to estimate kaléo’s enterprise value (“EV”) (the “DCF Method”) and the Company’s underlying share of kaléo’s equity value. Moreover, with net income as well as earnings before interest, taxes, depreciation and amortization (“EBITDA”), the EV of kaléo can also be estimated by applying the EV-to-adjusted EBITDA multiple of guideline public companies to kaléo’s most recent trailing 12-month adjusted EBITDA (the “EBITDA Multiple Method”).

The Company estimates the fair value of its investment in kaléo by: (i) computing the weighted average estimated EVenterprise value (“EV”) utilizing both the DCF Methoddiscounted cash flow method (the “DCF Method”) and EBITDAthe application of a market multiple to earnings before interest, taxes, depreciation and amortization (the “EBITDA Multiple Method (includingMethod”), (ii) applying adjustments for any surplus or deficient working capital and estimates of contingent liabilities), (ii)liabilities, (iii) adding cash and cash equivalents, (iii)(iv) subtracting interest-bearing debt, (iv)(v) subtracting a private company liquidity discount estimated at 15%20% at December 31, 2020 (versus 10% at December 31, 2019) of the net result of (i) through (iii)(iv), and (v)(vi) applying liquidation preferences and fully diluted ownership percentages to the estimated equity value computed in (i) through (iv)(v).

The Company’s estimate of kaléo’s EV as of December 31, 20182020 was determined by weighting the EBITDA Multiple Method by 80%20% and the DCF Method by 80% compared to an 80% and 20%. The weighting of the EBITDA Multiple Method and DCF Method, respectively, used in the Company's estimate of kaléo’s EV as of December 31, 2019. A heavier weighting towards the EBITDA MultipleDCF Method as of December 31, 2020 was due to its heuristic nature andused since kaléo’s transitionprojections better reflect ongoing pricing pressures and actual performanceexpected changes in 2018, versus the hypothetical nature of the projections used in the DCF Method.market access. The DCF Method projections rely on numerous assumptions and Level 3 inputs, including estimating market growth, market share, pricing, net margins (after allowances for temporary discounts, prompt pay discounts, product returns, wholesaler fees, chargebacks, rebates and copays), selling expenses, R&D expenses, general and administrative expenses, income taxes on unlevered pretax income, working capital, capital expenditures and the risk-adjusted discount rate.inputs. In
62


addition, there are various regulatory and legal enforcement efforts, including an ongoing Department of Justice investigation related to kaléo’s discontinued Evzio business, which could have a material adverse effect on kaléo’s business that require assessment in any valuation method applied.

The table below provides a sensitivity analysis of the estimated fair value of the Company’s investment in kaléo for changes in the EBITDA multiple used in applying the EBITDA Multiple Method and the changes in the weighting of the DCF Method.

($ Millions) EV-to-Adjusted EBITDA Multiple
  7.6x8.6x9.6x10.6x11.6x
Weighting to DCF Method50%$76.3
$81.2
$86.1
$91.0
$95.9
40%$73.8
$79.7
$85.6
$91.5
$97.3
30%$71.4
$78.3
$85.1
$92.0
$98.8
20%$69.0
$76.8
$84.6
$92.5
$100.3
10%$66.5
$75.4
$84.2
$93.0
$101.8
%$64.1
$73.9
$83.7
$93.5
$103.3




The ultimate value of the Company’s ownership interest in kaléo will be determined and realized only if and when a liquidity event occurs, and the ultimate value could be materially different from the $84.6$34.6 million estimated fair value reflected in the Company’s financial statements at December 31, 2018.2020.
On April 2, 2007, Tredegar invested $10.0 million in Harbinger Capital Partners Special Situations Fund, L.P. (the “Harbinger Fund”), a private investment fund that is subject to limitations on withdrawal. There is no secondary market for interests in the fund. The Company’s investment in the Harbinger Fund, which represents less than 1% of its total partnership capital, is accounted for under the cost method. The December 31, 2018 and 2017 carrying values in the consolidated balance sheets (included in “Other assets and deferred charges”) were $1.3 million and $1.7 million, respectively. The carrying value at December 31, 2018 reflected Tredegar’s cost basis in its investment in Harbinger, net of total withdrawal proceeds received and losses. Based on an observable price change, the Company recorded a loss of $0.5 million in 2018 (none in 2017 or 2016). No withdrawal proceeds were received in 2018, 2017 or 2016. The timing and amount of future installments of withdrawal proceeds, which commenced in August 2010, was not known as of December 31, 2018. The Company has determined that there is no readily determinable fair value for the Harbinger Fund and has elected to record its investment in the Harbinger Fund at cost, less impairment, adjusted for observable price changes. Gains on the Company’s investment in the Harbinger Fund will be recognized when there are positive observable price changes, including when the amounts expected to be collected from any withdrawal from the investment are known, which will likely be when cash in excess of the remaining carrying value is received. Losses will be recognized when management believes through observable methods that it is probable that future withdrawal proceeds will not exceed the remaining carrying value.
In 2018, Tredegar sold all its remaining interest in investment property it had held in Alleghany and Bath counties, Virginia. The total loss recorded on this investment property in 2018 was $0.2 million ($0.2 million after taxes). In 2016, the Company recorded an unrealized loss on this investment property of $1.0 million ($0.7 million after taxes) as a reduction in the estimated fair value of the investment that was not expected to be temporary. The Company’s carrying value in this investment property (included in “Other assets and deferred charges” on the consolidated balance sheets) was $1.6 million at December 31, 2017.5    BUSINESS SEGMENTS
5BUSINESS SEGMENTS
The Company's business segments are Aluminum Extrusions, PE Films and Flexible Packaging FilmsFilms. Aluminum Extrusions, also referred to as Bonnell Aluminum, produces high-quality, soft-alloy and Aluminum Extrusions.medium-strength custom fabricated and finished aluminum extrusions for the building and construction, automotive and transportation, consumer durables, machinery and equipment, electrical and renewable energy, and distribution markets. PE Films is comprisedcomposed of the following operating segments: personal care materials, surface protection films, polyethylene overwrap films and LED-based products.films for other markets. Flexible Packaging Films is comprised of the Company’s polyester films business, Terphane Holdings LLC (“Terphane”). Aluminum Extrusions,
The Company’s reportable segments are based on its method of internal reporting, which includes Bonnell Aluminumis generally segregated by differences in products. Accounting standards for presentation of segments require an approach based on the way the Company organizes the segments for making operating decisions and how the chief operating decision maker (“CODM”) assesses performance.
Earnings before interest, taxes, depreciation and amortization from ongoing operations (“EBITDA from ongoing operations”) is the measure of profit and loss used by the CODM (Tredegar’s President and Chief Executive Officer) for purposes of assessing financial performance. In the fourth quarter of 2019, the Company concluded that “EBITDA from ongoing operations,” instead of “operating profit from ongoing operations,” is the most relevant metric for measuring segment financial performance. This change resulted in a revision of the Company’s segment disclosures for all periods to report EBITDA from ongoing operations as the measure of segment financial performance. The Company uses sales less freight (“net sales”) as its operating divisions, AACOA and Futura, produces high-quality, soft-alloy and medium-strength aluminum extrusions primarily formeasure of revenues from external customers at the following markets: building and construction, automotive, and specialty, which consists of consumer durables, machinery and equipment, electrical and distribution end-use products.segment level. This measure is separately included in the financial information regularly provided to the CODM.
Information by business segment and geographic area for the last three years is provided in the segment tables below. There were no accounting transactions between segments and no allocations to segments. Net
Net Sales
(In thousands)202020192018
Aluminum Extrusions$455,711 $529,602 $573,126 
PE Films139,288 133,807 127,708 
Flexible Packaging Films134,605 133,935 123,830 
Total net sales729,604 797,344 824,664 
Add back freight25,686 28,980 27,170 
Sales as shown in consolidated statements of income$755,290 $826,324 $851,834 
Refer to Notes to Financial Tables that follow these tables.
63


EBITDA from Ongoing Operations
(In thousands)202020192018
Aluminum Extrusions:
Ongoing operations:
EBITDA$55,137 $65,683 $65,479 
Depreciation & amortization (d)(17,403)(16,719)(16,866)
EBIT37,734 48,964 48,613 
Plant shutdowns, asset impairments, restructurings and other (a)(3,506)(561)(505)
Goodwill impairment charge(13,696)
Trade name accelerated amortization (d)0 (10,040)
PE Films:
Ongoing operations:
EBITDA45,107 41,133 32,404 
Depreciation & amortization(6,762)(5,860)(6,201)
EBIT38,345 35,273 26,203 
Plant shutdowns, asset impairments, restructurings and other (a)(1,974)(733)(186)
Flexible Packaging Films:
Ongoing operations:
EBITDA30,645 14,737 11,154 
Depreciation & amortization(1,761)(1,517)(1,262)
EBIT28,884 13,220 9,892 
Plant shutdowns, asset impairments, restructurings and other (a)(18)(45)
Total85,769 86,123 83,972 
Interest income44 66 146 
Interest expense2,587 4,051 5,702 
Gain (loss) on investment in kaléo accounted for under the fair value method (a)(60,900)28,482 30,600 
Loss on sale of Bright View (f)(2,299)
Loss on sale of investment property (a)0 (38)
Unrealized loss on investment property (a)0 (186)
Stock option-based compensation expense2,161 4,132 1,156 
Corporate expenses, net (a)42,912 34,482 27,265 
Income (loss) from continuing operations before income taxes(25,046)72,006 80,371 
Income tax expense (benefit) (a)(8,213)13,545 18,807 
Income (loss) from continuing operations(16,833)58,461 61,564 
Income (loss) from discontinued operations, net of tax (a)(58,611)(10,202)(36,722)
Net income (loss)$(75,444)$48,259 $24,842 
Refer to Notes to Financial Tables that follow these tables.

64


Identifiable Assets
(In thousands)20202019
Aluminum Extrusions$244,560 $265,027 
PE Films119,013 124,269 
Flexible Packaging Films66,453 74,016 
Subtotal430,026 463,312 
General corporate71,508 109,655 
Cash and cash equivalents (b)11,846 31,422 
Discontinued operations1,490 108,279 
Total$514,870 $712,668 
 Depreciation and AmortizationCapital Expenditures
(In thousands)202020192018202020192018
Aluminum Extrusions$17,403 $26,759 $16,866 $10,260 $17,855 $12,966 
PE Films6,762 5,860 6,201 6,024 8,567 2,523 
Flexible Packaging Films1,761 1,517 1,262 4,959 8,866 5,423 
Subtotal25,926 34,136 24,329 21,243 35,288 20,912 
General corporate (e)520 186 163 200 223 427 
Discontinued operations5,511 9,962 9,312 1,912 15,353 19,475 
Total$31,957 $44,284 $33,804 $23,355 $50,864 $40,814 
Net Sales by Geographic Area (c)
(In thousands)202020192018
United States$530,243 $593,599 $636,968 
Exports from the United States to:
Asia80,217 82,342 74,499 
Canada18,024 15,022 16,467 
Europe5,440 5,752 3,909 
Latin America2,169 4,135 991 
Operations outside the United States:
Brazil93,511 96,274 85,868 
China0 220 5,962 
Total$729,604 $797,344 $824,664 
 Identifiable Assets
by Geographic Area (c)
Property, Plant & Equipment,
Net by Geographic Area (c)
(In thousands)2020201920202019
United States$363,106 $403,366 $132,268 $140,609 
Operations outside the United States:
Brazil49,157 41,890 15,588 15,348 
China17,763 18,056 16,245 16,210 
General corporate71,508 109,655 2,444 1,389 
Cash and cash equivalents (b)11,846 31,422 n/an/a
Discontinued operations1,490 108,279 0 69,334 
Total$514,870 $712,668 $166,545 $242,890 
Refer to Notes to Financial Tables that follow these tables.
The Company’s facilities in Pottsville, PA (“PV”) and Guangzhou, China (“GZ”) have a tolling arrangement whereby certain surface protection films are manufactured in GZ for a fee with raw materials supplied from PV that are then shipped by GZ directly to customers principally in the Asian market but paid by customers directly to PV.Amounts associated with this
65


intercompany tolling arrangement are reported in the table above as export sales (sales less freight)from the U.S. to Asia, and operating profitinclude net sales of $35.1 million in 2020, $32.1 million in 2019 and $28.9 million in 2018.
Net Sales by Product Group
(In thousands)202020192018
Aluminum Extrusions:
Nonresidential building & construction$253,126 $272,729 $289,572 
Consumer durables44,167 57,607 66,416 
Automotive35,895 46,461 48,037 
Machinery & equipment30,649 38,657 41,899 
Distribution28,339 34,753 40,924 
Residential building & construction40,049 43,554 43,943 
Electrical23,486 35,841 42,335 
Subtotal455,711 529,602 573,126 
PE Films:
Surface protection films109,097 103,893 98,126 
Packaging22,700 22,542 22,310 
LED-based products7,491 7,372 7,272 
Subtotal139,288 133,807 127,708 
Flexible Packaging Films134,605 133,935 123,830 
Total$729,604 $797,344 $824,664 
(a)See Notes 1, 2, 3, 4 and 17 for more information on losses associated with plant shutdowns, asset impairments and restructurings, unusual items, gains or losses from sale of assets, gains or losses on an investment accounted for under the fair value method and other items.
(b)Cash and cash equivalents includes funds held in locations outside the U.S. of $9.4 million and $8.9 million at December 31, 2020 and 2019, respectively.
(c)Information on exports and foreign operations are provided on the previous page. Export sales relate almost entirely to PE Films. Operations in China relate to PE Films. Operations in Brazil relate to Flexible Packaging Films.
(d)Depreciation and amortization for Aluminum Extrusions in 2019 excludes $10.0 million for accelerated amortization of trade names as a result of a rebranding initiative (see Note 8 for more information)
(e)Corporate depreciation and amortization are included in Corporate expenses, net, on the EBITDA from ongoing operations aretable above.
(f)In December 2020, the measuresCompany entered into a definitive agreement and completed the sale of sales and operating profit used by the chief operating decision maker (Tredegar’s President and Chief Executive Officer)Bright View. See Note 2 for purposes of assessing performance. PE Films’ net sales to The Procter & Gamble Company (“P&G”) totaled $106.5 million in 2018, $122.4 million in 2017 and $129.1 million in 2016. These amounts include plastic film sold to others that convert the film into materials used with products manufactured by P&G.more details. 
Net Sales
(In thousands) 2018 2017 2016
PE Films$332,488
 $352,459
 $331,146
Flexible Packaging Films123,830
 108,355
 108,028
Aluminum Extrusions573,126
 466,833
 360,098
Total net sales1,029,444
 927,647
 799,272
Add back freight36,027
 33,683
 29,069
Sales as shown in consolidated statements of income$1,065,471
 $961,330
 $828,341
6    ACCOUNTS AND OTHER RECEIVABLES


Operating Profit
(In thousands) 2018 2017 2016
PE Films:     
Ongoing operations$36,181
 $41,546
 $26,312
Plant shutdowns, asset impairments, restructurings and other (a)(5,905) (4,905) (4,602)
Goodwill impairment charge(46,792) 
 
Flexible Packaging Films:     
Ongoing operations9,892
 (2,626) 1,774
Plant shutdowns, asset impairments, restructurings and other (a)(45) (89,398) (214)
Aluminum Extrusions:     
Ongoing operations48,613
 43,454
 37,794
Plant shutdowns, asset impairments, restructurings and other (a)(505) 321
 (741)
Total41,439
 (11,608) 60,323
Interest income369
 209
 261
Interest expense5,702
 6,170
 3,806
Gain on investment in kaléo accounted for under the fair value method (a)30,600
 33,800
 1,600
Loss on sale of investment property (a)(38) 
 
Unrealized loss on investment property (a)186
 
 1,032
Stock option-based compensation expense1,221
 264
 56
Corporate expenses, net (a)28,893
 30,879
 29,607
Income (loss) before income taxes36,368
 (14,912) 27,683
Income tax expense (benefit) (a)11,526
 (53,163) 3,217
Net income (loss)$24,842
 $38,251
 $24,466
Identifiable Assets
(In thousands) 2018 2017
PE Films$231,720
 $289,514
Flexible Packaging Films58,964
 49,915
Aluminum Extrusions281,372
 268,127
Subtotal572,056
 607,556
General corporate (b)100,920
 111,696
Cash and cash equivalents (d)34,397
 36,491
Total$707,373
 $755,743
  Depreciation and Amortization Capital Expenditures
(In thousands) 2018 2017 2016 2018 2017 2016
PE Films$15,513
 $14,609
 $13,653
 $21,998
 $15,029
 $25,759
Flexible Packaging Films1,262
 10,443
 9,505
 5,423
 3,619
 3,391
Aluminum Extrusions16,866
 15,070
 9,173
 12,966
 25,653
 15,918
Subtotal33,641
 40,122
 32,331
 40,387
 44,301
 45,068
General corporate163
 155
 141
 427
 61
 389
Total$33,804
 $40,277
 $32,472
 $40,814
 $44,362
 $45,457

See footnotes following the tables.



Net Sales by Geographic Area (d)
(In thousands) 2018 2017 2016
United States$691,232
 $584,066
 $475,734
Exports from the United States to:     
Asia75,904
 84,846
 73,220
Canada51,984
 46,505
 45,683
Europe6,203
 8,505
 7,348
Latin America12,106
 15,199
 5,561
Operations outside the United States:     
Brazil101,217
 87,155
 90,571
The Netherlands45,667
 54,380
 54,352
Hungary33,512
 24,727
 24,207
China7,814
 12,199
 14,390
India3,805
 10,065
 8,206
Total (c)$1,029,444
 $927,647
 $799,272
  
Identifiable Assets
by Geographic Area (d)
 
Property, Plant & Equipment,
Net by Geographic Area (d)
(In thousands) 2018 2017 2018 2017
United States (b)$454,178
 $475,844
 $166,550
 $156,054
Operations outside the United States:       
Brazil52,796
 49,536
 16,072
 13,396
China21,610
 28,833
 19,213
 23,273
Hungary23,615
 28,573
 15,436
 18,230
The Netherlands15,020
 17,423
 6,005
 6,423
India4,837
 7,347
 3,692
 4,628
General corporate (b)100,920
 111,696
 1,401
 1,087
Cash and cash equivalents (d)34,397
 36,491
 n/a
 n/a
Total$707,373
 $755,743
 $228,369
 $223,091
Net Sales by Product Group
(In thousands) 2018 2017 2016
PE Films:     
Personal care materials$227,090
 $246,416
 $238,213
Surface protection films98,126
 99,079
 84,013
LED lighting products & other films7,272
 6,964
 8,920
Subtotal332,488
 352,459
 331,146
Flexible Packaging Films123,830
 108,355
 108,028
Aluminum Extrusions:     
Nonresidential building & construction289,572
 239,713
 212,863
Consumer durables66,416
 54,126
 39,293
Automotive48,037
 38,261
 34,700
Machinery & equipment41,899
 33,450
 20,872
Distribution40,924
 30,202
 20,506
Residential building & construction43,943
 40,354
 20,252
Electrical42,335
 30,727
 11,612
Subtotal573,126
 466,833
 360,098
Total$1,029,444
 $927,647
 $799,272
See footnotes following the tables and a reconciliation of net sales to sales as shown in the Consolidated Statements of Income in the first table of this Note 5.



(a)See Notes 1, 3, 4 and 17 for more information on losses associated with plant shutdowns, asset impairments and restructurings, unusual items, gains or losses from sale of assets, gains or losses on an investment accounted for under the fair value method and other items.
(b)The balance sheets include the funded status of each of the Company’s defined benefit pension and other postretirement plans. The funded status of the Company’s defined benefit pension plan was a net liability of $81.9 million and $91.8 million as of December 31, 2018 and 2017, respectively. See Note 13 for more information on the Company’s pension and other postretirement plans.
(c)The difference between total consolidated sales as reported in the consolidated statements of income and segment, geographic and product group net sales reported in this note is freight of $36.0 million in 2018, $33.7 million in 2017 and $29.1 million in 2016.
(d)Information on exports and foreign operations are provided on the previous page. Cash and cash equivalents includes funds held in locations outside the U.S. of $31.1 million and $32.7 million at December 31, 2018 and 2017, respectively. Export sales relate almost entirely to PE Films. Operations outside the U.S. in The Netherlands, Hungary, China and India also relate to PE Films. Operations in Brazil are primarily related to Flexible Packaging Films, but also include PE Films operations. Sales from locations in The Netherlands and Hungary are primarily to customers located in Europe. Sales from locations in China (Guangzhou and Shanghai) are primarily to customers located in China, but also include other customers in Asia. The facility in Shanghai was shut down in the fourth quarter of 2018.
6ACCOUNTS AND OTHER RECEIVABLES
As of December 31, 20182020 and 2017,2019, accounts receivable and other receivables, net, were $124.7$86.3 million and $120.1$89.1 million, respectively, made up of the following:
(In thousands) 2018 2017(In thousands)20202019
Customer receivablesCustomer receivables$122,182
 $113,556
Customer receivables$85,274 $88,822 
Other accounts and notes receivableOther accounts and notes receivable5,482
 9,883
Other accounts and notes receivable3,850 2,199 
Total accounts and other receivablesTotal accounts and other receivables127,664
 123,439
Total accounts and other receivables89,124 91,021 
Less: Allowance for bad debts and sales returnsLess: Allowance for bad debts and sales returns(2,937) (3,304)Less: Allowance for bad debts and sales returns(2,797)(1,904)
Total accounts and other receivables, netTotal accounts and other receivables, net$124,727
 $120,135
Total accounts and other receivables, net$86,327 $89,117 
A reconciliation of the beginning and ending balances of the allowance for doubtful accounts and sales returns for the three years ended December 31, 20182020 is as follows:
(In thousands)202020192018
Balance, beginning of year$1,904 $2,054 $2,227 
Charges to expense1,901 715 450 
Recoveries(90)(38)(85)
Write-offs and settlements(709)(756)(414)
Foreign exchange and other(209)(71)(124)
Balance, end of year$2,797 $1,904 $2,054 
66
(In thousands) 2018 2017 2016
Balance, beginning of year$3,304
 $3,102
 $3,746
Charges to expense553
 2,369
 1,410
Recoveries(56) (857) (32)
Write-offs and settlements(710) (1,322) (2,167)
Foreign exchange and other(154) 12
 145
Balance, end of year$2,937
 $3,304
 $3,102


7    INVENTORIES
7INVENTORIES
Inventories consist of the following:
(In thousands) 2018 2017(In thousands)20202019
Finished goodsFinished goods$24,938
 $20,281
Finished goods$15,251 $18,217 
Work-in-processWork-in-process15,648
 11,958
Work-in-process9,098 12,123 
Raw materialsRaw materials33,741
 35,909
Raw materials25,913 20,121 
Stores, supplies and otherStores, supplies and other19,483
 18,759
Stores, supplies and other16,175 13,744 
TotalTotal$93,810
 $86,907
Total$66,437 $64,205 
Inventories stated on the LIFO basis amounted to $18.2$14.4 million at December 31, 20182020 and $21.9$12.6 million at December 31, 2017,2019, which were below replacement costs by $16.4$12.1 million at December 31, 20182020 and $15.9$8.6 million at December 31, 2017. During 2018 and 2017, certain PE Films inventories accounted for2019. Inventories stated on a LIFOthe weighted average cost basis declined, which resulted in cost of goods sold being stated at below current costs by $0.3was $33.6 million and $1.5$32.9 million at December 31, 2020 and 2019, respectively, while inventories stated on the first in, first out method amounted to $18.4 million and $18.7 million at December 31, 2020 and 2019, respectively.


8    GOODWILL AND IDENTIFIABLE INTANGIBLE ASSETS
8GOODWILL AND IDENTIFIABLE INTANGIBLE ASSETS
The components of goodwill and identifiable intangibles at December 31, 20182020 and 2017,2019, and related amortization periods for continuing operations are as follows:
(In thousands)20202019Amortization Periods
Goodwill$67,708 $81,404 Not amortized
Identifiable intangible assets, net:
Customer relationships (cost basis of $29,450 in 2020 and $29,550 in 2019)17,551 20,198 10-12 years
Proprietary technology (cost basis of $3,726 in 2020 and $6,181 in 2019)194 895 Not more than 15 years
Trade names (cost basis of $13,397 in 2020 and $13,645 in 2019)1,075 1,543 5 - 13 years
Total carrying value of identifiable intangibles18,820 22,636 
Total carrying value of goodwill and identifiable intangible assets$86,528 $104,040 
(In thousands) 2018 2017 Amortization Periods
Goodwill$81,404
 $128,208
 Not amortized
Identifiable intangible assets:     
Customer relationships (cost basis of $29,568 in 2018 and $29,647 in 2017)22,785
 25,444
 10-12 years
Proprietary technology (cost basis of $6,185 in 2018 and $6,203 in 2017)1,093
 1,700
 Not more than 15 years
Trade names (cost basis of $13,690 in 2018 and $13,887 in 2017)12,417
 13,408
 
5 - 13 years(a)
Total carrying value of identifiable intangibles36,295
 40,552
  
Total carrying value of goodwill and identifiable intangible assets$117,699
 $168,760
  
(a) Includes $4.8 millionIn the third quarter of 2019, the Company implemented a rebranding initiative at Bonnell Aluminum whereby the use of the AACOA and Futura trade names was discontinued as of December 31, 2019. The associated trade names assets, with an indefinite life.a remaining net book value of $10.2 million, were amortized over the last four months of 2019.
A reconciliation of the beginning and ending balance of goodwill for each of the two years in the period endedat December 31, 20182020 and 2019 is as follows:
(In thousands)
Aluminum Extrusions1
PE Films1
Total
Net carrying value of goodwill at December 31, 2018$24,066 $57,338 $81,404 
Goodwill impairment charge
Net carrying value of goodwill at December 31, 201924,066 57,338 81,404 
Goodwill impairment charge(13,696)0 (13,696)
Net carrying value of goodwill at December 31, 2020$10,370 $57,338 $67,708 
1.The goodwill of Aluminum Extrusions and PE Films is carried by the Futura and Surface Protection reporting units, respectively.

67

(In thousands) PE Films Aluminum Extrusions Total
Net carrying value of goodwill at January 1, 2017$104,126
 $13,696
 $117,822
Acquisitions
 10,370
 10,370
Increase (decrease) due to foreign currency translation16
 
 16
Net carrying value of goodwill at December 31, 2017104,142
 24,066
 128,208
Goodwill impairment charge(46,792) 
 (46,792)
Increase (decrease) due to foreign currency translation(12) 
 (12)
Net carrying value of goodwill at December 31, 2018$57,338
 $24,066
 $81,404

The goodwill of PE Films is carried by its Surface Protection component in the amount $57.3 million as of December 31, 2018. The goodwill of Aluminum Extrusions is carried by its AACOA and Futura (which was acquired on February 15, 2017) components in the amounts of $13.7 million and $10.4 million, respectively, as of December 31, 2018.
The Company recorded a goodwill impairment charge of $46.8 million ($38.2 million after taxes) for goodwill associated with the acquisition of certain components of PE Films. During the third quarter of 2018, the Company performed a goodwill impairment analysis related to the Personal Care component of PE Films. This review was undertaken as a result of the expected loss of business from a key customer and revised projections for PE Films. Based on an evaluation of projections under various business planning scenarios, the Company concluded that the fair value of the Personal Care component of PE Films was less than its carrying value.


A reconciliation of the beginning and ending balance of identifiable intangibles for each of the two years in the period endedat December 31, 20182020 and 2019 is as follows:
(In thousands) Customer Relationships  Proprietary Technology  Trade Names  Total
PE Films:       
 Net carrying value at January 1, 2017$
 $959
 $
 $959
  Amortization expense
 (114) 
 (114)
 Net carrying value at December 31, 2017
 845
 
 845
  Amortization expense
 (115) 
 (115)
 Net carrying value at December 31, 2018$
 $730
 $
 $730
          
Flexible Packaging Films:       
 Net carrying value at January 1, 2017$12,084
 $5,574
 $6,375
 $24,033
  Amortization expense(1,793) (1,161) 
 (2,954)
  Increase (decrease) due to foreign currency translation(16) (2) (33) (51)
  Impairment loss(9,444) (4,051) (4,005) (17,500)
 Net carrying value at December 31, 2017831
 360
 2,337
 3,528
  Amortization expense(82) (55) (299) (436)
  Increase (decrease) due to foreign currency translation(88) (17) (176) (281)
 Net carrying value at December 31, 2018$661
 $288
 $1,862
 $2,811
          
Aluminum Extrusions:       
 Net carrying value at January 1, 2017$2,760
 $1,049
 $4,800
 $8,609
  Additions related to acquisition of Futura24,000
 
 6,700
 30,700
  Amortization expense(2,147) (554) (429) (3,130)
 Net carrying value at December 31, 201724,613
 495
 11,071
 36,179
  Amortization expense(2,489) (420) (516) (3,425)
 Net carrying value at December 31, 2018$22,124
 $75
 $10,555
 $32,754
          
Total net carrying value of identifiable intangibles at December 31, 2018$22,785
 $1,093
 $12,417
 $36,295
During the fourth quarter of 2017, in conjunction with annual business planning as well as valuation activities and other efforts, the Company determined that the carrying value of Terphane’s remaining long-lived assets were impaired (Terphane’s goodwill was written off in 2015).  Accordingly, the Company wrote down these assets based on an enterprise valuation for all of Terphane of approximately $30 million. This write-down resulted in a non-cash asset impairment loss recognized during the fourth quarter of 2017 of $101 million ($87 million after non-cash tax benefits). As part of this write-down, customer relationships, proprietary technology and trade names were impaired by $9.4 million, $4.1 million and $4.0 million, respectively, reducing their values to $0.8 million, $0.4 million and $2.4 million, respectively. The remaining part of this write-down was related to property, plant and equipment. Also, Terphane’s trade names were assigned estimated useful lives of 5 to 13 years, a change from the previous designation of an indefinite life.
(In thousands) Customer Relationships Proprietary Technology Trade Names Total
Aluminum Extrusions:
Net carrying value at December 31, 2018$22,124 $75 $10,555 $32,754 
Amortization expense(2,480)(20)(10,555)(13,055)
Net carrying value at December 31, 201919,644 55 19,699 
Amortization expense(2,480)(20)(2,500)
Net carrying value at December 31, 2020$17,164 $35 $$17,199 
PE Films:
Net carrying value at December 31, 2018$$730 $$730 
Amortization expense(120)(120)
Net carrying value at December 31, 2019610 610 
Amortization expense(120)(120)
Bright View disposal(490)(490)
Net carrying value at December 31, 2020$$$$
Flexible Packaging Films:
Net carrying value at December 31, 2018$661 $288 $1,862 $2,811 
Amortization expense(91)(55)(280)(426)
Increase (decrease) due to foreign currency translation(16)(3)(39)(58)
Impairment loss
Net carrying value at December 31, 2019554 230 1,543 2,327 
Amortization expense(84)(53)(260)(397)
Increase (decrease) due to foreign currency translation(83)(18)(208)(309)
Net carrying value at December 31, 2020$387 $159 $1,075 $1,621 
Total net carrying value of identifiable intangibles at December 31, 2020$17,551 $194 $1,075 $18,820 
Amortization expense for continuing operations over the next five years is expected to be as follows:
YearAmount
(In thousands)
2021$2,955 
20222,820 
20232,195 
20242,154 
20252,154 
9    FINANCIAL INSTRUMENTS
Year
Amount
(In thousands)
2019$3,585
20203,585
20213,585
20223,450
20232,824


9FINANCIAL INSTRUMENTS
Tredegar uses derivative financial instruments for the purpose of hedging margin exposure from fixed-price forward sales contracts in Aluminum Extrusions and exposure from currency volatility that exist as part of ongoing business operations (primarily in Flexible Packaging Films). These derivative financial instruments are designated as and qualify as cash flow hedges and are recognized in the consolidated balance sheet at fair value. The fair value of derivative instruments recorded on the consolidated balance sheets are based upon Level 2 inputs. If individual derivative instruments with the same counterparty can be settled on a net basis, the Company records the corresponding derivative fair values as a net asset or net liability.
In the normal course of business, Aluminum Extrusions enters into fixed-price forward sales contracts with certain customers for the future sale of fixed quantities of aluminum extrusions at scheduled intervals. In order to hedge margin exposure created from the fixing of future sales prices relative to volatile raw material (aluminum) costs, Aluminum Extrusions enters into a combination of forward purchase commitments and futures contracts to acquire or hedge aluminum, based on the scheduled purchases for the firm sales commitments. The fixed-price firm sales commitments and related hedging instruments generally have durations of not more than 12 months, and the notional amount of aluminum futures contracts that hedged future
68


purchases of aluminum to meet fixed-price forward sales contract obligations was $25.4$12.1 million (22.5(13.0 million pounds of aluminum) at December 31, 20182020 and $8.2$20.2 million (8.0(19.6 million pounds of aluminum) at December 31, 2017.2019.
The table below summarizes the location and gross amounts of aluminum derivative contract fair values (Level 2) in the consolidated balance sheets as of December 31, 20182020 and 2017:2019:
December 31, 2018 December 31, 2017 December 31, 2020December 31, 2019
(In thousands)
Balance Sheet
Account
 
Fair
Value
 
Balance Sheet
Account
 
Fair
Value
(In thousands)Balance Sheet
Account
Fair
Value
Balance Sheet
Account
Fair
Value
Derivatives Designated as Hedging Instruments    Derivatives Designated as Hedging Instruments
Asset derivatives:
Aluminum futures contracts
Prepaid expenses and other $20
 Prepaid expenses and other $578
Asset derivatives:
Aluminum futures contracts
Prepaid expenses & other$1,560 Accrued expenses$
Liability derivatives:    Liability derivatives:

Aluminum futures contracts
Prepaid expenses and other (1,650) Prepaid expenses and other (16)
    
Derivatives Not Designated as Hedging Instruments    
Asset derivatives:
Aluminum futures contracts
Prepaid expenses and other $
 Prepaid expenses and other $
Liability derivatives:
Aluminum futures contracts
Prepaid expenses and other 
 Prepaid expenses and other 
Liability derivatives:
Aluminum futures contracts
Accrued expenses(22)Accrued expenses(1,259)
Net asset (liability) $(1,630) $562
Net asset (liability)$1,538 $(1,253)
In the event that a counterparty to an aluminum fixed-price forward sales contract chooses not to take delivery of its aluminum extrusions, the customer is contractually obligated to compensate Aluminum Extrusions for any losses on the related aluminum futures and/or forward contracts through the date of cancellation.


The table below summarizes the location and gross amounts of foreign currency forward contract fair values (Level 2) in the consolidated balance sheets as of December 31, 20182020 and 2017:2019:
December 31, 2018 December 31, 2017 December 31, 2020December 31, 2019
(In thousands)
Balance Sheet
Account
 
Fair
Value
 
Balance Sheet
Account
 
Fair
Value
(In thousands)Balance Sheet
Account
Fair
Value
Balance Sheet
Account
Fair
Value
Derivatives Designated as Hedging Instruments    Derivatives Designated as Hedging Instruments
Asset derivatives:
Foreign currency forward contracts
Prepaid expenses and other $37
 Accrued Expenses $
Asset derivatives:
Foreign currency forward contracts
Prepaid expenses and other$853 Prepaid expenses and other$83 
Liability derivatives:
Foreign currency forward contracts
Accrued Expenses (1,090) Accrued Expenses (558)Liability derivatives:
Foreign currency forward contracts
Accrued expenses(466)Accrued expenses(935)
    
Derivatives Not Designated as Hedging Instruments    
Asset derivatives:
Foreign currency forward contracts
Accrued Expenses $
 Accrued Expenses $
Liability derivatives:
Foreign currency forward contracts
Accrued Expenses 
 Accrued Expenses 
Net asset (liability) $(1,053) $(558)Net asset (liability)$387 $(852)
The Company's earnings are exposed to foreign currency exchange risk primarily through the translation of the financial statements of subsidiaries that have a functional currency other than the U.S. Dollar. The Company estimates that the net mismatch translation exposure betweenfor the Flexible Packaging FilmsFilm's business unit in Brazil Terphane Limitada's (“Terphane Ltda.”) U.S. Dollarof its sales and raw materials quoted or priced in U.S. Dollars and its variable conversion, fixed conversion and sales, general and underlying Brazilian Real (“R$”)administrative costs (before depreciation and amortization) quoted or priced operating costs (excluding depreciation and amortization)in Brazilian Real is annual net costs of R$125 million. 119 million Brazilian Real ("R$").
69


Terphane Ltda. has the following outstanding foreign exchange average forward rate contracts to purchase Brazilian Real and sell U.S. Dollars:
USD Notional Amount (000s)Average Forward Rate Contracted on USD/BRLR$ Equivalent Amount (000s)Applicable MonthEstimated % of Terphane Ltda. R$ Operating Cost Exposure Hedged
$2,0253.6442R$7,380Jan-1973%
$2,0253.6527R$7,397Feb-1975%
$2,0253.6593R$7,410Mar-1970%
$2,0253.6690R$7,430Apr-1972%
$2,0253.6795R$7,451May-1973%
$2,0253.6904R$7,473Jun-1972%
$1,8003.8826R$6,989Jul-1965%
$1,8003.8950R$7,011Aug-1968%
$1,8003.9070R$7,033Sep-1966%
$1,8003.9203R$7,056Oct-1967%
$1,8003.9331R$7,080Nov-1967%
$1,8003.9455R$7,102Dec-1973%
$22,9503.7826R$86,812 70%
USD Notional Amount (000s)Average Forward Rate Contracted on USD/BRLR$ Equivalent Amount (000s)Applicable MonthEstimated % of Terphane Ltda. R$ Operating Cost Exposure Hedged
$1,2705.4638R$6,939Jan-2170%
$1,2905.4674R$7,053Feb-2171%
$1,2705.4693R$6,946Mar-2170%
$1,3205.4765R$7,229Apr-2173%
$1,2855.4778R$7,039May-2171%
$1,3955.4882R$7,656Jun-2177%
$1,4505.4945R$7,967Jul-2180%
$1,4305.4993R$7,864Aug-2179%
$1,5205.5105R$8,376Sep-2184%
$1,4005.5100R$7,714Oct-2178%
$1,4955.5224R$8,256Nov-2183%
$1,1705.5060R$6,442Dec-2165%
$16,2955.4913R$89,48175%
These foreign currency exchange contracts have been designated and qualify as cash flow hedges of Terphane Limitada'sLtda.’s forecasted sales to customers quoted or priced in U.S. Dollars over that period. By changing the currency risk associated with these U.S. Dollar sales, the derivatives have the effect of offsetting operating costs quoted or priced in Brazilian Real and decreasing the net exposure to Brazilian Real in the consolidated statements of income. The pre-tax net fair value of the open forward contracts was a negative $0.9 million as of December 31, 2018.2020.
These derivative contracts involve elements of market risk that are not reflected on the consolidated balance sheet, including the risk of dealing with counterparties and their ability to meet the terms of the contracts. The counterparties to any forward purchase commitments are major aluminum brokers and suppliers, and the counterparties to any aluminum futures contracts are major financial institutions. Fixed-price forward sales contracts are only made available to the best and most credit-worthy customers. The counterparties to the Company’s foreign currency cash flow hedge contracts are major financial institutions.


The pretax effect on net income (loss) from continuing operations and other comprehensive income (loss) of derivative instruments classified as cash flow hedges and described in the previous paragraphs for years ended December 31, 2018, 2017,2020, 2019, and 20162018 is summarized in the tables below:
(In thousands)Cash Flow Derivative Hedges
 Aluminum Futures Contracts
Years Ended December 31,202020192018
Amount of pre-tax gain (loss) recognized in other comprehensive income$74 $(2,359)$(1,123)
Location of gain (loss) reclassified from accumulated other comprehensive income into net income (effective portion)Cost of
goods sold
Cost of
goods sold
Cost of
goods sold
Amount of pre-tax gain (loss) reclassified from accumulated other comprehensive income to net income (effective portion)$(2,717)$(2,736)$1,069 
(In thousands)Cash Flow Derivative Hedges
 Foreign Currency Forward Contracts
Years Ended December 31,202020192018
Amount of pre-tax gain (loss) recognized in other comprehensive income$0 $(4,437)$$(856)$$(2,105)
Location of gain (loss) reclassified from accumulated other comprehensive income into net income (effective portion)Cost of
goods sold
Selling, general & adminCost of
goods sold
Selling, general & adminCost of
goods sold
Selling, general & admin
Amount of pre-tax gain (loss) reclassified from accumulated other comprehensive income to net income (effective portion)$62 $(6,069)$62 $(904)$62 $(1,796)
70


(In thousands)Cash Flow Derivative Hedges
 Aluminum Futures Contracts
Years Ended December 31,2018 2017 2016
Amount of pre-tax gain (loss) recognized in other comprehensive income$(1,123) $1,501
 $394
Location of gain (loss) reclassified from accumulated other comprehensive income into net income (effective portion)
Cost of
goods sold

 Cost of
goods sold

 Cost of
goods sold

Amount of pre-tax gain (loss) reclassified from accumulated other comprehensive income to net income (effective portion)$1,069
 $1,210
 $(1,630)
(In thousands)Cash Flow Derivative Hedges
 Foreign Currency Forward Contracts
Years Ended December 31,2018 2017 2016
Amount of pre-tax gain (loss) recognized in other comprehensive income$
$(2,105) $
$(561) $
Location of gain (loss) reclassified from accumulated other comprehensive income into net income (effective portion)Cost of
goods sold
Selling, general & admin Cost of
goods sold
Selling, general & admin Cost of
goods sold
Amount of pre-tax gain (loss) reclassified from accumulated other comprehensive income to net income (effective portion)$62
$(1,796) $62
$(43) $62
Gains and losses on the ineffective portion of derivative instruments or derivative instruments that were not designated as hedging instruments were not material in 2018, 2017 and 2016. For the years ended December 31, 2018, 2017 and 2016, unrealized net losses from hedges that were discontinued were not material. As of December 31, 2018,2020, the Company expected $1.1expects $1.2 million of unrealized after-tax losses on derivative instruments reported in accumulated other comprehensive income (loss) to be reclassified to earnings within the next 12 months.

For the years ended December 31, 2020, 2019 and 2018, net gains or losses realized, from previously unrealized net gains or losses on hedges that had been discontinued, were not material.

10ACCRUED EXPENSES
10    ACCRUED EXPENSES
Accrued expenses consist of the following:
(In thousands)20202019
Payrolls, related taxes and medical and other benefits$9,571 $6,227 
Incentive compensation8,138 9,603 
Vacation7,283 6,975 
Workers’ compensation and disabilities2,986 3,546 
Environmental liabilities (current)2,066 2,122 
Accrued severance1,894 1,180 
Accrued utilities1,460 1,711 
Customer rebates1,398 1,504 
Accrued freight1,397 1,389 
Derivative contract liability487 2,188 
Other4,061 3,020 
Total$40,741 $39,465 
11    DEBT AND CREDIT AGREEMENTS
(In thousands)2018 2017
Vacation$8,946
 $8,575
Incentive compensation6,979
 7,958
Payrolls, related taxes and medical and other benefits6,600
 6,034
Workers’ compensation and disabilities4,048
 3,746
Derivative contract liability2,720
 558
Accrued utilities2,420
 2,177
Accrued freight2,091
 1,581
Environmental liabilities (current)1,990
 3,110
Customer rebates1,476
 1,929
Accrued severance637
 783
Other4,588
 5,982
Total$42,495
 $42,433
A reconciliation of the beginning and ending balances of accrued expenses associated with asset impairments and costs related to exit and disposal activities for each of the three years in the period ended December 31, 2018 is as follows:
(In thousands)
Severance(a)
 
Asset Impairments(b)
 
Other(c)
 Total
Balance at January 1, 2016$1,462
 $
 $405
 $1,867
For the year ended December 31, 2016:       
Charges1,535
 603
 546
 2,684
Cash spend(1,143) 
 (397) (1,540)
Charges against assets
 (603) 
 (603)
Balance at December 31, 20161,854
 
 554
 2,408
For the year ended December 31, 2017:       
Charges589
 101,595
 304
 102,488
Cash spend(1,816) 
 (382) (2,198)
Charges against assets
 (101,595) 
 (101,595)
Balance at December 31, 2017627
 
 476
 1,103
For the year ended December 31, 2018:       
Charges2,654
 233
 118
 3,005
Cash spend(2,665) 
 (434) (3,099)
Charges against assets
 (141) 
 (141)
Reversed to income
 (92) 
 (92)
Balance at December 31, 2018$616
 $
 $160
 $776
(a) Severance primarily includes severance payments associated with the consolidation of North American PE Films manufacturing facilities in 2016 and 2017 and with the shutdown of the PE Films Shanghai, China facility in 2018.
(b) Asset impairments in 2017 primarily related to the Flexible Packaging Films’ impairment of $101 million.
(c) Other primarily includes other shutdown-related costs associated with the shutdown and sale of the Company’s aluminum extrusions manufacturing facility in Kentland, Indiana.
See Note 17 for more information on plant shutdowns, asset impairments and restructurings of continuing operations.
11DEBT AND CREDIT AGREEMENTS
On MarchDecember 1, 2016,2020, Tredegar entered into a $400 millionan amendment (“Amendment No. 1”) to its five-year secured revolving credit facility (“Creditagreement (the “Credit Agreement”), withwhich matures in June 2024. The material changes from Amendment No. 1 are as follows:
Aggregate borrowings available under the facility were reduced from $500 million to $375 million.
The definition of Credit EBITDA was amended to permit certain adjustments for prepayment of pension obligations on a pro forma basis.
Amendments were made to certain of the negative covenants, including, among other amendments, the following: (i) the restricted payments covenant was amended to permit a one-time special dividend payment of up to $200 million and allow for an optionaggregate amount of dividend payments up to increase that amount by $50 million.


$75 million subsequent to Amendment No. 1 through the maturity date of the Credit Agreement; (ii) the asset disposition covenant was amended to reduce the general basket to 20% of consolidated total assets over the life of the facility and was reset as of December 1, 2020; and (iii) the indebtedness covenant was amended to reduce several baskets to $25 million each.
Borrowings under the Credit Agreement bear an interest rate of LIBOR plus a credit spread and commitment fees charged on the unused amount under the Credit Agreement at various indebtedness-to-adjustedindebtedness-to-Credit EBITDA levels as follows:
Pricing Under Credit Revolving Agreement (Basis Points)
Indebtedness-to-Adjusted EBITDA Ratio
Credit Spread
Over LIBOR
 
Commitment
Fee
Pricing Under Credit Agreement (Basis Points)Pricing Under Credit Agreement (Basis Points)
Indebtedness-to-Credit EBITDA RatioIndebtedness-to-Credit EBITDA RatioCredit Spread
Over LIBOR
Commitment
Fee
> 3.5x but <= 4.0x> 3.5x but <= 4.0x250
 45
> 3.5x but <= 4.0x200.0 40 
> 3.0x but <= 3.5x> 3.0x but <= 3.5x225
 40
> 3.0x but <= 3.5x187.5 35 
> 2.0x but <= 3.0x> 2.0x but <= 3.0x200
 35
> 2.0x but <= 3.0x175.0 30 
> 1.0x but <= 2.0x> 1.0x but <= 2.0x175
 30
> 1.0x but <= 2.0x162.5 25 
<= 1.0x<= 1.0x150
 25
<= 1.0x150.0 20 
At December 31, 2018,2020, the interest cost on debt borrowed under the Credit Agreement was priced at one-month LIBOR plus the applicable credit spread of 150162.5 basis points.
The most restrictive covenants in the Credit Agreement include:
Maximum indebtedness-to-adjustedindebtedness-to-Credit EBITDA (“Leverage Ratio:Ratio”) of 4.00x;
Minimum adjusted EBIT-to-interestCredit EBITDA-to-interest expense of 2.50x;3.00x; and
71


Maximum aggregate distributions to shareholders over the remaining term of the Credit Agreement of $100 million plus, beginning with$75 million; provided, that if the fiscal quarter ended March 31, 2016, 50% of net income and, at a Leverage Ratio of equal to or greater than 3.00x, a limitation on such payments for the succeeding quarter at the greater of (i) $4$4.75 million and (ii) 50% of consolidated net income for the most recent fiscal quarter, and, at a Leverage Ratio of equal to or greater than 3.50x, the prevention of such payments for the succeeding quarter unless the fixed charge coverage ratio is equal to or greater than 1.20x.quarter.
The Credit Agreement is secured by substantially all of the Company’s and its domestic subsidiaries’ assets, including equity in certain material first-tier foreign subsidiaries.
At December 31, 2018,2020, based upon the most restrictive covenant within the Credit Agreement, available credit under the Credit Agreement was approximately $298$241 million. Total debt dueoutstanding was $134 million and outstanding at$42 million as of December 31, 2018 is summarized below:
Debt Due and Outstanding at December 31, 2018
(In thousands)
Year Due
Credit
Agreement
 Other 
Total Debt
Due
2019$
 $
 $
2020
 
 
2021101,500
 
 101,500
2022
 
 
2023
 
 
Total$101,500
 $
 $101,500
2020 and 2019, respectively.
Tredegar believes that it was in compliance with all of its debt covenants as of December 31, 2018.2020. Noncompliance with any of the debt covenants may have a material adverse effect on its financial condition or liquidity, in the event such noncompliance cannot be cured or should the Company be unable to obtain a waiver from the lenders. Renegotiation of the covenant through an amendment to the Credit Agreement may effectively cure the noncompliance, but may have an effect on its financial condition or liquidity depending upon how the covenant is renegotiated.
12STOCK OPTION AND STOCK AWARD PLANS
Tredegar has12    STOCK OPTION AND STOCK AWARD PLANS
As of December 31, 2020, the Company had one equity incentivestock-based compensation plan under whichthat permits the grants of stock options, stock appreciation rights (“SARs”), stock, restricted stock, and stock unit awards. Stock options may be granted to purchase a specified number of shares of common stock at a price no lower than the fair market value on the date of grant and for a term not to exceed 10 years. OneStock options granted by the Company in 2020, 2019, and 2018 vest after 2 years and have a 7-year life or vest after 3 years and have a 5-year life. Stock options exercisable totaled 1,287,792 and 360,218 shares at December 31, 2020 and 2019, respectively. Stock options available for grant totaled 484,835 shares at December 31, 2020.
On December 1, 2020, Tredegar’s Board of Directors declared a special cash dividend of $200 million, or $5.97 per share, on the Company’s common stock (the “Special Dividend”). The Special Dividend was payable on December 18, 2020 and had an ex-dividend date of December 21, 2020. All stock option awards that were outstanding at the time of the Special Dividend were modified pursuant to the nondiscretionary anti-dilution provisions in the related stock-based compensation plan. SARs that were outstanding at the time of the Special Dividend were also modified pursuant to the nondiscretionary anti-dilution provisions in the related SARs grant was madeagreements. The modifications included increasing the number of outstanding stock options and SARs as well as reducing the exercise prices of all outstanding stock options and SARS. The modification did not result in additional stock-based compensation expense. No other terms or conditions of outstanding awards were modified.
A summary of stock options outstanding at December 31, 2020, 2019 and 2018, with cliff vesting after two years. Twoand changes during those years, is presented below:
  Option Exercise Price/Share
  Number of
Options
RangeWeighted
Average
Outstanding at December 31, 2017608,520 $15.65 to$24.84 $19.75 
Granted451,083 19.35 to19.35 19.35 
Forfeited and expired(96,089)15.65 to24.84 19.58 
Exercised(73,398)15.65 to22.49 18.15 
Outstanding at December 31, 2018890,116 15.65 to24.84 19.69 
Granted758,287 18.48 to18.48 18.48 
Forfeited and expired(10,000)19.40 to19.40 19.40 
Exercised(9,500)19.40 to19.40 19.40 
Outstanding at December 31, 20191,628,903 15.65 to24.84 19.13 
Granted1
638,074 10.75 to14.62 11.90 
Modification for special cash dividend1
701,535 10.75 to14.62 11.90 
Forfeited and expired1
(141,074)10.75 to24.84 11.87 
Exercised0 0 to0 0 
Outstanding at December 31, 20201
2,827,438 $10.75 to$22.49 $13.55 
1.The option exercise price per share reflects the reduction to the exercise prices of outstanding stock options impacted by the modification due to the anti-dilution provisions in the stock-based compensation plan.
72


The assumptions used in the Black-Scholes options-pricing model for valuing Tredegar stock option grants were madeoptions originally granted in 2017, with one cliff vesting after two years2020, 2019 and 2018, and the other cliff vesting after three years. Norelated estimated fair values at the date of grant, were as follows:
202020192018
Dividend yield2.5 %2.4 %2.3 %
Weighted average volatility percentage43.8 %38.3 %38.3 %
Weighted average risk-free interest rate0.8 %2.4 %2.8 %
Holding period (years)555
Weighted average exercise price at date of grant (also weighted average market price at date of grant)1
$14.41 $18.48 $19.35 
Estimated weighted average fair value of options per share at date of grant$4.44 $5.43 $5.87 
Total estimated fair value of stock options granted (in thousands)$2,833 $4,117 $2,648 
1.In December 2020, the weighted average exercise price for outstanding stock option awards granted in 2020, 2019 and 2018 were modified to $10.75, $13.78 and $14.43, respectively. As the anti-dilution provisions in the stock-based compensation plan were structured to equitably adjust the award’s fair value before and after the modification, there is no resulting incremental fair value.
The dividend yield is the actual dividend yield on Tredegar’s common stock at the date of grant, which the Company believes is a reasonable estimate of the expected yield during the holding period. The expected volatility is based on the historical volatility of Tredegar’s common stock using a sequential period of historical data equal to the expected holding period of the option. The Company has no reason to believe that future volatility for this period is likely to differ from the past. The assumed risk-free interest rate is based on observed interest rates for U.S. Treasury debt securities appropriate for the expected holding period.
The following table summarizes additional information about stock options were granted in 2016.outstanding and exercisable at December 31, 2020:

 Options Outstanding at December 31, 2020Options Exercisable at December 31, 2020
  Weighted AverageAggregate Intrinsic Value  Aggregate Intrinsic Value
Range of
Exercise Prices
SharesRemaining Contractual LifeExercise
Price
SharesWeighted Average Exercise Price
$to$13.99 1,598,700 5.4 years$12.11 $7,338,799 425,219 $12.50 $1,785,553 
13.99 to18.65 1,059,138 4.4 years14.64 2,209,408 692,973 14.66 1,447,785 
18.65 to23.32 169,600 2.1 years20.27 169,600 20.27 
Total2,827,438 4.9 years$13.55 $9,548,207 1,287,792 $14.68 $3,233,338 

73


The option plan also permits the grant of stock appreciation rights (“SARs”), stock, restricted stock, stock unit awards and incentive awards. Restricted stock grants ordinarily vest three years from the date of grant based upon continued employment. The fair value of restricted stock awards is estimated as of the grant date using the closing stock price on that date. Stock unit awards vest upon the achievement of certain performance targets. No SARs have been granted since 1992 and none are currently outstanding.
A summary of stock options outstanding at December 31, 2018, 2017 and 2016, and changes during those years, is presented below:
   Option Exercise Price/Share
  
Number of
Options
 Range 
Weighted
Average
Outstanding at January 1, 2016881,513
 $17.13
 to $30.01
 $20.22
Granted
 
 to 
 
Forfeited and expired(246,394) 17.13
 to 30.01
 18.90
Exercised(134,200) 17.13
 to 19.84
 17.23
Outstanding at December 31, 2016500,919
 17.13
 to 30.01
 21.67
Granted209,551
 15.65
 to 15.65
 15.65
Forfeited and expired(60,685) 17.13
 to 30.01
 21.42
Exercised(41,265) 19.84
 to 19.84
 19.84
Outstanding at December 31, 2017608,520
 15.65
 to 24.84
 19.75
Granted451,083
 19.35
 to 19.35
 19.35
Forfeited and expired(96,089) 15.65
 to 24.84
 19.58
Exercised(73,398) 15.65
 to 22.49
 18.15
Outstanding at December 31, 2018890,116
 $15.65
 to $24.84
 $19.69
The following table summarizes additional information about stock options outstanding and exercisable at December 31, 2018:
      Options Outstanding at December 31, 2018 Options Exercisable at December 31, 2018
        Weighted Average 
Aggregate Intrinsic Value
(In thousands)
     Aggregate Intrinsic Value
(In thousands)
Range of
Exercise Prices
 Shares Remaining Contractual Life (Years) 
Exercise
Price
  Shares 
Weighted
Average
Exercise
Price
 
$
 to $15.00
 
 0.0 $
 $
 
 $
 $
15.01
 to 17.50
 163,641
 5.4 15.65
 34,365
 
 
 
17.51
 to 20.00
 516,883
 5.9 19.36
 
 65,800
 19.40
 
20.01
 to 25.00
 209,592
 4.5 23.69
 
 209,592
 23.69
 
Total 890,116
 5.5 $19.69
 $34,365
 275,392
 $22.66
 $



The following table summarizes additional information about unvested restricted stock outstanding at December 31, 2018, 20172020, 2019 and 2016:2018:
Unvested Restricted StockMaximum Unvested Restricted Stock Units Issuable Upon Satisfaction of Certain Performance Criteria
Unvested Restricted Stock Maximum Unvested Restricted Stock Units Issuable Upon Satisfaction of Certain Performance Criteria Number
of Shares
Weighted Avg. Grant Date Fair Value/ShareGrant Date
Fair Value
(In thousands)
Number
of Shares
Weighted Avg. Grant Date Fair Value/ShareGrant Date
Fair Value
(In thousands)
Number
of Shares
 Weighted Avg. Grant Date Fair Value/Share 
Grant Date
Fair Value
(In thousands)
 
Number
of Shares
 Weighted Avg. Grant Date Fair Value/Share 
Grant Date
Fair Value
(In thousands)
Outstanding at January 1, 2016132,353
 $21.19
 $2,805
 167,128
 $22.04
 $3,684
Granted144,546
 13.47
 1,947
 136,986
 11.34
 1,553
Vested(52,167) 21.56
 (1,125) 
 
 
Forfeited(17,377) 18.97
 (330) (65,685) 20.24
 (1,329)
Outstanding at December 31, 2016207,355
 15.90
 3,297
 238,429
 16.39
 3,908
Granted107,362
 18.29
 1,964
 46,205
 17.38
 803
Vested(50,154) 19.72
 (989) 
 
 
Forfeited(57,887) 16.16
 (935) (112,501) 17.73
 (1,995)
Outstanding at December 31, 2017206,676
 16.15
 3,337
 172,133
 15.78
 2,716
Outstanding at January 1, 2018Outstanding at January 1, 2018206,676 $16.15 $3,337 172,133 $15.78 $2,716 
Granted119,915
 17.39
 2,085
 61,227
 17.35
 1,062
Granted119,915 17.39 2,085 61,227 17.35 1,062 
Vested(64,702) 18.31
 (1,185) 
 
 
Vested(64,702)18.31 (1,185)
Forfeited(17,153) 15.84
 (272) (48,651) 13.23
 (644)Forfeited(17,153)15.84 (272)(48,651)13.23 (644)
Outstanding at December 31, 2018244,736
 $16.20
 $3,965
 184,709
 $16.97
 $3,134
Outstanding at December 31, 2018244,736 16.20 3,965 184,709 16.97 3,134 
GrantedGranted185,422 18.46 3,423 57,442 18.34 1,053 
VestedVested(117,834)14.76 (1,739)(69,926)10.96 (766)
ForfeitedForfeited(26,389)16.11 (425)(24,562)11.51 (283)
Outstanding at December 31, 2019Outstanding at December 31, 2019285,935 18.27 5,224 147,663 21.25 3,138 
GrantedGranted155,138 14.55 2,257 34,275 15.25 523 
VestedVested(148,709)17.39 (2,586)(37,370)17.38 (649)
ForfeitedForfeited(57,385)17.00 (976)(32,066)17.36 (557)
Outstanding at December 31, 2020Outstanding at December 31, 2020234,979 $16.68 $3,919 112,502 $21.82 $2,455 
The total intrinsic value of stock options exercised was $0.1 million and $0.4 million in 2019 and 2018, $0.2 millionrespectively. There were no stock options exercised in 2017 and $0.2 million in 2016.2020. The grant-date fair value of stock option-based awards vested was $3.0 million, $0.5 million, and $0.1 million in 2020, 2019, and 2018, $0.4 million in 2017 and $0.4 million in 2016.respectively. As of December 31, 2018,2020, there was unrecognized compensation cost for continuing operations of $2.0 million related to stock option-based awards and $1.8$1.7 million related to non-vested restricted stock and other stock-based awards. This cost is expected to be recognized over the remaining weighted average period of 1.2 years for stock option-based awards and 1.31.4 years for non-vested restricted stock and other stock-based awards. Commencing in 2019, stock option award grants include a retirement provision that allow for the immediate vesting of options held by a participant that ceases to provide service, including service as a member of the board of directors, with the Company, subsequent to reaching the age of 65.  As a result of this provision, the Company recognized accelerated stock compensation expense for continuing operations of $0.1 million and $1.3 million in 2020 and 2019, respectively. 
Stock options exercisable totaled 275,392 sharesSARs granted in 2020 have the same terms and vesting requirements as the 2020 stock option grants except SARs may be settled in cash upon exercise and therefore are classified as liabilities and included in accrued expenses in the consolidated balance sheet. The fair value of these liability awards is remeasured at each reporting period until the date of settlement. Increases and decreases in stock-based compensation expense is recognized over the vesting period, or immediately, for vested awards.
74


The following table summarizes SARs activity in 2020 as no SARs were granted prior to January 1, 2020 since 1992:
  Exercise Price/Share
  Number of
SARs
RangeWeighted
Average
Outstanding at January 1, 2020$to$$
Granted1
387,252 10.75 to19.64 11.60 
Modification for special cash dividend71,402 10.75 to19.64 11.60 
Forfeited and expired(82,214)10.75 to19.64 11.39 
Exercised0 0 to0 0 
Outstanding at December 31, 2020376,440 $10.75 to$19.64 $11.64 
1.The SARs exercise price per share reflects the reduction to the exercise prices of outstanding SARs as a results of the modification to the awards pursuant to the nondiscretionary anti-dilution provisions in the related SARs grant agreements.
The grant-date fair value of SARs awards vested in 2020 was $0.6 million. As of December 31, 2018 and 385,658 shares at December 31, 2017. Stock options available2020, the SARs unrecognized compensation cost for grant totaled 1,548,917 shares at December 31, 2018.

continuing operations was $1.5 million. This cost is expected to be recognized over the remaining weighted average vesting period of 1.1 years.

13RETIREMENT PLANS AND OTHER POSTRETIREMENT BENEFITS
13    RETIREMENT PLANS AND OTHER POSTRETIREMENT BENEFITS
Tredegar sponsors a noncontributory defined benefit (pension) plan covering certain current and former U.S. employees. The plansplan for salaried and hourly employees currently in effect is based on a formula using the participant’s years of service and compensation or using the participant’s years of service and a dollar amount. The plan is closed to new participants and pay for active plan participants for benefit calculations was frozen as of December 31, 2007. As of January 31, 2018, the plan no longer accrued benefits associated with crediting employees for service, thereby freezing all future benefits under the plan.
In addition to providing pension benefits, the Company provides postretirement life insurance and health care benefits for certain groups of employees. Tredegar and retirees share in the cost of postretirement health care benefits, with employees hired on or before January 1, 1993, receiving a fixed subsidy to cover a portion of their health care premiums. The Company eliminated prescription drug coverage for Medicare-eligible retirees as of January 1, 2006. Consequently, Tredegar is not eligible for any federal subsidies.
75


The following tables reconcile the changes in benefit obligations and plan assets in 20182020 and 2017,2019, and reconcile the funded status to prepaid or accrued cost at December 31, 20182020 and 2017:2019:
 Pension BenefitsOther Post-
Retirement Benefits
(In thousands)2020201920202019
Change in benefit obligation:
Benefit obligation, beginning of year$318,763 $287,240 $7,650 $6,889 
Service cost0 29 26 
Interest cost10,156 12,222 243 290 
Effect of actuarial (gains) losses related to the following:
Discount rate change26,887 38,919 644 894 
Retirement rate assumptions and mortality table adjustments(3,446)(2,589)13 21 
Other69 (1,047)55 (176)
Plan participant contributions0 606 649 
Benefits paid(16,270)(15,982)(1,076)(943)
Benefit obligation, end of year$336,159 $318,763 $8,164 $7,650 
Change in plan assets:
Plan assets at fair value, beginning of year$218,329 $205,367 $0 $
Actual return on plan assets18,800 20,624 0 
Employer contributions12,216 8,320 470 294 
Plan participant contributions0 606 649 
Benefits paid(16,270)(15,982)(1,076)(943)
Plan assets at fair value, end of year$233,075 $218,329 $0 $
Funded status of the plans$(103,084)$(100,434)$(8,164)$(7,650)
Amounts recognized in the consolidated balance sheets:
Accrued expenses (current)$181 $168 $481 $470 
Pension and other postretirement benefit obligations, net102,903 100,266 7,683 7,180 
Net amount recognized$103,084 $100,434 $8,164 $7,650 
 Pension Benefits  
Other Post-
Retirement Benefits
(In thousands)2018 2017  2018 2017
Change in benefit obligation:        
Benefit obligation, beginning of year$318,123
 $303,126
  $7,704
 $7,436
Service cost17
 194
  36
 33
Interest cost11,442
 12,575
  271
 301
Effect of actuarial (gains) losses related to the following:        
Discount rate change(23,653) 21,055
  (546) 471
Retirement rate assumptions and mortality table adjustments(914) (2,145)  6
 15
Other(2,326) (1,921)  (285) (245)
Plan participant contributions
 
  656
 646
Benefits paid(15,449) (14,761)  (953) (953)
Benefit obligation, end of year$287,240
 $318,123
  $6,889
 $7,704
Change in plan assets:        
Plan assets at fair value, beginning of year$226,354
 $214,559
  $
 $
Actual return on plan assets(14,148) 21,034
  
 
Employer contributions8,610
 5,522
  297
 307
Plan participant contributions
 
  656
 646
Benefits paid(15,449) (14,761)  (953) (953)
Plan assets at fair value, end of year$205,367
 $226,354
  $
 $
Funded status of the plans$(81,873) $(91,769)  $(6,889) $(7,704)
Amounts recognized in the consolidated balance sheets:        
Accrued expenses (current)$182
 $182
  $456
 $457
Pension and other postretirement benefit obligations, net81,691
 91,587
  6,433
 7,247
Net amount recognized$81,873
 $91,769
  $6,889
 $7,704


AssumptionsThe following table sets forth the assumptions used in accounting for financial reporting purposes to compute net benefit income or costthe pension and benefit obligations for continuing operations,other post-retirement benefits, and the components of net periodic benefit income or cost for continuing operations, are as follows:cost:
 Pension BenefitsOther Post-
Retirement Benefits
(In thousands, except percentages)202020192018202020192018
Weighted-average assumptions used to determine benefit obligations:
Discount rate2.57 %3.27 %4.40 %2.54 %3.25 %4.37 %
Expected long-term return on plan assets5.00 %5.00 %6.00 %n/an/an/a
Weighted-average assumptions used to determine net periodic benefit cost:
Discount rate3.27 %4.40 %3.72 %3.25 %4.37 %3.69 %
Expected long-term return on plan assets5.00 %6.00 %6.50 %n/an/an/a
Components of net periodic benefit cost:
Service cost$0 $$17 $29 $26 $36 
Interest cost10,156 12,222 11,442 243 290 271 
Expected return on plan assets(11,004)(13,528)(15,011)0 
Amortization of prior service costs and gains or losses15,494 10,891 13,894 (198)(258)(243)
Net periodic benefit cost$14,646 $9,585 $10,342 $74 $58 $64 
76

  Pension Benefits  
Other Post-
Retirement Benefits
(In thousands, except percentages)2018 2017 2016  2018 2017 2016
Weighted-average assumptions used to determine benefit obligations:            
Discount rate4.40% 3.72% 4.29%  4.37% 3.69% 4.24%
Expected long-term return on plan assets6.00% 6.50% 6.50%  n/a
 n/a
 n/a
Weighted-average assumptions used to determine net periodic benefit cost:            
Discount rate3.72% 4.29% 4.55%  3.69% 4.24% 4.49%
Expected long-term return on plan assets6.50% 6.50% 7.00%  n/a
 n/a
 n/a
Components of net periodic benefit cost:            
Service cost$17
 $194
 $231
  $36
 $33
 $38
Interest cost11,442
 12,575
 13,323
  271
 301
 337
Expected return on plan assets(15,011) (14,955) (15,980)  
 
 
Amortization of prior service costs and gains or losses13,894
 12,320
 13,312
  (243) (275) (214)
Net periodic benefit cost$10,342
 $10,134
 $10,886
  $64
 $59
 $161

Net periodic benefit income or cost is determined using assumptions at the beginning of each year. Funded status is determined using assumptions at the end of each year. The amount of the accumulated benefit obligation is the same as the projected benefit obligation. At December 31, 2018,2020, the effect of a 1% change in the health care cost trend rate assumptions would not impact the post-retirement obligation.
Expected benefit payments for continuing operations over the next five years and in the aggregate for 2024-20282026-2030 are as follows:
(In thousands)Pension
Benefits
Other Post-
Retirement
Benefits
2021$17,593 $481 
202218,001 482 
202318,205 478 
202418,445 473 
202518,511 468 
2026—203090,778 2,196 
(In thousands)
Pension
Benefits
 
Other Post-
Retirement
Benefits
2019$16,826
 $456
202017,337
 458
202117,713
 461
202218,048
 463
202318,268
 461
2024—202892,435
 2,236
AmountsThe pre-tax amounts recorded in 2018, 20172020, 2019 and 20162018 in accumulated other comprehensive income before related deferred income taxes, consist of:
Pension Other Post-Retirement PensionOther Post-Retirement
(In thousands)2018 2017 2016 2018 2017 2016(In thousands)202020192018202020192018
Prior service cost (benefit)$
 $5
 $10
 $
 $
 $
Net actuarial (gain) loss132,751
 144,377
 145,782
 (1,821) (1,238) (1,756)Net actuarial (gain) loss$150,267 $150,047 $132,751 $86 $(824)$(1,821)
Pension expense is expected to be $9.6$14.0 million in 2019.2021. The amounts in accumulated other comprehensive income, before related deferred income taxes, that are expected to be recognized as components of net periodic benefit or cost during 20192021 are as follows:
(In thousands)Pension 
Other Post-
Retirement
Prior service cost (benefit)$
 $
Net actuarial (gain) loss10,916
 (230)
$17.1 million of cost for the pension plan and $0.1 million of benefit for other post-retirement plans.
The percentage composition of assets held by pension plans for continuing operations at December 31, 2018, 20172020, 2019 and 20162018 are as follows:
 % Composition of Plan Assets
at December 31,
 202020192018
Pension plans:
Fixed income securities7.7 %8.7 %8.6 %
Large/mid-capitalization equity securities27.1 21.3 18.2 
Small-capitalization equity securities8.6 7.8 6.8 
International and emerging market equity securities20.6 19.7 16.0 
Total equity securities56.3 48.8 41.0 
Private equity and hedge funds12.1 35.0 42.3 
Cash and cash equivalents17.5 1.4 1.4 
Other assets6.4 6.1 6.7 
Total100.0 %100.0 %100.0 %
77

 
% Composition of Plan Assets
at December 31,
 2018 2017 2016
Pension plans related to continuing operations:     
Fixed income securities8.6% 7.7% 8.0%
Large/mid-capitalization equity securities18.2
 19.0
 14.7
Small-capitalization equity securities6.8
 6.4
 5.3
International and emerging market equity securities16.0
 15.1
 11.5
Total equity securities41.0
 40.5
 31.5
Private equity and hedge funds42.3
 44.6
 48.4
Other assets8.1
 7.2
 12.1
Total for continuing operations100.0% 100.0% 100.0%

Tredegar’s targeted allocation percentage for pension plan assets and the expected long-term rate of return on assets used to determine its benefit obligation at December 31, 2018,2020, are as follows:
Target % Composition of Plan Assets1
Expected Long-term Return %
Target % Composition of Plan Assets * Expected Long-term Return %
Pension plans related to continuing operations:   
Pension plans:Pension plans:
Fixed income securities12.0% 3.2%Fixed income securities12.0 %1.3 %
Large/mid-capitalization equity securities19.0
 6.1
Large/mid-capitalization equity securities27.0 6.3 
Small-capitalization equity securities6.0
 6.6
Small-capitalization equity securities8.0 6.8 
International and emerging market equity securities18.0
 7.3
International and emerging market equity securities20.0 5.6 
Total equity securities43.0
 6.7
Total equity securities55.0 6.1 
Private equity and hedge funds45.0
 6.1
Private equity and hedge funds33.0 4.4 
Total for continuing operations100.0% 6.0%
* Target percentages for the composition of plan assets represents a neutral position within the approved range of allocations for such assets.

TotalTotal100.0 %5.0 %
1.Target percentages for the composition of plan assets represents a neutral position within the approved range of allocations for such assets.
1.Target percentages for the composition of plan assets represents a neutral position within the approved range of allocations for such assets.
Expected long-term returns are estimated by asset class and generally are based on inflation-adjusted historical returns, volatilities, risk premiums and managed asset premiums. The portfolio of fixed income securities is structured with maturities that generally match estimated benefit payments over the next 1-2 years. The other assets category is primarily comprised of cash and contracts with insurance companies. The Company’s primary investment objective is to maximize total return with a strong emphasis on the preservation of capital, and it believes that over the long-term a diversified portfolio of fixed income securities, equity securities, hedge funds and private equity funds has a better risk-return profile than fixed income securities alone. The average remaining duration of benefit payments for the pension plans is about 1111.5 years. The Company expects its required contributions to be approximately $8.1$11.7 million in 2019.


2021.
Estimates of the fair value of assets held by the Company’s pension plan are provided by unaffiliated third parties. Investments in private equity and hedge funds and certain fixed income securities by the Company’s pension plan are measured at NAV,net asset value, which is a practical expedient for measuring fair value. These assets are therefore excluded from the fair value hierarchy for each of the years presented.
78


At December 31, 20182020 and 2017,2019, the pension plan assets are categorized by level within the fair value measurement hierarchy as follows:
(In thousands)(In thousands)Total 
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
(In thousands)TotalQuoted Prices
in Active
Markets for
Identical Assets
(Level 1)
Significant
Other
Observable
Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
Balances at December 31, 2018       
Balances at December 31, 2020Balances at December 31, 2020
Cash and cash equivalentsCash and cash equivalents$40,890 $40,890 $0 $0 
Large/mid-capitalization equity securitiesLarge/mid-capitalization equity securities$37,323
 $37,323
 $
 $
Large/mid-capitalization equity securities63,146 63,146 0 0 
Small-capitalization equity securitiesSmall-capitalization equity securities13,880
 13,880
 
 
Small-capitalization equity securities19,932 19,932 0 0 
International and emerging market equity securitiesInternational and emerging market equity securities32,931
 13,389
 19,542
 
International and emerging market equity securities24,325 24,325 0 0 
Fixed income securitiesFixed income securities17,769
 5,886
 11,883
 
Fixed income securities18,008 6,690 11,318 0 
Contracts with insurance companiesContracts with insurance companies9,118 0 0 9,118 
Other assetsOther assets6,779
 6,779
 
 
Other assets5,629 5,629 0 0 
Total plan assets at fair valueTotal plan assets at fair value$108,682
 $77,257
 $31,425
 $
Total plan assets at fair value$181,048 $160,612 $11,318 $9,118 
Private equity and hedge funds86,786
      
Contracts with insurance companies9,899
      
Total plan assets, December 31, 2018$205,367
      
Balances at December 31, 2017       
Investments measured at net asset value1
Investments measured at net asset value1
52,027 
Total plan assets, December 31, 2020Total plan assets, December 31, 2020$233,075 
Balances at December 31, 2019Balances at December 31, 2019
Cash and cash equivalentsCash and cash equivalents$3,076 $3,076 $$
Large/mid-capitalization equity securitiesLarge/mid-capitalization equity securities$42,920
 $42,920
 $
 $
Large/mid-capitalization equity securities46,440 46,440 
Small-capitalization equity securitiesSmall-capitalization equity securities14,477
 14,477
 
 
Small-capitalization equity securities17,135 17,135 
International and emerging market equity securitiesInternational and emerging market equity securities34,153
 16,409
 17,744
 
International and emerging market equity securities43,079 19,117 23,962 
Fixed income securitiesFixed income securities17,513
 5,374
 12,139
 
Fixed income securities18,911 6,209 12,702 
Contracts with insurance companiesContracts with insurance companies8,840 8,840 
Other assetsOther assets5,822
 5,822
 
 
Other assets4,509 4,509 
Total plan assets at fair valueTotal plan assets at fair value$114,885
 $85,002
 $29,883
 $
Total plan assets at fair value$141,990 $96,486 $36,664 $8,840 
Private equity and hedge funds100,974
      
Contracts with insurance companies10,495
      
Total plan assets, December 31, 2017$226,354
      
Investments measured at net asset value1
Investments measured at net asset value1
76,339 
Total plan assets, December 31, 2019Total plan assets, December 31, 2019$218,329 
1.Includes private equity, hedge funds and certain international equity securities measured at net asset value.
1.Includes private equity, hedge funds and certain international equity securities measured at net asset value.
Tredegar also has a non-qualified supplemental pension plan covering certain employees. Effective December 31, 2005, further participation in this plan was terminated and benefit accruals for existing participants were frozen. The plan was designed to restore all or a part of the pension benefits that would have been payable to designated participants from the principal pension plans if it were not for limitations imposed by income tax regulations. The projected benefit obligation relating to this unfunded plan was $2.0 million at December 31, 2018 and $2.2 million at December 31, 2017.2020 and December 31, 2019. Pension expense recognized for this plan was $0.1 million in 2018, $0.1 million in 20172020, 2019, and $0.1 million in 2016.2018. This information has been included in the preceding pension benefit tables.
Approximately 72 employees atPension and other postretirement benefit liabilities related to Personal Care Films have been retained by the Company’s film products manufacturing facility in Kerkrade, The Netherlands are covered by a collective bargaining agreement that includes participation in a multi-employer pension plan.Company. Pension expense recognized for participation by these former employees in this plan, whichthe Company’s plans is equal to required contributions, was $0.4 million in 2018, $0.4 million in 2017not material for the years ended December 31, 2020, 2019, and $0.4 million in 2016. This information has been excluded from the preceding pension benefit tables.2018.
14SAVINGS PLAN
14    SAVINGS PLAN
Tredegar has a savings plan that allows eligible employees to voluntarily contribute a percentage of their compensation, up to Internal Revenue Service (“IRS”) limitations. The provisions of the savings plan provided the following benefits for salaried and certain hourly employees:
The Company makes matching contributions to the savings plan of $1 for every $1 an employee contributes per pay period up to a maximum of 5% of eligible compensation.
The savings plan includes immediate vesting of matching contributions and automatic enrollment at 3% of eligible compensation unless the employee opts out or elects a different percentage.


The Company also has a non-qualified plan that restores matching benefits for employees suspended from the savings plan due to certain limitations imposed by income tax regulations (“restoration plan”). Charges recognized for these plans were $4.0 million in 2020, $3.9 million in 2019 and $3.7 million in 2018, $3.5 million in 2017 and $3.2 million in 2016.2018. The Company’s liability under the restoration plan was $1.0
79


$1.0 million at December 31, 20182020 (consisting of 65,28061,394 phantom shares of common stock) and $1.3$1.4 million at December 31, 20172019 (consisting of 65,54862,475 phantom shares of common stock) and valued at the closing market price on those dates.
The Tredegar Corporation Benefits Plan Trust (the “Trust”) purchased 7,200 shares of the Company’s common stock in 1998 for $0.2 million and 46,671 shares of its common stock in 1997 for $1.0 million, as a partial hedge against the phantom shares held in the restoration plan. There have been no shares purchased since 1998 except for re-invested dividends. The cost of the shares held by the Trust is shown as a reduction to shareholders’ equity in the consolidated balance sheets.
15RENTAL EXPENSE AND CONTRACTUAL COMMITMENTS
Rental expense15    LEASES
Tredegar has various lease agreements with terms up to 10 years, including leases of real estate, office equipment and vehicles. Some leases include options to purchase the leased asset, terminate the agreement or extend the term of the agreement for continuing operations was $5.2 millionone or more years. These options are included in 2018, $4.4 million in 2017the lease term when it is reasonably certain that the option will be exercised.
The following table presents information about the amount, timing and $2.9 million in 2016. Rental commitments under all noncancellableuncertainty of cash flows arising from the Company’s operating leases for continuing operations as of December 31, 2018, are2020:
(In thousands)
Future Lease Payments
2021$2,749 
20222,653 
20232,525 
20242,417 
20252,417 
Thereafter7,404 
Total undiscounted operating lease payments20,165 
Less: Imputed interest3,134 
Present value of operating lease liabilities$17,031 
As of January 1, 2019, an initial right-of-use asset of $20 million was recognized as follows:
(In thousands) 
2019$4,445
20204,007
20213,591
20222,391
20231,245
Remainder2,630
Total minimum lease payments$18,309
Contractual obligations for plant construction and purchases of real property and equipment amounted to $14.1 million at December 31, 2018.
16INCOME TAXES
The U.S. Tax Cuts and Jobs Act (“TCJA”) makes broad and complex changes to the U.S. tax code, including, but not limited to: (i) reducing the U.S. federal corporate income tax rate from 35% to 21%; (ii) requiring companies to pay a one-time transition tax on certain unrepatriated earnings of foreign subsidiaries; (iii) generally eliminating U.S. federal income taxes on dividends from foreign subsidiaries; (iv) creating new taxes on certain foreign earnings; (v) eliminating certain deductions; and (vi) providing the option to full expensing of qualified property.
The SEC staff issued Staff Accounting Bulletin No. 118 (“SAB 118”), which provides guidance on accounting for the tax effects of the TCJA. SAB 118 provides a measurement period that should not extend beyond one year from the TCJA enactment date for companies to complete the accounting under Accounting Standards Codification No. 740 (“ASC 740”). In accordance with SAB 118, a company must reflect the income tax effects of a company’s accounting for those tax effects of the TCJA for which the accounting under ASC 740 is complete. To the extent that a company’s accounting for certain tax effects of the TCJA is incomplete, but it is able to determine a reasonable estimate, it must record a provisional estimate in the financial statements. If a company cannot determine a reasonable estimate to be included in the financial statements, it should continue to apply ASC 740 on the basis of the provisions of the tax law that were in effect immediately before the enactment of the TCJA.
The Company applied the guidance in SAB 118 when accounting for the enactment-date effects of the TCJA in 2017 and throughout 2018. At December 31, 2017, the Company had not completed its accounting for all the enactment-date income tax effects of the TCJA under ASC 740, Income Taxes as described below. At December 31, 2018, the Company has now completed its accounting for the enactment-date income tax effects of the TCJA.
Item (i) above was completed in 2017 and resulted in a non-cash deferred income tax benefit inasset addition and an initial lease liability of $22 million was recognized as a non-cash liability addition with the fourth quarter of 2017 of $3.9 million to adjust applicable deferred income tax assets and liabilities for the change in the U.S. federal corporate rate. Income tax accruals on U.S. income in 2018 and future periods will apply the new 21% U.S. federal income tax rate.
Item (ii) was not completed in 2017. The Company did not accrue any deemed repatriation taxes on unremitted earnings of its foreign subsidiaries in 2017 since its preliminary assessment indicated that such foreign subsidiaries had no net cumulative unremitted earnings due to historical repatriation. Upon further analysis of the TCJA and notices and regulations issued and proposed by the U.S. Department of the Treasury and the Internal Revenue Service, the Company finalized its


calculations of the deemed repatriation tax liability in 2018 and concluded once again that the Company would not owe any transition tax and that no adjustment was required in 2018.
The applicationadoption of the new Global Intangible (“GILTI”) tax rules tolease accounting standard.
The following table summarizes lease costs, related cash flow and other information for the Company, which is part of item (iv), was not completed in 2017. The rulesyears ended December 31, 2020 and 2019. These costs are complex, and under GAAP the Company is allowed to make a policy choice of either: (a) treating taxes due on future U.S. inclusions in taxable income relate to GILTI as current period expense when incurred (the “period cost method”), or (b) factoring such amounts into the Company’s measurement of its deferred income taxes (the “deferred method”). The Company was not able to complete its analysis of these rules and could not reasonably estimate the effect of this provision of the TCJA in 2017. Accordingly, the Company did not make any adjustmentsprimarily related to the potential GILTI tax in its 2017 financial statementslong-term operating leases, but also include amounts for variable leases and did not make a policy decision whether to record deferred income taxes on GiLTI. After further consideration in 2018, the Company elected to account for GILTI in the year the tax was incurred. In 2018, application of the GILTI provisions did not result in any additional U.S. income tax.short-term leases.
(In thousands)20202019
Operating lease expense$3,260 $3,087 
Right-of-use assets recognized as non-cash additions from the execution of new operating leases$529 $20,709 
Other Information:
Weighted-average remaining lease term for operating leases8 years9 years
Weighted-average discount rate for operating leases4.21 %4.24 %

80


16    INCOME TAXES
Income (loss) from continuing operations before income taxes and income tax expense (benefit) for continuing operations are as follows:
(In thousands) 2018 2017 2016
Income (loss) before income taxes:     
Domestic$17,663
 $67,549
 $26,284
Foreign18,705
 (82,461) 1,399
Total$36,368
 $(14,912) $27,683
Current income tax expense (benefit):     
Federal$(187) $(20,560) $4,302
State815
 800
 (709)
Foreign2,090
 3,247
 3,255
Total2,718
 (16,513) 6,848
Deferred income tax expense (benefit):     
Federal8,708
 (23,302) (2,505)
State364
 (949) 1,396
Foreign(264) (12,399) (2,522)
Total8,808
 (36,650) (3,631)
Total income tax expense (benefit)$11,526
 $(53,163) $3,217



(In thousands)202020192018
Income (loss) from continuing operations before income taxes:
Domestic$(58,033)$52,536 $67,806 
Foreign32,987 19,470 12,565 
Total$(25,046)$72,006 $80,371 
Current income tax expense (benefit):
Federal$4,777 $7,551 $30 
State136 1,558 766 
Foreign2,374 579 771 
Total7,287 9,688 1,567 
Deferred income tax expense (benefit):
Federal(18,191)15,298 16,264 
State(640)187 948 
Foreign3,331 (11,628)28 
Total(15,500)3,857 17,240 
Total income tax expense (benefit)$(8,213)$13,545 $18,807 
The significant differences between the U.S. federal statutory rate and the effective income tax rate forrelated to continuing operations are as follows:
202020192018
(In thousands, except percentages)Amount%Amount%Amount%
Foreign rate differences$3,753 (14.9)$1,533 1.9 $1,576 2.1 
U.S. tax on foreign branch income1,409 (5.6)16,029 22.3 2,229 2.8 
Non-deductible expenses219 (0.9)285 0.4 99 0.1 
Valuation allowance for capital loss carryforwards52 (0.2)60 0.1 553 0.7 
Unremitted earnings from foreign operations13 (0.1)60 0.1 126 0.2 
Foreign derived intangible income deduction0 0 (319)(0.4)(695)(0.9)
Valuation allowance due to foreign losses and impairments0 0 (14,350)(19.9)(2,162)(2.7)
Stock-based compensation(24)0.1 292 0.4 177 0.2 
Dividend received deduction net of foreign withholding tax(52)0.2 (1,016)(1.4)
Tax contingency accruals and tax settlements(58)0.2 (2,543)(3.5)673 0.8 
State taxes, net of federal income tax benefit(373)1.5 1,050 1.5 1,203 1.5 
Research and development tax credit(633)2.5 (523)(0.7)(130)(0.2)
Changes in estimates related to prior year tax provision(2,472)9.9 (135)(0.2)(380)(0.5)
Brazilian tax incentive(4,787)19.1 (1,999)(2.8)(1,340)(1.7)
Income tax expense (benefit) at federal statutory rate(5,260)21.0 15,121 21.0 16,878 21.0 
    Income tax expense (benefit) at effective income tax rate$(8,213)32.8 $13,545 18.8 $18,807 23.4 
 2018 2017 2016
(In thousands, except percentages)Amount
%
 Amount
%
 Amount
%
Income tax expense (benefit) at federal statutory rate$7,638
21.0
 $(5,219)35.0
 $9,689
35.0
U.S. tax on foreign branch income1,901
5.2
 

 

Foreign rate differences1,805
5.0
 2,546
(17.1) 499
1.8
Non-deductible goodwill and asset impairment loss1,801
5.1
 228
(1.5) 13

Tax contingency accruals and tax settlements773
2.1
 (420)2.8
 104
0.4
Valuation allowance for capital loss carryforwards553
1.5
 83
(0.6) 267
1.0
State taxes, net of federal income tax benefit520
1.4
 656
(4.4) 647
2.3
Non-deductible expenses322
0.9
 434
(2.9) 396
1.4
Stock-based compensation175
0.5
 199
(1.3) 

Unremitted earnings from foreign operations126
0.3
 

 (256)(0.9)
Worthless stock deductions

 (61,413)411.9
 

Impact of U.S. Tax Cuts and Jobs Act

 (4,433)29.7
 

Settlement of Terphane acquisition escrow

 (4,200)28.2
 

Increase in value of kaléo investment held abroad

 (2,326)15.6
 (197)(0.7)
Domestic production activities deduction

 

 (735)(2.7)
Remitted earnings from foreign operations

 

 (6,574)(23.7)
Changes in estimates related to prior year tax provision(303)(0.8) 320
(2.1) 330
1.2
Research and development tax credit(420)(1.2) (375)2.5
 (550)(2.0)
Valuation allowance due to foreign losses and impairments(975)(2.7) 20,757
(139.3) (416)(1.5)
Foreign derived intangible income deduction(1,050)(2.9) 

 

Brazilian tax incentive(1,340)(3.7) 

 

    Income tax expense (benefit) at effective income tax rate$11,526
31.7
 $(53,163)356.5
 $3,217
11.6

Income taxes in 2020 were primarily impacted by the tax impact of Terphane Ltda. being included in Tredegar’s U.S. consolidated tax return as a foreign branch, the tax impact of the local statutory tax rates of Tredegar’s foreign subsidiaries being higher than the current US tax rate of 21%, the benefit of tax incentives in Brazil, and by claims for prior years’ U.S. research and development tax credits.
During 2019, due to favorable earnings trends, the Company released a $12.4 million valuation allowance on the net deferred tax assets of its Brazilian subsidiary Terphane Ltda. Because Terphane Ltda. is taxed as a foreign branch for U.S. tax purposes, Tredegar also recorded a related deferred tax liability of $12.4 million for the reduction in foreign tax credits that would result from continuing operationsTerphane Ltda. realizing this net deferred tax asset.
81


Income taxes in 2018 were primarily impacted by not recording a tax benefit on a portion of the PE Films Personal Care goodwill impairment charge, the additional tax impact of Tredegar’s Brazilian subsidiariesTerphane Ltda. being included in its USTredegar’s U.S. consolidated tax return as a foreign branchesbranch as well as the tax impact of the local statutory tax rates of Tredegar’s foreign subsidiaries being higher than the current USU.S. tax rate of 21%. These increases to income tax expense were offset by recording a tax benefit on a portion of foreign losses and impairments, by the tax benefit of the foreign derived intangible income deduction under the TCJA, and by the benefit of tax incentives in Brazil.

During 2017, the Company completed a plan to liquidate for tax purposes one of its domestic subsidiaries, which allowed it to claim an income tax benefit on the write-off of the stock basis of Terphane, Inc. (Terphane’s U.S. affiliate) on its 2017 U.S. federal income tax return. The Company recorded an income tax benefit during the second quarter of 2017 of $8.1 million related to this worthless stock deduction, net of valuation allowances and accrual for uncertain tax positions. Also, during the fourth quarter of 2017, as a result of valuation activities and other efforts, the Company claimed an ordinary loss for U.S. federal and state income tax purposes of $153 million for the write-off of the stock basis of Terphane Limitada (Terphane’s Brazilian entity). The full tax benefit accrued for the Terphane Limitada worthless stock deduction at the 35% U.S. corporate income tax rate applicable for 2017 was approximately $54 million. This benefit was reduced by $4.8 million in conjunction with the TCJA for the portion of the deduction that is expected to be applied to income generated after 2017 where the new U.S. federal corporate income tax rate of 21% is applicable. The significant foreign rate difference for 2017 is primarily due to the difference between Hungary’s income tax rate of 9% and the U.S. federal corporate income tax rate of 35%.
Tredegar accrues U.S. federal income taxes on unremitted earnings of all foreign subsidiaries where required. However, due to changes in the taxation of dividends under TCJA, Tredegar will only record U.S. federal income taxes on unremitted earnings of its foreign subsidiaries where Tredegar cannot take steps to eliminate any potential tax on future distributions from its foreign subsidiaries. Prior to the second quarter of 2016, deferred U.S. federal income taxes had not been recorded for the undistributed earnings for Terphane Limitada because the Company had intended to permanently reinvest these earnings. Due to concerns about the political and economic conditions in Brazil, Terphane Limitada began making cash distributions to the


Company in 2016. During the second quarter of 2016, Terphane Limitada paid a dividend of $10.7 million to the Company. During the second quarter of 2017, the Company recognized a net tax benefit of $0.4 million associated with additional U.S. tax related to this repatriation of cash from Brazil offset by the reversal of related tax contingencies. Because of the accumulation of significant losses related to foreign currency translations at Terphane Limitada,Ltda., there were no deferred income tax liabilities associated with the U.S. federal income taxes and foreign withholding taxes on Terphane Limitada’sLtda.’s undistributed earnings as of and December 31, 20182020 and 2017.
Income taxes in 2016 included the recognition of an additional valuation allowance of $0.3 million related to expected limitations on the utilization of assumed capital losses on certain investments. In 2016, the difference between the federal statutory rate and the effective tax rate is primarily driven by the $6.4 million tax benefit from excess foreign tax credits related to the repatriation of cash from Brazil discussed above.2019.
The Brazilian federal statutory income tax rate is a composite of 34.0% (25.0% of income tax and 9.0% of social contribution on income). Terphane’s manufacturing facility in Brazil is the beneficiary of certain income tax incentives that allow for a reduction in the statutory Brazilian federal income tax rate levied on the operating profit of its products. These incentives produce a current tax rate of 15.25% for Terphane (6.25% of income tax and 9.0% social contribution on income). The incentives have beenwere originally granted for a 10-year period which has a commencement date ofcommencing January 1, 2015 and will expireexpiring at the end of 2024. Terphane Brazil has been granted an additional three years of tax incentives through the end of 2027. The benefit from the tax incentives was $4.8 million, $2.0 million and $1.3 million in 2020, 2019 and 2018, and was immaterial for 2017 and 2016.respectively.
Deferred income tax liabilities and deferred income tax assets for continuing operations at December 31, 20182020 and 2017,2019, are as follows:
(In thousands)20202019
Deferred income tax liabilities:
Amortization of goodwill and identifiable intangibles$9,520 $12,080 
Depreciation10,844 7,395 
Foregone tax credits on foreign branch income5,714 12,361 
Excess of carrying value over tax basis of investment in kaléo4,905 17,504 
Derivative financial instruments659 
Right-of-use leased assets2,979 751 
Other285 488 
Total deferred income tax liabilities34,906 50,579 
Deferred income tax assets:
Pensions25,576 21,025 
Employee benefits9,757 7,963 
Excess capital losses7,462 1,551 
Inventory2,613 3,759 
Asset write-offs, divestitures and environmental accruals2,904 1,355 
Tax benefit on U.S. federal, state and foreign NOL and credit carryforwards18,305 17,992 
Timing adjustment for unrecognized tax benefits on uncertain tax positions, including portion relating to interest and penalties134 187 
Allowance for doubtful accounts141 383 
Lease liabilities3,144 967 
Derivative financial instruments 345 
Foreign currency translation gain adjustment1,423 255 
Deferred income tax assets before valuation allowance71,459 55,782 
Less: Valuation allowance17,485 3,787 
Total deferred income tax assets53,974 51,995 
Net deferred income tax (assets) liabilities$(19,068)$(1,416)
Amounts recognized in the consolidated balance sheets:
Deferred income tax assets (noncurrent)$19,068 $12,435 
Deferred income tax liabilities (noncurrent)0 11,019 
Net deferred income tax assets (liabilities)$19,068 $1,416 
82

(In thousands)2018 2017
Deferred income tax liabilities:   
Amortization of goodwill and identifiable intangibles$13,416
 $22,739
Foreign currency translation gain adjustment300
 433
Excess of carrying value over tax basis of investment in kaléo15,131
 8,602
Derivative financial instruments
 167
Other184
 
Total deferred income tax liabilities29,031
 31,941
Deferred income tax assets:   
Depreciation2,399
 4,917
Pensions17,153
 19,626
Employee benefits6,676
 6,842
Excess capital losses1,519
 4,695
Inventory3,644
 2,884
Asset write-offs, divestitures and environmental accruals1,200
 1,754
Tax benefit on U.S. federal, state and foreign NOL and credit carryforwards23,507
 33,384
Timing adjustment for unrecognized tax benefits on uncertain tax positions, including portion relating to interest and penalties267
 184
Allowance for doubtful accounts382
 406
Derivative financial instruments432
 
Other
 261
Deferred income tax assets before valuation allowance57,179
 74,953
Less: Valuation allowance24,736
 28,499
Total deferred income tax assets32,443
 46,454
Net deferred income tax (assets) liabilities$(3,412) $(14,513)
Amounts recognized in the consolidated balance sheets:   
Deferred income tax assets (noncurrent)$3,412
 $16,636
Deferred income tax liabilities (noncurrent)
 2,123
Net deferred income tax assets (liabilities)$3,412
 $14,513

Except as noted below, the Company believes that it is more likely than not that future taxable income will exceed future tax-deductible amounts thereby resulting in the realization of deferred income tax assets. The Company has estimated gross


federal, state and foreign tax credits and net operating loss carryforwards of $23.5$18.3 million and $33.4$18.0 million at December 31, 20182020 and 2017,2019, respectively. The U.S. federal foreign tax credits will expire in between 2026by 2027 and 2037. Thethe U.S. federal net operating loss carryforwards were fully utilized in 2018. The majority of the foreign net operating loss carryforwards do not expire.research and development tax credits will expire by 2040. The U.S. state carryforwards expire at different points over the next 9 to 20 years.
Valuation allowances of $7.7$5.5 million, $8.5$2.5 million and $1.5$6.6 million at December 31, 2018, 20172020, 2019 and 2016,2018, respectively, are recorded against the tax benefit on U.S. federal, state and foreign tax credits and net operating loss carryforwards generated by certain foreign and domestic subsidiaries that may not be recoverable in the carryforward period. The valuation allowance for excess capital losses from investments and other related items was $1.2$7.1 million, $4.4$1.3 million and $11.2$1.2 million at December 31, 2018, 20172020, 2019 and 2016,2018, respectively. The current year2020 balance increased primarily due to capital loss carryforwards created by the sale of Personal Care Films. The 2018 balance decreased primarily due to the expiration of a portion of theprior year capital loss carryforwards. The amount of the deferred income tax asset considered realizable, however, could be adjusted in the near term if estimates of the fair value of certain investments during the carryforward period change. Tredegar continues to evaluate opportunities to utilize capital loss carryforwards prior to their expiration at various dates in the future. As circumstances and events warrant, allowances will be reversed when it is more likely than not that future taxable income will exceed deductible amounts, thereby resulting in the realization of deferred income tax assets. A valuation allowance of $4.9 million was recorded in 2020 related to various deferred state tax assets. The valuation allowance for asset impairments in foreign jurisdictions where the Company believes it is more likely than not that the deferred income tax asset will not be realized was $15.8 millionzero at December 31, 2020 and $15.62019, and $15.8 million at December 31, 2018 and 2017, respectively (none2018. In 2019, the Company reversed a $12.4 million valuation allowance on the net deferred tax assets of its Brazilian subsidiary Terphane Ltda due to favorable earnings trends. Since Terphane Ltda. is taxed as a foreign branch for US tax purposes, Tredegar also recorded a related deferred tax liability of $12.4 million for the reduction in 2016).foreign tax credits that would result from Terphane Ltda. realizing this net deferred tax asset.
A reconciliation of the Company’s unrecognized uncertain tax positions since January 1, 2016,2018, is shown below:
  Years Ended December 31,
(In thousands) 2018 2017 2016
Balance at beginning of period$1,962
 $3,315
 $4,049
Increase (decrease) due to tax positions taken in:     
Current period13
 27
 1,151
Prior period1,430
 (532) 43
Increase (decrease) due to settlements with taxing authorities
 (51) (1,706)
Reductions due to lapse of statute of limitations(44) (797) (222)
Balance at end of period$3,361
 $1,962
 $3,315
 Years Ended December 31,
(In thousands)202020192018
Balance at beginning of period$881 $3,361 $1,962 
Increase (decrease) due to tax positions taken in:
Current period12 12 13 
Prior period0 49 1,430 
Increase (decrease) due to settlements with taxing authorities(265)(151)
Reductions due to lapse of statute of limitations0 (2,390)(44)
Balance at end of period$628 $881 $3,361 
Additional information related to unrecognized uncertain tax positions since January 1, 20162018 is summarized below:
 Years Ended December 31,
(In thousands)202020192018
Gross unrecognized tax benefits on uncertain tax positions (reflected in
current income tax, other noncurrent liability accounts, or deferred tax assets in the balance sheet)
$628 $881 $3,361 
Deferred income tax assets related to unrecognized tax benefits on uncertain tax positions (reflected in deferred income tax accounts in the balance sheet)(110)(163)(211)
Net unrecognized tax benefits on uncertain tax positions, which would impact the effective tax rate if recognized518 718 3,150 
Interest and penalties accrued on deductions taken relating to uncertain tax positions (approximately $2, $(144) and $107 reflected in income tax expense in the income statement in 2020, 2019 and 2018, respectively, with the balance shown in current income tax and other noncurrent liability accounts in the balance sheet)102 100 243 
Related deferred income tax assets recognized on interest and penalties(24)(23)(56)
Interest and penalties accrued on uncertain tax positions net of related deferred income tax benefits, which would impact the effective tax rate if recognized78 77 187 
Total net unrecognized tax benefits on uncertain tax positions reflected in the balance sheet, which would impact the effective tax rate if recognized$596 $795 $3,337 
83

  Years Ended December 31,
(In thousands) 2018 2017 2016
Gross unrecognized tax benefits on uncertain tax positions (reflected in
current income tax, other noncurrent liability accounts, or deferred tax assets in the balance sheet)
$3,361
 $1,962
 $3,315
Deferred income tax assets related to unrecognized tax benefits on uncertain tax positions (reflected in deferred income tax accounts in the balance sheet)(211) (153) (345)
Net unrecognized tax benefits on uncertain tax positions, which would impact the effective tax rate if recognized3,150
 1,809
 2,970
Interest and penalties accrued on deductions taken relating to uncertain tax positions (approximately $107, $(1) and $(262) reflected in income tax expense in the income statement in 2018, 2017 and 2016, respectively, with the balance shown in current income tax and other noncurrent liability accounts in the balance sheet)243
 136
 135
Related deferred income tax assets recognized on interest and penalties(56) (32) (49)
Interest and penalties accrued on uncertain tax positions net of related deferred income tax benefits, which would impact the effective tax rate if recognized187
 104
 86
Total net unrecognized tax benefits on uncertain tax positions reflected in the balance sheet, which would impact the effective tax rate if recognized$3,337
 $1,913
 $3,056



Tredegar, or one of its subsidiaries, files income tax returns in the U.S. federal jurisdiction, various states and jurisdictions outside the U.S. With few exceptions, Tredegar is no longer subject to U.S. federal, state or non-U.S. income tax examinations by tax authorities for years before 2014.2017. The Company anticipates that it is reasonably possible that Federal and state income tax audits or statutes may settle or close within the next 12 months, which could result in the recognition of up to approximately $3.2$0.5 million of the balance of unrecognized tax positions, including any payments that may be made.

17LOSSES ASSOCIATED WITH PLANT SHUTDOWNS, ASSET IMPAIRMENTS AND RESTRUCTURINGS, UNUSUAL ITEMS, GAINS FROM SALE OF ASSETS AND OTHER ITEMS
Losses associated with plant shutdowns, asset impairments, restructurings and other charges in 2018 (as shown in the segment operating profit table in Note 5) totaled $6.5 million ($5.9 million after taxes), and unless otherwise noted below, are also included in “Asset impairments and costs associated with exit and disposal activities” in the consolidated statements of income. Results in 2018 included:17    ASSET IMPAIRMENTS AND COSTS ASSOCIATED WITH EXIT AND DISPOSAL ACTIVITIES
Quarterly charges associatedIn connection with the shutdown of PE Films’ manufacturing facilityanticipated customer product transitions in Shanghai, China, which includes categories of expenses shown inSurface Protection, the table below (Accelerated depreciation and a portion of Other facility consolidation-related costs and Severance & employee related expenses, as noted in the table below, are included in “Cost of goods sold” in the consolidated statements of income):
 1st Quarter2nd Quarter3rd Quarter4th Quarter2018
($ in millions)BTATBTATBTATBTATBTAT
Severance & employee related expenses

0.4
0.4
1.3
1.3
0.5
0.5
2.2
2.2
Accelerated depreciation

0.1
0.1
0.4
0.4
0.1
0.1
0.6
0.6
Other facility consolidation-related costs

0.1
0.1
0.1
0.1
0.3
0.3
0.5
0.5
   Total

0.6
0.6
1.8
1.8
0.9
0.9
3.3
3.3
           
Amount included in “Cost of goods sold” in the consolidated statements of income

0.2
0.2
0.7
0.7
0.3
0.3
1.2
1.2
Note: BT = before taxes; AT = after taxes
Quarterly charges related to estimated excess costs associated with the ramp-up of new product offerings and additional expenses related to strategic capacity expansion projects by PE Films of $1.0 million ($0.9 million after taxes), $0.6 million ($0.5 million after taxes), $0.2 million ($0.1 million after taxes) and $0.3 million ($0.2 million after taxes) for the first, second, third and fourth quarter, respectively (included in “Cost of goods sold” in the consolidated statements of income);
Quarterly charges for professional fees associated with the Terphane Limitada worthless stock deduction, the impairment of assets of Flexible Packaging Films, determining the effect of the new U.S. federal income tax law, and a market study for PE Films of $0.3 million ($0.2 million after taxes), $0.4 million ($0.3 million after taxes) and $0.1 million ($0.1 million after taxes) for the first, third and fourth quarter, respectively (included in “Selling, general and administrative expenses” in the consolidated statements of income);
Quarterly charges forCompany recognized severance and other employee-related costs associated with restructurings in PE Filmsexpenses of $0.1$1.6 million ($0.1 million after taxes), $0.3 million ($0.2 million after taxes) and $0.3 million ($0.3 million after taxes) for the first, third and fourth quarter, respectively, and in Aluminum Extrusions of $0.1 million ($0.1 million after taxes) in the first quarter;
A fourth quarter charge of $0.5 million ($0.4 million after taxes) associated with business development projects (included in “Selling, general and administrative expense” in the consolidated statements of income and “Corporate expenses, net” in the statement of net sales and operating profit by segment);
A fourth quarter charge of $0.5 million ($0.4 million after taxes) for professional fees associated with the implementation of new accounting guidance and analysis and revisions to the Company’s internal control over financial reporting (included in “Selling, general and administrative expenses” in the consolidated statements of income);


A fourth quarter benefit of $0.3 million ($0.2 million after taxes) (included in “Other income (expense), net” in the consolidated statements of income) from the reversal of a PE Films’ contingent liability related to the acquisition of Bright View Technologies;
A fourth quarter charge of $0.1 million ($0.1 million after taxes) and a third quarter charge of $0.2 million ($0.1 million after taxes) related to expected future environmental costs at the aluminum extrusions manufacturing facility in Carthage, Tennessee (included in “Cost of goods sold” in the consolidated statements of income);
A third quarter charge of $0.1 million ($0.1 million after taxes) related to wind damage that occurred in the third quarter of 2018 at the aluminum extrusions manufacturing facility in Elkhart, Indiana (included in “Selling, general and administrative expenses” in the consolidated statements of income); and
A fourth quarter charge of $0.1 million ($0.1 million after taxes) related to a fire that occurred in the fourth quarter of 2018 at the PE Films facility in Rétság, Hungary (included in “Selling, general and administrative expenses” in the condensed consolidated statements of income).
Results in 2018 include a net unrealized gain on the Company’s investment in kaléo (included in “Other income (expense), net” in the consolidated statements of income) of $30.6 million ($23.9 million after taxes). Losses on the Company’s investment in the Harbinger Fund of $0.2 million ($0.1 million after taxes), $0.1 million ($0.1 million after taxes) and $0.2 million ($0.2 million after taxes) were recognized in the second, third and fourth quarters of 2018, respectively (included in “Other income (expense), net” in the consolidated statements of income). See Note 4 for additional information on investments.
In the third quarter of 2018, the Company recorded a goodwill impairment charge of $46.8 million ($38.2 million after taxes) for goodwill associated with the acquisition of certain components of PE Films. See Note 8 for additional details.
2020. The Company recordedrecognizes termination benefits that are covered by a contract or an unrealized loss on its investment property in Alleghany and Bath Counties, Virginia (included in “Other income (expense), net” in the consolidated statements of income) of $0.2 million ($0.2 million after taxes) in the third quarter of 2018. This loss was recognizedongoing benefit arrangement when the property was sold in the fourth quarter of 2018.
In June 2018, the Company announced plansit is probable that employees will be entitled to close its facility in Shanghai, China, which primarily produces plastic films used as components for personal care products (“Shanghai transition”).  Production ceased at this plant during the fourth quarter of 2018.  The Company expects to recognize costs associated with exit and disposal activities of $5.0 million, down from an initial amount of $7.1 million, comprised of: (i) retention, severance and related costs ($2.9 million), (ii) customer-related costs ($0.5 million), and (iii) legal, asset disposal and other cash costs ($1.6 million).  In addition, the Company expects non-cash asset write-offs and accelerated depreciation of $0.6 million, down from an initial amount of $0.9 million.  Net annual cash savings from consolidating operations of $1.7 million is expected.  Proceeds from expected property disposals are uncertain. The Company anticipates that these activities, including property disposals, will require 12-18 months to execute,benefits and the costs are expectedamount can be reasonably estimated. Other accrued expenses and losses related to be incurred during this period.
Total expenses associated with the Shanghai transition were $3.3 million ($3.3 million after taxes) in 2018, ($2.1 million included in “Assetasset impairments and costs associated with exit and disposal activities net of adjustments” and $1.2 million included in “Cost of goods sold” in the consolidated statements of income). Cash expenditures were $2.5 million in 2018.
Losses associated with plant shutdowns, asset impairments, restructurings and other charges for continuing operations in 2017 (as shown in the segment operating profit table in Note 5) totaled $94.0 million ($79.2 million after taxes), and unless otherwise noted below, are also included in “Asset impairments and costs associated with exit and disposal activities” in the consolidated statements of income. Results in 2017 included:
A fourth quarter charge of $101.3 million ($87.2 million after taxes) related to the impairment of assets at Flexible Packaging Films. During the fourth quarter of 2017, in conjunction with annual business planning as well as valuation activities and other efforts, the Company determined that the carrying value of Terphane’s remaining long-lived assets were impaired (Terphane’s goodwill was written off in 2015).  Accordingly, the Company wrote down these assets based on an enterprise valuation for all of Terphane of approximately $30 million;
Second quarter income of $11.9 million ($11.9 million after taxes) related to the settlement of an escrow arrangement established upon the acquisition of Terphane Holdings, LLC in 2011 (included in “Other income (expense), net” in the consolidated statements of income). In settling the escrow arrangement, the Company assumed the risk of the claims (and associated legal fees) against which the escrow previously secured the Company.  While the ultimate amount of such claims is unknown, the Company believes that it is reasonably possible that it could be liable for some portion of these claims, and currently estimates the amount of such future claims at approximately $3.5 million;


First quarter charges of $3.3 million ($2.0 million after taxes) related to the acquisition of Futura, i) associated with accounting adjustments of $1.7 million made to the value of inventory sold by Aluminum Extrusions after its acquisition of Futura (included in “Cost of goods sold” in the consolidated statements of income), ii) acquisition costs of $1.5 million and, iii) integration costs of $0.1 million (included in “Selling, general and administrative expenses” in the consolidated statements of income), offset in the second quarter by pretax income of $0.7 million ($0.5 million after taxes) related to the fair valuation of an earnout provision (included in “Other income (expense), net” in the consolidated statements of income);
Quarterly charges related to estimated excess costs associated with the ramp-up of new product offerings and additional expenses related to strategic capacity expansion projects by PE Films of $1.4 million ($1.3 million after taxes), $0.9 million ($0.8 million after taxes), $0.6 million ($0.5 million after taxes) and $0.6 million ($0.6 million after taxes)not material for the first, second, third and fourth quarter, respectively, and by Aluminum Extrusions of $0.3 million ($0.2 million after taxes), $0.1 million (less than $0.1 million after taxes) and $0.1 million (less than $0.1 million after taxes) for the first, second, and third quarters, respectively (included in “Cost of goods sold” in the consolidated statements of income);
A third quarter charge of $0.2 million ($0.1 million after taxes) associated with the consolidation of domestic PE Films’ manufacturing facilities for other facility consolidation-related expenses, a second quarter charge of $0.3 million ($0.2 million after taxes), which includes accelerated depreciation of $0.1 million (included in “Cost of goods sold” in the consolidated statements of income) and other facility consolidation-related expenses of $0.2 million ($0.1 million is included in “Cost of goods sold” in the consolidated statements of income), offset by a reversal of severance and other employee-related costs of $0.3 million ($0.2 million after taxes) and a first quarter charge of $0.7 million ($0.4 million after taxes), which includes severance and other employee-related costs of $0.2 million, asset impairments of $0.1 million, accelerated depreciation of $0.1 million (included in “Cost of goods sold” in the consolidated statements of income) and other facility consolidation-related expenses of $0.3 million ($0.2 million is included in “Cost of goods sold” in the consolidated statements of income);
Fourth quarter net gain of $5.1 million ($3.2 million after taxes), related to the explosion that occurred in the second quarter of 2016 at the aluminum extrusions manufacturing facility in Newnan, Georgia, which includes the recognition of a gain on the involuntary conversion of an asset of $5.3 million for insurance proceeds used for the replacement of capital equipment (included in “Other income (expense), net” in the consolidated statements of income), partially offset by excess production costs of $0.2 million ($0.1 million after taxes) (included in “Cost of goods sold” in the consolidated statements of income); a second quarter net gain on the expected recovery of excess production costs of $0.9 million ($0.6 million after taxes) incurred in prior periods for which recovery from insurance carriers was not previously considered to be reasonably assured (included in “Cost of goods sold” in the consolidated statements of income); and a first quarter net loss of $0.4 million ($0.2 million after taxes), which includes $0.3 million for other costs for which recovery from insurance carriers was not considered to be reasonably assured (reversed in the second quarter) and legal and consulting fees of $0.1 million (included in “Selling, general and administrative expenses” in the consolidated statements of income);
A fourth quarter charge of $1.5 million ($1.0 million after taxes) and a first quarter charge of $0.4 million ($0.2 million after taxes) related to expected future environmental costs at the aluminum extrusions manufacturing facilities in Carthage, Tennessee and Newnan, Georgia (included in “Cost of goods sold” in the consolidated statements of income);
A fourth quarter charge of $0.8 million ($0.5 million after taxes) at Corporate related to expected future environmental costs at various shutdown facilities (included in “Cost of goods sold” in the consolidated statements of income);
A fourth quarter charge of $1.3 million ($0.8 million after taxes), a third quarter charge of $0.2 million ($0.1 million after taxes), a second quarter charge of $0.6 million ($0.4 million after taxes), and a first quarter charge of $0.3 million ($0.2 million after taxes), associated with business development projects (included in “Selling, general and administrative expense” in the consolidated statements of income and “Corporate expenses, net” in the statement of net sales and operating profit by segment);
A fourth quarter charge of $0.1 million (less than $0.1 million after taxes) and a third quarter charge of $0.1 million (less than $0.1 million after taxes) for severance and other employee-related costs associated with restructurings in PE Films, and a fourth quarter charge of $0.1 million ($0.1 million after taxes) for severance and other employee-related costs associated with restructurings in Aluminum Extrusions and a fourth quarter charge of $0.1 million ($0.1 million after taxes) and a first quarter charge of $0.3 million ($0.2 million after taxes) for severance and other employee-related costs associated with restructurings in Corporate (included in “Corporate expenses, net” in the statement of net sales and operating profit by segment);


Fourth quarter charges of $0.4 million ($0.2 million after taxes) for professional fees associated with the Terphane Limitada worthless stock deduction and impairment of assets of Flexible Packaging Films;
A fourth quarter charge of $0.3 million ($0.3 million after taxes) associated with asset impairments at PE Films’ Hungary facility; and
A third quarter charge of $0.2 million ($0.1 million after taxes) associated with the settlement of customer claims and other costs related to the previously shutdown aluminum extrusions manufacturing facility in Kentland, Indiana.
Results in 2017 include a net unrealized gain on the Company’s investment in kaléo (included in “Other income (expense), net” in the consolidated statements of income) of $33.8 million ($24.0 million after taxes). See Note 4 for additional information on investments.
Total expenses associated with the North American facility consolidation project were $0.8 million ($0.5 million after taxes) in 2017 (included in “Cost of goods sold” in the consolidated statements of income) and the total expenses for the project since inception were $7.3 million. Cash expenditures for the restructuring were $1.9 million in 2017, which included capital expenditures of $0.1 million. Total cash expenditures since project inception were $16.0 million throughyears ended December 31, 2017, which includes $11.2 million for capital expenditures. Additional cash payments for remaining accrued costs of $0.4 million were paid in 2018.    2020, 2019 and 2018, respectively.
Losses associated with plant shutdowns, asset impairments, restructurings and other charges for continuing operations in 2016 (as shown in the segment operating profit table in Note 5) totaled $6.1 million ($3.9 million after taxes), and unless otherwise noted below, are also included in “Asset impairments and costs associated with exit and disposal activities” in the consolidated statements of income. Results in 2016 included:
Fourth quarter net loss $0.7 million ($0.4 million after taxes), related to the explosion that occurred in the second quarter of 2016 at the aluminum extrusions manufacturing facility in Newnan, Georgia, which consists of excess production costs for which recovery from insurance is not assured of $0.6 million ($0.4 million after taxes) (included in “Cost of goods sold” in the consolidated statements of income) and legal and consulting fees of $0.1 million ($0.1 million after taxes) (included in “Selling, general and administrative expenses” in the consolidated statements of income), third quarter net income of $1.7 million ($1.1 million after taxes), which includes the recognition of a gain of $1.9 million ($1.2 million after taxes) for a portion of the insurance recoveries approved by the insurer to begin the replacement of capital equipment, offset by the impairment of equipment damaged by the explosion of $0.3 million ($0.2 million after taxes) (net amount included in “Other income (expense), net” in the consolidated statements of income), and the reversal of an accrual for other costs related to the explosion not recoverable from insurance of $0.1 million ($0.0 million after taxes) (included in “Selling, general and administrative expenses” in the consolidated statements of income), and second quarter net loss of $0.6 million ($0.4 million after taxes) for other costs related to the explosion not recoverable from insurance (included in “Selling, general and administrative expenses” in the consolidated statements of income);18    CONTINGENCIES
Quarterly charges associated with the consolidation of domestic PE Films’ manufacturing facilities, which includes categories of expenses shown in the table below (Accelerated depreciation and a portion of Other facility consolidation-related costs as noted in the table below are included in “Cost of goods sold” in the consolidated statements of income):
 1st Quarter2nd Quarter3rd Quarter4th Quarter2016
($ in millions)BTATBTATBTATBTATBTAT
Severance0.3
0.2
0.4
0.2
0.3
0.2
0.3
0.2
1.2
0.8
Asset impairments0.3
0.2
0.1
0.1
0.1



0.4
0.3
Accelerated depreciation0.1
0.1
0.1
0.1
0.1
0.1
0.3
0.2
0.6
0.4
Other facility consolidation-related costs0.5
0.3
0.8
0.5
0.6
0.4
0.2
0.1
2.0
1.3
   Total1.1
0.7
1.3
0.9
1.1
0.7
0.8
0.5
4.3
2.8
           
Other facility consolidation-related costs included in “Cost of goods sold” in the consolidated statements of income0.4
0.2
0.7
0.4
0.4
0.2
0.2
0.1
1.6
1.0
Note: BT = before taxes; AT = after taxes


A fourth quarter charge of $0.6 million ($0.4 million after taxes) associated with the acquisition of Futura by Bonnell Aluminum (included in “Selling, general and administrative expenses” in the consolidated statements of income);
A fourth quarter charge of $0.5 million ($0.3 million after taxes) related to expected future environmental costs at the aluminum extrusions manufacturing facility in Newnan, Georgia (included in “Cost of goods sold” in the consolidated statements of income);
A first quarter charge of $0.4 million ($0.2 million after taxes) associated with a non-recurring business development project (included in “Selling, general and administrative expense” in the consolidated statements of income and “Corporate expenses, net” in the statement of net sales and operating profit by segment);
A third quarter charge of $0.3 million ($0.2 million after taxes) for severance and other employee-related costs associated with restructurings in PE Films ($0.1 million) ($0.1 million after taxes) and Corporate ($0.2 million) ($0.1 million after taxes) (included in “Corporate expenses, net” in the statement of net sales and operating profit by segment);
A fourth quarter charge of $0.3 million ($0.2 million after taxes) related to contingencies associated with the application of prior period Brazilian value-added tax credits in Flexible Packaging Films (included in “Cost of goods sold” in the consolidated statements of income);
A fourth quarter charge of $0.2 million ($0.1 million after taxes) associated with asset impairments in PE Films;
A fourth quarter gain of $0.1 million ($0.0 million after taxes) related to contractual indemnifications associated with the anticipated settlement of a Terphane pre-acquisition contingency (included in “Other income (expense), net” in the consolidated statements of income); and
A fourth quarter gain of $0.1 million ($0.1 million after taxes) associated with the shutdown of the aluminum extrusions manufacturing facility in Kentland, Indiana, which includes a pretax gain of $0.2 million ($0.1 million after taxes) related to the sale of the property, partially offset by pretax charges of $0.1 million ($0.0 million after taxes) associated with the shutdown of this facility and a third quarter charge of $0.3 million ($0.2 million after taxes) associated with shutdown costs.
Results in 2016 include a net unrealized gain on the Company’s investment in kaléo (included in “Other income (expense), net” in the consolidated statements of income) of $1.6 million ($1.2 million after taxes). The Company recorded an unrealized loss on its investment property in Alleghany and Bath Counties, Virginia (included in “Other income (expense), net” in the consolidated statements of income) of $1.0 million ($0.7 million after taxes) in the fourth quarter of 2016. See Note 4 for additional information on investments.    
18CONTINGENCIES
Tredegar is involved in various stages of investigation and remediation relating to environmental matters at certain current and former plant locations. Where the Company has determined the nature and scope of any required environmental remediation activity, estimates of cleanup costs have been obtained and accrued. As efforts continue to maintain compliance with applicable environmental laws and regulations, additional contingencies may be identified. If additional contingencies are identified in the future, the Company’s practice is to determine at that time the nature and scope of those contingencies, obtain and accrue estimates of the cost of remediation, and perform remediation. TheWhile the Company does not believebelieves it is currently adequately accrued for known environmental issues, it is possible that additionalunexpected future costs that could arise from those activities will have a material adverse effect on its financial position. However, those costsfor known or unknown environmental issues could have a material adverse effect on its financial condition, results of operations and cash flows at that time.
The Company is involved in various other legal actions arising in the normal course of business. After taking into consideration the relevant information, the Company believes that it has sufficiently accrued for probable losses and that the actions will not have a material adverse effect on its financial position. However, the resolution of the actions in a future period could have a material adverse effect on quarterly or annual operating results at that time.
From time to time, the Company enters into transactions with third parties in connection with the sale of assets or businesses in which it agrees to indemnify the buyers or third parties involved in the transaction, or in which the sellers or third parties involved in the transaction agree to indemnify Tredegar, for certain liabilities or risks related to the assets or business. Also, in the ordinary course of its business, the Company may enter into agreements with third parties for the sale of goods or services that may contain indemnification provisions. In the event that an indemnification claim is asserted, liability for indemnification would be subject to an assessment of the underlying facts and circumstances under the terms of the applicable agreement. Further, any indemnification payments may be limited or barred by a monetary cap, a time limitation, or a deductible or basket. For these reasons, Tredegar is unable to estimate the maximum amount of the potential future liability under the indemnity provisions of these agreements. The Company does, however, accrue for losses for any known contingent


liability, including those that may arise from indemnification provisions, when future payment is probable and the amount is reasonably estimable. The Company discloses contingent liabilities if the probability of loss is reasonably possible and material.
In 2011, Tredegar was notified by U.S. Customs and Border Protection (“U.S. Customs”) that certain film products exported by Terphane Ltda. to the U.S. since November 6, 2008 could be subject to duties associated with an anti-dumping duty order on imported PET films from Brazil.  The Company contested the applicability of these anti-dumping duties to the films exported by Terphane Ltda., and it filed a request with the U.S. Department of Commerce (“Commerce”) for clarification about whether the film products at issue are within the scope of the anti-dumping duty order.  In December 2014, the U.S. International Trade Commission separately voted to revoke the anti-dumping duty order on imported PET films from Brazil. On February 20, 2015, certain U.S. producers of PET films filed a summons with the U.S. Court of International Trade to appeal the determination by the U.S. International Trade Commission. After lengthy litigation, on June
84


19    2018, the U.S. Court of International Trade ruled in favor of Terphane Ltda. by upholding the determination by Commerce that Terphane Ltda.’s films are outside the scope of the anti-dumping duty order.  The plaintiffs chose not to appeal the U.S. Court of International Trade’s opinion affirming Commerce’s scope ruling.  On September 4, 2018, the plaintiffs filed to dismiss their appeal of the December 2014 decision that revoked the anti-dumping duty order on PET films from Brazil.  The U.S. Court of International Trade issued an Order of Dismissal on September 5, 2018.  The litigation has now ended.SELECTED QUARTERLY FINANCIAL DATA


19SELECTED QUARTERLY FINANCIAL DATA
Tredegar Corporation and Subsidiaries
(In Thousands, Except Per-Share Amounts)
(Unaudited)
First
Quarter
Second
Quarter
Third
Quarter
Fourth
Quarter
For the year ended December 31, 2020
Sales$192,136 $186,260 $184,370 $192,524 
Gross profit40,092 46,331 41,909 42,305 
Income (loss) from continuing operations, net of tax(20,663)14,332 (16,976)6,475 
Income (loss) from discontinued operations, net of tax(1,658)(3,136)(48,237)(5,580)
Net income (loss)$(22,321)$11,196 $(65,213)$895 
Earnings (loss) per share:
Basic:
Continuing operations$(0.62)$0.43 $(0.51)$0.19 
Discontinued operations(0.05)(0.10)(1.44)(0.17)
Basic$(0.67)$0.33 $(1.95)$0.02 
Diluted:
Continuing operations$(0.62)$0.43 $(0.51)$0.19 
Discontinued operations(0.05)(0.10)(1.44)(0.17)
Diluted$(0.67)$0.33 $(1.95)$0.02 
For the year ended December 31, 2019
Sales$207,948 $214,095 $205,968 $198,313 
Gross profit34,986 44,375 38,892 37,951 
Income (loss) from continuing operations, net of tax22,548 19,871 15,052 990 
Income (loss) from discontinued operations, net of tax(2,763)(5,394)2,081 (4,126)
Net income$19,785 $14,477 $17,133 $(3,136)
Earnings per share:
Basic:
Continuing operations$0.68 $0.60 $0.45 $0.03 
Discontinued operations(0.08)(0.16)0.06 (0.12)
Basic$0.60 $0.44 $0.51 $(0.09)
Diluted:
Continuing operations$0.68 $0.60 $0.45 $0.03 
Discontinued operations(0.08)(0.16)0.06 (0.12)
Diluted$0.60 $0.44 $0.51 $(0.09)
 
First
Quarter
 
Second
Quarter
 
Third
Quarter
 
Fourth
Quarter
For the year ended December 31, 2018       
Sales$258,711
 $263,759
 $267,294
 $275,707
Gross profit46,732
 44,652
 40,478
 47,826
Net income (loss)$18,165
 $14,722
 $(34,201) $26,157
Earnings (loss) per share:       
Basic$0.55
 $0.45
 $(1.03) $0.79
Diluted$0.55
 $0.44
 $(1.03) $0.79
Shares used to compute earnings (loss) per share:       
Basic32,982
 33,074
 33,110
 33,103
Diluted32,988
 33,108
 33,110
 33,112
For the year ended December 31, 2017       
Sales$221,026
 $247,347
 $247,121
 $245,836
Gross profit32,959
 44,149
 43,992
 38,998
Net income$3,703
 $44,204
 $8,274
 $(17,929)
Earnings per share:       
Basic$0.11
 $1.34
 $0.25
 $(0.54)
Diluted$0.11
 $1.34
 $0.25
 $(0.54)
Shares used to compute earnings per share:       
Basic32,920
 32,961
 32,954
 32,948
Diluted32,957
 33,051
 32,954
 32,949

The 2017 Gross profitDue to rounding, the sum of quarterly amounts have changed from the amounts disclosedpresented in the prior year duetable above may not add up precisely to the retrospective adoption of ASU 2017-07, which resulted in the separate presentation of “Pension and postretirement benefits” expense in the consolidated statements of income. Historically the Company had reported a portion of its pension and postretirement benefit expenses in cost of goods sold, a component used in the calculation of Gross profit.corresponding full year amounts.

Item 16. FORM 10-K SUMMARY
Not Applicable.




85


EXHIBIT INDEX
 

2.1
2.2
2.3
2.2
3.1
3.1.1
3.1.2
3.1.3
3.2
4.1
4.110.1

4.1.110.1.1

4.1.210.1.2

10.1.3
10.110.2
*10.210.3


10.310.4
10.410.5
*10.510.6
86


*10.5.110.6.1
*10.610.7
*10.6.110.7.1
*10.710.8
*10.810.9
*10.910.10
*10.1010.11
10.11*10.12
*10.1210.13
*10.12.110.14
*10.1310.15
*10.14
*10.1510.16
*10.17
+21
+23.123
+23.231.1
+31.1


+31.2
+32.1
+32.2
+101
+101XBRL Instance Document and Related Items
+104Cover Page Interactive Data File (formatted in iXBRL and contained in Exhibit 101)
*Denotes compensatory plans or arrangements or management contracts.
+Filed herewith
87



SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
TREDEGAR CORPORATION
(Registrant)
Dated:March 16, 2021
TREDEGAR CORPORATION
(Registrant)
By
Dated:March 18, 2019By/s/ John D. GottwaldM. Steitz
John D. GottwaldM. Steitz
President and Chief Executive Officer


Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities indicated on March 18, 2019.
16, 2021.
SignatureTitle
/s/John M. SteitzPresident, Chief Executive Officer and Director
(John M. Steitz)(Principal Executive Officer)
/s/D. Andrew EdwardsExecutive Vice President and Chief Financial Officer
(D. Andrew Edwards)(Principal Financial Officer)
/s/Frasier W. Brickhouse, IICorporate Treasurer and Controller
(Frasier W. Brickhouse, II)(Principal Accounting Officer)
/s/John D. GottwaldChairman of the Board of Directors
(John D. Gottwald)
/s/Gregory A. PrattLead Director
Signature(Gregory A. Pratt)Title
/s/John D. Gottwald    President, Chief Executive Officer and Director
(John D. Gottwald)(Principal Executive Officer)
/s/D. Andrew EdwardsVice President and Chief Financial Officer
(D. Andrew Edwards)(Principal Financial Officer)
/s/Frasier W. Brickhouse, IICorporate Treasurer and Controller
(Frasier W. Brickhouse, II)(Principal Accounting Officer)
/s/William M. GottwaldChairman of the Board of Directors
(William M. Gottwald)
/s/George C. Freeman, IIIDirector
(George C. Freeman, III)
/s/William M. GottwaldDirector
(William M. Gottwald)
/s/Kenneth R. NewsomeDirector
(Kenneth R. Newsome)
/s/Gregory A. PrattDirector
(Gregory A. Pratt)
/s/Thomas G. Snead, Jr.Director
(Thomas G. Snead, Jr.)
/s/John M. SteitzDirector
(John M. Steitz)
/s/Carl E. Tack, IIIDirector
(Carl E. Tack, III)
/s/Anne G. WaleskiDirector
(Anne G. Waleski)


102
88